home0007 - COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci (5)

COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci (5)

FULL PDF : [HG00D0][GDrive]

Part 1 / Part 2 / Part 3 / Part 4 / Part 5 / Part 6 / Part 7 / Part 8

dfdfdshave killed many people in the community where it originated, but thenstopped spreading. According to a comprehensive analysis carried outby the Times, at least four hundred and thirty thousand people havearrived in the U.S. on direct flights from China since the outbreak began.Forty thousand have arrived in the two months since Trump imposedrestrictions on travellers from China trying to enter the country.Fauci insists that an adequate defense against future pandemics will haveto be flexible . "I have been saying for eight , ten years that we shouldmake a list of microbes and try to develop a basic platform vaccine," hetold me in 2016. A platform vaccine addresses an entire class of virus,not just a particular strain. "We keep trying to develop a vaccine for onething-usually the last one-and it's a waste of time ," he said. "Everytime we get hit , it is always something we didn 't expect. So, instead ofpredetermining what it is you're going to prepare for, make universalplatforms. "Such an approach is eminently possible. Using gene-sequenceinformation and synthetic DNA , biologists are now capable of makingparts of a vaccine in advance . It takes almost no time to sequence a viralstrain , and with that information it should be poss ible to complete abespoke vaccine in a matter of weeks. "You could build a chassis for thevaccine, and you would have it on the shelf," Fauci said. "Then all youwould need to do is insert the gene of the protein you want to expressand make a gazillion doses and send it out."There are even more futuristic aspirations: the genomics pioneer J. CraigVenter has proposed using a sort of 3-D printer to manufacture vaccineson demand. It is already possible to print the nucleotides that make upDNA and asse1nble them. Venter argues that , in the time it takes for aninfected person to fly from one side of the world to the other, we shouldbe able to print, assemble, and administer a vaccine.To even contemplate creating these kinds of treatments, Fauci says,would require building an entirely new system for making vaccinesbefore a pandemic arises. But, in addition to the scientific obstacles , thiswould cost billions of dollars , and no company or politician has beenwilling to spend the money. Perhaps , just as AIDS transformed ourapproach to clinical trials, our experience with co vro-19 will change ourattitudes about preventing infectious diseases. A proper investment inboth research and emergency preparedness would have prevented atleast some of the unspeakable human loss we are now experiencing andthe economic crash that has just begun.The COVID-19 epidemic will eventually fade, but the public will demanda reckoning. Inevitably, there will be an investigation , along the lines ofthe 9/11 Commission , to look into the ramifications of the President'sdenialism, the shortages in testing and medical equipment, and thedismissal of so many warning signs. Fauci will not necessarily escapecriticism. He is an excellent spokesman for the value of scientificresearch, but he runs a single institute, and he lacks the authority tobroadly reshape our response to pandemics. "The kinds of things wereally desperately need as foundational tools for dealing with this stuffaren 't necessarily research enterprises," Harold Varmus told me. "Tonyisn't running C.D.C. He's not running FEMA. To tell him to stockpiledefense mechanisms or to move forward surveillance tools into massiveoperations around the world- that 's just not his remit."Even Fauci' s current value as a scientific adviser has been limited by thePresident's conte1npt for expertise. Trump 's coronavirus kitchen cabinetconsists of people like his son-in-law, Jared Kushner, who has nomedical knowledge or experience managing crises-yet has beenappointed to direct the response to the biggest medical emergency sincethe influenza pandemic of 1918. Trump has also turned for advice to Dr.Mehmet Oz, who for years has endorsed worthless treatments and usedhis television show to promote notorious quacks. Trump even seems tothink that his trade adviser, Peter Navarro, should debate Fauci about thevalue of specific drugs. When Navarro , who has a doctoral degree ineconomics, was asked about his medical qualifications , he said, "I havea Ph.D. And I understand how to read statistical studies, whether it's inmedicine, the law, economics , or whatever."Among Navarro 's enthusiasms is the malaria drug hydroxychloroquine ,which he believes could cure COVID-19. There is currently no evidenceto support this conclusion , as Fauci has pointed out on several occasions.On April 5th, as Trump continued to tout the drug as a miracle cure, areporter at the daily briefing asked Fauci to com1nent. Trump refused toallow him to speak. In an appearance two days later, Trump kept up thehype. "I say try it," he said. "You're not gonna die from this pill." Notlong afterward , he even suggested that zinc might help.To plan a coherent biological future , rather than simply scramble tocontain each new pandemic , will require an entirely new kind ofpolitical commitment. It would certainly include the creation of apermanent position , a special assistant to the President for biologicaldefense. Similar job s have existed in the past, but not for long, and notwith enough influence to matter. David Reiman , the Stanford professor ,told me, "This kind of job needs somebody with the authority to presideover domestic and international threats, both natural and deliberate. Andthat person has to sit in the White House with immediate access to thePresident. Without that, we will really have nothing that can work."Until then, we have Fauci, a seventy-nine-year-old infectious-diseaseexpert pinned between Donald Tru1np and the American people. It can 'tbe easy. As Fauci recently put it, with characteristic candor, "I give theappearance of being optimistic. But, deep down, I just do everything Ipossibly can, assuming that the worst will happen , and I've got to stopthe worst from happening." ♦Published in the print edition of the April 20, 2020 , issue, with theheadline "The Good Doctor ."Disclaimer: Any third-party material in this email has been shared for internal use under fair use provisionsof U.S. copyright law, without further verification of its accuracy/veracity. It does not necessar ily representmy views nor those of NIAID, NIH, HHS, or the U.S. government.From:Sent :To:Cc:Fauci, Anthony (NIH/NIAID) [E)Sat, 11 Apr 2020 16:30 :40 +0000Del Rio, Carlos;(b) (6)·(b)(6)Subject: RE: Infectious Diseases Society of America Guidelines on the Treatment andManagement of Patients with COVID-19 InfectionThanks, Carlos . As you know since Cliff has been in touch with the lDSA , the HHS guidelines will be coming outthis week.Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and lofectious DiseasesBuilding 3 I, Room 7 A-0331 Center Driv e, MSC 2520National Jnslirutes of HealthBethesda, MD 20892 -2520Phone: (b)(6)FAX: (301) 496-4409E-ma il: (b) (6)The infom1ation in this e-mail and any of its attachments is confidential and may contain sensi tive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. lfyou have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National lnstirute ofAllergy and Infectio us Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From : Del Rio, Carlos ______ ("b")'"("="Sent: Saturday , April J 1, 2020 12:08 PMTo: (b)(6) ; Fauci , Anthony (NTHINIAID) [E] (b)(6)Subject: Jnfectious Diseases Society of America Guidelines on the Treatment and Management of Patients withCOVID-19 InfectionIDSA guide lines are outhttps://www.idsociety.org /prac ti ce-gu idel ine/ covid- 19-guidel ine-trea tment-and-manag ement/Carlos de! Rio, MD.Sent from my iPhoneThis e-mail message (including any attachments) is for the sole use of the intended recipient(s) and may containconfident ial and privi leged information. If the reader of this message is not the intended recipient, you are herebynotified that any dissemination , distribution or copying of this message (includi ng any attachments) is strictlyprohibit ed.Jfyou have received this message in error, please contact the sender by reply e-mail message and destroy all copiesof the original message (inc luding attachments).From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sat, 11 Apr 2020 16:25 :29 +0000(b)(6)Subject: FW: Infectious Diseases Society of America Guidelines on the Treatment andManagement of Patients with COVID-19 InfectionLet us discuss.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in enorplease infonn the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NJAlD) shall not accept liability for any statements made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representatives.-----Original Message-----From: Del Rio, Carlos ______ (b ""~"'(=Sent: Saturday, April 11, 2020 12:08 PMTo: (b)(6); Fauci, Anthony (NIWNIAID) [E] CbH >Subject: Infectious Disea ses Society of America Guidelines on the Treatment and Management of Patients withCOVID-19 InfectionlDSA guidelines are outhttps:// www.idsociety.org/practice-guideline/ covid-19-guideline-treat tnent-and-management/Carlos del Rio, MD.Sent from my iPhoneThis e-mail message (including any attachments) is for the sole use of the intended rccipicnt {s) and may coi,tainconfid ential and privi leged information. If the reader of this message is not the intended rec ipient, you are herebynotified that any dissemination, distributio n or copying of this message (including any attachments) is strictlyprohibit ed.lf you have received this message in enor, please contact the sender by reply e-mail message and destroy all copiesof the original message (including attachments).From:Sent :Subject:Fauci, Anthony (NIH/NIAID) [E)Fri, 10 Apr 2020 15:12:24 +0000FW: Atlantic's coverage - Fauci as "h eartthrob"David Bradley is the Chairman of The Atlantic. Geeez ....From: David Bradley <dbradley@theatlantic.com>Sent : Friday, April 10, 2020 10:20 AM ------ ~~ To : Fauci, Anthony (NIH/NIAID) [E] (b)(6hSubject: Atlantic's coverage - Fauci as "heartthrob"Hi Tony,-----CbH6JI send you greetings and the deepest appreciation.(b)(6)I am only one of your millions of fol lowers who feel in your debt. But, I am the only one with amagazine that has dedica ted a who le art icle to "the thirst for Tony Fauci."This will be the least important item on today's to-do list. But, someday, your grandchildrenand their children, in turn, will want to readt his: https://www.theatlantic.com/technology/archive/2020/04/anthony -fauci -coronavirus crush/6095 44/My best wishes to you.DavidDavid G. BradleyChairmanAtlantic MediaFrom:Sent :To:Subject:David:Fauci, Anthony (NIH/NIAID) [E)Fri, 10 Apr 2020 15:10:47 +0000David BradleyRE: At lantic's coverage - Fauci as "heartthrob"Many thanks for sending this. I could not have even begun to make this up ..... Please staysafe and well.Warm regards,TonyFrom: David Bradley <dbradley@theatlantic.com>Sent: Friday, April 10, 2020 10:20 AM To: Fauci,A nthony (NIH/NIAID) [E]- _-_-_-_-- ---=-c-CbH=_6)Subject: Atlantic's coverage - Fauci as "heartthrob"Hi Tony,-----(b)(6) I send you greetings and the deepest appreciation.I am only one of your millions of fol lowers who feel in your debt. But, I am the only one with amagazine that has dedicated a who le article to "the thirst for Tony Fauci."This will be the least important item on today's to-do list. But, someday, your grandchildrenand their children , in turn, will want to readthis: https://www.theatlantic.com/technology/archive/2020/04/anthony-fauci-coronaviruscrush/609544/My best wishes to you.DavidDavid G. BradleyChairmanAtlantic MediaFrom:Sent :To:Cc:Subject:Attachments :FYIFrom: Griswold, KelseyFauci, Anthony (NIH/N IAID) [E)Fri, 10 Apr 2020 01:37:52 +0000Conrad, Patricia (NIH/NIAID) [E)Haskins, Melinda (NIH/NIAID) [E];Barasch, Kimberly (NIH/NIAID) [C]FW: Letter from Rep. C. Smith to Sec Azar and Dir Fauci2020-04-09 Smith to Azar and Fauci re Lyme and COVID19.pdf(b)(6)Sent: Thu rsday, April 9, 2020 8:41 PM ----------~~ To: Griswold, Kelsey (b)(6)>Subject: Lette r from Rep. C. Smith to Sec Azar and Dir FauciGood Evening All,Attached is a letter from Congressman Smith to Secreta1y Azar and Director Fauc i. Please letme know if there are questions or concerns associated with this.Best,KelseyA . Griswold I LegislativeD irectorCongressman Christopher H. Smith (NJ-04)2373 Rayburn HOBWashington, DC 20515p: (b)(6)From:Sent :To:Subject:(b)(6J:Fauci, Anthony (NIH/NIAID) [E)Fri, 10 Apr 2020 01:35:00 +0000(b)(6)RE: We Believe in YouMany thanks for your e-mai l. Stay well and safe.Best regards,TonyFrom: Cb)(Sent : Thursday, April 9, 2020 8:07 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E]- --------- CbH6J Subject: Re: We Believe in YouTony,I would only hope that one of your staff see my email and are prudent toknow that this is being sent to him by one of his kin and passes it alongto you.Sincerely,(b)(6)On Thursday, April 9, 2020 , 05:54:17 PM EDT, Fauci , Anthony (NIH/NIAID) [E] (b)(6)wrote : -------My work with the Coronavirus Task Force and the large volume of incomingemails precludes me or my staff from answering each individual message .I would encourage you to visit www.coronavirus.gov for the latestinformation and guidance related to COVID-19.Thank you, and best regards.Anthony S. Fauci, M.D.From:Sent :Eisinger, Robert (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAID) [ElThu, 9 Apr 2020 21:24:50 +0000To: Fauci, Anthony (NIH/NIAID) [E)Subject: FW: COVID 19 Briefing Document and COVID Vaccine OverviewAttachme nts: Overv iew of COVID-19 Vaccine Development_April9.pdf, Briefing DocumentNIAID Involvement with Pharma in COVID19_April 9_with table.pdfThe email below is from Larry Corey.Robert W. Eisinger, Ph.D.Special Assistant for Scientific ProjectsImmediate Office of the DirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of Health31 Center Drive, Room 7A-03Bethesda MD 20892Telephone: (b)(6)Email: (b)(From : Corey MD, Larry (b)(6)>Sent: Thursday, April 9, 2020 3:50 PM ------ ~= To: Fauci, Anthony (NIH/NIAID) [El (b)( ·>; Conrad, Patricia (NIH/NIA ID) [El--------- (b)( ; Marston, Hilary (NIH/NIAID) [El (b)(6)> Cc: Mascola, John (NIH/VRC) [El (b)(6) ; Erbelding, Emily (NIH/NIAID) [El-----=~ C>bC_6>); Dieffenbach, Carl (NIH/NIAID) [El (b)(6)>; Lane, Cliff(NIH/NIAID) [E] CbH6JSubject: COVID 19 Briefi ng Document and COVID Vaccine OverviewTony,We are sending you two documents relating to our strategy for COVID vaccine development . The(b) (4)(b) (4)LarryFrom:Sent :To:(b)(6)Thu, 9 Apr 2020 17:18:14-0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: INTERVIEW REQUESTw ith Or Anthony Fauci - Radio-CanadaN ewsProgram 24h/60minLet us discussBegin forwarded message:From: NATHA LIE LEMIEUX <nathalie.lemieux@radio-canada.ca>Date: April 9, 2020 at 5:02:20 PM EDTTo: "NIAID NEWS (NIH/NIAID)" <NWDNEWS@niaid .nih.gov>, "Fauci,Anthony (NIH/NIAID) [E]" (b)(6l , "Fauci, Anthony(NIH/NIAID) [E]" (b)CSubject: INTERVIEW REQUEST with Dr Anthony Fauci - Radio-CanadaNews Program 24h/60minHelloMy name is Nathalie Lemieux and I am a rnsearch journalist for 24b in 60min, aninformation and public affairs program hosted by Anne-Marie Dussault andbroadcast on the CBC/Radio-Canada's French national newsnetwork. https://ici.radio-canada.ca/tele/24-60/site We are based in Montreal and thebroadcast is aired across Canada weekdays on prime time (between 7pm and 8PMET)As we are also living through this Covid-19 pandemia , we would be delighted to doan interview with Dr Anthony Fauci*Of course, host Anne-Marie Dussault can do the interview in EnglishWhen: subject to Dr Fauci's availability ...How: Skype or Facetime (in respect of containment obligations)How long: 7-8 minCou ld this proposal be of inte rest to Dr Fauci?Thank you for letting me know the possibilities ... we are aware of Dr Fauci's tightschedu leYou can reach me at any time via this email natha lie .lemieux@radio-canada.ca oron my cell phone: Cb) (6)Nathalie LemieuxJoumalis te a la recbercheEmission 24 heures en 60 minutesRD I/Radio-Ca nadaCell: CbH6)4il~Ra o1-c0anaoaFrom:Sent:To:(b)(6)Thu, 9 Apr 2020 16:51:32 -0400Stover, Kathy (NIH/NIAID) [E]Cc:(NIH/NIAID) [E]Subject:Billet, Courtney (NIH/NIAID) [E];Folkers, Greg (NIH/NIAID) [E];Conrad, PatriciaRe: FOR ASF REVIEW: Draft PR re: SARS-CoV-2 serosurvey study launchLooks fine ! ThanksOn Apr 9, 2020, at l :48 PM, Stover, Kathy (NIH/NIAID) [E](b) (6) wrote:Hi Dr. Fauci,Please find attached for your review a draft press release announcing the launch of Dr.Memoli's serostudy to detect previously undiagnosed coronav irus infections. Your draftquote is as follows:"This study will give us a cleare r pichrre of the true magnitude of theCOVID-19 pandemic in the United States by telling us how many people indifferent commun ities have been infected without knowing it, because they had avery mild, undocumented illness or did not access testing while they were sick," saidAnthony S. Fauci, M.D., NIAID director. "These crucial data will help us measurethe impact of our public health efforts now and guide our COVID-19 responsemoving forward."Thanks much,KathyKathy StoverBranch ChiefNews and Science Writing BranchNational Instit ute of Allergy and Infect ious Diseases (NIAID)Office of Communications and Government RelationsNational Institutes of Health/HHS31 Center Drive, Room 7A17EBethesda, MD 20892Phone: (b)(6)E-mail: ,__ (b)(6) _____NIAID Media Line: (301) 402-1663<SARSCo V2 serosurvey Release FOG cleared.docx ><SARSCo V2 seros urvey NSWB Clearance Form.doc ><SARS _ COV2 _SERUM _ SAMPLING _ Clean Changes _ Copy_ 4.2.2020.docx >From:Sent :To:Subject:Inspector GeneralFauci, Anthony (NIH/N IAID) [E)Thu, 9 Apr 2020 16:40:28 +0000Cb) (6>:E)FW: New Yorker: Fauci Urges Trump to Attack the Coronavirus as if It Were anThis Borowit z guy is some thin g else ....Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone Cb) (6)FAX: (3 96':44li9E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Folkers, Greg (NIH/NIAID) [E] (b)(6)Sent : Thursday, Apr il 9, 2020 12:33 PMTo: NIAID COGCORE <COGCORE@mail.nih .gov>; NIAID OCGR Leg <NIAIDOCGRLeg@ma il.nih .gov>; NIAIDOD AM <NIAIDODAM@niaid.nih.gov>Subject: New Yorker: Fauci Urges Trump to Attack the Coronavirus as if It Were an Inspector GeneralSatire from The Borowitz ReportFauci Urges Trump to Attack the Coronavirusas if It Were an Inspector GeneralBy Andy BorowitzApril 8, 2020Photograph by Lo Scalzo/ Bloomberg/ GettyWASHINGTON (The Borowitz Report) - ln what he described as a "potentia lly major breakthrough," Dr.Anthony Fauci has convinced Donald Trump to attack COVID-19 as if it were an inspector general.Fauci, who has been frustrated in his efforts to get th rough to Trump, compared the global pandemic toan inspector general while in a closed-door meeting with the President on Wednesday."What do you hate more than anything, Mr. President?" Fauci asked."Jim Acosta," Trump immed iately replied."O.K., fine. But, besides Jim Acosta," Fauci said, "it would be an inspecto r general, right?""You're right, Tony," Trump agreed. "I hate those losers.""Well, think of COV/0-19 as the worst inspector general in the world," Fauci continued. " It's overseeingeverything you do and making you follow the law. It's keeping you from spending taxpayer money onanything you want. You wouldn't stand for that , would you?"Reportedly, Trump appeared shaken by Fauci's analogy. "Damn it, Tony, when you put it that way, we'vegot to do something about COVID-19," he said.Speaking to reporters, Fauci said that he was "caut iously optimistic" that his inspector -general analogywould finally spur Trump to action, but added, "Jared could still screw this up."Disclaimer: Any third-party material in this email has been shared for internal use under fair use provisionsof U.S. copyright law, without further verification of its accuracy/veracity. It does not necessarily representmy views nor those of NIAID, NIH, HHS, or the U.S. government.From:Sent :To:Subject:FYIFauci, Anthony (NIH/NIAID) [E)Thu, 9 Apr 2020 10:17:45 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Mediaset, Italian television broadcast, interview requestFrom: Alessandro Matarante <alessandro.matarante@outlook.it>Sent: Thursday, April 9, 2020 5:49 AMTo: Fauci, Anthony {NIH/NIAID) [E] <afauci@niaid.nih.gov>Cc: Barasch, Kimberly (NIH/NIAID) [C) <kimberly.barasch@nih.gov>; Conrad, Patricia {NIH/NIAID) [E)<conradpa@niaid.nih.gov>Subject: Mediaset, Italian television broadcast, interview requestHello Dr. Anthony Fauci,I'm Alessandro Matarante , an italian reporter , curr ently work ing for Mediaset, Italy's mostimp ortant television broadcast. Specifically , I work fo r Quarta Repubblica, a progra m airedevery Monday in prime-time, leaded by reporter Nicola Porro.I'm writing this e-mail because it would be a pleasure and an honor for us to interview youabout the coronavirus emergency and the way the United States are facing it.Clearly, we are availabl e to consider any kind of day and hour to make the intervi ew, and so weare to consider together the contents of the interv iew .Hoping for a posit ive answer,I wish you a pleasant day .Alessandro (b)(6)https://www .mediasetpla y .mediaset.it/programm i-tv/quartarepubblica b100002038From:Sent :To:(b)(6)Wed, 8 Apr 202017 :17:42 -0400Lusso, Paolo (NIH/NIAID) [E]Subject: Re: Research Day organized by the Italian EmbassyPaolo:I am very, very sorry, but I just cannot do this right now. I am swamped and my time is not myown. I hope that they understand .Best,TonyOn Apr 8, 2020, at 4:00 PM, Lusso, Paolo (NIH/NIAID) [E](b) (6)>wrote:Dear Tony:I am sorry to bother you with another request during this period. The Italian Embassy isorganizing its yearly Research Day (Giornata della Ricerca) that this year will be held str ictlyonline (via Zoom or other e-meeting tool) and centered entirely on the Coronaviruspandemic.The Italian Ambassador, Mr. Varricchio, would be delighted if you accept to be his guest ofhonor at the event and asked me to informally enquire with you, before sending an officialinvitat ion, if there is any chance you could part icipate. He understands how crazy yourschedule is during this crisis. They would like you to deliver a 30 min lecture on a theme ofyour choice, preferably related to the state of the art of the pandemic management. Thetentative date for the event is between April 20 and April 30, but they are waiting tofinalize the date based on your preference, if you are able to accept (even in early May).Please, let me know if you can accommodate t his additional engagement . You will makethem very very happy!All the best,PaoloPaolo Lusso, M.D., Ph.D.Chief, Section of Viral PathogenesisLaboratory of lmmunoregulationBldg. 10, Rm. 6AllNIAID, NIHBethesda, MD 20892Phone: Cb) (6) (personal)...._ ___ CHb6,) (lab)Fax: (301) 480-5291E-mail (b)(6) ________ _.The information in this e-mail and any of its attachments is confidential and may containsensitive information. It should not be used by anyone who is not the original intendedrecipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. The National Institute of Allergy andInfectious Diseases (NIAID) shall not accept liability for any statement made that are thesender's own and not expressly made on behalf of the NIAID by one of its representatives.From:Sent :To:(b)(6)Wed, 8 Apr 2020 16:58:55 -0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: request of interview by Giuseppe Sarcina, corriere della SeraLet us discussBegin forwarded message:From: Sarcina Giuseppe <gsa rcina@rc s.it>Date: April 8, 2020 at 4: 16:32 PM EDT -------~= To: "Fauci , Anthony (NIH/NIAID) [E]" (b)(6J:Subject: R: request of interview by Giuseppe Sarcina, corriere della SeraDear Doc. Fauci,this is Giuseppe Sarcina, the us correspondent of Corriere dell a Sera, the mainitalian newspaper.I understood that you are looking at the italian case with great attention.I wonder if you can grant me a short interview.I have sent an email march 21. But then I saw that you spoke with an other italiannewspaper. So I would like to have a chance to have your voice for our Readers aswell. Corriere della Sera is a newspaper based in Milano, Lombardy, The regionmost affected by the coronavirus.Thank youWarm RegardsGiuseppe SarcinaWashington de(b)(6)>Oggetto: request of interview by Giuseppe Sarcina, corriere della SeraDear Doc. Fauci,this is Giuseppe Sarcina, the us correspondent of Corriere dell a Sera, the mainitalian newspaper.I understood that you are looking at the italian case with great attention.I wonder if you can grant me a short interview.That would be really helpful for our readersThank youWarm RegardsGiuseppe SarcinaWashington deFrom:Sent:To:(b)(6)Wed, 8 Apr 2020 16:57:55 -0400Barasch, Kimberly (NIH/NIAID) [CJSubject: Fwd: Global Health Leaders Call, Thursday , 8 April at 14:30 CETAttachments : image001.png , ATT0000l.htm, COVID19 Strategy Update V3.2.docx,ATT00002.htmPlease print out for tomorrow. ThanksBegin forwarded messag e:From: "KABIR, Sophia" (b)( >Date: April 8, 2020 at 4:21:00 PM EDTTo: SHOC <shoc@who.int >, Office of the Director-Gen eral <DG0ffice @who.int> ,"Redfield, Rober t R. (CDC/OD)' (b)(6)---------- >, David Heym ann (bH6l , "Felicity HarveyI>, "I.Farra r" 4(NIH/NIAID) [E]"(b)(6) "Chris. Elias"(b)(6)"Fauci , Anthony(b)(6)"GREIN , Thoma s" (bH6) , "COX, Paul Michael""SCHW ARTLANDER, Bernhard F." (bH · , "MINHAS ,Raman" -------------. (b)(6) "Conrad , Patricia (NIH/NIAID) [E]" ---------. Jaouad" (b)(6) "FALL, fbrahima Soce"(b)(6) ~, "MAHJOUR,(b) (6) , "Thoma sR. Frieden" (b)(6)Lynn Banks<president@resolvetosavelives.org >,"AL-SHORBAJI, Farah"(b)(6) , President I Resolve to Save Lives(b)(6)Robynn Leidig (b) <"DRURY, Patrick Anthony" , "Dr VAN KERKHOVE, Maria"(b)(6)(b)(6) "GRAAFF, Peter Jan"CbH6J , "POOLE, Marcia" Cb()6 ), Tarik MohammedCb()6 ), CarlosNavarro Colorado (b)(6), Ryan Morhard"BRIAND, Sylvie" Cb)(6), "MORGAN , Oliver" CbH"Han-ies, Jenny" --------- CbH6)," Awwad, David (NIH/NIAI D) (C]" ---------,, >, "SIMONSON , Stewart" CbH6,) "SINGER, Peter Alexander" (b)(6) , "Jayatunga, Wik:um"(b)(6)"Julie.HALL"RIOUX"SHIN, Young-Soo" (b) (6)> ,CbC) Q6)! ·eng Ding(b)(6)------------ "SMITH, Ian Michael"(b )( · , "AYLWARD, Raymond Bruce J." (b)(6)Cc: SHOC <shoc@who.int>, Office of the Director-General <DG0ffice@w ho.int>,"SCHWARTLANDER, Bernhard F.",________ Cb><6J, "MAHJOUR,Jaouad" Cb>< , "FALL, Ibrahima Soce" (b)(6) , "GREIN,Tho mas'' CbH6) >, ~MINHAS, Raman" (b)(6) , "COX, PaulMichael" ..._ __ __,, (b)(6) , "AL-SHORBAJI, Farah" Cb)("POOLE , Marcia" (b)(6) , "DRURY, Patrick Anthony"------- CbH6J , "GRAAFF, Peter Jan" Cb>< , "Dr VAN KERK.HOVE, Maria" Cb<>6 J , "FARES, Christine Youssef''(b)(6)Subject: Global Health Leaders Call, Thursday, 8 April at 14:30 CETDear colleagues,On behalf of Mike Ryan, allow me to share with you the draft COVID-19 Strategy Update,which will be subject of discussion at tomorrow's Global Health Leaders Call at 14.30 CET.The epidemiological update and analysis, as well as the Zoom connection w ill be sharedtomorrow morning.Please find below, the key questions for your consideration and input.l. What is your view on the latest epidemiology, virus transmission and severity inaffected countries?2. What are the emerging issues/challenges that you see as impo rta nt?3. What should be the priorit ies for the 1-2 weeks?4. Any other issues you see as important?If you experience any technical difficulties jo ining this conference call, please contact theWHO HQ EOC operator at: +41 22 79 15 533Kind regards,SophiaSophia KabirExecutive OfficerOffice of the Executive DirectorWHO Health Emergencies Programme (WHE)Tel. (b) (6)Mobile ------ (b)(6)Website: WHO in emergencies I WHO Facebook I WHO TwitterHEALTHEMERGENCIESprogrammeFrom:Sent :To:Subject :Before They ExpireFauci, Anthony (NIH/N IAID) [E)Wed, 8 Apr 2020 17:28 :01 +0000Awwad, David (NIH/NIAID) [C)FW: NIAID Information RE: Update Your PIV Card (HHS ID Badge) CertificatesDo I need to do anyt hing?Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (301) 496-2263FAX : (301) 496-4409E-mail: afauci@niaid.nih.govThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and dele te it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: NIAID News and Information (NIH/NIAID) <niaidnewsinfo@nia id.nih .gov>Sent: Wed nesday, April 8, 2020 10:18 AMTo: NIAID Announcements <NIAID-announce@niaid.nih.gov>Subject: NIAID Information RE: Update Your PIV Card (HHS ID Badge) Certificates Before They Expire---- -Original Message---- -From: ORS Information Line <orsinfo@ors.od.nih.gov >Sent: Tuesday, Apr il 7, 2020 6:23 PM(b) (2)To: NIH-STAFF@LIST.NIH.GOVSubject: Update Your PIV Card (HHS ID Badge) Certificates Before They ExpireIf you need help, please contact t he NIH IT Service Desk: http:// itservicedesk.nih.gov/301-496 -4357 (HELP). 301-496 -8294 (TTY), or 1-866-319-4357 (HELP)(b) (2)From: Fauci, Anthony (NIH/NIAID) [E)Sent: Wed, 8 Apr 2020 17:25:25 +0000To: Billet, Courtney (NIH/N IAID) [E]Cc: Folkers, Greg (NIH/NIAID) [E];Conrad, Patr icia (NIH/N IAID) [E];Stover, Kathy(NIH/N IAID) [E];Routh, Jennifer (NIH/NIAID) [E];Doepel, Laurie (NIH/ NIAID) [E];Lane, Cliff (NIH/ NIAID) [E]Subject: RE: PR HHS Treatment Guidelines for COVID-19We should include in the statement something about ----------- (b) (5)Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone Cb) (6JFAX: (301 496-4409E-mail: (b)(6JThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Billet, Courtney (NIH/NIA ID) [E) CbH6J>Sent: Wednesday, April 8, 2020 12:-5-8- -P-M- ~~ To: Fauci, Anthony (NIH/NIAID) [E) CbH6J>Cc: Folkers, Greg (NIH/NIAID) [E] CbH6J; Conrad, Patricia (NIH/ NIAID) [E](b)( >; Stover, Kathy (NIH/NIAID) [E] (b)( >; Routh, Jennifer"':':"'."~""'.".""'."'.""'"':--:-:'.:";====-.;.._-_;_ --,;-,,~ (NIH/NIAID) [E] (b)(6J; Doepel, Laurie (NIH/NIAID) [E] (b)( 6JLane, Cliff (NIH/NIAID) [E) (b)(Subject; ASF: PR HHS Treatment Guidelines for COVID-19This is a press release that we (Laurie) drafted for HHS to announce the HHS treatment guidel ines. Cliffhas reviewed . I know how slammed you are. In the interest of time , I would like to move th is to Bill Hallnow, with the understanding t hat we can catch up with any changes you might have before the releaseis actually issued.FYI, t he release includes a quote for you as follows:(b)( 5)(b)(5From:Sent :To:Fauci, Anthony (NIH/N IAID) [ElWed, 8 Apr 2020 16:59:29 +0000Barillas, Carolina (NIH/NIAID) [ElCc:Subject:Holland, Steven (NIH/NIA ID) [El;Auchincloss, Hugh (NIH/NIAID) [ElRE: Art icle - BCG protect ion from COVID-19 mortalityThanks, Caro lina.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (3 96':44li9E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Alle rgy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From : Bari llas, Carolina (NIH/NIAID) [ElSent : Wednesday, April 8, 2020 12:39 PM ------~=(b) (6)>To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>Cc: Holland , Steven (NIH/NIAID) [El ..:=======:".:- (b")"("=" ; Auchincloss , Hugh (NIH/NIAID) [El(b) (6} >Subject: Article - BCG protection from COVID-19 mortalityHello everyone,I found this article that comes to a similar conclusion regarding the protective role of universal BCGvaccination on COVID-19 mort ality . I will be work ing with an epidemiologist from Virginia Tech to see ifwe can provide stronger quantitative analysis and modelling.All the best,CarolinaCarolina Barillas Mury, M.D ., Ph.D.Chief, Mosquito Immunity and Vector Competence SectionLaboratory of Malaria and Vector ResearchNational Inst itutes of Health12735 Twinbrook Parkway, Room 2E-20CRockville, MD 20852Phone: (b)(6) Fax: (301) 480 0930E-mail: (b)(6)From:Sent :To:Fauci, Anthony {NIH/NIAID) [E]Wed, 8 Apr 2020 15:09:38 +0000(b)(6)Subject: FW: Google Alert - Fauci AND Tony OR AnthonyClick on the "Cuomo Crush" and "Fauci Fever" link below. It will blow your mind.Our society is really totally nuts .Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Google Alerts <googlealerts-noreply@google.com>Sent: Tuesday, April 7, 2020 11:30 PMTo: Fauci, Anthony (NIH/NIAID) [E] ----- -=(b)""(=6J>Subject: Google Alert - Fauci AND Tony OR AnthonyGoogle AlertsFauci AND Tony OR AnthonyAs-it-happens update Apri 8 2020NEWSDr. Anthon y FaucL Trump address Iowa's lack of shelter-in-placeLittle VillageSpeaking at President Trump's press conference late Monday afternoon , Dr. Anthony Fauc imentioned Iowa, and a clip of his comments was quickly ...11 CJ Flag as ,rrelev<'!nlDr. Fauci: 'We need to put our foot on the accelerator' to see an end toCOVID-19 pandemicfox4kc.comWASHINGTON - Even though he says the worst is yet to come. Dr. Anthony Fauci, the nation's topinfectious-disease expert , has seen signs of ...11 CJ Fl<'lQ as IrrelevantFauci: African-American Community at Higher Risk for CoronavirusComplicationsNBC4 WashingtonDr. Anthony Fauci, director of the NIAID, spoke on Tuesday about the impact the coronaviruspandemic is having on the ... Read More ...John Calipari Confirms Bill Clinton. Mark Cuban. and Dr. Fauci as Guests on"Coffee With Cal"kentuckysportsradio.comAnthony Fauci. Every Monday for the next 25 weeks , Calipari's show will "feature positive messagingand conversation with high-profi le guests from the ...11 CJ FlaQ as 1rrelev;int'Cuomo Crush' and 'Fauci Fever' - Sexualization OfThese Men Is a Real Thing on The InternetTalent RecapThe coronavirus pandemic has led brothers Andrew and Chris Cuomo and Dr.Anthony Fauci to the forefront COVID news and updates, but it also ...11 CJ FlaQ as ,rreJ.,v;mtBefore the White House, Trump called NIH 'terrible,' questioned vaccinesKPQPresident Donald Trump speaks to the press while Director of the National Institute of Allergy andInfectious Diseases Anthony Fauci speaks during a ...11 CJ Flag as IrrelevantYou have received this email because you have subscribed to Google Alerts.Unsubscribe~Receive this alert as RSS feedSend FeedbackFrom:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [E)Wed, 8 Apr 2020 13:23:07 +0000Conrad, Patricia (NIH/NIAID) [E)RE: On the recordYes. Please point him to what I said ye sterday.Anthony S. Fauci , MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 3 I , Room 7 A-0331 Center Drive, MSC 2520Nationa l Institutes of HealthBethesda, MD 20892 -2520Phone: (b) (6)FAX: (301 496-4409E-mail: (b) (6)The informa tion in this e-ma il and any of its attachments is confidential and may contain sensi tive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. lf you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The Nationa l Institute ofAllergy and Infectio us Disease s (NlAID) shall not accept liabili ty for any stateme nts made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From : Conrad, Patricia (NIH/NIAID) (E] ---------(b)( Sent: Wednesday , April 8, 2020 9:20 A-M- -----=-::-=, To: Fauci, Anthon y (NTH/NlAID) [E] -------- (b)( Subject: FW: On the recordPis see below ... .Bob Franken ...-----Original Message-----From : Billet , Courtney (NJH/NTATD) [E] ______ Cb_H_ >Sent: Wednesday , April 8, 2020 9:03 AM- -----~~ To: Conrad , Patric ia (NTH/NJATD) [E (b)(6) >Cc: Stover , Kathy (NIH/NIATD) [E] ______ C_b)_(6 ) Routh, Jennife r (NIH/NIAID) [E](b) (6)Subject: RE: On the recordl think he probably knows Bob Franken pe rsonally so I'm wondering if you might want to flag this for him, as hemight decide it warra nts a personal respo nse.Otherwise, he did speak about health dispariti es at yesterday' s WH press confer ence , and we cou ld certa inly poin tFranken to those comments and then also direct him to NIMHD. ~(b) (5)-----Original Message-----From: Conrad, Patricia (NIH/NIAID) [E] (b)(6)Sent: Wednesday, April 8, 2020 8:56 A-M- ---- ~= To: Billet, Courtney (NIH/NIAID) [E] (b)(6) ? ; Stove r, Kathy (NIH/NIAID) [E]_______ CbH_6) Routh , Jennifer (NIH/NIAID) [E] (b) (Cc: NlAlD OCGR NSWB <NlAIDOCGRNSWB @mail.nih .gov>Subject: FW: On the recordDefer to you to decide on this-----Original Message -----From: Bob Franke n ______ __,("b')..(.,=>Sent: Wedne:sday, Apr il 8, 2020 5:17 A-M-- --- "="'~ To: Fauci, Anthony (NIH/NIATD) [E] _____ (b)_(6_)>Subject: On the recordTony :For my syndicated colunm, [ want to do a piece on the racial aspect of coronavirus. I'm not seeing any breakdownof deaths in the poorer areas as opposed to the more prosperous ones.Jsn 't that the telling statistic here that the economically less well off live in areas where medical services areinadequate and as a result they have more underlying conditions that make theM more vulnerable? Isn't it relevantthat people of color are predominantly among the poorer in our country for a variety of reasons?1 will appreciate your comments, particularly since you have so little to do these days.Warmest regards,BobBob Frankenwww.bobfranken.tvFrom:Sent :To:(b)(6)Wed, 8 Apr 2020 07:18:27 -0400(b)(6)Subject: Re: last questions , i prom iseIn first response , I mean t to say "I always qualified the statement.. ... " .not "I almost qualified thestatement. .. "On Apr 8, 2020, at 7:04 AM, Michae l Specter -------- (bH6>Jwrote:Tha nk you . Will do all this and take ou --------- (b)(6)On Wed, Apr 8, 2020 at 03:59 Fauci, Anthony (NIH/NIAID) [E](b) < >wrote:Michael:See comments below in red.Thanks,TonyFrom: Michael Specter (b)(6)Sent: Wednesday , April 8, 2020 1: 25 A--M-- ---~~ To: Fauc i, An thony (NIH/NIAID) [E] _______ (b_><6)Subject: last questions, i promiseHi. Mostly these are two second yes or no answers - though I need to understandthe b cell issue better.Thank you for all this . Hang in there:1.)Fauci has at times struggled to compel politicians and businesses to attack the problemsthat he considers most woJTisome. Over the years, he has become especially concerned aboutthe possible impact of a lethal strain of influenza." True, but I almost qualified thestatement and said it most likely would be inJluenza, but I was concerned with any typeof novel respiratory virus that efficiently spread from human to human and that had ahigh degree of morbidity and mortality2.) Dyker Heights versus Bensonhurst:•• What do we say about where he grew up.? He always says Bensonhurst. The•apartment was technically in Dyker Heights, though the neighborhood lines shift.And I never see him mention moving neighborhoods. Did he move? Yes. Imoved. I was born at (b) (6>n. the middle of the Bensonhurst sectionof Brooklyn. When I was 9 years old my father opened a Pharmacy on 8302-13 thAvenue at the outer edge of the Dyker Heights Section of Brooklyn (only Wemoved into an apartment over the pharmacy .3.) [ the question below is the meaning of hyperactive. Does it mean producing toomany B cells or that they were too active, as in working too hard, producing too manyantibodies??) Not necessarily too many B cells. It means that the B cells that are there,are aberrantly turned onHe had been investigating B-cells, which are involved in the production of antibodies.In 1983-before H.l.V. was even known by that name-his lab became the first to report thatB-cells became hyperactive in patients with AIDS. The virus was somehow leading its hoststo overproduce a defense that normally would keep them healthy. Fauci had ident ified one ofthe crucial features of AIDS. "We made that observation without having any idea of what wewere dealing with," he said. "l think that speaks for sound scientific and clinical observation ."The pol itics of seeking a cure, though, would be far harder to manage.• 4.). This I asked before you could not speak to me but we can take me out of it. Ordo whatever you like: I asked Fauci if he thought that novel coronavi rus wouldforce a change in attitude among olitical leaders and funding agencies . (b) (6)1(b)(6)•5.). This you lrnve said in rnore than one place. People kind of became alarmed when youwere absent so just want to be sure you don't mind it in here: No problem .Fauci said that there was nothing meaningful about his absence from the Mar.23White House briefing, "I was tied up in a task force meeting, and we were trying to work outsome difficult policies and the topic of the briefing that day was more related to othermembers of the Task Force. He also said, '41 have no troub le with the President. When .I talkto him, he listens.''Michael SpecterStaff WriterThe New YorkerAdjunct Professor of BioengineeringStanford University(b)(6)Phone: (Work, Cell, SMS)Michael SpecterStaff WriterThe New YorkerAdjunct Professor of BioengineeringStanford Univers ity(b)(6)(b)(6)Phone: (Work, Cell, SMS) (b)(6)From: Fauci, Anthony (NIH/N IAID) [E)Sent :To:Subject:Wed, 8 Apr 2020 10:42:24 +0000Perez-Stable, Eliseo (NIH/NIMHD) [E]RE: WH BriefingThanks, Eliseo. Stay safe and well.Best,TonyFrom: Perez-Stable, Eliseo (NIH/NIMHD) [E] ________ C>b<_·>(b)(6)Se nt: Tuesday, April 7, 2020 11:53 PMTo: Fauci, Anthony (NIH/NIAID) [E) -------- Subject: FW: WH BriefingHey Tony, you are the man! Best, EliseoFrom: Natasha Williams (b)(6) ------------ Date: Tuesday, April 7, 2020 at 8:42 PMTo : Eliseo Perez Stable Cb)( >, Courtney Aklin-------- (:b:)--:'(c6,;);>;-----------Subje ct : WH BriefingHello Eliseo and Courtney,During the White House briefing on COVID-19 this evening, there was a discussion on thedisproportionate impact of COVID-19 on African Americans, health disparities and data collection.Please see CSPAN Clips below I cued up.https://www.c-span.org/video/?c4866877 /user-clip-covid-19-african-american-communityhttps://www.c-span.org/video/?c4866892/user-clip-dr-fauci-hea1th-disparities-african-americancommunityhttps://www.c-span.org/video/?c4866897 /user-clip-data-collection-guestion-african-americancommunityI know we are not commenting but I would like to recommend that we have some ta lking pointsprepared and on hold in case we receive congressional inquiries. These topics are also receivingcoverage on the networks .Thank you,NatashaNatasha H. Williams , PhD, JD, LLM, MPHLegislative LiaisonNational Institut e on Min o rity Healt h and Health Dis pariti esNational Institutes of HealthBethesda, MD 20892Email: (b)(6)Phone·".'=; == (~b)~~;6;:);:-1: w-- -ww-.n"""m."'i"h'°:d"" ...n. ~ih .go-.Connect with us: Twitter I Facebook I You Tube I Email UpdatesNIMH-D- --.--,-.-_From: Fauci, Anthony (NIH/NIAID) [E)Sent: Wed, 8 Apr 2020 03 :06:30 +0000To: Grogan, Joseph J. EOP/WHOCc: Bonner, Maria K. EOP/WHO;Campana, Alexandra D. EOP/WHO; -_-_-_-_- ~~ C)b_C_6.;JBrarasch, Kimberly (NIH/NIAID) [C];Conrad, Patricia (NIH/NIAID) [E]Subject: RE: [EXTERNAL] RE: Good newsJoe:I would be happy to speak with him. However, it wou ld have to wa it until Thursday sincetomorrow is impossible. I bel ieve that we can work this out. Perhaps we can arrange for a callbetween me ,the CEO and some knowledgeable people in my program.Best regards,TonyFrom: Grogan , Joseph J. EOP/WHO ----------- (b) (6)'>Sent: Tuesday, April 7, 2020 10:19 PMTo: Fauci, Anthony (NIH/NIAID) [E]------ (=b),-(,=6)>_C__c : Bonn_e_r_, ;_ _M_a_ ria K. EO_;P__/W.....H.:=O ~(b~) ;(; ai>"_ ______ (b)_( l>l>; Campana, Alexandra D. EOP/WHOSubject: Fwd: [EXTERNAL) RE: Good newsDr., I would never abuse your personal email, but since the ceo of Lilly wants to speak with you, I thought I wouldshare this request. Just letme know how to respond-- ------------------------------------- (:b:-)-:c(5=)Sent from my iPhoneBegin forwarded message:From: Shawn O'Neail (b)(6)Date: April 7, 2020 at 10:07:37 PM EDT --------~~ To: "Grogan, JosephJ . EOP/WHO"- --------- (b)(6)> , "Bonner, Maria K. EOP/WHO" (b )( 6)Subject:[ EXTERNALR) E:G ood newsYou bet.Joe - Have an enormous req uest-for help or counsel.(b) (4)My CEO, Dave Ricks, would like to speak with Dr. Fauci in th is regard (given his role at theInstitute). I know that is a tall order-but underscores the importance.I did reach out to Dr. Fauci's Chief but received an automated reply indicated he wasbehind in email - any though ts in the regard greatly appreciated ....Best, ShawnShawn O'NeailVice President, Government AffairsEli Lilly and Company(b)(6) (office) I (b)(6) (mobile)---------(b) (6) I >www.lilly.com<CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for the sole use ofthe intended recipient(s) and may contain confident ial and privileged information. Any unauthorizedreview, use, disclosure, copying or distribution is strictly prohibited. If you are not the intendedrecipient, please contact the sender by reply e-mail and destroy all copies of the original message.From: Grogan, Joseph J. EOP/WHO ----------- (b) (6)> Sent : Tuesday, April 7, 2020 9:31 AMTo: Shawn O'Neail (b)(6) Bonner, Maria K. EOP/WHO------.!::::::==~ (b::);~:(6;)----Subject : [EXTERNAL] RE: Good newsEXTERNAL EMAIL : Use caution before replying, clicking links, andopening attachments.This is great. Thank you for sharing and everything you are doing. JoeFrom: Shawn O'Neail (b)(6)>Sent: Tuesday, April 7, 2020 9:26 AM ----------=-:--:-= To: Grogan, Joseph J. EOP/WHO (b)(6)>; Bonner, Maria K.EOP/WHO (b)( >Subject: [EXTERNAL] Good newsHi Joe and MariaI W<!nt to share an important update about Lilly's efforts to address insulin affo rdability. Inresponse to the crisis caused by COVID-19, Lilly is introducing the Lilly Insulin ValueProgram, allowing anyone with commercia l insurance - and those without insurance - tofill their monthly prescription of Lilly insulin for $35. The program is effective today andcovers most Lilly insulins. Details and more informa tion can be found in the press releasehere attached.Lilly has introduced several solutions in recent years to help meet the individual financialcircumstances of people living with diabetes that are still in effect during the COVID-19crisis, including:• The Lilly Diabetes Solution Center, through which representatives can directpeople to the $35 savings card, as well as affordability options that may reducetheir out-of-pocke t costs further - such as free insulin for people with minimalincome, or no income at all, that has been donated by Lilly to non-profitorganizati ons.• Three non-branded versions of our insulin options with list prices 50 percent lowerthan the branded versions.• In January, the company announced plans to donate at least 200,000 KwikPens® torelief agencies over the next three years.Hope all is well with you ....ShawnShawn O'NeailVice President, Government AffairsEli Lilly and Company(b)(6)office) I (b)(6) (mobile)---------- Cb)( 6) I >>www .lilly.com «CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for the sole use ofthe intended recipient(s) and may contain confidential and privileged information. Any unauthorizedreview. use. disclosure. copying or distribution is strictly prohibited. If you are not the intendedrecipient. please contact the sender by reply e-mail and destroy all copies of the original message.From:Sent :To:Subject:Cliff:Fauci, Anthony (NIH/N IAID) [E)Wed, 8 Apr 2020 02 :41 :56 +0000(b)(6)FW: [EXTERNAL] RE: Good newslet us discuss this. How do you think that I should respond?Thanks,TonyFrom: Grogan, Joseph J. EOP/WHO ------------ (b) (6), Sent : Tuesday, April 7, 2020 10:19 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] CbH6)> .;...;;.::::::========---::-:~ Cc: Bonner, Maria K. EOP/WHO (b)( ; Campana, Alexandra D. EOP/WHO___ _:_ ____ .:,__..!::::=-- (b=)--(~=6)-::--------Subject: Fwd: [EXTERNAL] RE: Good newsDr., I wou ld never abuse your perso nal email, but since the ceo of Lilly wants to speak with you, I thought I wouldshare this request . Just letme know how to respond , ------------------- (=b)----(::5=)Sent from my iPhoneBegin forwarded message:From: Shawn O'Nea il (b) (6)Date: April 7, 2020 at 10:07:37 PM EDT --------~~ To: "Grogan, Joseph J. EOP/WHO" ---------- (b)(6)> , "Bonner, Maria K. EOP/WHO" (b )( 6)Subject: [EXTERNA L) RE: Good newsYou bet.Joe - Have an enormous req uest -for help or coun sel.(b)(4)My CEO, Dave Ricks, would like to speak with Dr. Fauci in th is regard (given his role at theInstitute). I know t hat is a tall order - but underscores the importance .I did reach out to Dr. Fauci's Chief but received an automated reply indicated he wasbehind in email - any thoughts in the regard greatly appreciated ....Best, Shawn--------------------------------------------------Shawn O'NeailVice President, Government AffairsEli Lilly and Company(b)(6) (office) I (b)(6) (mob ile)---------(b)(6) I >www.lilly.com<CONFIDENTIALITY NOTICE: This e-mail message (including all attachments) is for the sole use ofthe intended recipient(s) and may contain confidential and privileged information. Any unauthorizedreview, use, disclosure, copying or distribution is strictly prohibited. If you are not the intendedrecipient, please contact the sender by reply e-mail and destroy all copies of the original message.From: Grogan, Joseph J. EOP/WHO ------------ (b) (6)> Sent: Tuesday, April 7, 2020 9:31 AMTo: Shawn O'Neail (b)(6) Bonner, Maria K. EOP/WHO------=== (=b")="('6c:):';;-----Subje ct: [EXTERNAL] RE: Good newsEXTERNAL EMAIL : Use caution before replyin g, clicking links, andopening attachments.This is great. Thank you for sharing and everything you are doing. JoeFrom: Shawn O'Neail (b) (6)Sent : Tuesday, April 7, 2020 9:26 AM ---------- --,;= To: Grogan, Joseph J. EOP/WHO (b)(6) Bonner, Maria K.EOP/WHO (b)( >Subje ct: [EXTERNAL] Good newsHi Joe and MariaI want to share an important update about Lilly's efforts to address insulin affordability. Inresponse to the cr isis caused by COVID-19, Lilly is int roducing the Lilly Insulin ValueProgram, allowing anyone with commercia l insurance - and those without insurance - tofill their monthly prescription of Lilly insulin for $35 . The program is effective today andcovers most Lilly insulins . Details and more information can be found in the press releasehere attached .Lilly has introduced severa l solutions in recent years to help meet the individual financialcircumstances of people living with diabetes that are still in effect during the COVID-19crisis, including:• The Lilly Diabetes Solution Center, through which representatives can directpeople to the $35 savings card, as well as affordability options that may reducetheir out-of-pocke t costs further - such as free insulin for people with minimalincome, or no income at all, that has been donated by Lilly to non-profitorganizations.• Three non-branded versions of our insulin options with list prices 50 percent lowerthan the branded versions.• In January, the company announced plans to donate at least 200,000 KwikPens® torelief agencies over the next three years.Hope all is well with you ....Shawn--------------------------------------------------Shawn O'NeailVice President , Government AffairsEli Lilly and Company(b)(6) (office) I (b)(6) (mobile)---------Cb)( 6) I »www .lilly.com«CONFIDENTIALITY NOTICE : This e-mail message (including all attachments) is for the sole use ofthe intended recipient(s) and may contain confidential and privileged information. Any unauthorizedreview , use, disclosure , copying or distribution is strictly prohibited. If you are not the intendedrecipient, please contact the sender by reply e-mail and destroy all copies of the original message.From:Sent:To:Subject:Conrad, Patricia (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAID) [ElTue, 7 Apr 2020 22:58:33 +0000Chris Joffe ;Fauci, Anthony (NIH/NIAID) [ElRE: Supporting Schools In Covid-19Due to the high demand on Dr. Fauci's time during the current outbreak -wemust decline your request at this time. Thank you for your understanding .Best,Patricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institut e of Allergy and Infectious DiseasesThe National lnstitues of Health=--=-=-;;-((:bb:))((,66))= ((:coe~fflilc) e)From: Chris Joffe <Chris@joffeemergencyservices.com>Sent: Tuesday, April 7, 2020 6:46 PM ------~= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)Subject: Support ing Schools In Covid-19Dr . Fauci -I'm a safety/security consultan t to independen t and charter schoo ls. I run a firm supporting~1,000 of them. What, if anything , would you wan tth ern to know? I'm wondering if there'sany chance in the world you'd be willing to join us and a few hundred schools for a 15 - 30-minute webinar one day next week?Specifically , schools are looking for infom1ation /perspectiv e as it relates to what to expec t as wereturn to a new normal and the like. Beyond that , they've begun to ask questions such as what wecan be thinking about for this short period of time between the return to schoo l and thedevelopment of a vaccine. What would best prac tice look like for us to educate, but maintainsocial distance? I believe we can manage a lot of the operationalizing but would beimmensely grateful for some high-level guidance to follow .I recognize how incredibly busy this time is for you and would be so incredibly grateful for anytime you might be will ing to spare for this audience .With imm ense gratitude,Chris JoffeChris JoffeCEO I Joffe Emergency ServicesHQ I Santa Monica, CATwitter : @joffec hris(b)(6)Executive AssistantE:P: CbH6>(b)(6)From:Sent:To:(b)(6)Tue, 7 Apr 2020 13:12:39 -0400Lane, Cliff (NIH/NIAID) [E]Fwd:~ -------------------------- (b)(4)(b)(4)Here it isBegin forwarded message:From: "Gelfand , Jeffrey A.,M.D." ___________ __, (b) (6)lDate: April 7, 2020 at 9:39:5 1 AM- E-D-T- --------~~ To: "Callahan , Michael Y.,M.D." (b)( ', "Fauci, ________ __,Anthony IH/NIAID E "Subject:(b)((b) (4)From:Sent:To:Cc:Subject :Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [ElTue, 7 Apr 2020 15:45:18 +0000Conrad, Patricia (NIH/NIAID) [E)Billet, Courtney (NIH/NIAID) [ElRE:N FLPA-NFLT ask ForceNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail (b) (6)(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Conrad, Patricia (NIH/NIAID) [E] ________ (b_H_ >Sent: Tuesday, April 7, 2020 11:09 AMTo: Fauci, Anthony (NIH/NIAID) [El ______ (b_H_6)Subject: FW: NFLPA-NFL Task ForcePis see below - (b) (5)From: Billet, Courtney (NIH/NIAID) [E] -------- (b) (6)>Sent: Saturday, April 4, 2020 12:06 PM ------- ~= To: Conrad, Patricia (NIH/NIAID) ;[E..] ....:.======(bH= ~> ~- Cc: Folkers, Greg (NIH/NIAID) [E] ______ (b_H_6)>; Auchincloss, Hugh (NIH/NIAID) [E](b)(6)>Subject: RE: NFLPA-NFL Task Force(b) (5)From : (b)(6) -------------------- Sent: Saturday, April 4, 2020 11:01 AMTo: Billet, Courtney {NIH/NIAID) [E] (b)(6)>Cc: Thom Mayer _________ C_>b_C_ >Subject: NFLPA-NFL Task ForceHi Courtney,15\ I hope you, your family and your loved ones are harboring safely through this storm . 2nd, thanks foryour efforts and those of Dr. Fauci-he is truly a national treasure during this crisis and it is deeplyappreciated.I appreciate your help and introductions on how our players can be helpful. As you know Drew andBrittany Brees made a $SM contribution to the Louisiana coronavirus efforts and they have done a lot ofpress. Drew's message has been "Hang in there-hang tough I We are in th is t ogether."I've done several webinars with our players and their fami lies, both educating them and pointing outthei r role both with friends and fam ily as well as on social media to let NFL fans know that whether ornot we have an NFL season depends to a large extent upon those fans following the guidelineszealously-as zealously as they follow NFL games!That message seems to be getting through .I write now with a request for a litt le bit of Dr. Fauci's time in about 2 weeks. I requested that we standup a joint NF LP A-NFL Task Force to scenario plan a pathway to getting NFL Club facilities open, with aview towards if and when we might look towards an NFL season, even if games are played with no fans.My request is to have Dr. Fauci give a telephone briefing to our group on this difficult topic, which wouldof course be confidential. The floor would be his and I can brief him prior to the call on what we havebeen working on. If he were willing, we can do the call anytime, probably during the week of April 13,although of course the modeling shows that would be during the peak of the outbreak. We could alsodo it the week befo re or after.Thanks so much for considering this . We are mindful of the psychological toll the virus is taking and thelift NFL games would give to a sports-starved population, but only if it can be done safely for the playersand the fans who (ultimately) allow them to play this great game.Again, thanks!Best,DocThom Mayer, MD, FACEP, FAAP, FACHEMedical Director■ NFLPA NFL Players Association11150 Sunset Hills Road, Ste 305Reston. VA 20190Mobile: (b)( ----- NFLPA.COMFrom: Fauci, Anthony (NIH/NIAID) [ElSent: Tue, 7 Apr 2020 15:24:35 +0000To: Barillas, Carolina (NIH/NIAID) [ElCc : Holland, Steven (NIH/NIA ID) [E];Auchincloss, Hugh (NIH/NIAID)[E] ----~ (b)~(6=)Subject :Caroli na:Best regar ds,TonyAnthony S. Fauci, MDDirectorRE: BCG protect ion from COVID-19 mortal ityNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail: Cb) (6)(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Bari llas, Carolina (NIH/NIAID) [E]Sent : Tuesday, April 7, 202011 :04 AM ------ ::;..,..-,=(b)( >To: Fauci, Anthony (NIH/NIAID) [E] (b)( 6J> '";::=======-=~ Cc : Holland, Steven (NIH/N IAID) [E] ________ Cb_H_6); Auchincloss, Hugh (NIH/NIAID) [E](b) (6) >Subject: BCG protec t ion from COVID-19 morta lityGood mornin g Tony,All t he bes t,CarolinaCarolina Barillas Mury, M.D., Ph.D.Chief, Mosquito Immunity and Vector Competence SectionLaboratory of Malaria and Vector ResearchNational Institutes of Health12735 Twinbrook Parkway, Room 2E-20CRockville, MD 20852Phone: (b)( Fax: (301) 480 0930E-mail (b) (6)(b) (5)From:Sent :To:Subject:Fauci, Anthony (NIH/N IAID) [E)Tue, 7 Apr 2020 14:51:59 +0000Alison Galvan iRE: Your PNAS articl e " Projecting hospita l utilizat ion during the COVID-19outbr eaks in the United States" has publishedAlison:Thanks for sending this. I hope that all is well with you. Keep up your greatwork.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Alison Galvani (b)(6)Sent: Friday, April 3, 2020 3:34 PMTo : Fauci, Anthony (NIH/NIAID) [E] -------,;-, (b)""'c= ,>Cc: Conrad, Patricia (NIH/NIAID) [E) (b)(6) •>; Singer,Burton H(b)(6) ; Seyed Mo ghadas (b)(6) ---------- Subject: Fwd: Your PNAS article "Projecting hospital uti lization during the COVID-19 outbreaks in theUnited States" has publishedHi Tony ,Please find attached our second COVID publ ication. This one focuses on projections of the number ofICU beds that will be needed at the peak of the outbreak.Please don't hesitate to let me know ifwe can be of any assistance.Take care,Alison---------- Forwarded message --------From:<journalstaff@pnascentral.org>Date: Fri, Apr 3, 2020 at 2:06 PMSubject: Your PNAS article "Projecting hospital utilization during the COVI0-19 outbreaks in the UnitedStates" has publishedTo: (b)(6) ----------PNAS is pleased to announce that your paper "Projecting hospital utilization dur ing the COVID-19outb reaks in the United Sta tes" has published on line at: www .pnas.org. Did you know article-levelmetrics data and article downloads are now available for all PNAS art icles? Article-level metrics providea new way of measuring the reach and impact of an article by tracking the ment ions it receives online.Clicking on the "Authors & Info" tab near the top of each article and scrolling down w ill reveal asummary of ment ions of the article across news sites, biogs, social media, and other on line sourceswhich are visualized in a colorful icon, or "badge." The number in the middle of the badge is theAltmetric score, wh ich is based on the volume, type, and author of the mentions. You can click on thebadge or "view more" to explore the individual mentions from each source. Art icle down loads by monthand by article format appear below the badge.Stay connected to PNAS:Follow Us on TwitterFind Us on FacebookAlison Galvani, PhDDirector, Yale Center for Infectious Disease Modeling and Analysis (CIDMA)Burnett and Stender Families Professor of EpidemiologyYale School of Public HealthYale School of MedicineNew Haven. CT 06520(b)(6)http:ljcidma.yale.edu/Follow me at @Alison_ GalvaniFollow CIDMA @YCIDMAFrom:Sent :To:Fauci, Anthony (NIH/N IAID) [ElTue, 7 Apr 2020 14:47:59 +0000Glass, Roger (NIH/FIC) [ElSubject:Thanks, Roger !Anthony S. Fauci , MDDirectorRE: To cheer you up!National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-O331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)( 6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Glass, Roger (NIH/ FIC) [El -------- (b)(6)>Se nt: Friday, April 3, 2020 12:36 PM To: Fauci, Anthony (NIH/NIAID) [El-- -------------- (=b)(6)- :--:= Subject: To cheer you up !TonyRead the last lines and see the photo! Your words from the past are remembered and have changed thecareers of our fellows.No need to respond .RogerSent from my iPadBegin forwarded message:From: (b)(6)Date : April 3, 2020 at 11:30 :23 AM CDTTo: "Glass, Roger (NIH/Fie) [E)" _____ ""(be~s"c=' >Subj ect: HelloDr. Glass,I hope you are well and I wanted to check in to see how you are doing inthis scary and traumatic time for our world.During these times, I'm especially thankful for the training Ireceived from the Fogarty Institute. I remember your wise wordsat our Fogarty orientation in 2011- on why investing in Globalhealth is so critical. No truer words have been spoken especially attimes like these!I'm currently communicating with my former colleagues in Zambia(Mpanji and Innocent pictured here withme https ://www.thermofisher.com/blog/behi ndt hebench/ usi ng-sa nger-seq uen ci ng-to detect-d rug-resistance-m utations-i n-h iv-i n-za m b ia/) from CIDRZ to see howtesting can be brought up via the public health infrastructure inplace currently. Thankfully, the number of cases is very low,although the unreported cases are much higher than likelycaptured( https://www .arcgis.com/apps/opsdashboard/index .html#/bda7594740 fd402994 23467b48e9ecf6 ) . My friend who is a Lieutenant Physician actually likelycontracted COVID-19 in January and wrote that she and othershad treated a patient returning from Wuhan who was pregnant ofrespiratory illness upon coming back to Lusaka to deliver, only todie of pleural effusion later. They subsequently developed flu-likesymptoms and resolved, but these are the types of cases thatlikely go undetected and can potentially contribute to communityspread of the disease .Thank you again for being such a wonderful role model, and I lookto leaders like you and Dr. Fauci to help our nation think withprudent but difficult decisions .Kind regards,Lillianase Th, atImplementation: Delivery oProven Interventions toPatients and PopulationsFrom:Sent:To :Fauci, Anthony (NIH/NIAID) [E)Tue, 7 Apr 2020 14 :44:25 +0000(b)(6)What do you thin k of this stud y?Anthony S. Fauci, MDDirec; torNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (301) 496-2263FAX: (301) 496-4409E-mail: afauci@niaid.nih.gov(b) (4)(b) (4)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Gelfand, Jeffrey A.,M .D. ----------- (b) (6)>Se nt: Tuesday, April 7, 2020 9:39 AM ---------- -,;-,-.,= To: Callahan, Michael V.,M.D. (b)(6J>; Fauci, Anthony {NIH/NIAID) [E] ___________ ......(b)(6)>Importanc e: HighDear Tony and Michael:Mark PoznanskyVaccine and Immunotherapy CenterDivision of Infectious DiseasesMassachusetts General Hospital(b) (4)(b) (4)(b) (4)CbH6) ( C)-J e ff------ Cb<>6 )-M arkFrom: Chen, Huabiao, M.D.Se nt: Monday, April 6, 2020 9:07 PM(b)(6)----------,;-;~ _T_o_: Gelfa_n_d;, , J_e ffrey.: _A...:,.M.,_.D_._ _;~~ (~b)~(6~)------ CbH6)>P; oznansky, Mark,M.B.,Ch.8.,Ph.D .Dear Jeff and Mark,Thanks,HuabiaoFrom: Chen, Huabiao, M.D. ------------ (b)(6) Sent : Monday, April 6, 2020 12:41 PM --------~~ To: Gelfand, Jeffrey A.,M .D. (b)(6)>(b) (4)Subject : Re: ====-------------------------- (b) (4)attached please find the supporting information in PDFFrom: Chen, Huabiao, M.D. ----------- (b)(6)>Se nt: Monday, April 6, 2020 12:23 PM ---------- == To: Gelfand, Jeffrey A.,M. (b)(6)Subject : Re: (b) (4)If needed please download the supporting information ------------- (b) (4)From: Gelfand, Jeffrey A.,M .D. ---------- (b)(6)>Sent : Monday, April 6, 2020 12:16 PM ---------~~ To: Chen, Huabiao, M.D.- ----------- CbH6)>(b) (4)(b) (4)Wow! Reading it now .. .JeffFrom: Chen, Huabiao, M.D. ------------ (b)(6)Sent: Monday, Apri l 6, 2020 11:46 AM To: Gelfand, Jeffrey A.,M.D. --'-=-"-':-=-=-=-=-.=.==(=b=)(6~b Subject: _______________________________ (b_H_4) -Importance: HighDear Jeff,I had a Chance getting this information fro m. (b)( 6)j Dr. Danlei Mou who works verydiligently and seriously on this clinical study. You may be interested in this primary information.Please keep it confidential.Best, HuabiaoThe information in this e-mail is intended only for the person to whom it isaddressed. If you believe this e-mail was sent to you in error and the e-mailcontains patient information , please contact the Partners Compliance HelpLine athttp://www.partners.org /complianceline . If the e-mail was sent to you in errorbut does not contain patient information , please contact the sender and properlydispose of the e-mail.From:Sent :To:Subject:Fauci, Anthony (NIH/N IAID) [E)Sat, 11 Apr 2020 23:21 :25 +0000Upton, FredRE: GOP lawmakers: Fauci may be doing more harm than good I TheHillThanks, Fred. I appreciate your note.Best rega rds ,Tony-----Original Messa ,..e.,-_- --- _____ ..,,.,.~From: Upton , Fred (b)(6) >Sent: Saturday, April 11, 2020 6:31 PM-- -----~~ To: Fauci. Anthony (NTHINIAID) [E] (b)(Subject: Re: GOP lawmakers: Fauci may be doing more hann than good I TheHillUpdate. Biggs and Buck are the only 2 members of Congress that voted agn the first two bills dea ling with COVID-19. The first vote had only the 2 of them vote no. NRNSent from my iPhone> On Apr 11, 2020, at 5:45 PM, Upton, Fred -------- (b)(6) wrote: >> It's upton again and no need to respond. U may get asked about this story and u should know that both Buck andBiggs were among the 40 that voted no on the 2nd package which provided assistance and testing (think it was$ 13B). It was not a surprise that they voted no as they r joined with Tom Massie in almost everything. Keep being ascience tn1th teller□ C> http s:/ /thehi 11. com/homen ews/ corona virm-report/ 4923 5 9-gop- lawmakers- fauci-may-be-doin g-more-harm-thangood>>> Sent from my iPhoneFrom:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sat, 11 Apr 2020 19:26 :02 +0000Upton, FredSubject: RE: It's Fred uptonFred:Thanks for the note. The answer is almost certai11ly yes, but there would not be enough of them whereby we cancompare the results in those who were rece iving Hydroxychloroquine or not for their lupus. Large natural historystudies, which we will be initiating could possibly answer that question.Best regards,TonyAnthony S. Fauci. MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-033 I Center Drive, MSC 2520National Jnslirutes of HealthBethesda, MD 20892 -2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National 1nstitute ofAllergy and Infectious Diseases (NJAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlA ID by one of its representatives.-----Original Messa~ge-----------~~ From: Upton, Fred (b)(6)Sent: Friday, April l 0, 2020 6:0 l AM --------=-,...,.= To: Fauci, Anthony (NIH/NlAlD) [E) --------- (b)(6) > Subject: It's Fred uptonU gave me your email at the Capitol briefing. Question, with all the discussion on hydrox.- have there been anyCovid-J 9 cases that have stmck. lupus victims? TYSent from my iPhoneFrom:Sent :To:Cc:Subject:Fauci, Anthony (NIH/NIAID) [E)Wed, 15 Apr 2020 22:29:20 +0000Bergmann, KennethLerner, Andrea (NIH/NIAID) [ElRE: a thought on selective vulnerability to SARS-CoV-2Thanks, Ken. Interesting concept. I will run it by our program people.From: Bergmann, Kenneth ___________ C_>b_<6>i>Sent: Wednesday, April 15, 2020 4:55 PMTo: Fauci,A nthony {NIH/NIAID) [E] ------ (=b)""('6=)>Subject: RE: a thought on selective vulnerab ility to SARS-CoV-2Hi, TonyThis is not my field but I had some ideas, so thank you for indulging me in thinking about "whynot kids." I attached citations I found useful. Hope you are not sorry you asked ... ©(b) (5)Best regards,KenFrom: Fauci, Anthony (NIH/NIAID) [E] -------- (b) ( > Sent: Tuesday, April 07, 2020 9:50 AM -----------~~ To: Bergmann, Kenneth (b)(6)Subject: RE: a thought on selective vu lnerability to SARS-CoV-2Ken:Best regards,TonyAnthony S. Fauci, MDDirectorI have thought about the same or similar issues.National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used bv anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyothe r storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.(b) (5)From: Bergmann, Kenneth (b)( >Sent: Saturday, Apr il 4, 2020 9:39 AMTo: Fauci, Anthony (NIH/NIAID) [E] ------ -(=b-Hs-=6-r)Subject: a thought on selective vulnerabil ity to SARS-CoV-2Dear Dr. FauciI read with interest your JAMA View point of February 25.Thank you for all you do.SincerelyKenKenneth J . Bergmann, MD, FAANSen ior Medical OfficerDivision of Neurology I. Office of NeuroscienceCenter for Drug Evaluation and ResearchU.S. Food and Drug AdministrationBuilding 22, Room 414310903 New Hampshire Avenue,Silver Spring, MD 20993-0002Office: (b) (6)Mobile: ) §)Email.._ _______ _._,,.(:,:©;, .,(b) (6). (b) (5)From: Fauci, Anthony (NIH/NIAID) [ElSent : Wed, 15 Apr 2020 22:28:57 +0000To: Lerner, Andrea (NIH/N IAID) [ElSubject: FW: a thought on selective vulnerability to SARS-CoV-2Attachments : l_Mab induced Cytokine Storm NEJM 2006.pdf , 2_Covid_pregnancy.pdf,3_Neonate _i nnate _immun ity_2018.pdf, 4_nihms832701.pdf, 5_12948_2017 _Article_77.pdfPlease check th is out with program people. Thanks.From: Bergmann, Kenneth (b)( >Sent: Wednesday, April 15, 2020 4:55 PM To: Fauci, Anthony (NIH/NIAID) (E]- ----- (~b)(=6)>Subject: RE: a thought on selective vulnerab ility to SARS-CoV-2Hi, TonyThis is not my field but I had some ideas, so thank you for indulging me in thinking about "whynot kids." I attached citations I found usefu l. Hope you are not sorry you asked ... ©(b) (5)Best regards ,KenFrom: Fauci, Anthony (NIH/NIAID) [E] (b)( >Sent: Tuesday, April 07, 2020 9:50 AM ---------- "=""= To: Bergmann, Kenneth (b)(6)>Subject: RE: a thought on selective vu lnerab ilit y to SARS-CoV-2Ken:Thanks for the note. I have thought about the same or similar issues.Best regard s,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not(b) (5)accept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Bergmann, Kenneth (b)(6)Sent : Saturday, Apr il 4, 2020 9:39 AMTo: Fauci, Anthony (NIH/NIAID) [E] -------= (b)""('=6J>Subject: a thought on selective vulnerabil ity to SARS-CoV-2Dear Dr. FauciI read with interest your JAMA Viewpo int of February 25.Thank you for all you do.SincerelyKenKenneth J. Bergmann, MD, FAANSenior Medical OfficerDivision of Neurology I. Office of NeuroscienceCenter for Drug Evaluation and ResearchU.S. Food and Drug AdministrationBuilding 22, Room 414310903 New Hampshire Avenue,Silver Spring, MD 20993-0002Office: (b) (6)Mobile: > §)Email:.__ ______ __."'-' @=(b) (6), (b) (5)From:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [E)Sun, 12 Apr 2020 22:44:30 +0000Marston, Hilary {NIH/NIAID) [E)FW: Collection of COVID-19 patient data from medical recordsPlease take a look at this and figure out whether we should do something.From: Hahn, Stephen (b)( >Sent : Thursday, March 26, 2020 5:40 PM To: Fauci, Anthony {NIH/NIAI_D) .[:E.] -.-.-.-:-.-.~.=: .=:=(b)(=6)>=; R=ed=fiel-d,~ Ro bert R. {CDC/OD) ------ (bH ; Debi Birx (b)(6)> Cc: Abernethy, Amy (FDA/OC) (b)( >; Lenihan, Keagan (FDA/OC)(b)(6)Subject: Collection of COVID-19 patient data from medical recordsTony, Bob and Debi,Amy is working on a pathway to collect data from electronic medical records in selected areas of thecountry (addressing all of the appropriate privacy concerns) . We're looking for data elements to collectand wonder if your teams could give us some insight from a public health perspective. I am copyingAmy to see if she has anything else to add. Perhaps you could assign someone to wo rk with Amy.ThanksSteveFrom:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [E)Sat, 18 Apr 2020 18:55:23 +0000Kamoie, BrianRE: Thank YouThanks, Brian. I appr eciate your not e.Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-O331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability fo r any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Kamoie, Brian -----------(b)( >Sent : Saturday, Apr il 18, 2020 12:33 PM To: Fauci, Anthony (NIH/NIAID) [E] -------------::--:-:-:(-b)=( > Subject: Thank YouTony,Thank you for all that you are doing in the fight against COVID-19. Your steady leadersh ip and groundi ngin the science, and your ability to communicate comp lex informat ion clear ly to policymakers and thepublic, are what the wor ld needs during this crisis. I know we will see the other side of th is pandemic,and you will have once again saved many lives with your wor k.I am one step removed from this response, as I am on a deta il assignment from FEMA to the NavalAcademy, but have been sharing information with the Superinten dent and his senior leadership team sothat t hey can make good decisions to protect the community while meet ing the Academy's mission. Ihave thought back to the H1N1 response in 2009-2010 many t imes since th is began.Again, t hank you for what you're doing. My best wishes to you and your family .Best,Brian(b)(S) - PCR

(bXS)- PCB
From: Fauci, Anthony (NIH/NIAID) [ElSent : Thu, 16 Apr 2020 03:00:26 +0000To : Collins, Francis (NIH/OD) [El;Myles, Renate (NIH/OD) [El;Tabak, Lawrence(NIH/OD) [El;Wolinetz, Carrie (NIH/OD ) [El;Lane, Cliff (NIH/NIAID) [ElCc: Burklow, John (NIH/OD) [E];Fine, Amanda (NIH/OD) [El;Wojtowicz, Emma(NIH/OD) [El;Fritz, Craig (NIH/OD ) [El ;Billet, Courtney (NIH/NIAID) [E];Stover, Kathy (NIH/NIAID)[El;Routh, Jennifer (NIH/NIAID) [ElSubject: RE: For review tonight: draft Sec. Azar statement on ACTIVDitto.From: Collins, Francis (NIH/OD) [E]- ------ (b)(6) Sent: Wednesday, April 15, 2020 10:57 PMTo: Myles, Renate {NIH/OD) [El Cb)( >; Tabak, Lawrence {NIH/OD ) [El(b)( >; Woli netz, Carrie (NIH/OD) [El (b)( ; Fauci, Anthony":'---:---'"""".""'."""':'====-.:----=~(NIH/NIAID) [El (b)(6) >; Lane, Cliff (NIH/NIAID) [El (b)(6)Cc: Burklow, John (NIH/OD) [E] (b)(6) Fine, Amanda (NIH/OD) [El-----~~==(=b)( =; W=oj-to=wic-z,- _Em;m,a_ (N.I~H/O D) [El (b)(6); Fritz, Craig (NIH/OD) [El (b)(6)>; Billet, Courtney (NIH/NIAID) [El CbH6J>; Stover,Kathy (NIH/NIAID) [El (b)(6J>; Routh, Jennifer (NIH/NIA ID) [El_ _;_..;._ __ _;__;_(~b)~(6=)->-------Subject: RE: For review tonight: draft Sec. Azar statement on ACTIVLooks generally OKFCFrom: Myles, Renate (NIH/OD) [El -------- CbH > Sent : Wednesday, April 15, 2020 10:44 PMTo: Collins, Francis (NIH/OD) [El CbH6J>T;a bak, Lawrence (NIH/OD) [E]------~===(b:)( :!>.;_ .W.o_.li:n e.,t -z, -C-a;rr.ie (NIH/OD) [El (b)( >; Fauci, Anthony (NIH/NIAID) [El CbH6J>L;a ne, Cliff (NIH/NIAID) [E] (b)(6)Cc: Burklow, John (NIH/OD) [El CbH6J; Fine, Amanda (NIH/OD) [El(b)(6)>; Wojtowicz, Emma (NIH/OD) [El (b)(6)>; Fritz, Craig":'--:-:-:-::-:--::-:-=: ==:;_;_- ~=(NIH/OD) [El --.-~:==(b=)(6=J>; =Bill-et.,~ ;C_ ou_rtn~ey (NIH/NIAID) [El (b)(6) 1>; Stover, Kathy (NIH/NIAID) [El (b)(6)>; Routh, Jennifer {NIH/NIAID) [El (b)(6)Subject: FW: For review tonig ht: draft Sec. Azar statement on ACTIVImportance: HighGood evening :I'm sending this direct ly to principals given the quick turnaround. I've let ASPA know that the goal is toissue the release sometime tomorrow .Thanks,RenateFrom: Brennan, Patrick (OS/ASPA) ---------- (b)(6)Sent : Wednesday, April 15, 2020 10:20 PM To : Burklow, John (NIH/OD) [El ------~~ Cb)( >; Fritz, Craig (NIH/OD) [El -------- Cb)( ; Myles, Renate (NIH/OD) [El (b)(6b; Fine, Amanda (NIH/OD) [El--.-".'""'."'~=(b=)(6:b::;: W::o!j:t!o..;w.i.c,.z,;=., .E mma (NIH/OD) [El -:--"".";:=====(b=)(6~h; ~A kinso, Woleo la (NIH/OD) [El (b)(6h; Stimson, Brian (HHS/OGC) CbH >; Charrow,Robert (HHS/OGC) (b)(6)>Cc: Mu rph y, Ryan (OS/ASPA) (b)(6b; Pratt, Michael (OS/ASPA)--------- (b)(6h; Oakley, Caitlin B. (05/ASPA) (b)(6)> Subject: For review tonight : draft Sec. Azar statement on ACTIVNIH and OGC,Can you let me know if the below and attached statement from the Secretary looks OK? Assuming it isgoing tonight from NIH, approval as soon as possible would be great. Thank you!- PatrickPat rick BrennanDirector of Speechwr itingDepartment of Health and Human ServicesOffice: (b) (6) I Cell: (b) (6)(b)(5)From: Fauci, Anthony {NIH/NIAID) [E)Sent: Mon, 13 Apr 2020 01:14:17 +0000To: Mascola, John (NIH/VRC) [E)Cc: Erbelding, Emily (NIH/NIAID) [E);'Dieffenbach, Carl (NIH/NIAID) [E]';Marston,Hilary (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [E]Subject: FW: Pursuant to My Email on FridayAttachments: Vaccine strategy-200411-v 13.pptx, Secretary Determination Memorandum-Project Warp Speed-041120 1825 draft .docJohn:Let us br iefly discuss this tomorrow AM .Best,TonyFrom: Kadlec, Robert (OS/A SPR/10)- -------- (b) (6)> Sent: Sunday, April 12, 2020 8:59 PM(b) (5)To: Hassell, David (Chris) (OS/ASPR/10) CbH6)C; ollins, Francis (NIH/OD) [El___ _;_ _ __; _ __;_.;._.;.__,;__,;.:::::====== C::>;b:;<:;56, i)"M":a'"s' cola, John (N IH/VRC) [El(b)(6),; Bright , Rick (OS/ASPR/BARDA) CbH6; )Fauci,Anthony {NIH/NIAID) [E] (b)( >; Disbrow, Gary {OS/ASPR/BARDA)========(b)-( ~; P atrick, Vanessa (OS/ASPR/BAR-D-A--) (-C-T-R-)- -:a- = ---------- CbH6)>; Moughalian, Jen {HHS/ASFR) CbH Red fie Id, Robert R. (CDC/OD) CbH >; Messonnier, Nancy (CDC/DDID/NCIRD/0D)=====C=bH: ;: L:a:n~e:,: =C.l;if f_ (N-IH/NIAID) IE] CbH6)>M; arks, Peter (FDA/CSER) ---------- CbH6)>; Yeskey, Kevin (OS/ASPR/10) (b)(6) Cc: Harrison, Brian (HHS/10S) (b)( ; Dareshori, Zack {HHS/10S)(b)(6)>; Conrad, Patricia (NIH/ NIAID) [E] ---------- (b)( Stecker, Judy (OS/10S) CbH6S) huy, Bryan (OS/ASPR/10)-------- CbH6)>W; olinetz, Carrie (NIH/OD) [El ---------- (b) (6) > Subject: Pursuant to My Email on FridayI want to share with you the product of the BCG team who drafted the attached briefing andDecision Memo drafted for the Secretary's review tomorrow. I want to thank all those whocontributed over this holiday weekend to offer their ideas and concepts that is represented inthese products. This represents just a first step of many steps that first outlines a concept thatwill then be operationalized into a histor ic effort for not only the Department and agencies whowill contribute to it, but to our Nation. Again, thank you for your contributions andcommitment. Best BobFrom: Fauci, Anthony (NIH/NIAID) [E)Sent: Mon, 13 Apr 2020 00:32:55 +0000To: Billet, Courtney (NIH/NIAID) [E]Cc: Folkers, Greg (NIH/NIAID) [E];Conrad, Patricia (NIH/N IAID) [E];Routh, Jennifer(NIH/NIAID) [E];Mar ston, Hilary (NIH/NIAID) [E]Subje ct: RE: daily data call from Sec OfcThis looks rea lly good. Thanks.From: Billet, Courtney (NIH/N IAID) [E) (b)(6)Sent: Sunday, Apr il 12, 2020 7 :27 PM ---------=-:-:-= To: Fauci, Anthony (NIH/ NIAID) [E] (bH6>r>Cc: Folkers, Greg (NIH/NIAID) [E] (b)( >; Conrad, Patr icia (NIH/N IAID) [E](bH6)>; Routh, Jennifer (NIH/NIAID) [E] (b)(6b; --------- Marston, Hilary (NIH/NIA ID) [E] (b)(6lSubject: ASF: dai ly data call from Sec OfcPer request from the Secretary's office that I sent you this morning, below is what I propose to submittomorrow morning for the new daily 9am data call. I will plan to submit pretty much the same thing everyday. I will not Glog your in-box with it unless there is a significant update.RFI from Staff Sec:1. For tomorrow's press conference , what information or topics do yourecommend be included in the President's remarks? Please provide talkingpoint-level details and support.Nothing specific from NIAID at this time.2. For tomorrow's press conference , on what information (if any) do youintend to speak?SpeGific topics will depend on questions from reporters. Dr. Fauci has been asked about the effect ofsocial distancing; considerations that would factor into returning the country to normal life; off-labeluse of treatments such as hydrochloroquine ; the status of clinical trials; and the disproportionateimpact of COVID-19 on communities of color.NIAID-specif ic talking points:• NIAID has mobilized a rapid research response to quickly develop effectivecountermeasures for COVID-19, including diagnost ics, vaccines to preventdisease and treatments.• NIAID is supporting a clinical trial of the antiviral remdesivir and isinvestigating other treatments , including antibody therapies and other antivirals ,for their activity against SARS-CoV-2 . Well-designed clinical trials are the bestway to evaluate potential treatments for safety and efficacy .• NIAID is supporting an early-stage clinical trial of an investigational vaccinecalled mRNA-1273, developed by NIAID scientists and the biotechnologycompany Moderna. The study launched first in Seattle, with a second siterecently added in Atlanta . NIAID is researching additional vaccine candidates.• NIAID has launched a serosurvey study that aims to determine how manyadults in the United States without a confirmed history of COVID-19 haveantibodies to the virus . Researchers will collect and analyze blood samp les fromas many as 10,000 adu lt volunteers without a confirmed history of COVID-19 .The results will help illumina te the extent to which the novel coronavirus hasspread undetected in the United States and provide insights into whichcommunities and populations are most affected. [NOTE : This serosurvey is forresearch purposes. It is not meant to be a way for people to access antibodytesting for personal knowledge of prior infection history. If it is portrayed as a wayfor people to "get tested" to understand their own infection history , we can expectthat peop le will inaccurately blame the government for not rece iving results in atimely manner . People can request to learn about their results, which will beavailable only after weeks or months of analysis.]• NIAID is expanding its portfolio of basic research on coronaviruses andemerging pathogens to characterize SARS-CoV-2 (the virus that causes COVID-19) and understand how it causes disease. NIAID also is using animal models tobetter understand the infection and to investigate optimal ways to treat andprevent COVID-19 .3. Are there topics or announcements for future press conferences (otherthan tomorrow's) that you would like to flag for the President's speechwritingteam?For HHS to consider mentioning: - - -------------- (b) (5)From: Fauci, Anthony (NIH/NIAID) [El -------- (b)(6)Sent : Sunday, April 12, 2020 1:55 PM ------~ = To: Billet, Courtney (NIH/NIAID) [El (b)(6)Subject: RE: Staff Sec POC - NIAIDOK. Sounds fine. Do what you can do .From: Billet, Courtney {NIH/NIAID) [E] CbH6)>Sent: Sunday, April 12, 2020 10:59 AM ------~~ To: Fauci, Anthony {NIH/NIAID) [E] (b)( >Cc: Conrad, Patricia (NIH/NIAID) [E] (b)(6)>; Stover, Kathy (NIH/NIAID) [E](b)(6)>; Routh, Jennifer (NIH/NIAID) [E] (b)(6)>; Folkers,Greg (NIH/NIAID) [E] CbH6)>Subject: FW: Staff Sec POC - NIAIDFYI - per request below, HHS is setting up a daily data call. We need to tell them at 9am whatyou are going to discuss at the daily press conference at the end of the day. My observation isthat this may be hard to predict. However, we can certainly come up with some boilerplatetalking points that we re-subm it every day, emphasizing the importance of properly designedclinical trials as the best way to identify treatments.From: Boyse, Natalie (OS/ASPA) ---------- (b)(6)Sent: Saturday, April 11, 2020 7:04 PM ------~~ To: Billet, Courtney (NIH/NIAID) [E] (b)(6)>Cc: Bird, Catherine (OS/OGC) (b)(6) ,>; Puesan, Cesar (HHS/OS/I0S)(b)(6)>; Agnew, Ann (HHS/10S) (b)(6) 1>; Brennan, Patrick-(o - s-;= A_-S_P_A'). "-"="====:!...:__::::____;_ (~b)~(6)Subject: Staff Sec POC - NIAIDHi Courtney -I hope you're having a good weekend. Just wanted to touch base because starting tomorrow, we will bereceiving requests for information from Staff Sec each evening ahead of the next day's press conference- for a turnaround by 9am the following morning. Staff Sec is requesting feedback (see the questionsbelow) from task force experts, including Dr. Fauci, on informa tion they recommend be included in thenext day's press confe rence.Could you please help me identify a primary POC at NIAID that I can work with to get information to StaffSec?(b) (5)Thank you,NatalieNatalie BoyseSpecial Assistant , Immediate Office of the SecretaryU.S. De artmen t of Health & Human ServicesM: (b)(6)(b) (5)From:Sent:To:Fauci, Anthony (NIH/NIAID) [ElSat, 11 Apr 2020 03:05:04 +0000Collins, Francis (NIH/OD) [ElCc: Tabak, Lawrence (NIH/OD) [El;Lane, Cliff (NIH/NIAID) [El;Mascola, John(NIH/VRC) [ElSubject: RE: COVID-19 Advisory Panel Recommendations Following UP on SecretaryMeeting this Am .I am sorry, but I am way behind on e-mai ls and I just saw this. What is going on here?From; Collins, Francis {NIH/OD) [El ------- (b)( >Sent: Friday, April 10, 2020 11:02 PMTo: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Cc: Tabak, Lawrence (NIH/OD) [E] ;;.========:c (b~) ~C6l; lane , Cliff (NIH/NIAlD) [E]-------- (b)(6); Mascola, John (NIH/VRC) [E] (b)(6) Subject: FW: COVID-19 Advisory Panel Recommendations Following UP on Secret ary Meetingt his Am.Importance: HighJust saw this. Huh? (b) (5) ------------------------- ---·?From: Kadlec, Robert (OS/ ASPR/10) CbH6)>Sent: Friday, April 10, 2020 7:27 PMTo: Hassell, David (Chr is) (OS/ASPR/10) CbH6)>C; onrad, Patricia (NIH/NIAID)[E] CbH6)>C; ollins, Francis (NIH/OD) [E] CbH6);'shl@fda.hhs.gov ' CbH6)>M; ascola, John (NlH/VRC) [E] CbH6)Dareshori, Zack (HHS/IOS) (b)(6)>; Bright, Rick (OS/ASPR/BARDA)-------- CbH6)>D; isbrow, Gary (OS/ASPR/BARDA) CbH6)>B; latner, Gretta (OS/ AS PR/BARDA) (b)( >; Patr ick, Vanessa (OS/ ASPR/BARDA) (CTR)...__-:--"""""."'-:--"""""':"'""""':("b:=)=(=6):·: .M.._o_u.g::h:,a_li_a.n.,,~;,Jen ( HHS/ ASFR) CbH6)>S; huy,Bryan (OS/ASPR/10) CbH6)R; edd, John (OS/ASPR/SPPR)-------- CbH6; )Redfie ld, Robert R. (CDC/OD) CbH6)S; tre ngth-McGaughey,Tracie (CDC/DDNID/NCIPC/0D) CbH >; Yeskey, Kevin (OS/ASPR/10)CbH6);> Marks , Peter (FDA/CBER) CbH6)>C; ochran,Norris (HHS/ASFR) (b)(6)>; Messonnier, Nancy (CDC/DDID/NCIRD/00)------ CbH6)>L; ane, Cliff (NlH/NlAlD) [E] CbH6)>J; ohnson, Robert (OS/ ASPR/BARDA) CbH6)>G; ershman, Lynn E. (CDC/DDPHSlS/0D)(b)(6b ; Lenihan , Keagan (FDA/OC) (b)(6); Mark Hartell____________________ Cb _H_6) Mascola, John (NIH/VRC) [E]CbH6)>S; uhana, Tina (NIH/VRC) [El CbH6)M; arston,Hilary (NIH/NIAID) [E] CbH6)>F; auci, Anthony (NIH/NIAID) [E]CbH6)>M; ango, Paul (HHS/I0S) CbH6)>S; huy, Bryan(OS/ ASPR/I0) (b)(6)Cc: Harrison, Brian (HHS/I05) CbH6)>S; tecker, Judy (05/ 105)========:C!b.H..6.)>:F;. -or-d~-B arnes, Arwenthia (OS/ASP-R-/I0-)- --~~ CbH6)T; ignor, Beth (HHS/I OS) CbH6);> Moreno,--:---"'.'""'.""----::----::----::-:;======~ ~~Rafael (OS/ASPR) CbH6)>C; allahan, Victoria (OS/ASPR/I0) (CTR)---------- (b)(6) ; Kemp, Micha (OS/ASPR/MFHC) CbH6); Holland , Tara (OS/ASPR/EMMO) CbH6)>Subject: RE: COVID-19 Advisory Panel Recommendations Following UP on Secretary Meetingthis Am.Importance: HighFirst thank you all for participating on Wednesday's evening call and producing the briefingmemo for the Secretary's review. As a consequence of that meeting and discussion, he fullyendorsed the recommendations of the vaccine portfolio you recommended .• (b) (5)This is an ambitious and challeng ing undertaking but one driven by the necessity to mitigate thepublic health, economic and national security threat this virus represents to our citizens, nationand our way of life. The Secretary is confident that together with our private sector partnersthis is achievable.Have a restful holiday weekend.BobFrom: Hassell, David (Chris) (OS/ ASPR/I0) (b)(6)Sent: Thursday, April 9, 2020 3:13 PM --------=-:-= To: Kadlec, Robert (OS/ASPR/I0) CbH6)>C; onrad, Patricia (NIH/NIAID) [E]--------- (b)(6)>; Collins, Francis (NIH/OD) [E] CbH6)>;========~;:;;:;--C-bH-6:):>D-; a:r-e-sh:o-r i, Zack (HHS/I-0S-)- -----,;~ CbH6)>B; right, Rick (OS/ASPR/BARDA) CbH6)D; isbrow,---:---:---:--~-;=~....:....--=:........:.-__:.~=G_a:r.y. (.O.:S../A_._S P:_R_/ _B:_A_R D.A.). .:.!:==~~""'.""""C-b-H-6)>;F ord-Barnes, Arwenthia (OS/ASPR/I0)(b)(6); Blatner, Gretta (OS/ASPR/BARDA)...=======- C~Hb~6;)>---;1 P'.'a"-'tr""ic.-":k' , Vanessa (OS/ASPR/BARDA) (CTR)CbH61>); Moughalian, Jen (HHS/ASFR)---------.. C">b' .<,,6.,)>;S huy,Bryan (OS/ASPR/I0) CbH6R) edd, John (OS/ASPR/SPPR)CbH6); Tignor , Beth (HHS/I0S) CbH >; Redfield, Robert R."":"-~:---:-::====~=(CDC/OD) CbH6)>S; trength-McGaughey, Tracie (CDC/DDNID/NCIPC/0D).,:.__:__...:...!::~;;:;-----:--------- (b)(6)>;Y eskey, Kevin (OS/A SPR/I0) CbH6)>C; allahan, Victoria (OS/A SPR/I0) (CTR) CbH6)>M; oreno, Rafael (OS/ASPR)CbH6)>M; arks, Peter (FDA/CBER) CbH6)>C; ochran,Norris (HHS/ASFR) (b)(6)>; Messonnier, Nancy (CDC/DDID/NCIRD/00)(b)(6)>; Windom, Robert (OS/ASPR/I0) (b)(6)>; Lane, Cliff(NIH/ NIAID) [E] (b)(6) Holland, Tara (OS/ASPR/EMMO)CbH6)>J; ohnson, Robert (OS/ASPR/BARDA)_ ______ --,C;--Hbs=--r>; --------- Gershman, Lynn E. (CDC/DDPHSIS/0D) CbH6)>K; emp, Micha (OS/ASPR/MFHC)(b)( >; Lenihan, Keagan (FDA/OC) (b)(6)>; MarkHarte II Cb)( >; Mascola, John (NIH/VRC)[E] (b)(6)>; Suhana, Tina (NIH/VRC) [E] (b)( >; Marston,Hilary (NIH/NIAID) [E] CbH6)>F; auci, Anthony (NIH/NI AID) [E]_ __:__;___.:._. _ .:_(_b:,).(:-6..c).-::---------Subject: COVID-19 Advisory Panel RecommendationsDear Panel members-Secretary Azar requested a summary paper with a recommendation from the Panel re theBARDA vaccine portfolio. His deadline was 3:30pm today.Based on the discussion last night and other discussions with the BARDA team, (b)(5)Please let me know as soon as possible if this isnot the case.Apologies for the fast turn. Thank you again for your participation in the Panel.Chris<< File: COVID Vaccines Briefing Memo V.3.docx >>(b)( >-----Origina l Appointment----From:Kadlec, Robert (OS/ ASPR/I0) --------- Sent: Monday, April 6, 2020 1:36 PMTo: Kadlec, Robert (OS/ASPR/I0); Conrad, Patricia (NIH/NIAID) [E]; Collins , Francis (NIH/OD) [E];------ (b)( 6); Daresho ri, Zack (HHS/I0S); Br ight, Rick (OS/ASPR/BARDA); Disbrow, Gary (OS/ ASPR/BARDA ); Ford-Barnes , Arwenthia (OS/ASPR/I0); Blatner, Gretta (OS/ASPR/BARDA);Patrick, Vanessa (OS/ AS PR/BARDA) (CTR); Mougha lian, Jen (HHS/ ASFR); Shuy, Bryan(OS/ASPR/I0); Redd, John (OS/ASPR/SPPR); Tignor, Beth (HHS/IDS) ; Redfield, Robert R.(CDC/OD); Strength -McGaughey, Tracie (CDC/DDNID/NCIPC/0D); Hassell, David (Chris)(OS/ ASPR/I0) ; Yeskey, Kevin (OS/ASPR/I0); Callahan, Victoria (OS/ASPR/I0) (CTR); Moreno,Rafael (OS/ASPR); Marks, Peter (FDA/CBER); Cochran, Norris (HHS/ASFR); Messonnier, Nancy(CDC/DDID/NCIRD/0D); Windom , Robert (OS/ASPR/I0) ; Lane, Cliff (NIH/NIA ID) [E]; Holland ,Tara (OS/ASPR/EMMO); Johnson, Robert (OS/ASPR/BARDA); Gershman, Lynn E.(CDC/DDPHSIS/00) ; Kemp, Micha (OS/ASPR/MFHC) ; Lenihan , Keagan (FDA/OC) ; Mark Hartel!----------- (b)(6) Mascola, John (NIH/VRC) [El; Suhana, Tina (NIH/VRC) [E]; Marston, Hilary (NIH/NIAID) [E]; Fauci, Anthony (NIH/NIAID) [E]Subject: #2 - COVID-19 Adv isory PanelWhen: Wednesday, April 8, 2020 5:15 PM-6:30 PM (UTC-05 :00) Eastern Time (US & Canada).Where: WEBEx - Cbc>s )Presentatio n fo r Wedne sday. HIS IST HE UPDATEDV ERSIO ,4 :26pm<< File : BARDA COVID Vaccines Whi te Paper 20200405b.docx »Meeting Objective:(1) Complete review of BARDA vaccine portfolio (to includ e related NIH and DoD pro grams), with emphasis ondiscussion among Panel members;(2) Formu late a recomm endation to Secretary Azar to eith er endorse or modify curr ent vaccine strategy, plans,proposed funding and contracts.AgendaBrief review of vaccine programs• BARDA (deeper dive after Sunday overview)• NIAID• DoDDiscussionRecommendat ion to Secretary AzarFor convenienc e, below are the presentation and Whit e Paper from last Sunday evening .<< File : BARDA COVID Portfolio Review 20200405b.pptx >> << File: Vaccine Discussion with S1and HHS Leadership V2 FINAL - Gary.pdf >>Hi Arwenthia Ford-Barnes,You updated this WebEx meeting:#2 COVID-19 Advisory Panel on behalf of Dr. Robert KadlecHost: Arwenthia Ford-BarnesWhen it's time , start your meeting from here:Start the meetingWhen: Wednesday, April 8, 2020, 5:15 pm (1 hr 15 mins), Eastern Daylight Time (New York, GMT-04:00).Access InformationMeeting Number :(b) (5)Password:(This meeting does not require a password.)Host Key:(b)(5) (Use this key during the meeting if you ever need to reclaim the host role.)Audio Connection----(b)(5 (Meeting Server Main Number)Access Code:(b) (5)Delivering the power of collaborationThe meetingserver.hhs.gov team© 2020 Cisco and/or its affiliates. All rights reserved<< File: BARDA COVID Vaccines White Paper 20200405b.docx » « File: BARDA COVIDPortfolio Review 20200405b .pptx » << File: Vaccine Discussion with 51 and HHS leadersh ip V2FINAL - Gary.pdf >>From: (b)(6)Sent : Thu, 9 Apr 2020 16:48:20 -0400To:Subject:Folkers, Greg (NIH/NIAID) [E);Conrad, Patricia (NIH/NIAID) [E)Fwd: HelloHow do we nicely say no to this person?Begin forwarded message:From: "Sachdev , Amit (HHS /IOS )" ---------- Date: April 9, 2020 at 2:04:56 PM EDT ------~~ To: "Fauci, Anthony (NIH/NlAID) [E]" --------- (b)(6J: Subject: HelloHi Dr. Fauci, my name is Arn tt Sachdev. I am a Whi te House fellow and physicianmost recently at the Brigham .I know you are super busy and I would love to partner with you and write a oped oncoronavirus and unite the nation.If you have a few minutes, I would love to speak. I thinkThank you for your time and consideration.Sincerely,Amit(b)(6)Sent from my iPhone(b)(SFrom:Sent :To:(b)(6)Wed, 8 Apr 2020 20:14:10 -0400Adams, Jerome (HHS/OASH)Subject: Re: Blacks/ minoritiesPlease text to me your cell phone numberOn Apr 8, 2020, at 7:29 PM, Adams, Jerome (HHS/OASH)(bHAlso, Deb has the data and knows it better than anyone ,VADM Jerome Adams20th US Surgeon GeneralOn Apr 8, 2020, at 7:13 PM, Adams, Jerome (HHS/OASH)(b) (6)>wrote:With greatest of respec t to the two of you,(b) (5)(b) (5)(b) (5)(b) (5)JeromeV ADM Jerome Adams20th US Surgeon General(b)(5From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Wed, 8 Apr 2020 14:38 :40 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: FW: HHS Sponsored Coronavirus Clinical Guidelines - Heads upFYIAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Stecker, Judy (OS/10S) ---------(b)( 'Sent: Wednesday, April 8, 2020 9:59 AM To: Harrison, Brian ~(H_HS_/1;0,5_)- .-..-.-.:-.-..-!-:=--~=~(--b-):(-6-)- =~- Cc: (b)(6) (OS/10S) (b)(6)>; Fauci, Anthony (NIH/N IAID) [E] (b)( ·>; Lane,Cliff ( N IH/NIAID) [E]!.======- (b~)(=l>Y> --------Subject: Re: HHS Sponsored Coronavirus Clinical Guidelines - Heads upThank you. Will have Beth connect with Patricia ASAP.Sent from my iPhoneOn Apr 8, 2020, at 9:48 AM, Harrison, Brian (HHS/IOS)- --------Cb) (6)> wrote:Sounds good, Dr, Fauci - we greatly appreciate the effort that you/Cliff and your teamhave put into this.Look forwar d to receiving and discussing the guidelines (no need for a separate meetingwith me first - we can go straight to the Secretary) and agree that they will not besubjected to additional layers of fo rmal clearance given the circumstances.Adding Judy to quickly help coordinate a time to meet with the Secretary.Thanks again,BHBrian HarrisonChief of StaffU.S. Department of Health and Human Services(b)(6)(b)(6)Thank you Tony. Obviously we will prio ritize time to meet/discuss . I'm at yourdisposal.AMAOn Apr 7, 2020, at 11:01 PM, Fauci, Anthony (NIH/NIA ID) [E]-------- (b)( > wrote:BLi_·a--n-,----------------------- ~~ - CbX5)-PC----------------------- CHb 5> Happy to discuss further before I brief the Secretary.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b)(6)(b) (5)The information in this e-mail and any of its attachments is confidentialand may contain sensitive information. It should not be used by anyonewho is not the original intended recipient. If you have received this emailin error please inform the sender and delete it from your mailbox orany other storage devices. The National Institute of Allergy andInfectious Diseases (NIAID) shall not accept liability for any statementsmade that are the sender's own and not expressly made on behalf of theNIAID by one of its representatives.From :Sent :To :Fauci, Anthony (NIH/N IAID) [E)Wed, 8 Apr 2020 13:49 :56 +0000Harrison, Brian (HHS/IOS)Subject: RE: HHS Sponsored Coronavirus Clinical Guidelines - Heads upThanks, Brian.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)( 6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Harriso n, Brian (HHS/10S)- --------(b)(6)> Sent: Wednesday, April 8, 2020 9:49 AMTo: (b)(6) (OS/10S) (b)(6)>Cc: Fauci, Anthony (NIH/NIAID) [E] (b)(6) ; Lane, Cliff (NIH/ NIAID) [E]-------- (b) ~ ; Stecker, Judy (OS/10S)- -------- (b)( Subject: Re: HHS Sponsored Coronavirus Clinical Guidel ines - Heads upSounds good, Dr, Fauci - we greatly appreciate the effort that you/Cliff and your team have put intothis.Look forwa rd to receiving and discussing the guidel ines (no need for a separate meet ing with me first -we can go straight to the Secretary) and agree that they will not be subjected to add itional layers offormal clearance given the circumstances .Adding Judy to quickly help coordinate a time to meet with the Secretary.Thanks again,BHBrian HarrisonChief of StaffU.S. Department of Health and Human Services(b)(6)(b)(6)------ (b)(6)> wrote :Thank you Tony. Obviously we will prioritize time to meet/discuss. I'm at your disposal.AMAOn Apr 7, 2020, at 11:01 PM, Fauci, Anthony (NIH/NIAID) [E]-------- (b)(6)> wrote:Brian:------------- (b)(S) Happy to discuss further before I brief the Secretary.Best regards,Tony(b) (5)Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infect ious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confident ial and mayconta in sensitive information . It should not be used by anyone who is not theoriginal intended recip ient. If you have received th is e-mail in error please inform thesender and delete it from your mailbox or any other storage devices. The NationalInstitute of Allergy and Infectious Diseases (NIAID) shall not accept liability for anystatements made that are the sender's own and not expressly made on behalf of theNIAID by one of its representa tives.From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Tue, 7 Apr 2020 14:48:49 +0000Becks, Karen (HHS/10S)Subject: RE: Crazy C0VID-19 face cover ideaKaren:Thanks for your note.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Becks, Karen (HHS/1OS) ---------- (b)(6)Sent: Friday, April 3, 2020 12:54 PM -------~~ To: Fauci, Anthony (NIH/NIAID) [E]- --------- CbH6) Subject: Crazy COVID-19 face cover ideaHi, Dr. Fauci.Thank you so much for keeping things honest and know th at I am such a champion of you.I hope tha t reaching out is okay. I work at HHS/1OS team. As I sit here at home and have beent hinking about the shortage of medical supplies, doggie cones actually can be used asprotection for our health care workers. Just a thought that looks and sounds crazy but canhelp.Stay safe.Kindest Regards,Karen BecksU.S. Department of Health and Human ServicesImmediate Office of the Secretary200 Independence Avenue, SWWashington, DC 20201Desk: (b)(6)Mobi le: (b)(6) -----Brian KamoieDHS/FEMA,_ (b)(6) (mobile) __ _From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Thu, ~ r 202_0 22:05:53 +0000(b)(6)Subject: RE: Greetings from your former employee (UNCLASSIFIED)(b)(6)Many thanks for your kind note. I hope that all is well with you.Best rega rds ,.Tony-----Original Message- ----From: (b)(6)Sent: Thursday, April 2, 2020 4:59 PM To: Fauci , Anthony (NTH/NIAID) [E] _-_-_-__-_-__-_-_-__- ---.-...-..,-...-..-...-,._.~._,._. ~__ _ (_b)_C_Subject: Greetings from your former employee (UNCLASSIFIED)CLASSIFICATION: UNCLASSIFIEDDear Dr. Fauci ,(b) (6)1 was in touch with (b)(6) back in January and he said you all were underwat er there with corona virus. Ican only imagine how much busier you arc now, with COVID-19 taking bold across America.We (myself, husband, and family) have followed the news since the start . ln watching, I was reminded of the oldsign we had posted on the printer between (b) (6).and my desk for quite some time that read, "Keep Calm andTrust Fauci". J can't recall whe ther we put that up during the Ebola outbreak or Zika, but never has it been more true.We never cease to be amazed at how well you carry yourself , respond to politically loaded questions, and get thetruth out in such a way that any viewer can understand.You also never seem to frustrate from answering the same question s which l am sure must get old. There bas beenone question l have yet to hear asked howe ver. Who is cutting your hair? I know you used to have a regular gal butwith soc ial distancing, we are specul ating that perhaps there is a White House barber you us e. Of course we knowhow busy you are so don't expect a reply, just wanted to throw you a question you may not have had yet. I am alsowondering how your office tree is doing. How many bungee cords are supporting it these days?We have found plenty ofreasons to smi le with the whole family getting in on what we're dubbing the ASF # I FanClub. From memes, to cartoon s, to l-shirt:;, we are all here support ing you and wishing for your continued health andsuccess. I am attaching some of our shenanigans in hopes you get a kick out of it and to provide some comic relie f.You've been thanked over and over but J must say it too. Thank you, Dr. Fauci, for all that you do. And thank you tothe staff behind the scenes that makes it happen. (b)(6) is no doubt just as busy as you as always C~, are youreading this emai l? Hi!). When we see you at all hours from the NIH studio and your office, I think of the mediastaff support you receive, and espec ially assistance from (b) (6) for helping the ship run smoothlywhile you are constantly engaged, ( (b) (6)a}n d your family , the list goes on. Thank you and thanks to your team.Directorate of Human ResourcesUSAG Foti Detrick(b)(6)NIH-000065NIH-000066CLASSIFICATION: UNCLASSIFIEDFrom:Sent :Eisinger, Robert (NIH/NIAID) [E) on behalf of Fauci, Anthony (NIH/NIAID) [E)Fri, 27 Mar 2020 11:23 :56 +0000To: Fauci, Anthony (NIH/NIAID) [ElSubject: FW: Reaching out about partnerships and COVID-19. // confidentialThe email below is from Maria Freire.Robert W. Eisinger, Ph.D.Special Assistant for Scientific ProjectsImmediate Office of the DirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of Health31 Center Drive, Room 7A-03Bethesda MD 20892(b)(6)(b)(6)From: Freire, Maria (FNIH) [T] ------- (b)(6)Se nt: Friday, March 27, 2020 6:03 AM To: Collins, Francis (NIH/OD) [E]- ----~~ (b)(6); Whalley, David (FNIH) [T] (b)(6)>Cc: Fauci, Anthony (NIH/NIAID) [:"'E=.']: '-::;:::::=====~ (b~) (-6=)>; Lane, Cliff (NIH/N IAID)._[_E] -----(b)(6)>Subject: Re: Reaching out about partnerships and COVID-19. // confidentialYes, quite a note . It is good to see such willingness to pitch in and the things J&J is doing. Let us knowwhat he says. We stand ready to help. Best, M .From : "Coll ins, Francis (NIH/OD) [El" (b)(6)>Date: Friday, March 27, 2020 at 4:37:15 AMTo: "Wholley, David (FNIH) [T]" (b)(6)>Cc: "Fauci, Anthony (NIH/NIAID) [El" (b)(6J>, "Lane, Cliff (NIH/NIAID) [E]"------- (b)(6)>, "Freire, Maria (FNIH) [T)" (b)(6) Subject: FW: Reaching out about partnerships and COVID-19. // confidentialHI David,Quite a message from Paul below. He seems open to the idea of a virtual meeting, to see whatcollaborative efforts might be most important. I'll try to speak with him today or tomorrow.FrancisFrom: Stoffels, Paul [JJCUS-) ------ (b) (6)>Se nt: Friday, March 27, 2020 3:54 AMNIH-000211To: Collins, Francis (NIH/OD) [E] (b)(6)Cc: Castillejos, Carlos [JJCUS) (b) (6)Subject: Re: Reaching out about partnerships and COVID-19. // confidentialFrancis,Lots to talk about. Happy to find a productive way to contribute in the discussion you are planning tohave.we can talk th is afternoon US time or over the weekend.I'm working (b)(6) at the moment.Carlos can provide more information on the ---(b-) (6) if you want.Best regards,NIH-0002 12(b) (4)PaulSent from my iPadOn Mar 27, 2020, at 1:37 AM, Collins, Francis( NIH/OD) [E) ------- (b)(6)> wrote:WARNING : This email originated from outside the company . Do not click on links unless you recognizethe sender and have confidence the content is safe. If you have concerns about this email , send it as anattachment to 'SuspiciousEmail@ITS .JNJ.COM'.Hi again Paul,One more question - is the pharma collaboration mentioned in the BioCenturystory below the same th ing as the Gates COVID Therapeutic Accelerator Program?Or is this something different? I'm just trying to understand the landscape.Best, FrancisPharmas on one page with action plan to solve COVID-19 togetherBIOCENTURY IS PROVIDING THIS STORY FOR FREE GIVEN THE URGENT NEED FORINFORMATION ABOUT THE COVID-19 CRISIS.BY C. SIMONE FISHBURN, EDITOR IN CHIEF I MAR 25, 2020 I 9:17 PM EDTA grand-sca le behind -t he-scenes effort by the pharmaceutical companies is underway to expedite the creation of therapies and vaccines to treat COVID-19.According to the participants who spoke with BioCentury under conditions ofanonymity, R&D heads from at least 10 companies have been gathering severaltimes a week, setting in motion an action plan to use their top talent in differentdisciplines to produce an industry-wide response, the likes of which haven't beenseen since the private sector's coordinated contribution during World War II.Regulatory heads and manufacturing heads have been holding meetings as well,coordinating to minimize duplication of effort, streamline work and advanceefficient testing of compounds and vaccines.The R&D group is creating working principles to accelerate new COVID-19 therapiesand vaccines agnostic to their market potential , eliminating bureaucratic andtechnical or scientific barriers, and focusing on filling gaps not adequately filled byother initiatives and which the consortium is uniquely suited to address.NIH-000213The pharma group's leaders also intend to offer resources to biotechs andacademic groups pursuing countermeasures who may not want to join the effortbut could benefit from expert guidance.Flying the plane as they build it, the collaborators intend to create a clearing houseof ideas for testing of molecu les and vaccines, with working groups to vet the ideasand expedite testing on the most promising via clinical or preclin ical testing.According to the participants who spoke to BioCentury, the structure will probablyevolve over time. Currently, the model involves five working groups, for clinicalphase repurposing, novel small molecule antivirals, novel antibodies, prevent ivevaccines and preclinical repurposing. Each will be headed by a pharma R&Dexecutive and will be responsible for prioritizing poten tial compounds andspecifying actions.Two platform groups will integrate across modalities: a clinical trial accelerationgroup and a data sharing group."This is not a t ime to think about proprietary information or IP or margins. Weneed to break down the barriers and solve the problem," said one participantinvolved in the consortium.From: Collins, Francis (NIH/OD) [E]Sent: Thursday, March 26, 2020 4:25 PMTo: Stoffels, Paul [JJCUS) (b)(6)>Subject: RE: Reaching out about partnerships and COVID-19Hi Paul,I have done some work on the idea of an "AMP like" COVID project. As Imentioned, Mikael Dolsten has been quite enthusiastic. For FDA, Peter Marks,Janet Woodcock, and Steve Hahn were all extremely positive about thisopportunity for a shared consideration about priorit ies. Tony Fauci and his teamare totally in favor, and the FNIH (David Whalley and Maria Freire) stands ready toserve as convener . I thought the first step would be a 90 to 120-minute virtualmeeting - hopefully next week. Attached is a draft precis of what t his might looklike; I have left out the roster because that is very much a work in progress.Meanwhile I saw reports that there are related partnership discussions going onamongst pharmas: https://www.globenewswire .com/newsrelease/2020/03/26/2006713/0/en/Novartis -and-life -sciences-companies-commit expertise-a nd-assets-to-the-fight-aga i nst-COV I D-19-pandemic-a I ongs id e-B ii IMelinda-G ates-Foundation. htm INIH-000214I am wondering how this might all fit together.Do you have a few minutes to speak with me about this? I'm at -----(b)( , and I'd greatly value your advice. Just let me know when you might be able to call, sothat I'm not in the midst of a Zoom meeting.Best, FrancisFrom: Stoffels, Paul [JJCUS-] ------- (b)(6)>Sent: Tuesday, March 24, 2020 12:58 PM To: Collins, Francis (NIH/OD) IE]_- _-_-_-_-_- ~~ C_>b<6lSubject: Re: Reaching out about partnerships and COVID-19Absolutely worthwile . I wi ll write an email in the next hours.(b)(4) .PaulVerstuurd vanaf mijn iPhoneOp 24 mrt. 2020 om 17:55 heeft Collins, Francis (NIH/OD) [E]------- (b)(6)> het volgende geschreven:Hey again Paul,Really hoping to hear your thoughts on this proposal. FDA is highlyenthusiastic. Dolsten is in. Other pharma R&D Chiefs that would bemost helpful? Jay Bradne r? John Reed? Roger Perlmutter?Thanks, FrancisFrom: Collins, Francis (NIH/OD) [E]Sent : Monday, March 23, 2020 5:17 PMTo: Stoffels, Paul (b)(6)>Subject : Reaching out about partnerships and COVID-19Dear Paul,I've been thinking that th is is a time where we ought to have the best andbrightest minds from industry, NIH, academia, and FDA around the sametable to identi fy ways that we can move the coronavirus agenda forward tolife-saving products as quickly as possible. Several pharmas and biotechs havebeen reaching out to NIH to ident ify viral assays and animal models that canNIH-0002 15NIH-000216be run in a BSL-3 facility. Other similar contacts I've had with pharma andbiotech tell me that there is a high degree of interest and willingness tocombine forces at this time of crisis.This isn't exactly a precise recipe for AMP-COVID, but it has some of the sameflavor. Would it be useful for FNIH to convene a virtua l meeting with a fewheads of R&D (hopefully you; Mikael Dolsten has already expressedenthusiasm; and I'd be interested in your suggestions of others), FDA (Marksand Woodcock), leaders from NIAID and a few other NIH Institutes withequity in this space. We might be able to make a short list of catalytic actionsthat neither sector can do optimally right now, but together we can dorapidly .The focus would be on therapeutics and vaccines. But I can imagine aseparate session on diagnostics .Does this sound worthwh ile to you?Thanks, I always value your advice and partnership .FrancisFrom:Sent:To:Fauci, Anthony (NIH/NIAID) [E]Thu, 2 Apr 2020 10:58:08 +0000Mascola, John (NIHNRC) [E)Subject: FW: Secretary's Medical Countermeasure Advisory PanelAs per our discussion.From: Kadlec, Robert (OS/ ASPR/IO) (b)(6) >Sent : Thursday, April 2, 2020 6:46 AMTo: Bright, Rick (OS/ASPR/BARDA) CbH ; Disbrow, Gary (OS/ASPR/BARDA)< CbH6); Lambert, Linda (O5/ASPR/BARDA) (b)(6)Cc: Shuy, Bryan (OS/ASPR/IO) CbH >; Harrison, Brian (HHS/IO5)(b)( ; Hassell, David (Chris) (OS/ ASPR/IO) (b)(6)> --------- Subje ct: Secretary's Medical Countermeasure Advisory PanelImportance: HighRick, Ga ry and Linda:The Secretary has directed me to establish a HHS Senior Adviso ry Panel of key HHS OperatingDivisions( (NIH, CDC & FDA) to include head of agencies or their designees to oversee andprovide recommendations to the Secretary concerning the development and procurementmed ical countermeasures (MCM), (vaccines, therapeutics, diagnostics and devices). In meetingthis direct ive, I have asked Dr. Chris Hassell to organize and serve as the intermediary toschedu le and coordinate. It is the intent to hold the first virtual meeting of this panel Sunday, 4April time TBD. The frequency of further meetings wil l be determ ined at the inaugu ral meet ing .The Agenda should include :• Overall COVID-19 Strategy & Plan (5 min)• Activities to Date (e.g. industry outreach, RFP BAA etc.) (5 min)• High level overview of current MCM portfolio (5 min)• Detailed briefing of current vaccine technical development efforts, timeline andcosts (30 min)• Discussion by participants (30 min)I ask that the materials for this meeting be subm itted by noon April 3 to the APSR 10 to bereviewed and be distributed to the Panel membership by noon Saturday April 4. Thank youBobNIH-000082From:Sent:To:Subject:alleviate shortageDr. Kavesh:Fauci, Anthony (NIH/NIAID) [E)Tue, 31 Mar 2020 01:57:13 +0000Kavesh, WilliamRE: Medical staff need COVID-19 NIH surv ival data on N-95 respirators to helpThanks for your note. This issue is now being actively discussed at the Task Force meetings .No guarantee, but I believe that there will be movement in that direction.Best regards,TonyFrom : Kavesh, William (b)( >Sent: Monday, March 30, 2020 5:10 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject : Medical staff need COVID-19 NIH surviva l data on N-95 respirators to help alleviate shortageDear Dr. Fauci,The biggest concern of my hospital colleagues is the shortage of protective masks. If any research isbeing done that might drive safe reuse of N-95 respirators, no one I know has seen it. These should besimple studies to do.If the virus is shown to die within a few days and moisture dries up, then the number of masksneeding disposal could drop drastically.In that situation, each provider at risk could be given five N-95 masks, one for each day of the week.The provider would wear the N-95 mask for one working day, say Monday. and then place it into a paperbag in a secure location. The provider would not use that mask again until the following Monday; ieseven days later.The only question, then, would be: how many times can t his be repeated? Will the mask lose anyprotective qualities over time?Please assign someone to do these studies soon.I'm also very pleased that our national leaders now seem to be listen ing to you more closely.Thank you for your efforts.William Kavesh MD, MPHCMC Philadelphia VA Medical CenterNIH-000117From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Tue, 24 Mar 2020 15:26:47 +0000Gottlieb , Lawrence A.Subject:Many thanks !Anthony S. Fauci, MDDirectorRE: SupportNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Gottlieb, Lawrence A. -----------(b)(6) Sent: Tuesday, March 24, 2020 11:19 AM ------ --=~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6J> Subject: SupportDr. Fauci,Just want to express my support for your indefatigable effo rts to thwart the spread of the Coronavirus.Many, many years ago, I was a lab assistant for Dr. Edward L. Kuff and Dr. Karen Lueders, at NCI inbuilding 37 ! ! ! Bravo for all you are doing.Lawrence Gottl ieb, PMP, MBA, COR, FAC/PPM IllSenior IT Project ManagerEnterprise Portfolio Management DivisionOffice of Information & TechnologyUS Department of Veterans Affairs810 Vermont Avenue, NWWashington, DC 20420(b)(6)Office: Cb) (6) .-!===~~ Cell: ------ (b)(6)"Alea iacta est" - CaesarNIH-000255VA Core Values: Integ rity Commitment Advocacy Respect ExcellenceVA U.S. Department of Veterans AffairsOffice of Information and Technologynter r st Proa,. ..m \fo 'll'.l '.1 m, nr ,fnr;NIH-000256NIH-000309NIH-000310NIH-000311NIH-0003 12(bX5)-PCINIH-000136NIH-000137NIH-000138(bX5) -PCENIH-000001NIH-000002 ~From:Sent :To:Cc:Subject :No!Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Tue, 7 Apr 2020 13:42:04 +0000Conrad, Patricia (NIH/NIAID) [E)Greg Folkers (b)(6) )FW: Keynote Speaker Invitation - 8th Interna tional mRNA Health ConferenceNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The Nat ional Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Conrad, Patricia (NIH/NIAID) [E) (b)( •> On Behalf Of Fauci, Anthony(NIH/NIAID) [E)Sent : Tuesday, April 7, 2020 9:33 AMTo: NIAID OD AM (b)(6)>Subject: FW: Keynote Speaker Invitat ion - 8th Internat ional mRNA Health ConferenceFrom: Pardi, Norbert <pnorbert@pennme dicine.upenn.edu>Sent : Tuesday, April 7, 2020 9:07 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: Keynote Speaker Invitation - 8th International mRNA Health ConferenceDear Dr. Fauci,On behalf of the organiz ing committee, I am writing to invite you to Keynotethe 8th International mRNA Health Conference (http://www.mrna-conference .com/) to be heldat the Boston Park Plaza Hotel on Nov 9-10, 2020 .NIH-000003NIH-000004The International mRNA Health Conference is a yearly non-profit event collaborativelyorganized by Curevac , BioNTech and Moderna. It brings together academic and industrythought leaders in the mRNA design and delivery space to explore the rapidly evolving science ,business and regulatory landscape of mRNA medicines. Over the last seven years, this 2-dayconference has become the premier destination for industry and academic professionals tonetwork with colleagues , learn about the latest advances in mRNA technology, and to attendscientific presentations given by the most esteemed experts in the field. Notably, it is the onlyannual conference dedicated solely to mRNA therapeutics.As a scientist with tremendous experience and the director of NIAID, the organizingcommittee thought that conference attendees would very much appreciate hearing aboutyour thoughts about mRNA therapeutics, particularly vaccines, and any perspectives youwish to share.The organizing committee recognizes that your calendar is likely filled years in advance, but weall have our fingers crossed that you might be able to fit this into your busy schedule.I look forward to hearing from you.all best wishes,NorbertP.S. In the event that the COVID- 19 crisis is still curtailing travel in the fall, our backup planwould be to have a completely virtual meeting on the same dates. We plan to make thatdecision in late AugusUearly September.Norbert Pardi, Ph.D.Research Assistant Professor of MedicineInfectious Disease DivisionPerelman School of MedicineNIH-000005University of PennsylvaniaPhiladelphia, PA 19104PH: 215-746-6552pnorbert@pennmedicine.upenn.eduFrom:Sent :To:Fauci, Anthony (NIH/N IAID) [ElTue, 7 Apr 2020 13:01:12 +0000Mark FeinbergSubject: RE: Greet ings and an Update : VSV-SARS-CoV-2 Vaccine DevelopmentThanks, Mark. This e-mail is very inform at ive and helpful.Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Mark Feinberg (b)(6)Sent: Saturday, Apr il 4, 2020 4:10 PM To : Fauci, Anthony (NIH/NIAID) [El ---------------=---:-(:b)=(6> :>; Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subje ct: Greetings and an Update : VSV-SARS-CoV-2 Vaccine DevelopmentDear Tony,I hope you doing well despite yo ur heroically busy schedule and the complexi ty and magnit ude of thecr itically impo rtant issues you are work ing so hard and effect ively to address. You are providing suchamazing and valuable leadership in the response to COVID-19 and the world is so fortunate to have youin t his key rol e!NIH-000006(b) (4)(b)(4)Please let me know if you have any questions or would like any additional information . I will keep youposted (b)(4) .Be well and hang in there!Very best,MarkNIH-000007Mark Feinberg, MD, PhD(b)(6)NIH-000008(bX5) -PCP.NIH-000009NIH-000010(b)(S) - PCINIH-000011NIH-0000 12NIH-0000 13(b)(S) - PC!NIH-000014NIH-0000 15(bX5) -PCENIH-000016(bXS) - PCPNIH-000017(bX5)-PCENIH-0000 18From:Sent :To:Subject:Anki:Fauci, Anthony (NIH/NIAID) [E)Mon, 6 Apr 2020 17:30:06 +0000Anki WolfRE: Elizabeth GlaserMany thanks for your kind note.Best regards,TonyA.nthony S. Fauci, MDDirectorNational Institute of Allergy and Iofectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Jnslitutes of HealthBethesda, MD 20892-2520Phone: (b)(6)f AX: (301) 496-4409E-mail: (b) (6)The informalion in this e-mail and any of its a1tachments is confidential and may contain sensitive information. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease infonn the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and lnfectious Diseases (NJAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of its representatives.-----Original Message-----From: Anki Wol ___________ ("b")"'("6=')Sent: Sunday, April 5, 2020 5:25 PM --------=-=-=- To: Fauci, Anthony (NIH/NlAfD) [E)- -----------Cb)( Subject: Elizabeth GlaserHJ Dr. Fauci,l am (b)(6) you diagnosed with AIDS back in the mid I 980's.lt was in those early days of the AIDS epidemic that you were instrumental in diagnosing and researching thisdreadful disease.(b)(6)My family had been associated with the NCI through my uncle, Lou Wasserman, who was a researcher for a periodof time. Lou did much research on polycythemia vera and was a hematologist at Mt. Sinai in NYC. J'm glad thathe's no longer around to witness the devastation of Covid-19.I was impressed with your knowledge at the time of (b) (6ldiagnosis and I am even more so in these times of theCovid-19 pandemic. Thanks for being the intelligent and informative face of the facts on the virus. There are manyaround the country who rely on your wisdom but also on your facts and data.Stay well, stay healthy, and keep providing the country with what we need to know and do.Be st,NIH-0000 19NIH-000020Anki WolfFrom:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [E)Mo n, 6 Apr 2020 17:27:18 +0000(b)(6)FW: clinical trials of Oral LL-37 on COVID-19Attachments : LL-37 ethic.pdf, three pati ents clinical study.pdf, CAS001 Subchronic toxicityexperiment.pdf, Internat ional research programme( l ).pdf, Wanzhu Jin CV.pdfAny suggestion of what to do with this type of thing? Can you have someonerespond to them.Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: JINWan-Zhu (b)(6)>Sent: Sunday, April 5, 2020 11:45 PM To: Fauci, Anthony (NIH/NIAID) [E] -------------=- (b=)( ·>; sunok301 -------- (b)(6)Subject: clinical trials of Oral ll-37 on COVID-19Dear Dr. Anthony S Fauci:Thank you very much for your hard work on COVID-19. You are the hero of word!This is Prof. Wanzhu Jin prof. Institute of Zoology, Chinese Academy of Sciences .(b) (4)NIH-000021(b) (4)NIH-000022(b) (4)Many thanks in advances !Wanzhu Jin & Gang SunNIH-000023From:Sent :To:Cc:Subject :Marianne:Fauci, Anthony (NIH/N IAID) [E)Mon, 6 Apr 2020 16:41:38 +0000info@marianneorlando.comGrady, Christine (NIH/CC/BEP) [ElFW: Fauci superheroMany than ks for doing and sending t his.Best rega rds,TonyAnthony S. Fauci , MODirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in enor please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Marianne Orlando <info@ma rianneorlando .com>Se nt: Friday, April 3, 2020 6:55 PM ------ ~= To : Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: Thank you, sirDear Dr. Fauci,Being a freelance illustrator, I am tryin g to keep myself producti ve dur ing thislife-altering pandemic by doing a ser ies of COVID-19 inspired drawings.This is my late st, tha t I call: "My Personal Superhero."I dedicated it to you like thi s: "In his own, quiet way, he is a BadAss:Disseminating info about this disease calmly and, always, backed by science ."NIH-000024Here is my drawing:So, Thank you, Sir. You are the voice of reason in what has been a dangerous,frightening situation. You are a real leader.Thank you,Marianne Francesca Orl andoThank you ,Marianne OrlandoMarianne Orlando Illustrations(b)(6)NIH-000025cell:.!:-'.-------. landline:(b)(6)(b)(6)MARIANNE :44 .. 1.J-gL.,.,.f-;A.,,._.j _0 R LANO O WM/YV'fMIVIATf'VYinfo@marianneorlando.comwww.marianneorlando.comNIH-000026From:Sent:To:Cc:Fauci, Anthony (NIH/NIAID) [E)Mon, 6 Apr 2020 14:57:23 +0000Billet, Courtney (NIH/N IAID) [E]Conrad, Patricia (NIH/NIA ID) [ElSubject : FW: Request for your support in promoting new WHO recommendation foremergency response operation to provide universal access to mandatory hand hygiene against COVID-19Attachments: who -interim -recommendation-on -obligatory -hand-hygi ene-againsttransmission-of-cov id-19 .pdfLet us discuss. I am not sure what I should do with t his. Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: HOYER,S tefan Detlef Leo ------- (b)( 6)·> Sent: Monday, April 6, 2020 8:34 AMTo: Fauci, Anthony (NIH/NIAID) [E)------= (b")"('=6)>Cc: Emanuele CAPOBIANCO~ -:--:-====~~Cb()-6 >-b; GORDON,B ruce Allan ------- (b) ( 6)t >; ROGERS,P aul (b)(6) Subject: Request for your support in promoting new WHO recommendat ion for emergency responseoperation to provide universal access to mandato ry hand hygiene against COVID-19Import ance: HighDear Dr. FauciPlease find enclosed the new WHO recommendat ion on establishing universal access to hand hygienestations at thresholds of publicly accessible buildings and means of public transport. It is now officiallypublished at : https://who.int/who-documents-detail/interim-recommendations-on-obligatory-handhygiene-against-transmission-of-covid -19 I attach a pdf copy for easy reference .I wou ld like to request your support in promoting the recommendation as part of an internationalemergency response operation providing universal access to mandatory hand hygiene and/or sanitat ionagainst COVID-19 infect ions. Provided it is now made available and made obligatory whenever enteringNIH-000027and leaving a facility to wh ich the general public has access, it could become possible to prevent mostsmear infections by decontaminating all hands prior and after each possible contamination, both activeor passive. In addition, the measure should massively reduce transmission of other viruses and bacteriacurrently burdening diffe rential diagnosis of COVID-pneumonias. Based on the excellent experiencesmade with the acceptability and adherence during Ebola outbreaks, repeated mandatory hand hygieneor sanitation should thus become an almost unconscious routine of everyday life for any person havingto leave his or her private home in Corona-affected countries.I have been asked by senior WHO emergency management to promote the WHO recomme ndation forrapid implementation with particular focus on current COVID-19 transmission epicenters such as theUSA. Providing a systematic access to hand hygiene stations and making their use obligatory prior toentering and whenever leaving any public facility will also provide a safety net whenever currentrestrictions on movements and commerce are to be progressively reduced. Given the high resourcesettings in the current COVID-epicentres, and the negligible cost of implemen ting this public healthemergency measure compared to prolonged mass confinement without safe exit strategy, I do presumethat the wherewithal to carry it out will not be limiting facto r.Thank you for considering the collaboration in this emergency measure proposed within th e USA at thelargest possible scale. WHO has requested IFRC to alert the American Red Cross to support large scaleimplementation should your Government decide to implement the public health measure proposed.With best wishes for success in all of your endeavours,Stefan HoyerDr Stefan Leo HoyerMedical OfficerFocal Point for EmergenciesGlobal Malaria Programmet: (b) (6) e :- ---(b-) (6-) m: ______ w: www.who.int/ma lariaWorldH eaIt hOrganizationNIH-000028From :Sent:To:Subject:Thanks, Larry.Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Mon, 6 Apr 2020 13:40:45 +0000Jameson, James LRE: COVID-19 RxNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From : Jameson, James L (b)(6)>Sent : Monday, April 6, 2020 9:35 AMTo: Anthony Fauci (b) (6) >Cc: Conrad, Patricia (NIH/NIAID) [E] ----------(b)( ; Fauci, Antho ny (NIH/NIAID) [E) (b )( 6) >Subject: Re: COVID-19 RxTony,T completely understand - we are all thinking about you as you help the country .navigate thiscrisis - thanks so much. Let me know if there is any way that I, or people at Penn, can be helpful. Ourscient ists, severa l of whom are Coronavirus experts (Susan Weiss, Paul Bates), have coalesced form aCenter to focus on potential treatme nts and immuno logy related to the virus. I list few below and youmight triage to others to flu further:NIH-000029(b) (4)Best regards,LarryFrom: Anthony Faud (b)(6)>Date: Monday, April 6, 2020 at 8:25 AMTo: "J. Larry Jameson" (b)(6)> --=========::.....-=-c-"C=s(b) (4)Cc: Dennis Kasper (b)(6)>, Joseph Loscalzo_____ ....:.,_...:::====- (b;):(:;6:; ;);-J:-a-m_e_s_S::h-a_n_a-h;-a_n_ ---------------, (ab)-,:.(.=6., ).Subje ct : Re: COVID-19 RxLarry:I am so sorry that I have not gotten back to you and others in so long. I am completely swamped (3 to4 hours sleep per night just does not work very well) and have not been able to even check my non-NIH(b)(6) . I will try my best to catch up soon. Thank for your understanding .Best regards,TonyOn Fri, Mar 13, 2020 at 9:33 AM Jameson, James L- -------- (b)(6)wrote:Dennis and TonBest rega rds,LarryAnthony S. Fauci, M.D.Editor, Harrison's Principles of Internal Medicin eNIH-000030(b) (4)From:Sent:To:Cc:Subje ct:Kim:Fauci, Anthony (NIH/NIAID) [E]Mon, 6 Apr 2020 02:27:39 +0000Barasch, Kimberly (NIH/NIAID) [CJConrad, Patricia (NIH/NIAID) [E);schoofs@usc.eduFW: 2nd try: Mark Schoofs reaching outPlease have me call Mark tomorrow.Thanks,TonyFrom: Mark Schoofs <schoofs@usc.edu>Sent: Sunday, April 5, 2020 7:28 PMTo: Fauci, Anthony (NIH/NIAID) [E],------- ~(b-):(-= >; Fauci, Anthony (NIH/NIAID) [E](b)(6)Subject : 2nd try: Mark Schoofs reaching outHi Tony,God knows you are doing the world' s most important work right now, but if possible, I wouldlove to talk with you for my COVID-19 project . I promised to keep it under 10 minutes, probablyjust 5.My cell: ------ (b)(6)All best ,MarkFrom: Mark SchoofsSent: Saturday, March 28, 2020 10:04 AMTo (b)(6) --------------------------- Subject: Mark Schoofs reaching outHi Tony,I hope you're hanging in there! If you have 5 minutes - 10 max - I'd like to talk with you for aCOVID-19 project I'm working on .My cell is ----- (b) (6) .Thank you .NIH-000031NIH-000032All best,Mark SchoofsVisiting Professor of JournalismUniversity of Southern CaliforniaNIH-000033NIH-000034From: Fauci, Anthony (NIH/N IAID) [E)Sent: Sun, 5 Apr 2020 15:59:51 +0000To: Marston, Hilary (NIH/NIAID) [ElSubject: FW: GPMB: MESSAGE ON BEHALF OF THE CO-CHAIRS: PROPOSED BOARDTELECONFERENC-E3 0 MARCH 15:00 CESTAttachments: Statement on the COVID-19 pandemic and the Extraord inary G20 leaders'Summit - 1Apr2020 .pdf, GPMB Teleconference 30 March 2020 - Meeting Report 1 Apr 2020.pdfPlease check th is out and let me know if there is anything we need to do. Thanks.From: RIOUX, Amelie (b)(6)Sent: Sunday, April 5, 2020 11:37 A-M- ------=~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Cc: Marston , Hilary {NIH/NIAID) [El (b)(6)>; Steven T. Smith (b)(6) ;Conrad, Patricia (NIH/NIAID) [E) (b)(6) >; SMITH, Ian Michael (b)(6)Subject: FW: GPMB: MESSAGEO N BEHALF OF THE CO-CHAIRS:P ROPOSEDB OARDT ELECONFERENC-E30 MARCH 15:00 CESTDear Dr Fauci,Please find attached the meeting report from the GPMB teleco nference on 30 Mar ch 2020 and theGPMB co-Chairs' Statement on the COV/0-19 pandemic and the Extraordinary GlO Leaders' Summit onCOV/0-19. I apologize, your email was deleted by mistake in the last two messages to the GPMB.With kind regards,AmelieGPMB SecretariatFrom : RIOUX, AmelieSent: Friday, 3 April 2020 14:18To: 'VDzau@nas.edu' (b)(6)>; J.Farrar (b)( >; 'hfo re@unicef.org'(b)(6)>; 'Gao Fu' (b)(6) ':'"'.""--::======~,;;--.---:-:--:-:--:-.==========,=;e:;;-' Gash um b a Diane' (b)(6)> ; Ilona Kiekbusch (b)(6);'Skvortsova Veronika' (b) ( >; 'Vega Morale s Jeanette' ---!:==== ("b:)"=:(6~)--(b)(6)Subject: RE: GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS:P ROPOSEDB OARDT ELECONFERENC-E3 0MARCH 15:00 CESTDear Board Members,NIH-000035Please find the link to the GPMB co-Chairs' Statement on the COVID-19 pandemic and the ExtraordinaryG20 Leaders' Summit on COVID-19 (also attached):https://apps.who.int/gpmb/assets/odf/Statement%20on%20the%20COVID-19%20pandemic%20and%20the%20Extraordinary%20G20%20Leaders'%20Summit%201Apr2020.pdfWe encourage you to circulate the Statement through your channels. You may wish to use the origina lhashtag from our report #AWorldatRisk in social media posts.Wi th kind regards,AmelieGPMB SecretariatThis message is being sent to GPMB members and their designated staff in copy.From: RIOUX, AmelieSent: Wednesday, 1 April 2020 16:42To: 'VDzau@nas.edu' (b)(6J; J.Farrar (b)(6); 'Gao Fu' Cb) (6) ----======-==---::--------=======~=;:- ; 'Gashumba Diane' (b)(6)>; Ilona Kiekbusch (b)(6J; --=======~.--- 'Skvort sova Veronika' (b) ( >; 'Vega Mor ales Jeanette (b) (6)(b)(6)Subject: RE: GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS:P ROPOSEDB OARD TELECONFERENC-E3 0MARCH 15:00 CESTDear Board Members,On behalf of the co-Chairs, please find attached the report from Monday's teleconference.With kind regards,AmelieGPMB SecretariatThis message is being sent to GPMB members and their designated staff in copy .From : RIOUX, AmelieSent: Tuesday, 31 March 202009:17To: 'VDzau@nas.edu' (b)(6J>; J.Farrar (b)(6)(b)(6)--------- (b)( >; Ilona Kiekbusch (b)(6J>;NIH-000036'Skvortsova Veronika' (b) ~ >; 'Vega Morales Jeanette' (b)(6)>;(b)(6)(b)(6)Scott Dowell(b)(6) William-H:a--1::=1-=========================. (~b)~(;::'=T;-:e--re_sa~Miller de ---:-:===================---~-- (b)(6)(b)(6)(b)(6)(b)(6); 'office-psa@nic .in' <office-psa@nic.in >; Toomas_-...::====::e::::,,,,:(b;-)(-6-):>-;- GPMB Secretariat <gpmbsecretariat@who.int >; GABEDAVA,T sira-------- (b) ( 6) >; 'Steve Landry' (b)( > Subjec t: RE: GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS: PROPOSEDB OARDT ELECONFERENC-E3 0MARCH 15:00 CESTMESSAGE ON BEHALF OF THE GPMB CO-CHAIRS DR BRUNDTLAND AND MR SYDear GPMB Members,Many thanks for your contributions to our teleconference, and to Jeremy and Victor for their veryhelpful report on the GPMB COVID-19 advocacy.Several of you mentioned that you had additional points that you might wish to make in writing; pleasedo so as soon as possible, copying them to all Board members.If you have not already nominated a 'sherpa ' to represent you in the informal support group that willwork with the secretariat, please do so as soon as possible. The secretariat is organizing ateleconference with the informal support group to follow up on the direction given by the Board on theannual report and work plan .Kind regards,Gro &AsGPMB Co-chairsNIH-000037From: RIOUX, AmelieSent : Monday, 30 March 2020 12:19(b)(6)>; J.Farrar (b)(6)'Gao Fu' (b)(6) "'":"'"----:======~~-:---'"""':""~--:--::::=====~~- ; 'Gas-h-um--ba- !D:i:an:e:': :~~;--:-----(b-)(6); Ilona Kiekbusch (b)(6)>; ' S k v or ts ova Veronika' (b)(6) ; 'Vega Morales Jeanette' (b)(6);(b)(6)>>; SMITH, Ian Michael(b · SCHWAR , ernhard F. (b)(6) ; RYAN, Michael J.====~~~ ·(b)( >; 'Pate Muhamed' (b)(6l; 'Goda I, Tore' (b)( >;'Tore Godal' (b)(6)>; Alveberg, Bened ikte Louise (b)(6)>;(b)(6)Scott Dowell(b)(6) William-"'.':":==========================::;: (b:);(:~6;)-'~T-e-re_sa_Miller de(b)(6)(b)(6)(b)(6)(b)(6)'office-psa@nic.in' <office-psa@nic.in >; Toomas(b)(6); GABEDAVA, Tsira =========-=- -------- (b) ( 6); 'Steve Landry' (b)( > Subject: RE: GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS:P ROPOSEDB OARDT ELECONFERENC-E3 0MARCH 15:00 CESTDear Board Members and Colleagues,A kind reminder that Europe has switched to Daylight Saving Time over the weekend.The call takes place today at 15:00 Geneva time, which is 06:00 Seattle time, 09:00 DC time, 21:00Beijing t ime, and 22:00 Tokyo time.Best,AmelieFrom: SMITH, Ian Michael (bH >Sent: Friday, 27 March 2020 19:19To : (b)(6)>; Chris.Elias ------------ (bH >; J.FarrarNIH-000038(b)(6)Fu' --".'-:::======-=~~~--"'."".""-~-====C=b()6 =) =:-=~ umba Diane' (b)( >; Ilona Kiekbusch (b)(6)>;'Skvortsova Veronika'-----.::::====:~i:'.""'.'"--:-:--(b) (6)'Vega Morales Jeanette' (b) (6)(b)(6)(b)(6)(b)(6)(b)(6)(b) (6)>;>; 'office -psa@nic.in' <office-psa@nic.in >; Toomas Palu ----.!::::==-=~~---- GP MB Secretariat <gpmbsecretariat@who.int >; GABEDAVA, Tsira (b)(6); 'Steve Landry'(b) (6) RIOUX, Amelie (b) (6) -------------- Subject: RE: GPMB: MESSAGEO N BEHALFO F THE CO-CHAIRS: PROPOSEDB OARDT ELECONFERENC-E3 0MARCH 15 :00 CESTDear Board members, dear Colleagues,Thank you very much to those of you who confirmed your participation in the teleconference onMonday from 15.00-16.00 CET. If you have not done so yet, we would be grat eful if you could let usknow as soon as possible.If you cannot attend, the co-Chairs would welcome your written comments in advance of the call.In prepa rat ion for the call, please find attached:1. Agenda2. Extraord inary G20 Leaders' Summit Statement on COVID-19 (shared with you earlier)3. Update on the GPMB urgent COVID-19 funding call from the GPMB COVID-19 sub group4. Overv iew of Existing Global Appeals and Funding Mechanisms for COVID-19 (for informatio n)The call- in details are copied below .Please note that as several of you have nom inated an Alternate to attend on your behalf, the co-chairswill invite Board Members to speak first, followed by Alterna tes speaking on behalf of Board memb ers.NIH-000039Given the very limited time, the co-Chairs have asked that keep your interventions as short as possible.We look forward to the call. Please let us know if you have any questions.With kind regards,Ian SmithGPMB Secretariat********Call-in Details:By clicking on the link Access via Web, you will find local and toll-free call-in numbers.Participant access-------- ('"b).". (..4- .).Security code: For thisconference a Securitycode is not necessary.Access via WebFrom: RIOUX, AmelieSent: Wednesday, 25 March 2020 14:16Optional dial-in numbersinternationa l+41 58 262 07 22 (English) +41 58262 07 44 (Italiano) +41 58 26207 11 (Deutsch) +41 58 262 07 33(Fran~ais)To: (b)(6)Jeremy Farrar' (b)(6) ----==============~ Anthony Fauci (b)(6); Gao Fu (b)(6)>;:;:::::======~(b~)(6-)-· Gashurnba Diane CbH6l>I;l ona Kiekbusch (b )( 6) >; Skvortsova Veronika (b)(6)>; Vega Morales Jeanette(b)(6)Cc: (b)(6);A s Sy CbH6JS;M ITH, Ian MichaelSCHWARTLANDERB,e rnhard F.======== C"">;b:~;6=) RYAN,M ichael J_..:====~~ >; PateMuhamed (b)(6)>; Goda I, Tore< (b)(6)>; Tore Godal (b)(6);NIH-000040-T-o-om--a-s =Pa=lu ~~----- (b)(6J>;G PMB Secretariat ----------- CbH6JG; ABEDAVAT, sira (b)(6)>Subject: GPMB: MESSAGEO N BEHALFO FT HE CO-CHAIRS:P ROPOSEDB OARDT ELECONFERENC- E30MARCH 15:00 CESTMESSAGEO N BEHALFO FT HE GPMB CO-CHAIRSD R BRUNDTLANDA ND MR SYDear Board Members,We would like to propose to hold a Board teleconference on Mond ay 30 March 2020, 15 :00-16:00 CESTtime. The purpose of the call will be to update you on the GPMB's COVID-19 advocacy and to discussnext steps. A more detailed agenda and call-in details will be shared shortly.We wou ld appreciate if you could confirm your participation to Amelie Rioux- ----- (b)(6)Thank you for your continued support and engagement.With kind regards,Gro and AsNIH-000041From:Sent :To:Subject:deathThanks, Teresa.Fauci, Anthony (NIH/NIAID) [E)Sun, 5 Apr 2020 01:57:37 +0000Teri McPeakRE: Association between Proton Pump Inhibitors and increased risk of Covid-19From: Teri McPeak <t.mcpeak@live.ca>Sent: Saturday, April 4, 2020 5:44 PMTo: Fauci, Anthony {NIH/NIAID) [E]_ _____ "("b"")"("=6")Subject: Association between Proton Pump Inhibitors and increased risk of Covid-19 deathDr. Fauci,There is a wealth of medical research papers about the association between Proton PumpInhib itors (PPI) and increased risk of community acquired pneumonia. Long term use of PPlsreduce the pH of the stomach from 1 to 5. This reduction in stomach acid reduces the body'sability to fight viruses.In addition, the lower stomach pH reduce the ability to absorb key nutrients that requiregastric acid for breakdown and absorption (calcium, vitamin C & 812, iron, magnesium,potassium, zinc). Lack of proper nutrients lead to a compromised immune system.Seniors and individua ls with chronic illnesses are at higher risk of ploypharmacology and dyingfrom Covid-19 due to PPls. The more medicat ions an individual tak es, the more likely they willsuffer from acid reflux and thus be prescribed a PPLThank you for your commitment and compassion during the pandemic. God bless you.Regards,Teresa McPeak(b)(6)NIH-000042From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 5 Apr 2020 01:54:27 +0000Silver, David (NIH/NCI) [C]Subject: RE: QuestionDavid:Thanks for the note. Since they both effected adequate quarantine, they are OK with eachother .... provided that they practice physical distancing wit h everyone else, i.e. 6 feet apart andmasks when out in situations where they cannot guarantee 6ft distance. With regard to yoursecond question, it is not a question of temperature, it is a question of what surface the virus inon - stainless steel versus cloth, versus cardboard. Each of these have differ time frames ofsurvival of replicatio n competent vi rus from a couple of hours to about 2 days.Best regards,TonyFrom:S ilver, David (NIH/NCI) [C)- ------- (b)( Sent: Saturday, April 4, 2020 9:04 PMTo: Fauci,A nthony (NIH/NIAID) [E] -------= (b,.),.=(6,)Subject: QuestionDr. Fauci,You are doing a great job and I am sure that things must be very challenging.Please let me know your thoughts on this, although I think I know the answer.Is it safe for them tosee each other at this point?I was also wondering if it has been determined how long COVID-19 can live in a refrigerato r orfreezer.Thank you.Stay Healthy.DavidDavid Silver - Contractor(b)(6)National Institutes of Health , NCICenter for Biomedical Informatic s and Informati on Techno logy (CBIIT)9609 Medica l Center Dr.NIH-000043NIH-000044Rockville , MD 20850From:Sent :To:Subject:Tony:(b)(6)Sat, 4 Apr 2020 15:50:32 -0400anthony trocchiRe: An aquaintence from the pastThank you for your note. I hear you!Best rega rds ,Tony> On Apr 4, 2020, at 12:25 PM, anthony troccbi -------- (b)(6) > wrote: >>> Hi Tony, You probably don't rememb er me, T was (b) (6) husband back when she was at NIH, youcame to dinner at our hou se once. We also hung out in Boulder and drank beer together. I am just a working clas sguy, but keep up with science and politics for what it is worth. I don't know what you hear from the street level, butfrom here in . NY we are pretty concerned with the risk of Covid-19 and the Federal response to the pandemic. Youhave been the only reasonable voice in the administration. The leadership from the top is utterly lacking andincom pete nt and dangerous to the American people. You have had a long and venerab le career and I am asking youto stand up to power and speak the harsh truth to the peop le of this country and the without regard to your personalconsequences. We need a u11ified and professiona l federal response to this unprecedented c1is is. I think you may bethe only person of repute and status that has the power to change the course of history. I have spoken witti a goodfriend of mine who is a respected epidemio logist and he said that Covid-19 will infect half the population of theworld and those numbers are frightening statistically. My dad was born during the first worldwide modern pandemicand I don't really want to see him leave from this current one. I know I am somewhat out of place writing to you,b11t one can only do what one can do to influe nce the events that hist ory arises from. With utmost respect. TonyTrocchi> Sent from my iPhoneNIH-000045From:Sent :To:(b)(6)Sat, 4 Apr 2020 15:42:37 -0400Stuart CoulterSubject: Re: Early Successesin ClinicalT rial on COVID-19P atients with High Dose IVVitamin CThanks, Stuart. I appreciate your sending me this information. I will pass it on to relevantprogram people.Best regards,TonyOn Apr 4, 2020, at 3:38 PM, Stuart Coulter (b)( >wrote:Dear Dr. Fauci,Early Successesin ClinicalT rial on COVID-19P atients with High DoseI V Vitamin CThank you for the invaluable work that you are doing in guiding the United Statesthrough the current COVID-19 pandemic.I hope that you do not mind me contacting you, but I wanted to bring yourattention to a clinical trial that is currently taking place in China on COVID-19patients with high dose IV Vitamin C.There are reports of some early successes with this treatment and I wondered ifthis could be a possible stop gap treatment - that cou ld possibly save many lives -whi le we await the development of suitable drug treatments and a reliablevaccine.The trial in China is not due to conclude until September of this year, however,previous trials of IV Vitamin C have shown it to be a very safe treatment with litt leor no adverse side effects. I have read tha t the Northwell Hospital Group in NewYork, which operates 23 hospitals, have already started to give this treatmentto many of their COVID-19 patients.This treatment also appears to meet the normally required criteria for a clinic trial.The treatment has been shown to be:1) Effective (Please see the link below to the promising tria l results currently takingplace in China).2) Safe (The treatment has been shown to be safe in many previous tr ials goingback well over 40 years).3) Correct dosage is understood (The dosage is fully understood - please see theattached Protocol).4) The correct patients to give this treatment to (Virtually everyone in hospitalinfected with COVID-19).5) The correct time in the illness to give the treatment (As soon as the infectedpatient comes into hospita l).NIH-000046NIH-000047I hope that you and your team find the details of this clinical trial of some interest.The hospital protocol for this treatment is attached and here is a link to details ofthe current trial in China along with some other relevant links:http://www.orthomolecular.org/resources/omns/v16n18.shtmlhttp://www.orthomolecular.org/resources/omns/v16n19.shtmlhttp://www.orthomolecular.org/resources/omns/v16n07.shtmlhttp://orthomolecular.org/resources/omns/vl6n21.shtmlhttps://www.sciencedirect.com/science/article/pii/S2590098620300154?via%3DihubKind regards,Stuart Coulter<Journal Pre-proof - Can early and high intravenous dose of vitamin C prevent andtreat corona virus disease 2019 . pdt><Protocol - IV AA-COVID19-Hospital-Use-Anderson-03.24.2020.pdt>From:Sent:To:(b)(6)Sat, 4 Apr 2020 12:42:38 -0400Conrad, Patricia (NIH/NIA ID) [E]Subject: Fwd: Interview Request: #1 Hiking PodcastFYIBegin forwarded message:Fro m: Zach Davi s <zac h@thetrek.co >Date: April 4, 2020 at 12:39:25 PM EDT To: "Fauci , Anth ony (NIH/NJAID) [E]" --------------=--= CbH Subject: ln terview Request: #1 Hiking PodcastHey Dr. Fauci-My name is Zach Davis, I'm the founder and editor-in-chief at The Trek, amedia company dedicated to long distance backpackers. Thank you for thetremendous service and leadership you've given this country during a timeof great need.I'm reaching out to inquire about the possibility of your doing a shortinterv iew for our fl agship podcast, Backpacker Radio, the #1 rated hikingpodcast on iTunes. We're putting together an episode related to howCOVID-19 has impacted this year's class of backpackers, and would love tofeature your expert insight on why social distancing is important, and whatthe future may hold for our community.The interv iew would be alx>ut 20-25 minutes, though if you're onlyavailable for a shorter period, we'll take what we can get!Thanks for your time and thank you again for your terrific service to thiscountry.Happy hiking,Zach Davisfounder 11 editor-in-chiefhikerlink I thetrek.co I backpacker radioNIH-000048NIH-000049From:Sent :To:Subject:CORONAVIRUS DISEASEGood for them!! !Fauci, Anthony (NIH/NIAID) [E)Sat, 4 Apr 2020 16:25:36 +0000Folkers, Greg (NIH/NIAID) [E)RE: AFRICA CDC: STATEMENT ON MEDICATIONS TO TREAT NOVELFrom: Folkers, Greg {NIH/N IAID) (E] (b)(6)Sen t: Saturday, April 4, 2020 12:2 1 PMSubject: AFRICA CDC:S TATEMENTO N MEDICATIONS TO TREATN OVELC ORONAVIRUSD ISEASENIH-000050From:Sent :To:Subject:Attachment s:fi nal.docxFauci, Anthony (NIH/N IAID) [E)Sat, 4 Apr 2020 15:18:14 +0000Barasch, Kimberly (NIH/NIAID) [CJFW: Excellent start to COVID PPPCOVID PPP April 3 actions.docx , Introductory call short bios - 3 Apr 2020Please print out these attachments and put into a folder labelled "COVID-19 Public PrivatePartnerships" Thanks.From: Collins, Francis (NIH/OD) [El (b)( >Sent: Saturday, Apr il 4, 2020 10:26 AMTo: (b)(6) (OS/IOS) (b)(6)Cc: Harrison, Brian (HHS/10S) (b)( ; Tabak, Lawre nce (NIH/OD) [El---------- (b)(6); Fauci, Anthony (NIH/NIAID) [El (b)( > Subject : Excellent start to COVID PPPHi Mr. Secretary,Just wanted to let you know - we had a very productive and significant two-hou r virtua l meeting withleaders of industry, FDA, and NIH yesterday . I attach the bios of those who attended - which includesthe heads of R&D of nine major pharmaceutica l companies. There is unanimous support for bringingtogether all of the sectors to accelerate development of therapeutics and vaccines for COVID-19. Tonycompared this to what happened in the early 1990s that led to successful ant ivirals for HIV.I attach the action items that came out of this meeting . Working groups for each of the four main top icswill be rapidly organ ized. I will keep you posted .Best, FrancisNIH-000051From:Sent :To:Cc:(b)(6)Fri, 3 Apr 2020 16:42:08 -0400Cantor, Harvey l.,M.D.NIAIDODAMSubject: Re: COVID-19Harvey:Thank you for your kind note. It is much apprec iated. I will let the team know about yourwillingness to serve on committees and study sections .Best regards,TonyOn Apr 3, 2020 , at l :20 PM, Cantor, Harvey I.,M.D.(b) (6)>wrote:Dear Tony,In these unsettli ng t imes, you are a much-appreciated voice of reason andproponen t of rationa l science.A great credit to NIH and NIAID ... we're all very proud of you.I know that you have long advocated preparation of viral vaccines againstfuture pandemic threats.I'm sure tha t it has been difficu lt to convince pharmas, charitable agenciesand even the government to fund these efforts.which would include vaccine production and storage for indefinite periods.Perhaps there will be a greater will ingness torevisit a cost-benefit analysis of this effort in the near future.I would be happy to serve on committee s, study sections etc. in an effort toincrease our ability to identify and fund first-rateImmunology research that might accelerate innovative, safe and effectiveapproaches to improved viral vaccines going forward.All very best regards, h.Harvey Cantor, MDBaruj Benacerraf Professor of ImmunologyDepartment of Immunology,Harvard Medical SchoolDept. of Cancer Immunology &Virology,Dana-Farber Cancer InstituteNIH-000052Boston MA 02215(b)(6)The information in this e-mail is intended only for the person to whom it isaddressed. If you believe this e-ma il was sent to you in error and the e-mailcontains patient infonnation, please con tact the Pattners Compliance HelpL ine athttp ://www.partners .org/compliance line. If the e-mail was sent to you in errorbut does not conta in patient information, p lease contact the sender and properlydispose of the e-mail.NIH-000053From: (b)(6)Sent :To:Subject:Fri, 3 Apr 2020 16:29 :45 -0400Hasenkrug, Kim (NIH/NIA ID) [E]Re: Thanks from the troopsKim:Many thanks for your kind note .Best regards ,TonyOn Apr 3, 2020 , at l :56 PM, Hasenkrng, Kim (NIH/NIAID) [E](b)(6)Hi Tony, I just want to express my sincere gratitude for all you are doingto get us through this crisis. Everyone I've talked to at RML expressestheir deep admiration and apprec iation for your strong leadership, andwe feel proud to be working for you. We listen to your hoarse voiceevery day. Personally, I have started two new lines of research todevelop and test possible therapeutics for COVID-19. The cooperationand collaboration from everyone I've talked to , both here and aroundthe nation, has been unb elievable. Please take care of yourself and staystrong and healthy for the sake of all of us!Best regards,KimKim J Hasenkrug, Ph.D.Senior InvestigatorChief, Retroviral Immunology SectionLaboratory of Persistent Viral DiseasesRocky Mountain LaboratoriesNat ional Institute of Allergy and Infectious DiseasesNational Institut es of Health903 S. 4th StreetHamilto n, MT 59840phone ------ (b)(6)NIH-000054FAX (406)363-9286(b)(6)Disclaimer:The information in this e-mail and any of its attachments is confidentialand may contain sensitive information. It should not be used by anyonewhois not the original intended recipient. If you have received this e-mail inerror please inform the sender and delete it from your mailbox or anyotherstorage devices. National Institute of Allergy and Infectious DiseasesNIH-000055(bX5)-PCINIH-000056NIH-000057NIH-000058From:Sent :To:Cc:Subject:Fauci, Anthony (NIH/N IAID) [ElFri, 3 Apr 202011:07:58 +0000Ghafoor, Azam (NIH/NCI) [ElNIAIDODAMRE: HelpThanks for your note. I will circulate to others in NIAIDFrom: Ghafoor, Azam {NIH/NCI) [E] _______ Cb_H_6)>Sent: Thursday, April 2, 2020 11:10 PMTo: Fauci, Anthony {NIH/NIAID) [E] ______ "("b"")"("=6" )Subject: HelpDear Dr. Fauci,I am thoracic oncologist at the NCI. I wanted to commend you on your tremendous (andexhaust ing) job on managing and steering our country with the COVID -19 pandemic. If youneed additiona l any personnel to help with any clinical or non-clinical aspects of the currentsituation, I am more than happy to help. As you know we have scaled down our clinicaloperations and trials at the NIH CC and so I have more time.Best regards,Azam Ghafoor, MDAssistant Research Physician & Staff OncologistThoracic Oncology SectionThoracic and GI Malignancies BranchNational Cancer Institute, National Institutes of Health10 Center Drive, Building 10, Room: 4G-5330Bethesda, MD 20892e: (b)(6)o: (b)(6)c: --==-- page ID Cb) (6)NIH-000059From:Sent:To:Cc:Subject:David:Fauci, Anthony (NIH/NIAID) [E)Fri, 3 Apr 2020 02:40 :47 +0000David BarrGiroir, Brett (HHS/OASH;C) onrad, Patricia (NIH/NIAID) [ElIntroductionI am using this e-mail to introduce you to Adm. Brett Giroir who is the Assistant Secretary forHealth at HHS and a key member of the Coronavirus Task Force. I have explained to Brett theissues that you and your colleagues brought up over the phone with me the ot her night. Brettis willing o get on the phone with the group and go over some of these issues and perhaps helpto resolve them. He is wait ing o hear from you. Many thanks.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The Nat ional Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-000060From:Sent:To:Cc:Subject:Steve:Fauci, Anthony (NIH/NIAID) [E)Fri, 3 Apr 2020 02:10:12 +0000Stephen Hahn(b) (6)'FDA releaseMy staff just pointed out to me a _proposedF DA press release regarding convalescent plasmaand hyperimmune globulin. The press release reads as follows:I just wanted to bring this to your attention for further consideration. Many thanks.Best regards,TonyNIH-000061(b) (5)From: Fauci, Anthony (NIH/NIAID) [E)Sent: Fri, 3 Apr 2020 01:53:59 +0000To: Emilio EminiCc: Conrad, Patricia (NIH/NIAID) [E);Mascola, John (NIH/VRC) [E];Erbelding, Emily(NIH/NIAID) [E];Bright, Rick (OS/ASPR/BARDA;C) ollins, Francis (NIH/OD) [E] CbH6l;'TrevorMundel'Subject: RE: Connection Request per Bill GatesEmilio:Thank s for your note. As I had ment ioned to Bill yesterday evening, I am enthusiastic aboutmoving towards a collaborative and hopefully synergistic approach to COVID-19 on the part ofNIAID/NIH, BARDA and the BMGF. I will ask John Mas cola and Emily Erbe lding to connect withyou to stay a conversation. Perhaps they can organize a call with you including BARDA. I willtry to engage as much as I can given my current circumstances. We look forward to workingwith you.Best regards,TonyFrom: Emil io Emini ------------- (b)(6)> Sent: Thursday, April 2, 2020 9:58 AM -------~~ To : Fauci, Anthony {NIH/NIAID) [E]- --------- (b)(6)> Subject: Connection Request per Bill GatesTony-I received a note from Trevor and Bill that they connected with you yesterday and they asked meto reach out . I've taken on the role of coordinating the foundat ion's contributions to the global COVIDvaccine efforts, in particular for those approaches that are (or soon will be) in early development.There's an obvious need for coordination among the various primary funders or the focus we need tohave given the state of the pandemic will become lost through uncoordinated activities .Bill tells me that you will take on a central role in coordinating BARDA's funding to the ongoing efforts .And, of course, there are the NIH/VRC activities. I'm reaching out to ask how we can coordinate andcross-inform each other's activities. I am very sensitive to how busy you are and very grateful for yourengagement. I see you on TV almost every day, and although you continue to have considerable energy,I am seriously worried about you. The nation and the wor ld absolutely need your leadership.As a next step we can connect 1: 1 briefly or you can pass this on to an appropriate member of yourstaff.If you wish, you can always reach out to me directly at any time though my personal mobile at -Please stay well. ... EmilioEmilio A. Emini, Ph .D., FCPP, FAAMDirectorNIH-000062(b)(6)NIH-000063TB and HIV ProgramBill & Melinda Gates FoundationFrom:Sent :To:Subject:Thanks, Roger.Fauci, Anthony (NIH/NIAID) [ElThu, 2 Apr 2020 23:50:04 +0000Glass, Roger (NIH/FIC) [ElRE: COVID-19 in Africa: TanzaniaFrom: Glass, Roger (NIH/Fie) [E] -------- (b)(6)Se nt: Thursday, April 2, 2020 6:05 PM To: Fauci, Anthony (NIH/NIAID) [E]-- ---------~-~-- (b)(6) Subject: FW: COVID-19 in Africa: TanzaniaTony,You have a fan club in Tanzania-Julie Makani and Lucio with your textbook!Keep up the heroic work .RogerFrom: Julie Makani <jmakani@blood.ac. tz>Sent: Wednesday, April 1, 2020 5:46 PM To: Glass, Roger (NIH/FIC) [E] -_-_-_-_-_- ~= C_Hb_6JSubject: Re: COVID-19 in Africa: TanzaniaPlease pass greetings to Dr FauciHis authorship on Google Scholar including of Harrison's has been under discussion on social mediaLucio has been writing the chapter on hemo lytic anemiaHe is heading to Italy for 3 months. He has been incredible . He was leaving his copies with the Sickle cellprogramme as we plan on getting keen scientists to read themStay safeProf Julie Makan i, T: ------ (b)(6) E: jmakan i@blood .ac.tzNIH-000064From:Sent :Fauci, Anthony (NIH/N IAID) [ElThu, 2 Apr 2020 21:52:30 +0000To:Subject:Lerner, Andrea (NIH/N IAID) [El;NIAID OD AMRE: My take on masksThanks, AndreaFrom: Lerner, Andrea (NIH/NIAID) [El ---------- (b)(6) Se nt: Thursday, April 2, 2020 1:01 PMTo: NIAID OD AM <NIAIDODAM@niaid.nih.gov>Subject : My take on masksGiven our discussion this AM, just thought I would summarize my take on masks across varyingscenarios:NIH-000067(b)(5)From:Sent:To:Fauci, Anthony (NIH/NIAID) [ElThu, 2 Apr 2020 21:14:40 +0000Balasundaram, David (NIH/CSR) [ElSubject: RE: Correlation between universa l BCG vaccination policy and reducedmorbidity and mortality for COVID-19: an epidemiological studyThanks, David.From: Balasundaram, David (NIH/CSR) (E] (b)(6)Sent: Wednesday, April 1, 2020 7:19 AMTo: Fauci, Anthony {NIH/NIAID) (E] ------ (=b)""('6=) >Cc: Balasundaram, David (NIH/CSR) [El (b)(6)Subject: Correlation between universal BCG vaccination policy and reduced morbidity and mortality forCOVID-19: an epidemiological studyImportance: HighDear Dr. Fauci,I thought that you may be interested in reading this paper (Unless you already know about this ofcourse!). This is obviously a data -driven set of correlative observations, but could be worth look inginto.I salute your outspoken efforts to galvanize this country into action in the midst of so many mixedmessages and dragging of feet.Cheers,davtdDavid Balasundaram, PhD.,Scientific Review Officer,Cell Biology Integrated Review Group,http://public .csr .nih.gov/S tudySections/ lntegratedReviewGroups /CBIRG /Pages/default .aspxReferral Officer,Division of Receipt and Referral~ <:.mf'l'b~ Sc,gn•l',c ~6701 Rockledge Drive , Room 5136, Bethesda, MD- 20-8-92--7-76-8 ---== Office (b)(6) I Fax: 301-480-1988 I Email: (b)(6)Integrity matters. Say something ! For concerns or quest ions about possible violations of peer reviewintegrity, please contact your Scientific Review Officer, or the CSR Review Integrity Officer atcsrrio@mail.nih.gov , or the NIH Review Policy Officer at reviewpolicyofficer@mail.nih .gov. See the NIHGuide Notice on integr ity in review.NIH-000068From:Sent :To:Subject:(b)(6)Thu, 2 Apr 2020 13:29:05 -0400Vollmer, SebastianRe: Estimate of undetected COVID-19 infectionsThanks, Sebastian. Very helpful> On Apr 2, 2020, at 8:43 AM, Vollmer , Sebastian ----------------- (b) (6}> wrote: >> Dear Dr. Fauci ,>> we have used estimates of COVTD-19 age specifc infection fatality rates and time from onset to death that wererecently published in The Lancet Infectiou s Disease to estimate COVTD- 19 detection rates and the true number ofinfected people (in contrast to confirmed cases that are widely repo1ted) for the 40 most affected countries. Weestimate a detection rate of on average six percent and number of cases of a few tenth of mi !lions. We thought youmight be intere sted and have attached the note to this email.>> Thanks for doing such a great job in such a difficult time. I lived in Boston for a few year when J was a postdocand later adjunct professor at the Harvard Chan School of Public Health. My thoughts are with my friends in theUnited States, particularly in New York.>> Warmly,> Sebastian Vollmer>>>> <Bommer & Vollmer (2020) COVID-19 detection April 2nd .docx>NIH-000069From:Sent:To:(b)(6)Thu, 2 Apr 2020 13:02:41-0400Jim WestSubject: Re: THANK YOU TONY!Jim:Thank you for your kind note. It is much apprec iated.Best regards,TonyOn Apr 2, 2020 , at 10:08 AM, Jim West (b)( >wrote: ---------Dear Tony,My name is Jim West and (b)(6)- Most people did not know (b)(6)·, excepthis immediate family, close friends and of course Jack Whitescarver. I am writingto congratulate you on the job you are doing with the Coronavirus. There is nodoubt in my mind it has been exceedingly stressful for you and your family, and Ijust wanted to offer my support and reassurance that you are indeed doing a greatjob. I know (b)(6) could have never handled the stress of all of this, and he wouldbe most proud of the job you are doing .Take good care of yourself and keep steadfast in what you are doing. You arethe true medical advisor of the United States during this pandemic, and mill ions ofus are incre dibly grateful.Sincerely yours,Jim WestNIH-000070(b)(S) - PCfNIH-000071(bX5) -PCINIH-000072From:Sent:To:Fauci, Anthony (NIH/N IAID) [E)Thu, 2 Apr 2020 13:21:29 +0000WAYNE REYNOLDSSubject: RE: Heads Up - Dr. Fauci Bobblehead w ith a CauseWayne and Catherine:Thank you for your kind note . Much appreciated . Please stay safe and well sothat we can some time soon (I hope) resume our normal lives together.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and de lete it from your mailbox or anyother storage devices . The National Ins t itute of Allergy and Infectious Diseases (NIAID) shall notaccept liability fo r any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: WAYNE REYNOLDS (b)(6)>Sent: Wednesday, April 1, 2020 3:43 PM ------~~ To: Fauci, Anthony {NIH/NIAID) [El (b)(6):>Cc; Grady, Christine (NIH/CC/BEP) [El CbH >Subject: Fwd: Heads Up - Dr. Fauci Bobblehead with a CauseTony,You've finally hit the big time. The National Bobble head Hall of Fame and Museum. Thank you for allyou' re doing for the country.Warmest wi shes,Wayne and Catherin eSent from my iPhoneNIH-000073Begin fo rw arded message:From: "Jordan, Mary" <Mary .Jordan@washpost.com>Date: April 1, 2020 at 3:39:44 PM EDTTo: Wayne Reynolds (b)(6)>Subject: Fw: Heads Up - Dr. Fauci Bobblehead with a CauseWho knew there was a Nat ional Bobblehead Hall of Fame and Museum !From: Phi l Sklar <phi l.sklar@bobbleheadhall.com>Sent : Wednesday, Apri l 1, 2020 3:34 PMTo: Jordan, Mary <M ary.Jordan@washpost.com>Subject: Heads Up - Dr. Fauci Bobblehead with a CauseIC AUTION:E XTERNALS ENDERHi Mary ,I hope you are staying well dur ing these unprecedented times! I wanted to give youa heads up that we will be unveiling a bobb lehead of Dr. Anthony Fauci this Friday,Apri l 3rd . Dr. Fauci has become Amer ica's voice of reason as one of the leadmembers of the White House Corona virus Task Force. The National BobbleheadHa ll of Fame and Museum will be donating $5 from every Dr. Fauci Bobbleheadsold to the American Hospital Association in support of the I 00 Million MaskChallenge [icm-track ing.meltwater .com] . The bobb leheads will be available for preorderon our website beginning on Friday.Bobbleheads are the ultimate honor, and we think Dr. Fauci deserves it given whathe has done and continues to do for our country and the world in the battle againstCOVID-1 9. The bobblehead will j oin a grow ing number of items including donuts,socks and t-shirts featuring Dr. Fauc i. We rece ived a lot of requests for a bobbleheadof Dr. Fauci and are excited to be able to use the bobb lehead to raise funds for avital organization that is helping limit the spread of the Coronavims whi le makingpeople smile dur ing these unprecedented times.Let me know if you would like the press release, pictures and graphics in advance ofFriday's release. Please hold off on publicizing anything related to the bobbleheadunt il Friday- any time on Friday is okay. Please also let me know if you would likea sample when they an-jve or if you have any questions.Thank you,NIH-000074NIH-000075PhilPhil SklarCo-Founder and CEONational Bobblehead Hall of Fame and MuseumPhil.Sklar@bobbleheadhall.com414-519-2625www.bobbleheadhall.com [icm-tracking .meltwater.com]This email was sent to mary.jordan@washpost.comNational Bobblehead Hall of Fame and Museum , PO Box 0982 , Milwaukee, WI53201-0982, usUnsubscribe [icm-tracking.meltwater.com]From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Thu, 2 Apr 2020 12:59:53 +0000Auchincloss, Hugh (NIH/N IAID) [CJ(b)(6)Subject: FW: COVID-19 PlanningLet us discuss.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301) 496-4409E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The Nat ional Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Ta bak, Lawrence (NIH/OD) [El (b)(6)Sent: Wednesday, Apr il 1, 2020 7:35 PMTo: ICDDIR-L@LIST.NIH.GOV; List DEPDIR-L <DEPDIR-L@list. nih.gov>Cc: NIH Director's Executive Committee <OD-SmallStaff@mail.n ih.gov>Subject: Re: COVID-19 PlanningImportance: HighColleagues,The momentum behind a 4th COVID supplement seems to be building in the Congress evenmore quickly than we had expected. We have received a TA request to prov ide rough numbersfor NIH efforts by Friday afternoon. With regrets for adding more burdens to the intenseefforts you are already engaged in, I ask that you submit a rough estimate of the first year andthe five year budget for your (i) IC-specif ic init iat ive(s) and/or your (ii) proposals to contr ibuteto economic recovery, no later than Friday April 3 at noon. This will be non-binding, and you arefree to revise it for the submission that we already asked you for by Friday COE. The only thingwe need Friday at noon is the budget - the narrative can come later in the day (or the night).Please use the second page of the t emplate we sent you yesterday to provide this draft budget.Send to me.NIH-000076I apologize for the impossible turn-around and appreciate al l the hard work that will be neededto get us this information by the Friday noon deadline.Many thanks,LarryFrom: "Tabak, Lawrence (NIH/OD) [E]" < (b)(6J 1>Date: Tuesday, March 31, 2020 at 4:20 PMTo: " ICDDIR-L@LIST.NIH.GOV " <ICDDIR-L@LIST.NIH.GOV >, List DEPDIR-L <DEPDIRL@list.nih.gov >Cc: NIH Directo r's Executive Committee <0D -SmallStaff@mail.nih .gov>Subje ct : COVID-19 PlanningColleagues,Francis is sending out a note shortly to the co-chairs of each of the ten tra ns-NIH initiatives, asking fortheir assistance in putting together workplans and budgets for those projects. But in addition to thesetrans-NIH activities, we invite ICDs to submit a short description of no more than two IC-specific ideasthat you believe merit consideration for support in a fourth supplemental bill, should one be putforward. Please use the same template that is being used for th e tran s-NIH activities, but just check theappropriate tick box. Your submission should include budget estimates for the first year and subsequentoutyears (for a total of 5 years). (b)(5). Please send these to me by COE, Friday,April 3rd .Finally, l! we are asked about technical assistance regarding economic recovery, please send ideas forthat option. As part of this, Mike Lauer and Michael Gottesman will submit estimates on what might beneeded for extramural institutions and the IRP to "make them whole" . However beyond that there areinfra structu re, training, and other requests that wou ld with help national economic recovery by creatingnew jobs (construction, IT, biomedical, etc.) and help prepare the nation for COVID-202X. Please use thesame template that will be used for the trans-NIH activities (again, checking the correct box) and includebudget estimates for the first year and subsequent outyears (for a total of 5 years). Please send these tome by COE, Friday, April 3rd .Many thanks,LarryNIH-000077From: (b)(6)Sent:To:Subject:Thu, 2 Apr 2020 07:28:32 -0400Conrad, Patricia (NIH/NIAID) [E)Fwd: media inquiry on COVID-19Begin forwarded message:From: "stefano. va lentino @globalreporter.it" <s tefano. valen tino@globalreporter.it >Date: April 2, 2020 at 5:54:54 AM EDTTo: "Fauci, Anthony (NIH/NIAID) [E]" <f (bH6))>Subject: media inquiry on COVID-19Dear Dr. Fauci,I am a Brussels-based journalist, member of the European DataJournalism Network (EDJNet) , a digital news-making platform thataffiliates media outlets across Europe.I found a quote from you in this article which seems to be quiteprophetic: https :/ /www.theatlantic .com/health /archi ve/2020/02/covidvaccine/607000/I contact you to have a discussion about the effectiveness of the epidemicoutb reak preparedne ss and response measures put in place by governme nts,particularly in te1ms of vaccine development.I would like to know if we could ave a chat on sk:ype. Or, if you prefer, I can sendyou some questions by email.I wait for your kind feedbackRegard sStefano ValentinoFounderMobileReporterSpecial Investigations ContributorVoxEuropNIH-000078Fatto QuotidianoFullbright AlumniBerkley School of JournalismMemberships:Italian Press AssociationEuropean Data Journalism NetworkItalian Science Writers AssociationSociety of Environmenta l Joumas/istsOnline News AssociationTel: .___.., CbH,6_l_,,~Whatsapp: CbH6)Skype: globalreporterTwitter: @M0BILEREP0RTERi nfo@mobilereporter. infowww.mobilereporter.infoNIH-000079From:Sent :To:Subject:fyiFauci, Anthony (NIH/NIAID) [E)Thu, 2 Apr 2020 10:58:29 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Possible lneterview via FaceBookFrom: Brendan Taglianetti <btaglianetti@milfo rd.nh.gov>Se nt: Thursday, April 2, 2020 6:34 AM ------ == To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject: Possible lneterview via FaceBookDear Dr. Anthony S. Fauci,My name is Brendan Taglianetti; I am a Full-Time Advanced EMT provider for MilfordAmbulance Service in Milford, NH. I want to help relay your message of COVID-19 information for stateof New Hampshire, by conducting a Facebook Live chat with myself to project information and messagesto the citizens of New Hampshire . This is a chance for us to chat for around 10 minutes and ta lk with afirst responder to the general public.I have seen you do interviews with the media/ daytime talk shows, a Facebook live chat withMark Zuckerberg, and even an lnstagram live video with Stephen Curry from the Golden State Warriors.I run the social media aspect of the departmen t, and I would love to do a 10-15 minute discussion (withinformation to the public, as well as some question and answer) with you on Facebook (live) to have thegeneral public watch us talk about the pandem ic and the next steps, and also maybe take somequestions asked of the publ ic watch ing when they comment. I also will be reaching out to the NewHampshire State Governor Chris Sununu and Dr. Benjamin P. Chan (who is the state's epidemiologist). Iwould love to have them chat with me, and have you join in on the discussion as well. I have noconfirmed with them if they are available yet, but I am putting things in motion.I know that if I was able to set up a time and date that would work around your busy andimportant schedule, then I could with ample time promote it. I would love to not only get the town onMilford to watch th is, but have the state of New Hampshire and other states nearby tune in. I know thisis a long shot and that you have way more important aspects of your job to complete, but I think th is animportant time to have the public hear you talk.Please let me know if this could be possible and I would love to set this up, I don't expect totake too much of your time if this can happen. Sometimes in life you just need to ask and see whathappens and this is a t ime where that risk is worth it to have a conversation with you about thispandemic we are facing, especially as we ramp up for starting to "peak" in the number of peopleaffected .NIH-000080NIH-000081Please let me know if this is possible and tell me if you are interested in doing this with us forthe greater good of the general public to keep them informed .Sincerely,Brendan J. Taglianett iFull-Time Advanced EMT/ Field Training OfficerMilford Ambulance Service66 Elm Street, Milford , NH 03055Phone: (603) 249-0610 (ext . 275)Email: btaglianetti@milford.nh.govFrom:Sent :To:(b)(6)Wed, 1 Apr 2020 22:15:42 -0400McNeil Jr, Donald GSubject: Re: Heads Up - Dr. Fauci Bobblehead with a CauseYikes!!!On Apr 1, 2020, at 9:55 PM, McNeil Jr, Donald G <mcneil@nytimes.com>wrote:-I'm order ing one for my office desk and maybe anothe r for --- (b)(6)----------Forwarded message ---------From: Phil Sklar <phil.sklar@bobbleheadhall.com>Date: Wed, Apr I, 2020 at 3:35 PMSubject: Heads Up - Dr . Fauc i Bobblehead with a CauseTo : <mcneil@nytimes.com>Hi Donald,I hope you are staying well during these unprecedented times! I wanted to give you aheads up that we will be unveiling a bobblehead of Dr. Anthony Fauci this Friday, April 3rd.Dr. Fauci has become America's voice of reason as one of the lead members of the WhiteHouse Coronavirus Task Force. The National Bobblehead Hall of Fame and Museum will bedonating $5 from every Dr. Fauci Bobblehead sold to the American Hospital Association insupport of the 100 Mil lion Mask Challenge. The bobbleheads will be available for pre-orderon our website beginning on Friday.Bobbleheads are the ultimate honor, and we think Dr. Fauci deserves it given what he hasdone and continues to do for our country and the wor ld in the battle against COVID-19.The bobblehead will join a grow ing number of items including donuts, socks and t-shirtsfeat uring Dr. Fauci. We received a lot of requests for a bobblehead of Dr. Fauci and areexcited to be able to use the bobblehead to raise funds for a vital organ ization that ishelping limit the spread of the Coronavirus while making peop le smile during theseunprecedented times.Let me know if you would like the press release, pictures and graphics in advance ofFriday's release. Please hold off on publicizing anything related to the bobble head untilFriday-any time on Friday is okay. Please also let me know if you would like a samplewhen they arrive or if you have any questions.NIH-000083Thank you,PhilPhil SklarCo-Founder and CEONational Bobblehead Hall of Fame and MuseumPhil.Sklar@bobbleheadhall.com4 14-519-2625www.bobbleheadhall.comThis email was sent to mcneil@nytimes.comNational Bobblehead Hall of Fame and Museum, PO Box 0982, Milwaukee, WI53201-0982, usDonald G. McNeil Jr.Science Correspondentl~r~rwflorkeimcsTel: (b)(6)mcneil@nytimes.comUnsubscribeArticles: https://www.nytime s.com/b y/donald-g-mcneil- jrNIH-000084From:Sent:To:Attachment s:Guard in.oft, message,Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [E)Wed, 1 Apr 2020 19 :59 :55 +0000Awwad, David (NIH/NIAID) [C]message,, Re message.oft, Re messagel.oft, u r hypo crite .oft , Call the NationalNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (3 96':44li9E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-000085From:Sent:To:(b)(6)Wed, 1 Apr 202017:51:34 -0400Duchin, JeffSubject: Re: FEMA Test KitsJe ff:Thanks for your note. It was very helpful to me to speak with your group last night. I causedquite a stir at the Task Force meetin g when I repo rted on our telephone conversat ion. I believethat this fixed the FEMA issue .Best regards ,T onyOn Apr l , 2020, at 5:43 PM, Duchin , Jeff ------------(b)(6) wrote:Tony,Thank you for taking some precious time to hear from some of the folks on the groundconfronting COVID-19 around the country. I can't tell you how much we all value yourengagement and leadership on behalf of the nation. I'd love to get your take on whetheryou think the type s of things described it eh recent AEI report are realistic. I have seriousdoubts.Quick question - I ment ioned the problem we had with FEMA test kits being recalled fromus because we did not want to use their call line and lab because too slow, - justwondering if that came up in your meeting today because I just heard the kits werereleased to us without restrictions on how we use them. So either way, apparentlyresolved.Stay well and best regards,JeffJeffrey S. Duchin, MDHealth Officer and Chief, Communicable Disease Epidemiology &Immunization SectionPublic Health - Seattle and King CountyProfessor in Medicine, Division of Infectious Diseases, University of WashingtonAdjunct Professor, School of Public Health401 5th Ave, Suite 1250, Seattle, WA 98104Tel: (b)(6); Direct : (b)(6); Fax: (206) 296-4803E-mail: (b)(6) ----------NIH-000086From:Sent :To:Subject:Bob:See emai l below.(b)(6)Wed, 1 Apr 2020 16:54 :57 -0400Kadlec, Robert (OS/ASPR/10)Fwd: (b) (5)(b) (5) ------------------------Thanks,TonyBegin forwarded message:From: "Mascola , John (NIHN RC) [E]" --------- (b)( Date: April 1, 2020 at4:40:39 PM EDTTo: "Fauci, Anthony (NIH/NJAID ) [E]"Cc: "Conrad , Patricia (NIH/NIAID) [E]"Emi ly (NIH/N IAID) [E]"(NIH/N IAID) [E]"Subject: __________ ____,Tony,John(b)< 61,) "Erbelding,--(b-)(6,S.).-,. ,-,M- a-r-st-on H_i.lary ' 'NIH-000087(b) (5)(b) (5)NIH-000088From :Sent :To:Subject :Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Wed, 1 Apr 2020 16:02 :51 +0000Barasch, Kimberly (NIH/NIAID) [C);Conrad, Patricia (NIH/ NIAID) [E)(b)(5)- PCNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .(b)(5)- PCINIH-000089(bX5) -PCl1NIH-000090(bX5) -PCl1NIH-000091From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Wed, 1 Apr 2020 16:01:03 +0000Gallo, RobertCc:Subject:Barasch, Kimberly (NIH/NIAID) [C];Conrad, Patricia (NIH/NIAID) [ElRE: informationI got it. I will have my staff try to set something up.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (3 96':44li9E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Gallo, Robert (b)(6)Sent: Wednesday, April 1, 2020 11:15 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6) Subject: RE: informationTONY-this is from me-Bob GalloFrom: Fauci, Anthony (NIH/NIAID) [E] -------- (b) ~ > Sent: Wednesday, April 1, 2020 11:08 AMTo: Gallo, Robert Cb()6 )Subject: RE: informationMy work with the Coronavirus Task Force and the large volume of incomingemails precludes me or my staff from answering each individual message. I wouldencourage you to visit www.coronavirus .gov for the latest information andguidance related to COVID-19.Thank you, and best regards.NIH-000092NIH-000093Anthony S. Fauci, M.D.From:Sent:To:Subject :Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Wed, 1 Apr 2020 14:04 :37 +0000Berkowitz, Avrahm J. EOP/WHO;Gidley, Hogan H. EOP/WHORE: Quick callNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)(b)( 5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Berkowitz, Avrahm J. EOP/WHO ------- (b)(6)Sent: Wednesday, April 1, 2020 9:48 AM To: Fauci, Anthony (NIH/NIAID) [E) -_-_-_-_-_~_ ~ CbH_6,)>; Gidley, Hogan H. EOP/WHO(b) (6) >Subject: Quick callDr Fauci - can you please jump on a quick call with Hogan about a press inqu iry we received at theWhite House? He is at (b)(6)(and I am at (b)( .Thank you!AviNIH-000094From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Wed, 1 Apr 2020 13:22 :58 +0000(b)(6)Subject: RE: FW: Wpost: Fauci socks, Fauci doughnuts, Fauci fan art: The coronavirusexper t attracts a cult follow ingIt is not at all pleasant, th at is for sure.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From : (b)(6)Sent: Wednesday, April 1, 2020 9:14 AM To: Fauci, Anthony (NIH/NIAID) [E]-- --------------=--:-:(b-):(6-) = Subject: Re: FW: Wpost: Fauci socks, Fauci doughnuts, Fauci fan art : The coro navirus expert attracts acult follow ingCompletely surreal (b)(6)Dizzying, even . Can't imagine what it is like for you, especially in the midst of allthis.On Tue, Mar 31, 2020 at 10:58 AM Fauci, Anthony (NIH/NIAID) [E] _____ CbC>6)> wrote:Truly surrea list ic. Hopefu lly, t his all st ops soon.A nthonv s. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301) 496--4409E-mail Cb)(NIH-000095The information in this e-mail and any of its attachments is confidential and may containsensitive information. It should not be used by anyone who is not the original intendedrecipient. If you have received this e-mail in error please inform the sender and delete it fromyour mailbox or any other storage devices. The National Institute of Allergy and Infec tiousDiseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representatives.From: Folkers, Greg (NIH/NIAID) [E] --------- (b)(6)> Sent : Tuesday, March 31, 2020 10:43 AMSubje ct: Wpost: Fauci socks, Fauci doughnuts, Fauci fan art: The coronavirus expert attract s a cultfollowingFauci socks, Fauci doughnuts, Fauci fan art:The coronavirus expert attracts a cultfollowingDoughnuts bearing the likeness of Anthony S. Fauci,director of the Nation al Institute of Allergy and Infectious Diseases, rest on a plate at Donuts Delite inRochester, N.Y., on March 25. (Shawn Dowd/Rochester Democrat & Chronicle/AP)ByAntonia Noori FarzanMarch 31, 2020 at 5:15 a.m. EDTEarly last week, Nick Semeraro wanted to find a way to hono r Antho ny S. Fauci. As the owner of asmall doughnut shop in Rochester, N.Y., he had been closely tracking the latest news about thecoronavi rus pandemic. And night after night, he'd been impressed by how Fauci, the director of theNational Institute of Allergy and Infectious Diseases, approached the crisis in a calm, knowledgeablemanner.So, as a tribute , Semeraro put the renowned immunologist's face on a doughnut. Expecting to sell afew hundred, he was shocked when the store sold out day after day, with thousands flying off theshelves. Donuts Delite was besieged with requests to ship the buttercream-frosted creat ions all overthe country, and one Fauci fan drove three hours just to pick up a dozen. Soon, bakeries in Wisconsinand Pennsylvania followed suit, using edible paper to decorate pastries with Fauci's likeness."We had no idea it was going to blow up thi s big," Semeraro told CNN."We didn't know everyone elsefelt the same way we did ."While Fauci was already a respected scientist before the outbre ak, his appearances during WhiteHouse press briefings have made him a household name and an unlikely celebrity . With hisNIH-000096NIH-000097straightforward demeanor and willingness to contradict President Trump, he's begun to develop thesame kind of cult following as Supreme Court Justice Ruth Bader Ginsburg and former special counselRobert S. Mueller Ill, who inspired countless "Plank like RBG" tank tops and a bizarre illustratedchildren's book, respectively .Even as whole swaths of the global economy collapse, the pandemic has created a robust cottageindustry of Fauci-themed merchandise, including bottle openers, magnets and mugs. On Etsy, you canbuy "Honk for Dr. Fauci" bumper stickers, prayer candles depicting "St. Fauci" and socks printed withFauci's face. Graphic T-shirts bear slogans such as "I Need a Hero" and "In Dr. Fauci We Trust."If so inclined, you can even decorate your home with an "I Heart Dr. Fauci" throw pillow, or purchasea replica of Fauci's jersey from the time he captained the basketball team at Manhattan's Regis HighSchool. Lingua Franca, which sells cashmere sweaters embroidered with resistance-fr iendly slogansfor $380 and up, recently began taking orders for an army-green "Dr. Fauci Fan Club" knit.In honor of Fauci's Italian heritage, a clam bar in Long Island named a linguine dish after him thisweek . (Available for pickup only, "the linguine with white clam sauce shares origins with Fauci, as thesauce itself was invented in the Fauci Family's native Sciacca, Italy," the restaurant claimed in astatement.)As countless Americans remain glued to the news while trying to stay indoors, a robust Fauci fandomhas flourished on line. On Face book, the "Dr. Anthony S. Fauci Fan Club" has over 32,000 members.Thousands more congregate in groups with names such as "Dr. Anthony S. Fauci, the Man, the Myth,the Legend," "Dr. Fauci Speaks, We Listen" and "Dr. Fauci Memes for Social Distance Teens."An unassuming 79-year-old public servant who has advised six presidents, Fauci has become a"reliable constant in a time of uncertainty," The Washington Post's Ellen McCarthy and Ben Terrisreported . But his admirers - and there are a lot of them - worry that it's only a matter of timebefore he's sidelined by Trump .When Fauci missed a White House news conference earlier this month, panic erupted on Twitter,along with speculation that he could be sick. There was palpable relief when he resumed his regularposition at the podium the following day and appeared to hide some exasperation as Trumpreferenced "the deep state."Fauci later explained that he had simply been trying to dislodge a lozenge from his throat . But themuch-analyzed "Fauci facepalm" had already become a meme, deployed by liberal members ofwhat's known as the resistance.Fauci's newfound fame can be partially attributed to his willingness to engage with all forms of media- in recent weeks, he's gone on a Barstool Sports podcast, chatted with basketball star Steph Curryon lnstagram Live as Barack Obama listened in, and appeared on "The Daily Show With Trevor Noah."But it also undoubtedly helps that his fans tend to take social distancing seriously and consequentlyhave ample spare time to produce fan art or perform songs written (or modified) in his honor .On social media, Fauci's virtual fan clubs peruse old photos of the infectious disease expert in searchof "comfy turtleneck vibes," stitch his face on embroidery hoops and discuss erecting statues astribute . They frost his name on cookies and joke about constructing shrines in his honor. Prominentactivists and entertainers confess to wanting to marry him, or have him tuck them into bed.Fauci has remained characteristically modest about his new status as a cult figure. "Well, that's verynice," he responded when McCarthy and Terris mentioned that people all over the country werepraying for him. Of course, that means that his fan base has only continued to grow."I never met a guy that, worldwide, he is so loved," Semeraro, the Rochester doughnut shopowner,to ld CNN. "And a month ago, we never knew his first and last name."NIH-000098Disclaimer: Any third-party material in this email has been shared for internal use und er fair useprovisions of U.S. copyright law, without further verification of its accuracy/veracity. It does notnecessaril y represent my views nor those of NIAID, NIH, HHS, or the U.S. government.From:Sent :To:(b)(6)Wed, 1 Apr 2020 06:26:32 -0400DMID Word NerdsSubject: Fwd: Covid-19 comments on UK responseAttachment s: image001.png , ATT0000l.htm, Covid19, UK pharmavaccine response .pdf,ATT00002.htm, Covid19, UK Urgent Action response.pdf, ATT00003.htm, VACCINEarticle.pdf,ATT00004.htmSent from my iPhoneBegin forwarded message:From: Karl SimpsonDate: Apri l 1, 2020 at 5 :46: 14 AM EDT(b)( '>------- == To : "Fauci, Anthony (NJH/NIAID) [E]" ---------- (bH6J Subject: Covid-19 comments on UK responseDear Dr FauciI was just re-reading your January 23 Viewpoint article in JAMA. So little time has passed,but so much has changed, and your comments seem prescient.I have been working on emergent/ re-emergent infectious agents for some time, andauthored a 2018 report for the UK government on vaccine responses that was summarisedin a Vaccine publication last October attached . As almost everyone else, my attention hasbeen redirected to Covid-19, although monkeypox remains a focus of my interest.You and your colleagues may be interested in two short documents I produced for the UKgovernment on the 20th and 22nd of March. That also seems long ago now!As fellow citizen of our planet, I thank you and colleagues for your unstinting efforts tocontrol infectious disease and Covid-19 in particular .Warmest wishesKarlNIH-000099NIH-000100J. Karl Simpson CBiol FRSBCEO, JKSBioscience Limited........ .. .. . . .J SbioscienceNIH-000101JKSbioscience2 Midanbury Court, 44 Midanbury LaneSouthampton S018 4HF, UKTel: (b) (6) _____ ___,Mobile: ------(b) (6)Mail: (b)(6)Website: http://www.jksb ioscience.co.ukSkype: ----(b)-(6)(;ompany Numbe r: 10051396VAT number: 238 0528 12NIH-000102From:Sent :To:Subject:Attachment s:Conrad, Patricia (NIH/NIAID) [El on behalf of Fauci, Ant hony (NIH/NIAID) [ElTue, 31 Mar 2020 21:07:00 +0000NIAIDODAMFW: Additiona l data on masksMacIntyre BMJ.pdf, Figure 3.jpgAdding everyone since it was discussed in am meeting . thxFrom: Lerner, Andrea (NIH/NIAID) [El CbH6>>Se nt: Tuesday, March 31, 2020 5:04 PMTo: Fauci, Anthony (NIH/NIAID) [El ------~=Cc: Folkers, Greg (NIH/NIAID) [E] (b)( >; Marston, Hilary (NIH/NIAID) [E](b)(6) Eisinger, Robert (NIH/NIAID) [E] CbH6>>D;o epel, Laurie(N ._IH-/:N-_I_A_ ID _"") ."-[:"-E--:]- ::.:::::====---=-..;., ("b")~"(6)Subject: Additional data on masksDr. Fauci,In addition, I found the attachedd review on masks that addresses use in the community settings.Attached are the paper and figure 3, which summarizes the data from 9 very diverse RCTs (overlappingwith what I had sent earlier) .Bottom line: generally there were not differences in Ill/URI/or flu rates when masks were used,although when early use and complian ce was taken into account, a few times a difference was seen.In addition:This case cont rol study noted tha t, among SARS pat ients in Hong Kong without a known source ofinfect ion, cases {27.9%) were less likely than uninfec ted controls {58.7%) to report wearing a maskfrequently in public , for what tha t's worth.https://wwwnc.cdc.gov/eid/article/10/4/03-0628 article(b)(5)AndreaNIH-000103From:Sent :To:(b)(6)Tue, 31 Mar 2020 07:25:55 -0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Harvard Business School/ Wharton Business SchoolSent from my iPhoneBegin forwarded message:From: A.rash Farin <arash@arash.tv>Date: March 30, 2020 at 10:32:04 PM ED--T- ---~~ To: "Fauci , Anthony (NIH/NIAID ) [E]" (b)( >Subject: Re: Harvard Business School / Wharton Business SchoolHi Dr. Fauci,I just wanted to confirm you received this .I also just read a great story on you in the WSJ, which discussed your amazingbasketball and leadership skiJls when you were in coUege. Not surprisingly, eventhen , your teammates were seeking your advice on leading them through difficulttimes.Talk to you soo n.Regards,Ara shOn Sat, Mar 28, 2020, at 7:54AM, Arash Farin wrote:Hi Dr. Fauci,I'm a graduate of both Harvard Business School and The WhartonSchool, and have truly enjoyed watching the leadership you have shownour nation during these challenging times. Your steady hand, calmdemeanor, incisive thoughts, and inteJlectual rigor, have au been quitecomforting to us the last few weeks.I would like to see if you may have a few minutes to participa te in awebcast interview with myself and classmates from Harvard andNIH-000104Wharton this coming week or next week. We would love to hear yourthoughts on dealing with the coronavirus, lessons learned from othercountries, and how we can prepare for a potential recuJTence, as hasbeen discussed in the media , along with other topics you deemimportant.I may also be able to get students from Oxford University to join, as Iattended there as well, and I know the UK is dealing with its own set ofchallenges.I look forward to hearing from you, and can be reached at ii. or via email (arash@ara sh.tv). ----(b)(6)God bless you, and thank you for everyth ing you have been doing.Best Regards,ArashNIH-000105From:Sent :To:(b)(6)Tue, 31 Mar 2020 07:24:50 -0400DMID Word NerdsSubject:deleteFwd: VVIP informat ion for diagnostic and therapy for COVI0-19- Kindly do notSent from my iPhoneBegin forwarded message:From: "anahar." <anahar@abgenics.in>Date: March 31, 2020 at 3:38:38 AM ED-T- ------::-,--:=, To: "Fauci, Anthony (NIH/NIAID) [E]" (b)(6)Subject: Fwd: VVIP information for diagnostic and therapy for COVID-19-Kindly do not deleteDear SirWe request you to spare a few minu tes to read this email.Abgenics is a life-sc iences company (Abgenics Life sciences Pvt Ltd,www.abgenics.in) based in Pune, India conducting pioneering research in thearea of drug discovery using camelid antibody against in fectious diseases in thepast 10 years. Abgenics Life Sciences was founded in 2010 and is managed byAnil Nahar (Entrepreneur) and Dr Sanjib an K Bane1jee (Technical). Dr Banerjeehas studied and lived in the USA for more than 7 y and worked in the area ofinfec tious diseases all his life. He has conducted extensive research in the area ofcamelid antibody technology in USA. After returning to India and with an urgeto help the people of India in area of infectious diseases. Dr Banerjee inassoc iation with Ani l Nahar started this ventu re. Since then, the company hasextensively worked and developed novel camelid antibody technology forvarious infectious diseases causing bacteria (Multi drug resistant) and funguslike Pseudorno nas, Staphylococcus Aureus, Candida Albicans and otherNIH-000106important pathogens. Our company is the only company in India working onCamelid antibody platform. Camelid antibody is a very robust and noveltechnology and can be used to develop drngs against any kind of antigengenerated from bacteria and viruses. The specialty of camel antibody, it occursin nanosize, high temperature and high Ph stable. It has very high affinitytowards any antigen . A video explaining our technology is attached in theemail.An Abgenics Life science was warded twice by --------- (b) (4)- USA in the form of research projects to develop technology for(b) (4)NIH-000107~b na virus is a spiked v irus and the spikes are used by the virus to first att achi.to, "\!1d then invade into the host cells. Subsequently the genetic materials, RNAat~ njected whe re it hijacks the host replication machinery to multiple and reinfect more cells. If the initial attachment or the fusion of the vims and hostmembranes can be blocked, the virus replication cycle can be stopped, bringingthe infection under control. The spike protein consists of two components, aglobular head, S1 that helps the initial attachment and a spiral part S2 that isresponsible for membrane fusion which forms the channel for the entry of theNIH-000108(b) (4)RegardsAnil NaharMDAb gen ies Life sciences Pvt LtdKant HelixBho ir ColonyChinchwadPuneIndiaPh ----- (=b>=c=6 )(b) (4)NIH-000109From:Sent :To:(b)(6)Tue, 31 Mar 2020 07:23:59 -0400DMID Word NerdsSubject: Fwd: New biological disin fection automates, also effect ive against new Coronavirus and multi -resistant germs, from a Florida CompanyAttachments: PastedGraphic-1.png, ATTOOOOl.htm,MSDS_Saniswiss_biosanitizer_aHP _P _rev_16032018.pdf, ATT00002.htm,br_automate_aH P _HTA_EN.pdf, ATT00003.htm, br_ biosanitiz er aHP C_EN2.pdf, ATT00004.htm, ABSAconclusion Kopie.pdf, ATTOOOOS.htmS, HS_2308201 9_W EB.pdf, ATT00006 .htmSent from my iPho neBegin forwarded message:From: Alexa nder Friedrich <a.friedrich@biosan itize.us>Date: March 31, 2020 at 6:02:53 AM ED-T- -----~~ To: "Fauci, Anthony (NIH/NIAID) [E]" (bH6JCc: Tayfun Tay lor <mr.t aylo r@mailbox. org>, "ceo@b iosan itize.us"<ce o@biosani tize.us>Subject: New biological disinfection automat es, also effective against newCorona virus and multi-resistant germs, from a Florida CompanyDear Mr.Fauci,I know you're busy. But at this special time for all of us, I just need to write to you.The new Corona Virus is chang ing the world. It affects all of us in health, social andeconom ic terms. The importance of hygiene and disinfection can be seen especiallynow in the andemic.(b) (4)NIH-000110(b) (6), (b) (4)NIH-000111do not hesitate to contact us.Yours, sincerelyAlexander FriedrichRepr. Biosanitize USAAlexander FriedrichRepr. Biosanitize USAcontact: a.friedrich@biosanitize.usBio-Sanitize USA LCC12601 New Brittany Blvd33907 Fort Myers, Florida , USAtm ci..ner spaces. Slftr places.✓ ✓ ✓NIH-000112(b)( 4l✓ ✓From:Sent:To:Cc:Subject:Moshe:Fauci, Anthony (NIH/N IAID) [E)Tue, 31 Mar 2020 02:07:49 +0000Moshe LeviGraham, Barney (NIH/VRC) [ElRE: Question from GeorgetownI am not sure that I can help you with this. I am referring your e-mail to Dr. Barney Grahamof the NIAID VRC. Perhaps he can help you.Best regards,TonyFrom: Moshe Levi ----------- (b)(6) Sent: Monday, March 30, 2020 3:45 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)( > Subject: Question from GeorgetownDear Tony:I know that you are busy 7 /24 with the current crisis.BUT I have a question for you or for one of your colleagues.Please let me know.Meanwhile there are not adequate ways to thank you for all you do.I should have seen that when you were my attending while you were at Cornell as a VisitingProfessor Professor around Cb<> 6>MosheCell: (b)(6) -----Moshe Levi, MDDean for ResearchProfessor of Biochemistry and Molecular & Cellular BiologyGeorgetown University3900 Reservoir RoadNIH-000113(b) (4)Med Dent NW 105Washington, DC 20057Office: Cb()6 )E-mail:- --------- (b)(6)NIH-000114From:Sent:To:Subject:David:Fauci, Anthony (NIH/NIAID) [E)Tue, 31 Mar 2020 02:02:50 +0000David KatzRE: COVID-19 ·- URGENT (Please do not disregard!)I know that it is you. I am sorry, but I am getting more than 2000 e-mails pe day. I to tallyagree with you and this issue is being actively discussed as recently as today at the task Forcemeet ing. I am not sure what you mean by aerial "eradication" procedures that could bepractically implemented. There are some data from NIH that indicate that mere speakingwithout coughing elicits aerosols that travel a foot or two. If that is the case, then perhapsuniversal wearing of masks in the most practical way to go.Best regards,TonyFrom: David Katz (b)(6)>Sent: Monday, March 30, 2020 5:43 PM --------=:-:-= To: Fauci, Anthony (NIH/NIA ID) [E] (b)(6)Subject: Re: COVID-19 -- URGENT (Please do not disregard!)For God's sake, Tony -- this is me, not simply an unknown"messenger" from the general public! We go back togetherfor many, many years (to our days together at the NIH ,remember?). As you may recall, we worked (successfully)during the infamous 1969 "March on Washington", amongother historically im octant events.Although I am now (b)(6) I continue to pay carefulattention to world events, and this is one that exceeds anyothers that have occurred in our lifetime!As I wrote in my previous e-mail , I have become convinced that COVID-19 isbehaving as an airborne virus, and, therefore, we should be directing ourmitigation efforts toward more compr ehen sive aerial eradicationprocedures!Think about the most recent reports -- namely that imprisoned inmates, anda young baby, have recently been reported as "infected" with this virus.NIH-000115Person-to-person infection in these circumstances is difficult to explain! Buttransmission by viable airborne virus could certainly happen!I look forward to your response, with best wishes,DavidDavid H. Katz, M.D.La Jolla, CaliforniaOn Sun, Mar 29, 2020 at 11:18 AM Fauci, Anthony (NIH/ NIAID) IE] ______ Cb _H_6l'> wrot e:My work with the Coronavirus Task Force and the large volume of incomingema ils precludes me or my staff from answering each individual message. Iwould encourage you to visit www .coron avirus.gov for the latest informationand guidance related to COVID-19.Thank you, and best regards.Anthony 5. Fauci, M.D.NIH-000116From:Sent :To:(b)(6)Mon, 30 Mar 2020 16:29:31-0400(b)(6)Subject: Fwd: Hello from Canada!Could you please respond to her for both of us. Thank sBegin forwarded message:From: "El-Gabalawy , Nadia (PHAC /ASPC)" ------------ (b)(6) Date: March 30, 2020 at 2:48:41 PM ED-T- -----~~ To: "Fauci , Anthony (NIH/NIAID) [E]" (b)(6) --------- Subject: Hello from Canada!Hi Dr. Fauci,I thought I would reach out to you amidst this crisis; I respect the work you're doing a greatdeal. (b)(6) Hani EI-Gabalawy, did a research sabbatical at NIH (b)(6) -Amazing work that you're doing. I've been following your discussions and scientificinnovation regarding COVID-19. I've been working for the federal government inIntelligence for about thirteen years and recently moved to the Canadian Public HealthLaboratory Netwo rk Secretariat to support the Emergency Operations Centre at theNational Mic robiology Lab. I've been with the NML for almost my whole career.Just a quick hello and deep respect for your work. My colleagues and Director have saidthat we're on the exact same page as you, in terms of your perspective and assessment ofthe pandemic. Although there is a border between us, know that we are in agreement withyour work and I'm thrilled to see you advising the public . There is no better person to dothe job .Kindest regards,Nadia EI-GabalawyTeam Lead, Support Services, Canadian Network for Public Health IntelligencePublic Health Agency of Canada/Government of Canada(b)(6)NIH-000118Chef d'equipe, Services de soutien, Reseau canadien de renseignements sur la santepubliqueAgence de la sante pub lique du Canada/ Gouvernement du Canada(b)(6)NIH-000119(b)(5) -PCfNIH-000120From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Mon, 30 Mar 2020 12:23:38 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: FW: Invitation to be the keynote speaker at an Insurance Medicine Conferencein Washington, DC in October .RSVP sorry no.From: Pinho, Paulo <Paulo.Pinho@optimumre .com>Sen t: Monday, March 30, 2020 8:18 AMTo: Fauci, Anthony {NIH/NIAID) [E]_ ______ ("b'"),',(.=6.,).>:Subject: Invitation to be the keynote speaker at an Insurance Medicine Conference in Washington, DC inOctober .Dear Dr. Fauci,I hope this email finds you wel l. It is abundantly obvious from the countle ss sifts through data andtallies of cases, interviews and press conferences, social media appearances, etc. that your schedule iscrazy these days. As a practicing physician and an American, I am proud to be represented by you andthank you for your efforts on our behalf. I realize with your schedule and with the thousands of emails,t his one may not make it, but I wanted to take a shot in the dark.I am currently the Chief Medical Off icer of a reinsurer and am on the planning committee for theAmerican Academy of Insurance Medicine's annual meeting which will be held in DC th is year October18-21. Dr. Michael Osterholm had agreed to speak at the conference back in January as our firstkeynote speaker on the subject of pandemics, preparedness. I'd heard him speak before at Prudent ial (Iwas medical director there and we were a member company of CIDRAP) and his ta lk mirrored his bookwhich I've also read. Regretfully, 2 weeks ago I received notice from Laurel, his EA, that he is unable toattend the meeting because he needs to travel to London that week for a meeting he is heading. I thinkthat a talk on the topic is a must at any medical meeting and after hearing your pressers and coming torely on your sage status updates and advice, coupled with the fact that the conference is in DC, I thoughtI'd give this a shot . Would you be AAIM's keynote speaker this year?In the midst of the current COVID-19 pandemic, we understand many industry conferences have had tobe canceled. We are continui ng to closely monitor the trend of the COVID-19 virus, and may have to dothe same for the AAIM meeting in October, but if there is an opportunity to gather and learn, we'd liketo prepare for it .The audience is medical directors that work in the life, health, disability and longterm care space. Someare clinically active . Some of them are resources for health emergency planning fo r their companies.The audience comes mostly from North America, although other countries/continents are wellrepresented.The purpose of the meeting is really to illustrate novel trends in the industry that will likely impactmorbidi ty and mortality in the near or distant future . We've had talks on CRISPRm, arijuana, precisionmedicine, data analytics. They're not hard core morbidity or mortality focused, but do touch on it .NIH-000121NIH-000122Given the scope of the meeting and the attendees and industries they represent, I think that a lectureon pandemics, bioterrorism and emerging infectious disease, especially in light of COVID-19, isnecessary. I think you would teach new concepts to a team of doctors that would identify with some ofthe system gaps in our current supply chain and their impact on human health, wellbeing and survival.You'd provide experience and insight on what went wrong and what could be fixed in the future to makeus collectively better prepared.We would be honored to have you speak and I'm glad to continue discussion of logistics with someoneelse on your team. If you needed more information about scope, I can certainly provide that. We doprovide an honorarium and will cover travel and hotel expenses.Thanks so much in advance for any consideration you might give this request/offer and most of all thankyou for your direction, demeanor and dedicat ion at this global time of crisis.Best,PauloPaulo Bandeira Pinho , MD, FAAP, FACPChief Medical DirectorOPTIMUM RE INSURANCE COMPANY% +1 214 528-2020, ext. 30984~ Paulo.Pinho@optimumre.com ----------- -----==(8} 1345 River Bend Drive, Suite 100Dallas, TX 75247, U.S.A.c:J optimumre.comI-~OP TIMUM~i, Life ReinsuranceThis email and its attachments is confidentia l and is inte nded only for the individual(s) to whom it isaddressed . Distribution or copying of this email by anyone other than the named recipien t isprohib ited. If you receive this email in error, please not ify us by email and permanent ly delete thisemail and its attachments.From:Sent :To:(b)(6)Mon, 30 Mar 2020 06:06:00 -0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Int erview with Or Anthony Fauci in The Times of LondonSent from my iPhoneBegin forwarded message:From: "Rivalland, Monique" <monique .rivalland@the-times.co.uk >Date: March 30, 2020 at 4:30:39 AM ED-T- ----~~ To: "Fauci , Anthony (NIH/NIAID ) [E]" (b)( >Subject: Interview with Dr Anthony Fauci in The Times of LondonDear Anthony,I'm an editor at The Times of London. I'm gett ing in touch to discuss the possibilityof interviewing you this week for our Saturday Interview slot next weekend. Youhave an incredibly tricky role in the fight against coronavir us and have spoken withgreat clarity. We would love to speak to you about your position and predictions forAmerica.The interview slot in question is the most prestigious in the weekend edition of TheTimes - a double-page spread reserved each week for the most influentialindividuals in public life. Fonn er interv iewees range from Boris Johnson to JeremyFarrar.We would need 40 - 50 minutes of your time before Friday morning, but preferab lyby Thursday even ing. The interview can be conducted over Skype/GoogleHangouts/Zoom or whichever method of video chat you prefer.We would be delighted if you were to consider om request.Kind regardsMoniqueMonique RivallandFeatures EditorTHE~ TIMESNIH-000123(b)(6)@MoniqueLouiseR"Please consider the environment before printing this e-mail"This e-mail and any attachments are confident ial, may belegally privileged and are the property of News Corp UK &IrelandLimited on whose systems they were generated . News Corp UK&Ireland Limited is the holding company for the News UK group,is registered in England &Wales under number 81701, has itsregistered office at 1 London Bridge Street, London, SE1 9GF andis registered with VAT number GB 243 8054 69. If you have receivedthis e-mail in error, please notify the sender immediately and do notuse, distribute, store or copy it in any way. Statements or opinions inthis e-mail or any attachment are those of the author and are notnecessari ly agreed or authorised by News Corp UK &Ireland Limitedor any member of its group. News Corp UK &Ireland Limited maymonitor outgoing or incoming emails as permitted by law. It acceptsno liability for viruses introduced by this e-mail or attachments .News Corp UK &Ireland Limited and its titles are committed to abiding byIPSO's regulations and the Editors' Code of Practice that IPSO enforces .NIH-000124From:Sent :To:(b)(6)Mon, 30 Mar 2020 06:05:28 -0400DMID Word NerdsSubject: Fwd: Chloroquine is a thromboxane inhib itor: there is a readily available analogSent from my iPhoneBegin forwarded messag e:From: "Dr. Josh Backen" <backon@mail.huji. ac.il>Date: March 30, 2020 at 5:52:32 AM EDT ------~= To: "Fauci , Anthony (NIH/NIAID) [E]" (b)(6)Subject: Chloroquine is a thromboxane inhibitor: there is a readily availableanalogDear Dr. Fauci,I'm (b) (6) internist.I have a sugge stion for 2 potent antiviral agent s, cheap and readilyava ilable, that may prevent viral shedding. No viral shedding? Noinfectivity. The concept is that EVERYONE should take these items.First a short bio:Dr. Josh Backon was affiliated with the Hebrew University Faculty ofMedicine for over 33 years. He has a good track record (84+publication s quoted by over 750 other researchers in jou rnal articleshttps ://scho lar. google. com/scholar?start =0&q=%22backon ++j. %22&hl=en&as sdt=0,5and in over 250-300 texts as perhttps ://www.google.co m/search ?tbo=p&tbm=bks&q=%22backon+j. +%22&num= I 00 ) .In the 1980's he was Consulting Editor of the Jomna l of PediatricEndocrinology, Editor of Reviews in Pure and Applied Phann acologicalSciences, and Associate Editor of the International Journal ofAdolescent Medicine and Health . From 1990-2004 , he was a consultantNIH-000125NIH-000126on emergency planning and management at Israel's National PoliceHeadquarters with Nitzav Mishneh Dannny Fisher.Chloroquine, an antimalarial drug, is now being used to treat Covid-19.Its mechanism was found in the 1970's to inhibit thromboxanehttps ://scholar. goo gle. com/scholar?hl=en&as sdt=0%2C5 &g=chloroguine+thromboxane&btnG = The problem with chloroquine was that italso elevated level of prostaglandin F2alpha. In 1980, Sriva tava, anIndian biochemi t working in Denmark found that GINGER i a potentinhibitor of thromboxane yntheta e. I wrote a number of paper in the1980's on u e of ginger:htt :// cholar. oo le.com/ cholar?hl=en&as dt=0%2C5& =backon+mger&btnG=-GINGER IS A POTENT ANTIVIRALsdt=0%2C5& er+a-THE SECOND ANTIVIRAL AGENT IS TURMERIC [add blackpepper since piperine dramatically increases oral bioavailability ofturmeric)htt s://scholar. oo le.com/scholar?hl =en&as sdt=0%2C5& =turmeric+anti viral&og=turMultisite inhibitors for enteric coronavirus: antiviralcationic carbon dots based on curcuminD Ting, N Dong, L Fang, J Lu, J Bi. .. -ACS Applied Nano ... , 2018 -ACS Publications... These results offer theoretical support for the development of CCM-CDs as a hopefulantiviral drug for the treatment of coronavirus infections, including PEDV ... Curcumin(CCM) is a polyphenol compound obtained from turmeric roots ...NAC AND PIPERINE TO INHIBIT INFLAMMATORYCYTOKINES (iNOS, NF KappaB, TNFalpha) INVOLVED INARDSNIH-000127Morta lity in COVID-19 patients is usua lly from ARDS (acuterespirato ry distress syndrome) via inflammatory cytokines. Apart fromN-acetylcysteine which was found 3 years ago to elevate atrialnatriuretic factor [found by Kiemer in 2001 to zap inflammatorycytokines: iNOS, NF KappaB, and TNFalpha) now piperine in blackpepper was found to inhibit inflamma tory cytoki nes [piperine alsodramatically increases oral bioavai lability of turmeric [ which has beenused as a potent antiviral]:N-ACETYLCYSTEINEPIPERINEhtt ://scholar. oo le.com/ cholar?h l=en&as sdt=0 5& - i erine%20inflammatory%20cytokines&btnG =&fbclid= I w AR0kXZxI66JPLFPry2MDTDxOAe lgGnmBZdKBw7 c I v7 8Hfi7t0J Jnx0Y2zuEBTW the thromboxane hypothe i exp lain the increased male to female ratio ininfectivity a well as the low incidence in younger people.http ://www .ncbi.nlm.nih.gov /pmc/article /PM 1433448/Gut. 1987 Oct; 28(10): 1323.doi: 10.1136/qut.28.10.1323PMCID: PMC1433448PMID: 18668886Ginger and carbon dioxide as thromboxanesynthetase inhibitors:p otential utilityi n treatingpeptic ulcerationJosh BackonFrom:Sent :To:Subject:Nancy:Fauci, Anthony (NIH/ NIAID) [E)Mon, 30 Mar 2020 02:06:21 +0000Tim BoydRE: You Rock!Thank you for your kind note.Best rega rds ,Tony----- Orig inal Messag e-----_...;::;.....----~~From: Tim Boyd (b) (6)Sent: Sunday. March 29. 2020 8:53 PM ---------=.,...,-= To : Fauci, Anthony (NTH/NIAID) [E] Cb)(Subject: You Rock!Dea r Dr. Fauci,Atle r rea ding the article about you on the front of the New York Times this morn ing, 1 was dist ressed to learn thatyou have recently been negat ively targe ted via soc ial media by members of a certain US politica l factio n. Theunfairness of these pers onal attacks upon you is shocking, and I cannot imagine somet hing so bL11ftul happeni ng tosomeone like you who possesses such a depth of knowledge and unimpeachable integrity . You are the affable,truthful and reassu ring centre of calm during this de adly coronavirus storm. Your job is difficult enough withoutpeop le taking verbal pot-shots every time you speak.1 wish you all the best during this try ing time. Stay well (and I hope you don 't completely lose your voice, too) ! Ilook forward to seeing and hearing more from you on CNN and other media out lets.Best wishes,Nancy Hill(b)(6)CanadaSent from my iPhoneNIH-000128NIH-000129NIH-000130From: (b)(6)Sent: Sun, 29 Mar 2020 11:31:58 -0400To:Subject:Auchincloss, Hugh (NIH/NIAID) [E];DMID Wo rd NerdsFwd: Intro to Tony FauciFrom partyHugh- I thought u responded to Carmona the formerSurgeon general?Sent from my iPhoneBegin forwarded message:From: Richard Carmona <rcarmona@canyonranch.com>Date: March 29, 2020 at 9:42:33 AM EDTTo: "Fauci, Anthony (NIH/NJAID) [E]" (bH6JiSubject: Fwd: Intro to Tony FauciTony, first and foremost.. .. thank u for ur continued leadership and integrity in the"combat zone".I know u r drinking from the proverbial fire hose so I would not send anything urway ifI didn't think it may have merit to address our current challenge withCoronavirus.I email introduced u to this group some time ago. Their science has advanced and inparticular there seems to be a potential opportu nity to address the somet imes lethal "cytokine storm" in some coronavirus patients as described in the attached e mail.So I forward to you for your consideration as an adjunc t.On a daily bas is I receive numerous " ideas" to address coronavirus from many wellintended people. A few have merit. Is there a Fed innovation review group that someof these potential ideas could be funneled too?I pray for you and your familyBe wellRichRichard Carmona17th Surgeon General of The United StatesChief of Health InnovationsDistinguished Professor University of ArizonaNIH-000131CANYONRANCH.Begin forwarded message:8600 E. Rockcliff Road I Tucson, AZ 857500: 520 .749.7754M: (b)(6)canyonranch.comFrom: James Thacker <jim_thacker@therimunex.com>Date: March 29, 2020 at 06:04:40 MSTTo: Richard Carmona <rcarmona @canyonranch.com >Cc: Patricia Maxwell <PMaxwell @canyonranc h.com>,"dgrange @osp reyg lobalsol utions.com"<dgran ge@ospreyg lobalsoluti ons .com>Subject: Intro to Tony Fa uci!External SendedDear Rich,NIH-000132(b) (4)I hope you and the family are healthy . As you can tell, I am st ill kickin ass andtak in names. DDBe well and be safe my Brother! DOL!Sine Pari,JimJames D. Thacker, PhDPresident/Founder - Head of Discovery &Science1250 Sussex TPKE, Unit 647Mount Freedom, NJ 07970Cell: (b)(6)Email: jim thacker@therimunex.comURL: www.therimunex.comPrivileged, confidentia l and/or copyright information may be contained in thise-mail. This e-mail is intended for the sole use of the addressee. If you are notthe intended addressee, or the person responsible for delivering it to theintended addressee, you may not copy, forward, disclose or otherwise usethis message, or any part of it in any way whatsoever, to do so is prohibitedand may be unlawful. If you receive this e-mail by mistake, please advise thesender immediately by using the reply facility in your e-mail software .NIH-000133From: (b)(6)Sent :To:Subject:Sun, 29 Mar 2020 11:25:38 -0400Conrad, Patricia (NIH/NIAID) [E)Fwd: Phone Intervie w- COVID19Sent from my iPhoneBegin forwarded messag e:From: "mton-es8@myse neca.ca " <mtorre s8@myseneca .ca>Dat e: March 29, 2020 at 11:06:49 AM E-D-T- ----~~ To: "Fauci , Anthony (NIH/NIAID ) [E]" (b)(6)Subject: RE: Phone Interview- COVID19Hi Dr. Fauci,I'm look ing to do a qu ick 10 minute phone interv iew on COVID-19. I've seen yourinterview s on CNN and they are very informat ive so I think you would be perfectfor our podcast.This wou ld be for a podcast available to faculty and students at Seneca MediaDepartment in Toronto .Thanks,Mon ika To rreswww .senecajoumalism.caNIH-000134From:Sent:To:(b)(6)Sun, 29 Mar 2020 11:24:55 -0400DMID Word NerdsSubject: Fwd: URGENTA TTN DR FAUCIR E:C OVID-19 IDEAF ROMA USTRALIANG P!Please just read and see it this has the merit I believe it does!!Sent from my iPhoneBegin forwarded message:From: Stevie <stevie@empowerme.e nterprises>Date: March 29, 2020 at 11:18:55 AM E-D-T- ------=-=--:-= To: "Fauci, Anthony (NIH/NIAID ) [E]" (b)(6)Subject: URGENT ATTN DR FAUCI RE: COVID-19 IDEA FROMAUSTRALIAN GP! Please just read and see it this has the merit I believe itdoes!!Dear Sir,My OP friend, Dr P'ng is a genius. He has a radical idea for fighting COVID- 19.Please find his idea , petition, projections and research attached to the petit ion. I toldhim he needed to get this is front of you and Bill Oates . Please cons ider it. I believeit is viable and the best shot we have . I know you are the expert but I think this isviable way we can help save millions of lives!Yours sincerely,StephanieStephanie Russell-FarnhamFounder &CEOEmpowerME EnterprisesM (b)(6)E stevie@empowerme . enterpriseshttps: //www.cha nge .org/p/world-health-organisation-belp-defeat-covid-19-save -theworld?recruiter= 1066780682&utm somce=share petition&utm rnedium=facebook&utm campaign=share petition&utm term=share petition&recmited by id=40795060-7lab-llea-a9:f8-13e6b487f548&utm content=starter 1b share content en-au%3Avl 1NIH-000135From:Sent :To:Subject:fyiFauci, Anthony (NIH/N IAID) [E)Sun, 29 Mar 2020 11:23:39 +0000Conrad, Patricia (NIH/NIAID) [E)FW: New Zealand interview requestFrom: Pat Brittenden <info@blindfish .media>Sent : Sunday, Marc h 29, 2020 7:21- A-M- -----, .....,..,= To: Fauci, Anthony (NIH/NIAID) [E] --------- (b)(6) Subject : New Zealand interview requestHey Dr Fauci,Am wondering if you would be interested in having a chat with us in NZ, over Zoom, as we all sit in ourhouses fighting CoronavirusI do a podcast which is normally live streamed but we currently have a country wide lockdown and lotsof us have moved our gear home to continue providing content for people who are stuck in their homesthe US is like out big brother, we love you guys and would like to connect in solidar ity about COVID19 soI'm hoping that maybe you could find us sometime to have a chat over the internet . Some contentwould also help us give some more content to Kiwi's who have gotten to the end of Netf lix ;)Find out more about the podcast at www.theDOC.nz and more about meat www.patbrittenden.com/aboutCan make anytime happen, fingers crossed we'll hear back from 'someone'.Pat Brittendenwww.theDOC.nzwww.patbrittenden.com/about(b)(6)NIH-000139From:Sent :To:(b)(6)Sat, 28 Mar 2020 19:01:58 -0400ldonae LovetrueSubject:irinotecan+etoposideRe: COVID-19 aetiology and treatment for critically ill patients:Thank you for your noteAS FauciSent from my 1PhoneOn Mar 28, 2020, at 6:36 PM, Idonae Lovetrue<idonae@demiurge. technology >wrote:Dear Dr. Fauci,In addition , I'd like to share with you the following clin ically relevant geneticdifferences between patients in the US and in East Asia:Please find attached dosage recomme ndation and my team is standing by if youneed any further assistance.Sincerely,ldonaeldonae Lovetrue I CEO, Demiurge Technologies AG, Switzerlandwww . demiurge .technologyThis email and any attachments thereto may contain private, confidential, and privileged material for theso!e use of the intended recipient. Any eview. copying, or distribution of this email (or any attachmentsthereto) by others 1s stnctly prohibited. If you are not the intended recipient, please contact the senderimmediately and permanently delete the original and any copies of this email and any attachments thereto.This email is intended for information purposes only and is provided without any warranty of any kind,either expressed or implied. While some information used on th1s document may have been obtained fromNIH-000140(b) (4)va,1ous published and unpublished sources considered to be reliable, Dem:urge 1 echnologies AG neitherguarantees its accuracy or completeness nor accepts iabil1ty for any direct or consequential losses arisingfrom its use.Thank you.From: Idonae Lovetrue <idonae@demiurge.technology>Date: Saturday, 28 March 2020 at 15:53To: Cb><Subject : COVID-19 aetiology and treatment for critically ill patients:irinotecan+etoposideDear Dr. Anthony S Fauci,This is ldonae , CEO at Demiurge Technologies AG, a Swiss Albiopharmacompany making accurate and rapid drug discoveries fordiseases with limited available clinical data. We are committed to thenon-profit dissemination of our COVID-19 discoveries to the public tofacilitate the search for COVID-19 effective treatments.SARS-CoV-2 is fundamentally different from all the other viruses that theworld has hitherto known, so treatments must be rationally designed toavoid fueling the adaptive mutation and the latent infection of SARSCoV-2.Demiurge is the world's first company that has discovered the detailedaetiology of COVID -19 that consistently explains the clinical features ofCOVID-19 and the MoA-based scientific rationale of the candidatetreatments for COVID-19(https://www.preprints .org/manuscripV202003.0341 /v1 ).NIH-000141(b)(4lThank you for your consideration and my team is standing by for anyfurther assistance .Sincerely ,ldonaeldonae Lovetrue I CEO, Demiurge Technologie s AG, SwitzerlandNIH-000142(b) (4)NIH-000143www.demiurg e.technologyThis email and any attachments thereto may contain private, confidential, and privilegedmaterial for the sole use of the intended recipient. Any review, copying, or distribution of thisemail (or any attachments thereto) by others is strictly prohibited. If you are not the intendedrecipient, please contact the sender immediately and permanently delete the original and anycopies of this email and any attachments thereto . This email is intended for information purposesonly and is provided without any warranty of any kind, either expressed or implied. While someinformation used on this document may have been obtained from various published andunpublished sources considered to be reliable, Demiurge Technologies AG neither guarantees itsaccuracy or completeness nor accepts liability for any direct or consequential losses arising fromits use. Thank you.<mime-attachment >From: (b)(6)Sent : Sat, 28 Mar 2020 17:58:32 -0400To: Hallett, Adr ienne (NIH/OD) [E]Cc: Collins, Francis (NIH/OD) [E];Tabak, Lawrence (NIH/OD) [E];Wolinetz, Carrie(NIH/OD) [E];Shapiro, Neil (NIH/OD) [EJ;Lauer, Michael (NIH/OD) [E]Subject: Re: Brad ShermanThanks to everyone.On Mar 28. 2020, at 5:32 PM, Hallett, Adrie nne (NIH/OD) [E](b) (6J>wro te:Thanks Franc is. I just spoke to his Deputy Chief of Staff ________ (b_H_6)I'll share what I see when I see it.AdrienneOn Mar 28, 2020, at 2:27 PM, Collins, Francis (NIH/OD) [E](b)( t:Hi Adrienne,NIH-000144(b) (5)I spoke with Brad Sherman (D-CA) yesterday . He had origi nally reached out toTony, and Cliff Lane spoke to him Thursday, but I stepped in to try to lift onetask off of Tony's plate .He said he is sending a letter to Tony and me, asking what we need to go flatout against COVID-19. He wanted to know who from my office his staff couldwork with. I said you!FrancisNIH-000145(b) (5)From:Sent :To:Subject:(b)( 6)Sat, 28 Mar 202017 :31:25 -0400Jiaxian Zhou WuRe: Thank you for your service!Many thanks for your kind note.> On Mar 28, 2020, at 4:40 PM, Jiaxian Zhou Wu ------------ (b) (6) wrote : >>> Dear Dr.Fauci,>> I am writ ing this emai l to personal ly thank you for your invaluable service to our country. The United States ofAmerica. Th is virus, COVTD-19, is really dangerous and Jam very scared of it. T am really worried about mycountry, about the count less deaths . Your advice to the president has proven really important to prevent the spreadof the disease , however, in this nation, there is another epidemic based on lies and self~interest, now the peoplebehind the fake news are targeting to you, one examp le is the post of an email that relates to you with the fonne rSecretary of State, Hillary Clinton. This is why l decided to write a letter of support, I am sick of fake news ,personalattacks and violation of the First Amendment , the 1ight to have an opinion,to civil servants serving this country.>> I am still young but I still want to live in a United country. I ask you to continue your job, I want you to know thatmost Americans regardless of ideology are grateful of your service and sacrifice . A virus does not understandboundaries nor ideology , I am not an expert on this topic nor the presiden t and pol iticians. Please guide us with thetruth in these dire and dark days .NIH-000146From: -----(b)( 6) (NIH/NIAID) [E) Sent : Sat, 28 Mar 2020 19:43:52 +0000To: (b)(Subject: RE: medRxiv: Anti-hypertensive Angiotens in II receptor blockers associated tomitig ation of disease severity in elderly COVID-19 pati entsThanks for the note.Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail (b) (6)(b)( 6)(b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives.From: (b)(6b ----------------- Sent : Friday, March 27, 2020 2:37 PM -------~~ To: Fauci, Anthony (NIH/NIAID) [E]- --------(b)(6) Subject: Re: medRxiv: Anti-hyper tensive Angiotensin II receptor blockers associated to mitigation ofdisease severity in elderly COVID-19 patientsHi Tony,NIH-000147Thanks for the update. All of th is early science is certai nly confusi ng - (b)(6)Much the same th ing t hat we arehear ing from Am Colle ge of Card iology . I appreciate your keeping me informed.How are you do ing? (b)( 6)Best,~From: Fauci, Anth ony (NIH/N IAID) [E] --------- (b)(6) Sent: Friday, March 27, 2020 1:29 PMTo: (b)(6) > ---------------- Subject: [EXTERNAL) FW: medRxiv: Anti-hypert ensive Angiot ensin II receptor blockers associated tomiti gat ion of disease severity in elderly COVID-19 patients** A TTENTfON: This email originated from outside the MedStar network.** DO NOT CLlCK links or attachments un less you recognize the sender and know the content is safe.)(6):See below. The situ ation continu es to get more complicated .Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)( 6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .Anti-hypertensive Angiotensin II receptorblockers associated to mitigation of diseaseseverity in elderly COVID-19 patientsYingxia Liu, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Mengli Cao, Zhaoqin Wang, Xiaohe Li,Shaogeng Zhang, Lu Ye, Jingjun Lv, Jie Wei, Tuxiu Xie, Hong Gao, Kai-Feng Xu, Fusheng Wang, Lei Liu,Chengyu JiangNIH-000148NIH-000149doi: https:Udoi.org/10.1101/2020.03 .20.20039586This article is a preprint and has not been certified by peer review [what does this mean?]. Itre orts new medical research that has et to be evaluated and so should not be used to uideclinical practice.• Abstract• Info/H isto ry• Met rics••• Preview PDFAbstractSummary Background The novel coronav irus (CoV) severe acute respiratory syndrome (SARS)-CoV-2outbreak started at the end of 2019 in Wuhan, China, and spread over 100 countr ies. SARS-CoV-2 usesthe membrane protein Angiotensin I converting enzyme 2(ACE2) as a cell entry receptor . Indeed, it wasreported that the balance of Renin-Angiotensin System (RAS), regulated by both ACE and ACE2, wasaltered in COVID-19 patients. It is controversial, however, whether commonly used anti-hypertensivedrugs Angiotensin I converting enzyme inhibitor (ACEI) and Angiotensin II receptor blocker (ARB) shall becontinued in the confirmed COVID-19 patients. This study was designed to investigate any difference indisease severity between COVID-19 patients with hypertens ion comorbid ity. The included COVID-19patients used ACEI, ARB, calcium channel blockers (CCB), beta blockers (BB), or th iazide to treatpreexisting hypertens ion prior to the hospital were compared to patients who did not take any of thosedrugs. Methods In this multicentre retrospect ive study, clinical data of 511 COVID-19 pat ients wereanalyzed. Patients were categor ized into six sub-groups of hypertens ion como rbidity based ontreatment using one of anti -hypertension drugs (ACEI, ARB, CCB, BB, th iazide), or none. A meta -analysiswas performed to evaluate the use of ACEI and ARB associated with pneumonia using published stud ies.Findings Among the elderly (age>65) COVID-19 patients with hypertension comorbidity, the risk ofCOVID-19-S (severe disease) was significantly decreased in patients who took ARB drugs prior tohospitalization compared to patients who took no drugs (OR=0.343, 95% Cl 0.128-0.916, p=0.025). Themeta-analysis showed that ARB use has positive effects associated with morb idity and mortality ofpneumon ia. Interpretat ion Elderly (age>65) COVID-19 patients with hypertension comorb idity who aretak ing ARB anti -hypertension drugs may be less likely to develop severe lung disease compared topatients who take no anti -hypertens ion drugs. Funding Nationa l Natural Science Foundat ion of China,Chinese Academy of Medica l SciencesDi claimer: Any third-party material in thi email has been hared for internal use under fair use provisionsof .. copyri0 ht law, without further verification of it accuracy/veracity. It docs not ncccs arily reprc entmy views nor th ose of IAID , NIH HH , or th e U . . governm ent.MedStar Health is a not-for-profit, integrated healthcare delivery system, the largest m Maryland and the Washington, D.C., region Nationallyrecognized for clinical quality in heart, orthopaedics, cancer and GIIMPORTANT: This e-mail (Including any attachments) may contain information that 1s private, confidential, or protected by attorney-client orother privilege. If you received this e-mail in error, please delete it from your system without copying it and notify sender by reply e-mail. sothat our records can be corrected ... Thank you.Help conserve valuable resources - only print this email if necessary.From:Sent :To:Subject:Paco:Fauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 2020 19:26:52 +0000Real. FranciscoRE: A thank you noteThank you for your kind not e.Warm regards,TonyAnthony S . Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mai l (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It shou ld not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Ins t itute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representa t ives .From: Real.Francisco <freal@cn io.es>Sen t: Saturday, March 28, 2020 3:20 PM To: Fauci, Anthony {NIH/NIAID) [E]-- -------------- (~b)(=6) Subject: A thank you noteDear Tony,please allow me to call you Tony as I feel somewhat close to you (although there is no reason why youshould rem ember me). In early 19811 was doing a clini cal fellowship in Immunology/Oncology atMemorial Sloan-Kettering Cancer Center and wrote to you (b) (6)During my period at Memorial I workedextensively on AIDS and Kaposi's sarcoma ... and ever since - I moved in 1988 to Spain, my home country- I have followed and admired your wo rk.----------------------- (b)(6) I always felt close to you and your amazing work . Now, when I see you taking care of your count ry's action against Covid-19, I am proud tohave been attracted and inspired by your work in biomedical research and I am proud of what we -physician-scientists - can do for your societies and fo r human beings.NIH-000150NIH-000151From my very modest end as a human being, thanks for your responsible, honest, scientific leadership.Best wishes, we need people like youFrancisco X. Real (Paco)Epithelial Carcinogenesis GroupMolecular Oncology ProgrammeCentro Nacional de lnvestigaciones Oncol6gicasMelchor Fernandez Almagro, 328029-Madrid (Spain)Phone +34 917328000 ext 3660E-mail preal@cnio.eswww.cnio.esHAZTE AMIGO/ADEL CNIOmas INVESTIGACl6Nmenos CANCERFb Hazte Amigo de\ CN\O I Tw @HazteAmigoCNIO I Youtube canalcnio** ADVERTENCIA LEGAL**: Este correo electr6nico, yen su caso los fichero s adjuntos, pueden contenerinformaci6n protegida para el uso exclusivo de su destinatario. Se prohfbe la distribuci6n, reproducci6no cualquier otro tipo de transmisi6n por parte de otra persona que no sea el destinatario. Si usted recibepor error este correo, se ruega comunicarlo al rem itente y borrar el mensaje recibido.De conformidad con lo dispuesto en el Reglamento (UE) 2016/679 relativo a la protecci6n de los datospersonales de las personas ffsicas, la informaci6n personal que nos pueda facilitar a traves de estecorreo electr6nico quedara registrada por la Fundaci6n CNIO con la finalidad de tramitar el objeto delpresente correo electr6nico . El tratamiento de sus datos personales se encuentra legitimado por sernecesario para gestionar el objeto del presente mensaje. Estos datos personales no seran comunicadosa ningun destinatario salvo a aquellos que usted nos auto rice o asf venga exigido por una ley. Ud. podraNIH-000152ejercer los derechos de acceso, rectificac i6n, supresi6n, limitaci6n de tratamiento , portabil idad yoposici6n en la siguiente direcci6n : c/Melchor Fernandez Almagro 3, 28029 (Madrid). Podra ponerse encontacto con el Delegado de Protecci6n de Datos en: delegado lopd@cnio.es. Para el caso de que Ud.precise conocer informaci6n adicional sobre el tratamiento de sus datos personales, puede consultardicha informaci6n adicional en el siguiente enlace dentro de nuestra pagina web:https://www.cnio.es/es/privacidad/index .asp**LEGAL NOTICE**: This email and any attached files may contain protected information for the soleuse of its intended recipient or addressee. Anyone other than the intended recipient or addressee isstrictly prohibited from distributing , reproducing or transmitting the email and its contents in any way. Ifyou receive this email in error, please notify the sender and delete the message.Pursuant to the provisions of EU Regulation 2016/679 regarding the protection of personal data, anypersonal information you provide through this email will be registered by the CNIO Foundation in orderto deal with content of this email. Your personal data must be processed in order to be able to deal withthe content and purpose of this message. Your personal details will not be passed on to anyone elseunless you authorise us to do so or we are required to do so by law. You may exercise your rightsregarding access, rectification, suppression, limitation of processing, portability and opposition bywriting to the following address: c/Melchor Fernandez Almagro 3, 28029 (Madrid). You may contact theData Protection Delegate (Delegado de Protecci6n de Datos) at: delegado lopd@cnio.es. If you requirefurther information about the processing of your personal data, go to the follow ing link on our webpage :https://www . en io. es/ es/privacidad/index. aspFrom: Fauci, Anthony (NIH/N IAID) [E)Sent: Sat, 28 Mar 2020 19:00:32 +0000To: Auchincloss, Hugh (NIH/N IAID) [CJ- --------- (b)(6);Harper, Jill (NIH/NI A ID) [E];McGowan, Robert (Kyle) (CDC/OD/OCS)Cc: (b)(6)Subject:Attachments:FW: Time-Sensitive OSTP Request - Due 12 pm Monday , March 302020-03-28 _ COVID-19 FOAs-Projects .xlsxPlease respondAnthony S. Fauci, MDDirec;torNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representa t ives.From: Schwetz, Tara (NIH/OD) [E] (b)(6) >Sent: Saturday, March 28, 2020 2:57 PMTo: ICDDIR-L@list.nih.govCc: List DEPDIR-L <DEPDIR-L@list.nih.gov>; NIH Director's Executive Committee <ODSmallStaff@mail.nih.gov> ; NIH P&E Principals and Alternates <NIHP&EOfficers@mail.nih.gov>; Walsh,Elizabeth (NIH/OD) [E) (b)( >Subject: Time-Sensit ive OSTP Request· Due 12 pm Monday, March 30Importance: HighGood afternoon,We received a time -sensit ive request from OSTP that we are asking for your help to comp lete . Apo logiesin advance for the short turn -around .Action - Complete the attached template to provide FOAs and projects on " innova tion" and COVID-19,specifically focused on the topics described below . If your ICO has no noth ing to report, please let usknow .Requestor - OSTPNIH-000153POCs and Due Date - Please send the completed template to Elizabeth Walsh(Elizabeth.walsh@nih.gov) by noon on Monday, March 30Timeline -NIH Receipt Institut e Response to OD OD Office Review DateDate Due Date3/28/20 3/30/20 3/30/20Additional Instructions -NIH Final ResponseDue Date3/30/20• I pulled all the COVID-19 FOAs from the Guide; however, I did not sort through which ones arerelevant to this request. Please submit only those that your IC is the lead on that meet thecriteria listed above. Delete any that do not apply.Attachment s -• Response template (FOAs tab, Grants-Contracts tab)Do let me know if you have any questions.Best,Tara A. Schw etz, PhDActing Director, NINRAssociate Deputy Director, NIHA: Building 1, Room 13-8- - ~-,=, P: (b)(6) I M: (b)(6)NIH-000154(b)(5)From:Sent :To:Subject :GeeeezAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 202018:43:17 +0000(b)(6)FW: Washi ngtonian : You Can Now Buy Anthony Fauci SwagNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Folkers, Greg (NIH/NIAID) [E] -------- (b) ~ >Sent: Friday, March 27, 2020 6:11 PMTo: NIAID OD AM <NIAIDODAM@niaid .nih.gov>; ------------------- (b)( Subject : Washingtonian : You Can Now Buy Anthony Fauci SwagYou Can Now Buy Anthony Fauci SwagT-shirts, mugs, pillows-and, yes, even a Fauci prayer candle.Written by Daniella ByckI Published on March 27, 2020NIH-000155About Coronavirus 2020Washingtonian is keeping you up to date on the coronavirus around DC.More from Coronavirus 2020Fauci stans, assemble! Dr. Anthony Fauci, director of the National Institute of Allergy and InfectiousDisease, has emerged as the celebrity of the coronavirus crisis. Like others before him (rememberMueller mania?), his prominence has yielded but tons , t-shirts, and gifts, all flaunting the Fauci.NIH-000156Fauci face socksAnother reason you won't want to wear your shoes inside. $9.99, Etsy.NIH-000157"Dr. Anthony Fauci Fan Club" buttonFauci-fy any look with this pin. $3.16, Etsv.NIH-000158"I need a hero" T-shirtPaying homage to Fauci and Bonnie Tyler? This shirt is working overtime . $19.99, Etsv.NIH-000159"Honk for Dr. Fauci" lawn signA social distancing win: Show your support without leaving the house. $14.95, Etsy.NIH-000160Fauci Prayer CandlePraying you washed your hands . $20.20, Etsy.NIH-000161"Fauci 2020" T-shirtFinally, a shirt for those White House coronavirus briefings. $18, Etsy.NIH-000162"Hope" sweatshirtThanks, Fauci. $18.99, Amazon .NIH-000163KEEPCALMANDWASHYOURHANDS"Keep calm and wash your hands" mugA little PSA to go with your morning coffee. $19.95, Etsy.NIH-000164Dr. Anthony Fauci T-shirtA perfectly acceptable day-to -evening look in your self-quarantine. $29.00, Esty."I Heart Dr. Fauci" throw pillowFor sweet, scientific dreams. $20.66, Redbubb/e .Keep Up on DC's Latest Fashions with Our Shopping NewsletterFashion finds and deals, and the latest trends for you and you r home.Disclaimer: Any third-party material in this email bas been shared for internal use under fair use provisionsof U.S. copyright law, without further verification of its accuracy/veracity. It does not necessarily representmy views nor those of NIAID, NIH, HHS, or the U.S. government.NIH-000165From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 2020 18:26:42 +0000(b)(6)Subjec t: FW: Wpost : How the Viet nam War may have changed Anthony Fauci's lifeFYIAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Folkers , Greg (NIH/NIAID) [E] ---------(b)(6) Sent: Friday, March 27, 2020 6:15 PMSubject: Wpost: How the Vi etnam War may have changed Anthony Fauci's lifeOpinionsHow the Vietnam War may have changedAnthony Fauci's lifenthony S. Fauci, director of the National Institute of Allergy andInfectio us Diseases, speaks with th e coronavirus task forc e at the Wh ite House on Tuesday. (JabinBotsford/The Washington Post)By Ray GreenbergMarch 27, 2020 at 3:34 p.m . EDTRay Greenberg is a physician epidemiolog ist, former executive vice chancellor for health affairs at theUniversity of Texas System and the author of "Medal Winners: How the Vietnam War Launched NobelCareers."NIH-000166NIH-000167Americans may have the war in Vietnam to thank for Anthony S. Fauci.An adviser to six presidents and now the trusted public face of the scientific response to the coronaviruspandemic, Fauci has worked at the National Institutes of Health (NIH) for more than a half-century -beginning in 1968 with a group of doctors cheekily known as Yellow Berets.During the conflicts in Korea and Vietnam, the U.S. military faced a pressing need for physicians. In 1966,during Fauci's senior year at Cornell University Medical College, a military recruiter came to tell theassembled students: "After you finish medical school, every one of you except the two women willeither be in the Air Force, the Army, the Navy, or the Public Health Service." The last option, enteringthe Public Health Service, entailed assignment at the NIH, the Centers for Disease Control or the IndianHealth Service.Those who were selected to serve at the NIH were known officially as clinical associates, but informallythey were referred to as Yellow Berets. Whether the designation was born in jest or derision, it wasintended as a foil to the Green Berets of the Army Special Forces. Fauci never liked the label because itimplied an unwillingness to serve in harm's way. "As a physician," Fauci said, "I felt if I had to go [toVietnam], I would gladly do my part to try to help."The competition for the limited number of Yellow Beret slots was so intense that only the best andbrightest young physicians were selected. Fauci, the top graduate in his medical school class, was one ofseven chosen from 140 applicants to train in his laboratory of interest. As described in my book "MedalWinners: How the Vietnam War Launched Med ical Careers," the class of Yellow Berets that entered withFauci included four future Nobel laureates : Joseph Goldstein, Michael Brown, Harold Varmus and RobertLefkowitz .Each new appointee completed two years of clinical training before arriving at the NIH. Their primaryresponsibility was learning how to conduct basic research under the guidance of a senior scientist. Thesecond job was to care for patients at the NIH Clinical Center. Fauci and his fellow infectious diseasecolleagues also helped to care for wounded service members at the nearby National Naval MedicalCenter.Fauci, who had some research experience in medical school, trained at the NIH for three years under thetutelage of Sheldon Wolff - a pioneer in the relationship between the immune system and infectiousdiseases. Following a year of additional clinical training back in New York, Fauci returned to the NIH as asenior scientist conducting pioneering work, first on autoimmune conditions, then transitioning to studythe newly emerging disease that would become known as AIDS.When he entered the clinical associate program, Fauci's ambition was to become a medical schoolprofessor. Had the Vietnam War not brought him to the NIH, Fauci probably would have remained inacademia and the country never would have benefited from his extraordinary public service.Instead, from his position as director of the National Institute of Allergy and Infectious Diseases, Faucihas helped shape national policies related to HIV, bioterrorism and a series of pandemic threatsincluding avian influenza, H1N1 (swine) influenza, Ebola and severe acute respiratory syndrome. It ishard to imagine any other physician who has had such a sustained and profound impact on the health ofour nation.While Fauci remained at the NIH for his entire professional career, most of his fellow Yellow Berets leftBethesda after their training was completed and headed for jobs at universities . Across the nation, theformer Yellow Berets became medical school scientists, department chairs and deans. More than 60former clinical associates, including Fauci, were elected to the prestigious National Academy of Sciences,and he also was one of the more than 125 Yellow Beret alumni elected to the Institute of Medicine (nowthe National Academy of Medicine). In addition, Fauci was one of 10 alumni to receive the NationalMedal of Science.NIH-000168For all the scars left by the Vietnam War, we should not overlook the fact that in its absence, SO yearslate r the country would probably not have Anthony Fauci guiding us through our current crisis. Dr. Fauci,we salute you and your fellow Yellow Berets.Disclaimer: Any third-party material in this email has been shared for internal use under fair use provisionsof U.S. copyright law, without further verification of its accuracy/veracity. It does not necessarily representmy views nor those ofNIATD, NTH, HHS, or the U.S. governme nt.From:Sent:To:Subject:Thanks.Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 202017:52:04 +0000Billet, Courtney (NIH/N IAID) [E]RE: Dr. Fauci hits and requestsNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Billet , Courtney (NIH/NIAID) [E] -------- (b) (6)> Sent : Friday, March 27, 2020 6:24 PM ------ ~= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)( ·>; Conrad, Patricia (NIH/NIA ID) [E] (b )( 6)Cc: Stover, Kathy (NIH/NIAID) [E] -------- (b)(6)>; Routh, Jennifer (NIH/NIAID) [E] (b) (6) >Subject: FW: Dr. Fauci hits and requests(b) (5)From : Billet, Courtney (NIH/NIAID) [E]Sent: Friday, Ma rch 27, 2020 6:23 PM ---------~~ To: O'Malley, Devin M. EOP/OVP (b)(6) •>Subject: RE: Dr. Fauci hits and requestsDevin-From: Routh, Jennifer (NIH/N IAID) [E) ---------(b)(6)Sent : Friday, March 27, 2020 6:18 PMNIH-000169(b) (5)Cb) (5lTo: O'Malley, Devin M. EOP/OVP~ --:-:---:-::-:-::-::-:-".".'":""::--:.:==::.;(_b_H.; ._;. .L..o..v;.e , Kelly_ A_. EOP/OVP ..;___,:-:-=,--------- (b)(6)>; Henning, Alexa A. EOP/WHO (b)(6)>; _B_ owm_a_n_,; __L_a;_ u_r_e n K. EO....P.;./_W~ HO(b ~)( ~6)'> _________ (b)_(6 ); Porter , Macaulay V. EOP/OVPCc: Billet, Courtney (NIH/NIAID) [E] (b)( ; Stover, Kathy (NIH/NIAID) [E](b)(6J>; Conrad, Patricia (NIH/NIAID) [E] (b)(6); Hall, Bill":"----:-----:--:::====~~~=(HHS/ASPA) (b)(6)>; Mu rphy, Ryan (OS/ASPA) (b)( >Subject: RE: Dr. Fauci hits and requestsThanks, Devin. We have declined and scheduled as you advised. Below is an updated list and schedule .Friday 3/27• Pittsburgh, PA (also airs in OH and WV) - Bloomdaddy radio - 634 am live hit completed• Baton Rouge, LA- Morning News w/ Brian Haldane - 7:05 am live hit completedSaturday 3/28Showtime Desus and Mero - taping at 2 p.m. scheduledSund ay 3/29CNN State of the Un ion - live hit 9: 15 a.m. scheduledMonday 3/30• Apple TV+ Oprah - tape 11 :30 a.m. scheduled• Radio - Rantz show Seattle - 8 p.m. live hit schedule d• Radio - John/Ken show California - 8:30 p.m. live hit scheduledTuesday 3/31• CBS The Late Show with Stephen Colbert-tape 11 a.m. schedule d• CNN Coro navirus podcast with Sanjay Gupta - tape 12 noon sche duled• Wall Street Journa l The Journal Podcast - tape 1 p.m . ET-Wednesday 4/1New York Times The Daily podcast- tape 12 noon schedu ledThanks,JenJennifer Routh [E]NIH-000170(b)(5)News and Science Writing BranchOffice of Commu nications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7 A 17CBethesda, MD 20892Direct: Cb) (6)(b)(6)Disclaimor : The information in this e-mail and any of its attachments is confidential and may contain sensi tive information. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases shall not accept liability for anystatements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.J:rom : O'Mall ey, Devin M. EOP/OVP -------------- (b)(6)Sent: Thursday , March 26, 2020 6:58 PMTo: Routh, Jennifer (NIH/N IAID) [El-------=-:~ >; Love, Kelly A. EOP/OVP----------(b)(6)>; Henning, Alexa A. EOP (b)(6) 6 ow man, Lauren K. EOP/WHO (b)(6) ; Porter, Macaulay V. EOP/OVP(b)(6)> -------~ = Cc: Billet , Courtn ey (NIH/NIAID) [E] (b)(6); Stover, Kathy (NIH/NIAID ) [E]CbH 6); Conrad, Patricia (NIH/NIAID) [E] CbH6J; Hall, Bill"':":'":':-:-:--:-:-::::-:--:.=====---,.,_=.;-(HHS/ ASP A) (b)(6) Mu rphy, Ryan (OS/ASPA) (b)(6)Subject: RE: Dr. Fauci hits and requestsYellow means scheduleGreen means let's revisitCrossed out means please declineFrom: Rout h, Jennifer (NIH/NIA ID) [E] --------- (b)(6)Se nt: Thursday , March 26, 2020 6:52 PM ----------~~ To: O'Malley, Devin M. EOP/OVP (b)( >; Love, Kelly A. EOP/OVP-:-----:-:-----:--::--:-::-7."'.'"'.".'":""'.'.-.:===:..._;_ -__.;;_. _ _ ...;,.._--=-~----------- (b)(6); Henning, Alexa A. EOP/WHO (b)(6); Bowman, Lauren K. EOP/WHO (b)(6J> ; Porter , Macaulay V. EOP/OVP___ .;__ ___ ...;_ _,(~b)~(6~) ->----------------~ = Cc: Billet , Courtney {NIH/NIAID) [E] (b)(6)>; Stover, Kathy (NIH/NIA ID) [ElCbH 6J>; Conrad, Patricia (NIH/NIAID) [El"':":'":':-:-:--:-:-::::-:--:-;:::===::!....:-~ ~(HHS/ASPA) (b)(6)>; Mu rphy, Ryan (OS/ASPA)Subject : RE: Dr. Fauci hit s and requestsGood even ing-Below is a list of pending hits and requests for Dr. Fauci:Thursday 3/26• WTOP- 6:10 a.m . completed• NPR Morn ing Ed ition - 7:07 a.m . completed• YouTube content creato r inte rviews - 11 a .m. completed .NIH-000171o The content creators will publish the interviews on YouTube over the next fewdays. We expect Trevor Noah will publish tonight.• lnstagram Live video with Steph Curry- 1 p.m. completed• CNN Town Hall- scheduled 8 p.m. liveFriday 3/27• Pittsburgh , PA (also airs in OH and WV) - Bloomdaddy radio - 634 am live hit scheduled• Baton Rouge, LA - Morning News w/ Brian Haldane - 7:05 am live hit scheduledNIH-000172(b) (5)Jennifer Routh [E]News and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda, MD 20892Direct: (b) (6)(b)(6)Disclaimer : The information in this e-mail and any of its attachments is confidential and may contain sensitive informat ion. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sende r and delete itfrom your mailbox or any other storage devices . The National Institute of Allergy and Infectious Diseases shall not accept liability for anystatements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: O'Malley, Devin M. EOP/OVP --------------(b)(6)Sent: Wednesday, March 25, 2020 9:24 PM --------~~ To: Routh, Jennifer (NIH/NIAID) [E] (b)(6); Love, Kelly A. EOP/OVP----------- (b)(6 b ; Henning, Alexa A. EOP/WHO (b)(6) ; Bowman, Lauren K. EOP /WHO (b)(6) ; Porter , Macaulay V. EOP /OVP(b)(6 )>Cc: Billet , Courtney {NIH/NIAID) [E] (b)(6J>; Stover, Kathy (NIH/NIAID) [E]"'.'----:-----:-(:b:)(=6)>=; =Co=nr-a.d.,: _Pa~tri~cia {NIH/NIAID) [E] (b)( >; Hall, Bill (HHS/ASPA) (b)(6J>; Mu rphy, Ryan (OS/ASPA) (b)(6)>Subject: RE: Dr. Fauci hits and requests(b) (5)From: Rout h, Jennifer (NIH/NIAID) [E] ______ (b)_(6)>Sent: Wednesday, March 25, 2020 5:07 PM ------------=-:-:= To: O'Malley, Devin M. EOP/OVP.__ _________ (b_) <; Love, Kelly A. EOP/OVPNIH-000173(b) (5)----------- (b)( Henning, Alexa A. EOP/WHO (b)(6) ; _Bow_m_an, Lauren K. EOP/WHO (b)( >; Porter, Macaulay V. EOP/OVP ,:__ ____ ,:___~:;;----------- (b )( 6) >Cc : Billet, Courtney (NIH/NIAID) [E] _____ --,;;(b-H,-.=6); Stover, Kathy (NIH/NIAID) [E](b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b)( >; Hall, Bill"'.".-"'~~~=====-.;;__ ~= (HHS/ASPA-) ------- (b)(6)>; Murphy, Ryan (OS/ASPA) (b)(6) Subject: RE: Dr. Fauci hits and requestsGood evening-Below is a list of pending hits and requests for Dr. Fauci. Flagging a few new inquiries:(b) (5)Wedne sday 3/25• Bob Rose Radio Show - Gainsville Fl - 6:33 am live hit - completed• Bern ie and Sid Radio Show - NYC - 7:05 am live hit - completed• CNN Cuomo - scheduled live hit 9:05 p.m.Thur sday 3/26• WTOP- schedu led live hit 6:10 a.m.• NPR Morning Edition - scheduled live hit 7:07 a.m .• YouTube content creato r interviews - scheduled 11 a.m.• lnstag ram Live video with Steph Curry- schedu led remote conversat ion 1 p.m.• CNN Town Hall - scheduled 8 p.m. live-Podcasts :(b) (5)NIH-000174Jennifer Routh [E]News and Science Writing BranchOffice of communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7 A 17CBethesda, MD 20892Direct: Cb) (6)(b)(6)Disclaimer : The information in this e-mail and any of its attachmen ts is confidential and may contain sensitive informat ion. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . The National Institute of Allergy end Infe ctious Diseases shall not accept liabi lity for anystatements made that are sender's own and not expressly made on behalf of the NIAIO by one of its representative s.From: Routh, Jennifer (NIH/NIAID) [E]Sent: Tuesday, March 24, 2020 8:00 PM ------------=-~ To: 'O'Malley, Devin M. EOP/OVP' (b)( '>; 'Love, Kelly A. EOP/OVP'------------ (b)(6)>; 'Henning, Alexa A. EOP/WHO' (b)(6)>; _'Bo_wm_a n_, :L_a_ur e_n K_. E_O P./.W:H,O ' _ ..!=::,,;--------(b-)(-6)>-; -'Porter, Macaulay V. EOP/OVP' (b )( 6) >Cc: Billet, Courtney (NIH/NIAID} [E] >; Stover, Kathy (NIH/NIAID) [E]"':""-."".""."":--:""'"""."".(="b=)==(6::):.>..,;·: .C.._o_n,r.a.,..d...,.,;, ,.Patricia (NIH/NIAID) [E] (b)(6); Hall, Bill(HHS/ASPA) (b)(6); Murphy, Ryan (OS/ASPA) (b)(6)Subject: RE: Dr. Fauci hits and requests(b) (5)(b) (5)Jennifer Routh [ElNews and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda, MD 20892Direct (b) (6)(b)(6)Disclaimer : The information in this e-mail and any of its attachmen ts is confidential and may contain sensitive information. It should not beused by anyone who is not the original intended recipient. If you have received this e-ma il in error please inform the sender and delete itNIH-000175from your mailbox or any other storage devices . The Natio nal Institute of Allergy and Infe ctious Diseases shall not accept liability for anystatements made that are sender's own and not expressly made on behalf of the NIAIO by one of its representatives.From: Routh , Jennifer (NIH/NIAID) [E]Sent: Tuesday, March 24, 2020 7:48 PM To : O'Malley, Devin M. EOP/OVP ------~-------:--------::-===--(b.-)(, =;_>;_ -Lo.:v.~e,,: _K e_lly. A,_,. ,E_:O_ P /OVP ..:__~ =_________ Cb)_C6); Henning , Alexa A. EOP/WHO (b)(6)Bowman, Lauren K. EOP/WHO (b)(6)>; Porter, Macaulay V. EOP/OVP___ .,:___ ___ __:__~ (~b)~(6:)::->:-,-;---------Cc: Billet, Courtney (NIH/NIAID) [E] >; Stover, Kathy (NIH/NIAID) [E](b)(6)>; Conrad, Patricia (NIH/NIAID) [E) (b)(6)>; Hall, Bill"(':H"-:H--:S:--7/:A:.:-S:-:P::A:--):--;:::===:::..;..--,;- (b=H=6)>; Murphy, Ryan (OS/ASPA) (b)(6)Subject: RE: Dr. Fauci hits and requestsJennifer Routh [E]News and Science Writing BranchOffice of Communications and Government Relat ionsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda, MO 20892Direct: (b) (6)(b)(6)(b)(5)Disclaimer : The information in this e-mail and any of its attac hments is confidential and may contain sensitive informat ion. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sende r and delete itfrom your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases shall not accept liability for anystatements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives .From: O'Malley, Devin M. EOP/OVP --------------(b)(6)Sent : Tuesday, March 24, 2020 7:41 PMTo: Love, Kelly A. EOP/OVP -------- (-b=)"-"(="6=)>; Routh, Jennife r (NIH/NIA ID) [El(b)(6); Henning, Alexa A. EOP/WHO (b)(6)>; ---------- 8 ow man, Lauren K. EOP/WHO CbH >; Porter , Macaulay V. EOP/OVP___ .,:___ ___ __:__~ (~b)~(6:)::->:-;---------Cc: Billet, Courtney (NIH/NIAID) [E] (b) (6)>; Stover, Kathy (NIH/NIAID) [E](b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b)(6); Hall, Bill"('.H """.H."""S'..'."/"'."A"":S.~"P'.A"-"):'.- ===::::..,;:,._ =(b-SH"=6":)> ; Mu rphy, Ryan (O S/ ASPA) CbH >Subject: RE: Dr. Fauci hits and requestsNIH-000176(b) (5lFrom: Love, Kelly A. EOP/OVP --------- (b) (6)>Se nt: Tuesday, March 24, 2020 7:34 PM ------~~ To : Routh, Jennifer (NIH/NIAID) [El (b)( >; Henning, Alexa A. EOP/WHO(b)(6); Bowman, Lauren K. EOP/WHO ===========-~(b:)-(6-) ; Porter, Macaulay V. EOP/OVP- _-_-_-_-_-_-_-- --~ C_)b_(6.=.).Cc: Billet, Courtney {NIH/NIAID) [El (b)(6)>; Stover, Kathy (NIH/NIAID) [El.~:-:-:--::-:-:-::=== (b=) (=6)~; co""n"..r,a=..d. , Patricia (NIH/N IAID) [El (b)(6); Hall, Bill(HHS/ASPA) CbH6)>; Mu rphy, Ryan (O5/ASPA) CbH >; O'Malley,Devin M . EO'P:"-/:0-:--V:"-'P.-"=':==== CbT<6l>Subject: RE: Dr. Fauci hits and requests(b) (5)From: Routh, Jennifer (NIH/NIAID) [El ---------- (b)(6)Sent : Tuesday, March 24, 2020 7:26 PM ---------=-=-:-= T_o : L_ov.e ,. K.e.lly: A._. _EO_ _P_/_O.V. P: !.,::= ~~----(b)-(6)->; Henning, Alexa A. EOP/WHO (b )( 6) >Cc: Billet, Courtney (NIH/NIAID) [El (b)(6)>; Stover, Kathy (NIH/NIAID) [E](b)(6)>; Conrad, Patricia (NIH/NIAID) [El,__"""".""'""""""-0:-::===:::!...,;,-c:-:-:=, --:-:::======~~ (HHS/ASPA) (b)(6)>; Mu rphy, Ryan (OS/ASPA) --------- Subject: Dr. Fauci hits and requestsGood evening-Below is an updated list of t he hits and pending requests for Dr. Fauci.Tuesday 3/24• 7 am firm live hit Chris Stigall Radio Show (Ph illy) - completed• WMAL in woe - comp leted• 10 pm live with Laura Ingraham truck from his house - scheduledWednesday 3/25• Bob Rose Radio Show - Gainsville Fl - 6:33 am live hit - scheduled• Bernie and Sid Radio Show - NYC - 7:05 am live hit - scheduled• WTOP - working to schedu le• NPR Morning Edition - working to schedule(b) (5)NIH-000177Jennifer Routh [E]News and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CBethesda, MD 20892Direct: (b) (6)(b)(6)Disclaime r: The information in this e-mail and any of its attachments is confidential and may contain sensitive info rmation. It should not beused by anyone who is not the original intended recipient. If you have received this a-ma il in error please inform the sander and delete itfrom your mailbox or any other storage devices . The Natio nal Institute of Allergy and Infectious Diseases shall not accept liabi lity for anystatements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.NIH-000178(b) (5)From:Sent :To:Subject:Coronav irusBob:Fauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 20201 7:17:12 +0000Eisinger, Robert (NIH/N IAID) [E)FW: Proposta da un med ico ricercato re it aliano per arginare l'infezione daCan you figure out a way to get thi s tran slated so th at we can figure out wh at hewan ts and wh et her we can he lp him.Thank s,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MO 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail (b) (6)The information in th is e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: sandragiudic i@libero.it <sandragiudi ci@libero.it>Sent : Saturday, March 28, 2020 1:14 PM ------~~ To: Fauci, Anthony (NIH/ NIAID) [E] (b)(6)Subject: Proposta da un medico ricercatore ital iano per arginare l'infez ione da CoronavirusImportance: HighEgregio Professo r Fauci,NIH-000179foreign liiigiii gcforeign laiigiiigcNIH-000180foreign liiigiiigedott.ssa Sandra Liliana GiudiciOggetto : Proposal from an Ita lian research doctor to stem the Coron avirus infect ionDear Professor Fauci.I'm an Italian research doctor, with a qualification in Internal Medicine, who trained at the PolyclinicHospital of Milan.NIH-000181(b) (4)(b) (4)NIH-000182I'm very grateful for the precious time and for the attention that You will want to devote to my "app licationhypothesis". Trusting in Your kind reply, I send my best regards.dr. Sandra Liliana GiudiciNIH-000183(b) (4)From:Sent :To:Cc:Fauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 202017:15:57 +0000Janet TobiasConrad, Patricia (NIH/NIA ID) [E)·,- ----------- (b)(6) Subject: FW: Update on Film details, Task Force conversation s, etc.Janet:Thanks for the note to Patty. We can do some of #4 below . Patty wil l contactyou and we can also chat by phone today to update me on details. As you mightimagine, thing are very hectic and the most important thing is for me to get myjob done. And so we will do what we can but may not be able to do everythingthat you would like. I look forward to speaking with you later.Best regards,TonyAnthony S. Fauci, MODirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MO 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From:C onrad , Patricia (NIH/NIAID) IE]- -------- (b)( '> Sent: Saturday, March 28, 2020 7:28 AM --------=- = To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6) Subject: Fwd: Update on Film details , Task Force conversa t ions, etc.Sent from my iPhoneBegin forwarded message:From: Janet Tobias <janet@ikanamedia.com>Date: March 28, 2020 at 7:24:48 AM EDTTo: "Conrad, Patricia (NIH/N IAID) [E]" _______ "("b,").(.=.6,)>NIH-000184Cc: "Bil let, Courtney (NIH/NIAID ) [E]" --------- (b)(6)>, "Routh, Jennifer (NIH/NIAID) [E)" (b)(6)Subject: Update on Film details, Task Force conversations, etc.Hi Patty: A few import ant updates. And a request for this weekend/Sunday.2) We have been working with John Burklow/Dr . Collins/HHS on access to the Task Force. TheTask Force came back to us and asked us for more details about our approach, we gave them awritt en description of the overall approach of document ing for history the role of the TaskForce, it's leadership, NIH, NIAID, and Dr. Fauci. Burklow is working with us on this .3) Could I have a ten minute phone conversat ion with Dr. Fauci th is weekend, important- Ithink-to update him on details personally.4) We wou ld like, if possible to start filming wit h Dr. Fauci this weekend . Could we film Dr.Fauci exiting his house and going to the live truc k for Sunday morn ing inte rviews and thengoing back home or off to the WH. We would then match that in the film wi th the feed fromthe truck of him sit ting down and get archive from the shows he appears. We are close by. Zac(DP, who Dr. Fauci knows) has been in complete self-quarantine for two weeks before he leftNew York State and we are now here a week . He is completely good by self-quarantine rulesfor above filming .Thanks to the th ree of you fo r the work . The communication is life -saving. I have a couple ofclose friends on the frontline and they asked me to re lay how deeply grateful they are for thework you are all doing.JanetNIH-000185(b)(4)On Mar 24, 2020, at 3:38 PM, Conrad, Patricia (NIH/NIAID) [E]----------Cb)< · wrote :Hi JanetI gave him a hardcopy of your email earlier today ... he doeshave it- we had to add some meetings at the WH prior tohis Task Force meet ing so I know he was a bit distracted ..Wil I keep trying ...Patricia L. Con radPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infect ious DiseasesThe National Institut es of Health31 Center Drive, MSC 2520 - Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The informat ion in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statemen t made that are sender's own and not express ly made on behalf ofthe NIAID by one of its representatives.From: Janet Tobias <janet@ ikanamedia.com>Sent: Monday, March 23, 2020 9:26 PMTo: Conrad, Patricia (NIH/NIAID) [E]_ ______ -(,ba,)-..(.=,6)>Subject: Here and workingHi Patty:Zac and I are here and situated . I know you are drinking th rough ten firehoses. I wantto preserve sleep and health for Dr. Fauci. But it would be fantastic to have a 15minute video (with distancing) Q and A in the garden of his house or in the housethis week--- what he is working on just scientifica lly-vaccines, t reatments, diseaseunderstanding. I want to capture the focus and urgency of the real time scientificwork on COVID-19. lfwe need to we can figure out how to do it with audio, butwould love to see if we could do this in 15 minutes on video. Again, anytime thisweek.NIH-000186NIH-000187Thanks,JanetFrom:Sent :Fauci, Anthony (NIH/N IAID) [ElSat, 28 Mar 202017 :00:15 +0000To:Cc:Auchincloss, Hugh (NIH/N IAID) [El;Erbe lding , Emily (NIH/NIAID) [El------- (bH ;Conrad, Patricia (NIH/NIAID) [El Subject : FW: NIAID-NIBIB discussionAttachment s: COVI D _ ICD _ Trom berg.pptxHugh/ Emily:Please handle th is and respond to Bruce for me.Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Tromberg , Bruce (NIH/N I BIB) [El (b)(6)Se nt: Saturday, March 28, 2020 10:55 AM ------~= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>; Auchincloss, Hugh (NIH/N IAID) [El________ (b_)C6)>; Erbelding, Emily {NIH/N IAID) [El (b)(6)Cc: Heemskerk , Jill {NIH/NIBIB) [El (b)( >; George, David {NIH/N IBIB) [El(b)(6)>Subject : NIAID-NIBIB discussionHi Tony, Hugh, and EmilyHope you are doing well and gett ing a chance to pause (especia lly Tony!) after ano t her breathless sprintof a week .The NIBIB comm unity has unique capacity to design, build , and deploy an array of power ful biomedicaltechnolog ies. Much of our attention over the past year has been on early disease detect ion andprevention, and the integration of digital/pe rsonal health with conventional medicine . The COVID-19crisis seems to have many challenges that are ideally matched for our capabilities . With the $60M NIBIBwill receive in the supplement, we are in a unique posit ion to make a contribution.NIH-000188I am hoping we can meet with you to refine ideas and coordinate as we develop mechanisms to marshalthese resources. Your insight will play an essential role in helping us move forward wisely. NIBIB hasnever received anything remotely like this before and we are in unfamiliar territory. I think it reflects, inpart, the confidence---and hope, that people have in advanced technologies to change lives. We aredetermined to convert these dollars into tangible methods and devices and need your help in optimizingour strategy.I am forwarding my slide from the science presentation on Wednesday and my follow up email toFrancis and Larry to give you a sense of our direction {apologies for the information blast!). We havealso been drafting a NOSI with several topic areas that I am adding below ... note that we are in theprocess of condensing and refining these to simplify and more closely resemble our pay plan. I had agreat conversation with Francis in a follow up call Thursday and he suggested Cb()5 )I look forward to your thoughts/comments and hope we {cc'd NIBIB leadership Jill Heemskerk and DavidGeorge) can schedule a time to talk. Thank you for considering this, I know you are overflowing withemails and requests! If it's easierto just give me a call, my cell is (b)(6), I can give you the quick"cliff notes" summary.Best,BruceFrom: "Tromberg, Bruc_e. ;.(_N.I.H../;N. I_ BIB..); .[E..;]"; ....;;....::::=.~~------- (b)( > on behalf of "Tromberg ,Bruce (NIH/NIBIB) [E]" ----------- CbH6>(> Date: Thursday, March 26, 2020 at 7:22 AM ------~~ To: "Collins, Francis (NIH/OD) [E]" ______ CbC>_6>) , "Tabak, Lawrence (NIH/OD) [E]"NIH-000189(b) (5)(b)(6)Subject: Summary thoughtsHi Francis and Larry,Thanks for the opportuni ty to present yesterday . (b) (5)(b)( S)NIH-000190Best,BruceBruce J. Tromberg, Ph.D.DirectorNational Institute of Biomedical Imaging and BioengineeringNational Institutes of HealthBuilding 31, Room 1C14Bethesda, MD 20892-2281(b)(6)301-480-0679 - FAX(b)(6)http://www.nibib.nih.govNIH-000191(b) (5)(b)(5)- PCRNIH-000192(bX5) -PCINIH-000193From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sat, 28 Mar 2020 16:19:28 +0000Folkers, Greg (NIH/NIAID) [E)Subject: RE: What's new for 'fauci as' in PubMedthanksAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Folkers, Greg (NIH/NIAID) [E]- ------- (b)( 6)> Sent: Saturday, March 28, 2020 11:16 AM ------ ::;..,..-,= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6J> Subject: FW: What' s new for 'fauci as' in PubMedWill see to that these are on your cvFrom: NLM/NCBI efback <efback@ncbi.nlm. nih.gov>Sent: Saturday, March 28, 2020 6:17 AMTo: Folkers, Greg (NIH/NIAID) [E]..------- -(,b,.)_(=...,>Subject: What's new for 'fauci as' in PubMedThis message contains My NCBI what's new results from the National Center for BiotechnologyInformation (NCBD at the U.S. National Library of Medicine (NLM).Do not reply directly to this message.Sender's message: Search: fauci asSent on Saturday, 2020 March 28Search: fauci asView complete results in PubMed (results may change over time).NIH-000194NIH-000195Edit saved search settings, or unsubscribe from these e-mail updates.PubMed ResultsItems 1 - 2 of 21 Covid-19 - Navigating the Uncharted.Fauci AS, Lane HC, Redfield RR.N Engl J Med. 2020 Mar 26;382(13) :1268-1269. doi : 10.1056/NEJMe2002387 . Epub 2020 Feb 28. Noabstract available.PMID: 32109011 [PubMed - indexed for MEDLINE]Similar articles2 Role of T-cell trafficking in the pathogenesis of HIV disease.Cicala C, Arthos J, Fauci AS.Curr Opin HIV AIDS. 2019 Mar;14(2):115 -120. doi: 10.1097 /COH.0000000000000529 . Review.PMID: 30601238 [PubMed - indexed for MEDLINE]Similar articlesFrom:Sent :Eisinger, Robert (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAID) [ElSat, 28 Mar 2020 14:18:32 +0000To: Fauci, Anthony (NIH/NIAID) [E)Subject: FW: Updates, In DCEmail below from Janet Tobia s.Robert W. Eisinger, Ph.D.Special Assistant for Scientific ProjectsImmediate Offi ce of the Directo rNational Institu te of Allergy and Infectious DiseasesNationa l Institu tes of Health31 Center Drive , Room 7A-03Bet besda MD 20892Tel ephon e: (b)(6)Emai l: (b)(-----Original Message- ----From: Janet Tobias <janet@ikanamedia .com>Sent: Saturday, March 28, 2020 7:27 A-M- ------==-=-=-: To: Fauci, Anthon y (NIH/NlAJD) [E] --------- (b) (6) Subject: Re: Updates, In DCDear Ton y: 1 sent a note to Patty with upda tes. Task Force in progress (asked for more information) and we havefinalized plans for dis tribution/release of the film for when this is over next year and we all feel good about beingtogether in a theater. Will now push to do tiny bits of filming and audio a couple of times a week.Thanks for everything and thanks yesterday for talking to the frontline. Close friends there have asked me to pass ontheir gratitu de.See you soon and follow Chris ' advice about taki ng care of yourself.Jan et> On Mar 22, 2020 , at I 0: 1.9P M, Fauci , Anthony (Nil-I/NlAID) [E] ______ C.Hb_.6..l.>, wrote:>> My work with the Coronavi rus Task. Force aod tbe large vo lume of incoming email:, preclud es me or my ~tafffrom answer ing each individua l messag e. l would encourage yo u to visit www .coronavirus.g ov<http: //www.coronaviru s.gov> for the latest informati on and guidance related to COVID - 19.>> Thank you, and best rega rds.>> Anthony S. Fauci, M.D.>>>NIH-000196From:Sent :To:Subject:Thanks, John!Fauci, Anthony (NIH/N IAID) [E)Sat, 28 Mar 2020 12:29:31 +0000Burklow, John (NIH/OD) [E)RE: Great videos!From: Burklow, John (NIH/OD) [E) -------- (b)(6)Se nt: Friday, March 27, 2020 6:32 PM -----~~ To: Myles, Renate (NIH/OD) (El (b)( >; Fine, Amanda (NIH/OD) (El(b)(6); Akinso, Woleola (NIH/OD) [E] (b)( •>; Olander, Alyson"'(."N'."I'.H"'."/.O"'."D'":)': :-(::E"''l."= "":":=":";:=====~-__=; ==~(~b=) (6) ~>; C ox, Todd (NIH/CIT) [E] CbH ; Rosado, Andrew (NIH/CIT) [E) (b)(6) Collins, Scott (NIH/CIT) [E (b)(6) Chen,Josephine (NIH/CIT) [E) (b)( ; Welch, Will (NIH/CIT) [E) ~ CbH~ >; DianeBaker Cb()6 ); Awwad, David (NIH/NIAID) [CJ -------- Cb)( >; Rice, David (NIH/OD) [E]Cc: Collins, Francis (NIH/OD) [E] _______ ; Fauci, Anthony (NIH/NIAID) [E](b)(6)>; Tabak, Lawrence (NIH/OD) [E] (b)(6); Norris, Andrea(NIH/CIT) [E] (b)(6) ; Alboum, Stacie (NIH/CIT) [E] (b)(6)>; Johnson,---:---'.======:f..-~~Alfre d (NIH/OD) [E] (b)( Prince, Scott (NIH/OD) [E] (b)(6)] Chew,Debra (NIH/OD) [E] (b)(6); Folkers, Greg (NIH/NIAID) [E] (b)(6)Billet, Courtney (NIH/NIAID) [E) (b)(6)]; Conrad, Patricia (NIH/N IAID) [E](b)(6)Subject : Great videos!Congratulations to all of you who made today's COVID-19 videos a tremendous success! I know therewere a lot of quickly moving, intricate parts and it went off flaw lessly - all remotely, to boot! Everyoneworked as a team, under very tight timelines, and thanks to Renate, who orchestrated the FC HomeEdition! I know NIH staff will greatly appreciate the videos-they're chockful of content! And specialthanks to Dr. Fauci, who took time out of his "leisurely" day to devote more than an hour to thetaping - incredible!You all make us very proud!JohnNIH-000197From:Sent:To:(b)(6)Fri, 27 Mar 2020 17:51 :23 -0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Reaching out from Frame/UrgentBegin forwarded message:From: Ben Moe <be n@frame.media >Date: March 27, 2020 at 5:47:50 PM ED-T- ----~~ To: "Fauci , Anthony (NIH/NIAID ) [E]" -------- (b)(6Ji Subject: Re: Reaching out from Frame/UrgentDear Dr. Fauci,I hope all goes well. I wanted to quickly follow up and see if you might befree for a quick interview on Monday - it would mean so much to includeyour voice in the piece.Is there a time on Monday that might work for you? We can jump on thephone for a 5 - 1 O minute call if that works better for you.Best,BenOn Thu, Mar 26, 2020 at 5: 10 PM Ben Moe <ben@frame.media >wrote:Dear Dr. Fauci,I hope this finds you well and thank you for all the work you are doing. Irun the digital magazine, Frame, which publishes interactivedocumentaries made for mobile phones. We are working on a story aboutthe current effort to create a coronavirus vaccine and would love tointerview you for the piece.We've interviewed Regeneron's Chief Scientific Officer, GeorgeYancopoulos , and the piece will tell the story of Regeneron's push tocreate a coronavirus vaccine in record time. I was hoping you could speakto the broader issue of the often undercovered global threat of diseasesand the lack of funding going toward infectious diseases .NIH-000198NIH-000199Would you potentially be available for a short video interview sometimebetween 1 0am - 7pm EST tomorrow? Alternatively, would you be freesometime between 12pm - 2pm or 5pm - 7pm EST on Monday?Look forward to hearing back and we'd be honored to have your voice inthe story.Here's a brief overview of Frame:Frame is a newsmagazine that publishes interactive documentaries madefor mobile phones. Every Frame story tells a compel ling, human story thathelps shine a light on a major social or political issue.Frame stories include interactive features throughout, from maps totimelines, that allow viewers to engage more deeply with the piece. Ourstories are delivered through a messaging platform that allows subscribersto have conversations with our journalists and subscribe to news updateson topics they want to follow, all through SMS. Frame has been coveredby TechCrunch, Poynter, and Journalism.co.uk, and our investors includeSnap lnc.'s Yellow Accelerator.The very best,Ben MoeFounder and CEO, Frameben@frame.media@beneliasm oeFounder and CEO, Frameben@frame.media@beneliasmoeFrom:Sent :To:Subject:Fauci, Anthony (NIH/N IAID) [ElFri, 27 Mar 2020 17:48 :31 +0000Hirsch, Vanessa (NIH/NIAID) [E]RE: appreciat ionThanks, Vanessa. I appreciate your note .Best,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-O331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b)( 6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Hirsch, Vanessa (NIH/NIAID) [El --------- (b)( 6)Sent : Friday, March 27, 2020 10:28 AM To: Fauci, Anthony (NIH/NIAI D) [El ------------:-:--:-:-:(-b)=( 6) > Subject: appreciat ionHi Tony,I ju st wanted to express my appreciat ion for your sane voi ce during the Covid-19 cris is. Keep up thegood work . I know it has to be exhaust ing.Best regards,Vanessa HirschNHPVS, NIAID, NIHNIH-000200From:Sent:To:Cc:Subject :David:Fauci, Anthony (NIH/NIAID) [ElFri, 27 Mar 2020 15:57:33 +0000Morens, David (NIH/NIAID) [E)Folkers, Greg (NIH/NIA ID) [E]RE: (b)(4)Provided you (b)(6), if --------- you could do this wit hin t he next 2 to 3 weeks, that would be great .Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Morens, David (NIH/NIAID) [E] ---------- (b) (6) >Sent : Friday, March 27, 2020 11:27 AM -------~~ To : Fauci, Anthony (NIH/ NIAID) [E.] .:..==-===(b)(=6) =-~~ Cc: Folkers, Greg (NIH/NIAID) [El (b)(6) ---------- Subject : Cb) (4)Tony, ----------------------------- (b)(4), so I wil l start to think about what might work .Do you have a hoped-for t imetable? We are both overwhelmed, but I will try to do at least a bitdaily as long as (b)(6) . davidNIH-000201From: Morens, David (NIH/NIAID) [E]Se nt: Friday, March 27, 2020 11:24 AMTo : Narasimhan, Sri Devi (ELS-CMA) <srnarasimhan@cell.com>Cc: Fauci, Anthony (NIH/NIAID) [E] <AFAUCl@niaid.nih.gov>Subject: RE: Subject: CbH4)Dear Sri, thank you and we wish you and colleagues well too. These are certainly difficult timesfor all.(b) (4)We'll ponder that some more and get back toyou later. Thanks, again, and stay safeDavid M. Morens, M.D.CAPT, Uni ted States Publi c Health ServiceSenior Advi sor to th e DirectorOffice of the DirectorNational Institute of Allergy and Infectious DiseasesNationa l Institut es of HealthBuilding 31, Room 7 A-0331 Center Drive, MSC 2520Bethesda, MD 20892-2520CbH assistants: Kimberly Barasch; Whitney Robin son)QDisclaimer: This message is intende d for the exclusive use of the recipient(s) named above. It may contain information that is PROTECTED,PRIVILEGED, and/or CONFIDENTIAL, and it should not be disseminated , disttibuted , or copied to persons not authorized to receive suchinformation . All sensitive documents must be propuly labeled before dissem.in1ctionv ia email. If you are not the intended recipient, anydissemination, distribution, or copyin,g is strictly prohibited. If you have received this communication in error , please erase all copies of the messageand its attachments and notify us immediately.NIH-000202From: Narasimhan, Sri Devi (ELS-CMA) <>Sent: Thursday, March 26, 2020 9:2-3- -P-M- ---~~ To: Morens, David (NIH/NIAID) [E] (b)(6)Cc: Fauci, Anthony (N_IH_/N_IA ID.) ..[E:.] ...:,....:..:;=======--~.-:=-- Subject: Re: Subject: (b)(4) ---------------Dear Tony and David,Thank ou for writin back. First! I would like to sa thank ou for all that ou are doin . OnI hope you, your families and colleagues stay safe and healthy through this. Please take care.I look forward to staying in touch.Best wishes,Sri.Sri Devi Narasimhan, PhDDeputy Editor, CellCell Press/Reed ElsevierSO Hampshire St., Cambridge, MA 02139srnarasimhan@cell.comFrom: Morens, David (NIH/NIAID) [E] --------- (b)(6)>Sent: Thursday, March 26, 2020 4:53 PMTo: Narasimhan, Sri Devi (ELS-CMA) <srnarasimhan@cell.com >Subject: Subject: (b)(4)(b)(4)Dear Sri, we're responding, at long last, to your inv itation to Tony Fauci several weeks back, to(b) (4)NIH-000203First, apologies are in order. We tried to meet about this and get you a quick response the dayafter you and Tony emailed, but then coronavirus chaos ensued. We had to cancel 5 successivemeetings to go over this; in one case minutes before we were to start he got an urgent call togo down to the White Hose asap, and that was that. Few of us in the office have even seenTony in recent weeks as he is down at the White Hose daily from early morning until late atnight.Finally this morning we sat down and had a relaxed discussion. Assuming you are still___________(b)( .4.).. ._.C razy time_s, f or sure.Thank you, I look forward to hearing from you,<< OLE Object: Picture (Device Independent Bitmap)>>David M. Morens, M.D.CAPT, United States Public Health ServiceSenior Advisor to the DirectorOffice of the DirectorNational Ins ti tute of Allergy and In fectious DiseasesNational Institutes of HealthBuilding 31, Room 7 A-0331 Center Drive, MSC 2520Bethesda, MD 20892-2520ir (b)(6)stants: Kimberly Barasch; Whitney Robinson)~~(b) ( 4L_.,,_,(b) (4)Disclaimer: This message is intended for the exclusive use of the recipient(s) named above. It may contain information that is PROTECTED,PRIVILEGEDa,n d/or CONFIDENTIALa,n d it should not be disseminated,d istributed, or copied to persons not authorized to receive suchinformation. All sensitive documents must be properly labeled before dissemination via email. If you are not the intended recipient, anydissemination, distribution, or copying is strictly prohibited. If you have received this communication in error, please erase all copies of the messageand its attachments and notify us immediately.NIH-000204<< OLE Object: Picture (Device Independent Bitmap)>>From: Narasimhan, Sri Devi (ELS-CMA) <srnarasimhan@cell.com >Sent: Monday, January 27, 2020 4:00 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E] < CbH >Subject: Cb()4 )Dear Tony,I hope all is wel l. I had the great pleasure of meeting you in person when you were thekeynote speaker at our Cell Symposium on Emerging and Re-emerging Viruses in 2017. Youthen gave a wonderful talk that covered AIDS to Zika and your expe riences across differentoutbreaks, administrations and the challenges you encountered.My best wishes,Sri.Sri Devi Narasimhan, PhDDeputy Editor, CellCell Press/Reed Elsevier50 Hampshire St., Cambridge, MA 02139srnarasimhan@cell.comNIH-000205(b) (4)From:Sent:To:Subject:Attachments :Fauci, Anthony (NIH/N IAID) [ElFri, 27 Mar 2020 15:56:36 +0000Lerner, Andrea (NIH/N IAID) [ElFW: Offering help to fight the Civod-19Presentation Doc-line.pdfPlease check it out and respondAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (3 96':44li9E-mail: Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Peter Lermen (b) (6)Sent: Friday, March 27, 2020 11:30 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6)> Subject: Offer ing help to fight the Civod-19Dear Dr. Fauci,I don 't want you to waste too much time in th is stressful situation.As the doctor in charge of the hygiene of the Berner cli nic in Crans-M ontana in Swit zerland, as well asbeing in contact with my colleagues in private practice, I see every day how important the need forinformation and consultation of the population in this situation of insecurity is. At the same time , we areunder threat of a shor tage of doctors if we have to strictly apply the federal swiss guidelines (Art. 10band 10c, regulation 2 COVID-19) or if the wave of illness reduces the number of colleagues available forconsulta tions.(b) (4)NIH-000206Thank you for your timeGood luckBest regards,[) () C-} i 11 CPeter LermenMD internal medicine, interna l oncological rehabil itationCo-President oncoreha.ch(b)(6)www.doc-lin e.chNIH-000207From:Sent :To:Subject:Attachments:Fauci, Anthony (NIH/N IAID) [E)Fri, 27 Mar 2020 13:30 :18 +0000Mascola, John (NIHNRC) [E)FW: Vir updateVir Barda TechWatch _05 Mar20_vF.pptxPlease take a look at this and respond if appropriate.. Too long an e-mail for meto tackle . I have 745 others .Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone Cb) (6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Skip Vi rgin (b)(6)>Sent: Tuesday, March 10, 2020 11:33 PMTo: Fauci, Anthony (NIH/NIAID) [E]------ (=b)""(='6)>Subject: Vir updateTonyMy apologies for the slow update. You asked that I get back to you afteram. Notes in sections.NIH-000208CbC>4 >ansdo here I(b) (4)(b) (4)NIH-000209Any advice welcomeHappy to talk ____ Cb_H6)Be well and thanks for all of your public work to help us prepare. I wish they listened more.SkipHerbert W. 'Skip' Virgin M.D., Ph.D.Executive Vice President, ResearchChief Scientific OfficerVir Biotechnology499 Illinois AvenueSan Francisco CA 94158he/him/hisNIH-000210(b) (4)From:Sent :To:Cc:Fauci, Anthony (NIH/NIAID) [E]Thu, 26 Mar 2020 16:19:31 +0000Giroir, Brett (HHS/OASH)Kadlec, Robert (OS/ ASPR/IO);Birx, Deborah L-------------- (b)(6);Lerner, Andrea (NIH/N IAID) [E];Conrad, Patricia (NIH/NIAID) [ E]; Redd, Stephen (CDC/DDPHSIS/0D)Subject:Attachmen ts:Brett:FW: Draft of email for ASF to send to Brett Giroir cc'ing KadlecIMG_2072.movThe proposal below was sent to my office by David Margulies (Harvard/Boston Childrens) who is part ofa group of prominent physicians and healthcare executives in Boston developing this idea (David Martinof the Brigham, Gary Gottlieb of Partners and others). See this op-ed th ey wrote in the Boston Globeyesterday regarding their proposal https://www.bostonglobe.com/2020/03/25/opinion/mass-needscomprehensive-care-response-coronavirus /l .(b) (5)Can you take a look at this and let me know what you think? (b) (5J. David -..:=.=======:::::;;::;;;;-:~ Margulies can be contacted direc tly at (b) (6) or (bJ (6) if you needadditional information.Thanks,TonyNIH-000217(b) (4). (b) (5)David Margulies, M.D.(b)(6)NIH-0002 18(b) (4), (b) (5)From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Thu, 26 Mar 2020 13:25:30 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: RE: FOR TASK FORCE Considerat ion -- Some sound th inking on COVID-19We have been discussing each and every one of the se suggestion s and th ey are allon the t able for considerat ion of imp lementati on.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from you r mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sende r's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Conrad, Patricia (NIH/NIAID) [E] (b)(6)>Sent: Thursday, March 26, 2020 9:08 AMTo: Fauci, Anthony (NIH/NIAID) [E]------= (b")"~=' >Subject: FW: FOR TASK FORCE Consideration -- Some sound thinking on COVID-19Importance: HighPatricia L. ConradPublic Health Ana lyst andSpecial Assistant to the Directo rNational Instit ute of All ergy and Inf ectious DiseasesThe Nati ona l Inst itutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, M aryland 20892(b)(6)301-496 -4409 faxDiscla imer:The informat ion in this e-mail and any of its attachm ents is confide ntial and may contain sensi tive information . It shou ld not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itNIH-0002 19from your mailbox or any other storage devices. Nationa l Institute of Allergy and Infect ious Diseases (NIAID) shall not acceptliability for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Conrad , Patricia (NIH/NIAID) [E] (b)(6J>Sent: Wednesday, March 25, 2020 6-:3-1 -PM- ----, ~= To: Conrad, Patricia (NIH/NIAID) [E] (bH >Subject: FW: FOR TASK FORCE Considerat ion --Some sound think ing on COVID-19Importance: HighFrom: Pierce, William <wpierce@apcoworldwide .com>Sent : Wednesday, March 25, 2020 4:24 PM To: Conrad, Patricia (NIH/NIAID) [E]- ---------=-::(-b):(6-)=Subject: FOR TASK FORCE Consideration -- Some sound th ink ing on COVID-19Importance: HighPatty:I know Tony is the expert, but I thought this memo would be of interest and perhaps of help to him inhis battles .The attached memo is from Dr. Paul Offit (U of Penn) and a colleague of his David Rubin. Tony may knowhim, I would not be surprised.But for you, Paul is one of the country's topic vaccinologists and virologists. Paul developed a vaccine fora deadly disease. I know him well and he's the real deal. Next to Tony he is my go to science source.Paul in particular is a highly credible , well known nat ional expert.They wrote this memo on the 19th of March and it has many suggestions that are incredibly smart and Ithought tony would want to see th is immediately. Paul and David are obviously available to talk asap .Let me know.BillWilliam PierceSenior DirectorAPCO Worldwide1299 Pennsylvania Ave, N.W.Suite 300Washington, DC 20004(t) +1 202 659 7931 (m) ___ _(,l_>).,..,..,,NIH-000220wpierce@apcoworldwide.com@apcowortdwide:::::: Learn more about APCO resources available during the COVID-19 outbreak::::.:CONFIDENTIALITYThis email may contain material that is confidential, privileged and/or work product for the sole use of the intended recipient Any review,reliance or distribution by others or forwarding without express permission Is strictly prohibited. If you are not the intended recipient, pleasecontact the sender and delete all copiesWilliam PierceAPCO Worl<Jvvidt:~)+12026597931 (m) -------(b-)(6)NIH-000221From: Fauci, Anthony (NIH/N IAID) [E)Sent: Thu, 26 Mar 2020 12:44:24 +0000Bee: Crew, Page (NIH/NIA ID) [E];Davey, Richard (NIH/N IAID) [E);Doepel, Laurie(NIH/NIAID) [E];Eisinger, Robert (NIH/NIAID) [E];Higgs, Elizabeth (NIH/NIAID) IE];Kuriakose, Safia (NIH)[C];Lerner, Andrea (NIH/NIAID ) [E];Nason, Martha (NIH/NIAID) [E];Seam, Nitin (NIH/CC/CCMD) [E];Singh,Kanai (NIH/NIAID) [El, (b)( ;Brooks, John T. (CDC/DDID/NCHHSTP/DHPSE);Pau,Alice (NIH/NIAID ) [E];Lane, Cliff (NIH/NIAID) [E]Subject: Memo to NIH/CDC/VA Support Staff for t he HHS Panel on COVID-19 TreatmentGuidelinesDear colleagues,The purpose of t his email is to thank-you for agree ing to provide support to the HHS COVID19Treatment Guidel ines Panel. As you are aware clinicians are doing the ir best to nav igate acomplicated landscape with little to guide them. I realize everyone is very busy and I appreciateyou taking on this additiona l wor k at a difficult time.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-000222From:Sent:To:Cc:Subject:Fauci, Anthony (NIH/NIAID) [E)Thu, 26 Mar 2020 10:42:30 +0000Conrad, Patricia (NIH/NIAID) [E)Awwad, David (NIH/NIAID) [CJFW: BBC NewsLet us see if we can do this from my NIH office today during the day.From: Chris Foote <chris.foote@bbc.co .uk>Sent: Thursday, March 26, 2020 5:02 AMTo: Fauci, Anthony {NIH/NIAID) [E]_ _____ "("b"")"("=6' )Subject: BBC NewsHello Dr FauciI'm the programme editor of The Nine, a nightly news and current affairs programme on the BBC. I washoping you could spare ten minutes at some point today (March 26) to speak to us over Skype orFace Time about the US response the Coronavirus pandemic.If that's possible, I' ll ask one of my producers to arrange it at a time convenient for you .Chris FooteSenior JournalistBBC News(b)(6)http://www.bbc.co.ukThis e-mail (and any attachments) is confidential and may contain personal views which are notthe views of the BBC unless specifically stated .If you have received it in error, plea5e delete it from your system.Do not use, copy or disclose the information in any way nor act in reliance on it and notify thesender immediately.Please note that the BBC monitors e-mails sent or received.Further conununication will signify your consent to this.NIH-000223(bX5)-PCENIH-000224NIH-000225From:Sent :To:Subject:Bonnie:Fauci, Anthony (NIH/NIAID) [ElThu, 26 Mar 2020 02:27:28 +0000Joubert, Bonnie (NIH/NIEHS) [ElRE: Thank youThanks for the note. Much appreciated.Best regards,TonyFrom: Joubert, Bonnie (NIH/NIEHS) [El --------- (b)(6) Sent : Wednesday, March 25, 2020 9:50 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] -------- CbH6J> Subject: Thank youDear Dr. Fauci,I just want to say THANK YOU for all that you are doing for the country to address the COVID-19pandemic. As an epidemiologist at NIEHS, it is inspiring and encourag ing to be part of NIH and to haveleaders like you involved in the national and global response during this critical time.Regards,BonnieBonnie Joubert, MPH, PhDPopulation Health BranchDivision of Extramural Research and TrainingNational Institute of Environmental Health SciencesResearch Triangle Park, NC 27709Phone: (b)(6)NIH-000226From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Wed, 25 Mar 2020 17:20 :55 +0000Friedmann, TheodoreSubject: RE: George Church interviewThanks, Ted. I appreciate your note.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Friedmann, Theodore <tfriedmann@health.ucsd.edu>Sent: Tuesday, March 24, 2020 4:22 PM ------- ---,= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: Fwd: George Church interviewDear Tony : I sent a brief note to my friend Jon Cohen to congratulate him on what I thought was his fineinterview with you. In his response, he suggested that I should send a copy to you. I've been a littlereluctant to do that because of what I assumed must be a flood of comments and advice that you aregetting in your role on the task force. I attach the message to Jon below and I hope that some of thethoughts are useful and maybe a little comforting for you. With my very warmest regards and bestwishes,TedBegin forward ed message:From: The odo re Friedman n <tfriedmann@health .ucsd .edu>Subject : Re: George Church interviewDate: March 24, 2020 at 12:09:20 PM PDTTo: Jon Cohen <jcohen@ aaas.org>NIH-000227Dear Jon: Greetings from La Jolla. Congratulations on your interview with Tony Fauci. Ihave to admit that, until a couple of weeks ago, I have been quite critical of Tony'sapparent acquiescence with so much dangerous, incorrect and politically motivatedmisinformation from the administration. I feared that the upside-down explanations fromthe administration had the effect of destroying the concepts and tenets of epidemiologyand even rat ionalizing a completely wrong concept of communicable disease that holdsthat it is unnecessary to screen for carriers in an epidemic but only important to screensymptomatic people. That is upside-down from what we all know about dealing withepidemics and has even been endorsed by Trump, Pence and other members of theCOVID-19 task force. It seems to have become a new normal concept of communicabledisease management. Like so many things in the Trump era, facts and history are thrownout the window and replaced by governmentally espoused but obviously wrong concepts.We assume to be preparing to complete ly deny established concepts of communicabledisease - screen only the prime suspects or the afflicted. In conversations with colleagueshere I wondered "where is Tony Fauci?" They suggested that he must be quietly andheroically working hard being the scenes and at his personal peril to educate our leadersrather than correcting them publicly. But I thought that, in desperate times, the publicmust hear and see clear truth and denials of lies. My concept of heroes are people who actat their personal peril - Rosa Parks, Martin Luther King, Martin Niemoller, DietrichBornhoffer, Thankfully, I th ink that the real Tony Fauci has emerged, obviously to his peril.I wish him good luck and survival. I find myself wondering what the responses will be toTrump 's likely premature lifting of isolation and quarantining procedures and if theconcept of disobeying illegal and unethical orders will survive the times.TedOn Dec 6, 2018, at 11:17 AM, Jon Cohen <jcohen@aaas.org> wrote:So good to hear from you and do te ll Carl to contact me.Yes, George has received ample criticism, but my job is to air his views,regardless of what I think. And I like his independent, damn the torpedoesapproach. He speaks his mind. As for He, everything about th is is bizarre,from ethics to science to PR to regulation .Best,JonNIH-000228On Dec 6, 2018, at 1:19 PM, Friedmann, Theodore<t friedmann@ucsd.edu> wro te:Hello Jon - Greetings fro rrC: (b> c<1. It has been a long time sincewe last connected and talked about gene therapy, etc. and(b)(6)I was very interested to read George Church's troublesomeresponses in your interview with him in Science and to see hisethical evaluation of He's CCRS editing experiment in China. I'mnot as generous to He as George seems to be and I think thatth is work is clearly unethical. George inexplicably conjures upthe sad history of Jess Gelsinger and the effect of his death onthe evolut ion of the field of gene therapy. Happily, he's rightabout the fact that gene therapy is now proving itself in agrowing list of intractable diseases (underscored by the 2015Japan Prize). That has happened because stud ies are now muchmore carefully designed and carried out. But sadly, we are in anenvironment in which some people conclude that humanmedical manipulations - gene therapy, genome editing, stemcell therapy- are ethical as long as they "work". The rationa le is,"let's do the study and if it works and doesn't kill or ot herwiseharm, it's OK". It's not a post- factor evaluation that determinesif an instance of human experimen tation is ethica l andpermissible - it is the design of a study that determines if it isethical or not. George should be reminded of that fact andshould re-read the Helsinki declarations or similar codes ofhuman experimentation.In any event, your interview was fascinating. Best regards,Ted FriedmannNIH-00022 9From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Wed, 25 Mar 2020 16:59:20 +0000(b)(6)Subject:Attachment s:FW: Developing Control Charts for Covid 3 24 20 with graphs.docxDeveloping Control Charts for Covid 3 24 20 with graphs.docxPlease take a look at this. What do you think?Anthony S. Fauci, MDDirectorNational Institute of Allergy and Tnfectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2 520National Institutes of HealthBethe sda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b) (6)The informa tion in this e-mail and any of its attachm ents is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. If you have received this e-mail in en-orplease inform the sender and delete it from your mailbox or any other storage devices. The Nat ional Institute ofAHergy and Infectious Diseases (NlAlD) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIAID by one of is representatives.-----Original Message----- ---------=-:-:-= From: Steve Sternberg (b) (6)Sent: Wednesda y , March 25, 202 0 8:3-9 A-l\-'[ -----=-=-= To: Fauci, Anthony (NlH /NlAlD) [E] (b) (6}Subject: Developing Control Charts for Covid 3 24 20 with graph s.docxTony ,Here are reconfigu red charts which factor in the guidance from mathematicians at Rockefeller. As you can see, thetrend in the U.S. is visibly worse. If this pattern holds, we're going to see many more deaths before things get better .We would be grateful for a comment. Could you offer a perspective? We're going to try to publish today.SteveNIH-000230From:Sent :To:Cc:Subject:Jean-Francois:Fauci, Anthony (NIH/N IAID) [ElWed, 25 Mar 2020 15:01 :21 +0000DELFRAISSYJe an-fr ancois(b)(6)RE: France situation COVID-19Thank you for your note . I do not see Yazdan copied on your e-mail, andl soplease forward this e-mail to him. The NIH position is that we should preferablymake drugs available on randomized , controlled clinical trials and not freelydistribute them. There is a strong push in the USA, favored by the President, tomake certain of these drugs more widely available outside of an RCT usingmechanisms such as "compassionate usage". In the USA, as you know, HC(plaquenil) is an approved drug for malaria as well as for certain autoimmunediseases such as SLE. Thus, physicians can prescribe the drug on an "off label"usage. This likely will be the majo r modality of distribut ion of this drug in theUSA, at least for the foreseeable future.I am copying Cliff Lane on this e-mail. Please include him on any furthercorrespondence on this subject.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: DELFRAISSYJ ean-franco is (b)( 6)> -------------- Sent: Wed nesday, March 25, 2020 -1-0-:3-5- ~AM~ To: Fauci, Anthony (NIH/NIAID) [El CbH6J>Cc: DELFRAISSYJ ean-francois ,...:....:;....;;,,!;;=======-----=- (b")"("=6) >Subject: France situation COVID-19NIH-000231NIH-000232Hello,I am once again in service since the global sanitary crisis COVID-19 hit France a couple of weeks ago. Iam now leading the Scientific Council for COVID-19, composed of 10 persons, serving the FrenchPresident , Emmanuel Macron.The Council was created on March the 10th and we were heavily involved in advisory activities in relationto the President's decision to put the generalized quarantine into force, because we didn't have anybetter choice.FirstlyWe have a limited number of diagnosis tests, this prevents us from taking up a Korean-like strategywithin the next few days. However, by the end of the quarantine (within the following six weeks), we willbe able to have a generalisation of the diagnosis test and develop korean-like apps, as well as a strategyfor testing and treatment if we have any drugs available by th is time. Before this, we will go through adifficult phase in the following weeks, because we won't have enough beds in our care units in some partof France ...SecondlyOn the therapeutic level, Yazdan Yazdanpanah has taken my place and who is now leading REACTing.Tomorrow morning a french -european medical trial will begin, under the control of the WHO, with 5 arms(placebo/kalatra/kalatra +interferon beta / product of Guilead / hydroxychloroquine alone or incombination for next week).As you may know, we are currently facing a press buzz since the announcement made by Dr. Raoultabout the effectiveness of hydroxy-chloroquine. His data is not particularly convincing. We can dist inguisha slight positive signal but it must be confirmed by a well made randomised tr ial. We also started amonkey-model study with HC and we should have the results by the end of next week. Also a cohort ofsevere COVID+ patients have been created and some will be treated with HC : we will analyse thoseresults with all the consciousness needed. It will also be possible to do a prevention trial for healthcareprofessionals and aging people with HC. I have an enormous political pressure to release HC and to giveit to everyoneb ut I am currently resisting.. .How is the situation in the USA, especially after Trump's announcement ? What is the NIH position ?What will be put into force ?Thanks for your answer.I put YazdanY azdanpanahin a copy of this email.Best regardPr. Jean-Fran~ois DelfraissyPresident I PresidentComite consultatifnational d'ethique pour !es sciences de la vie et de la santeNational Ethical Consultative Commiteefoe life sciences and healthAncien Directeur de l' ANRS I ANRS former DirectorMT_""::::::::::::NIH-000233From:Sent:To:Cc:Subject:PANTHEONFauci, Anthony (NIH/NIAID) [E)Wed, 25 Mar 2020 13:57 :28 +0000Folkers, Greg (NIH/NIAID) [E)Conrad, Patricia (NIH/NIAID) [ElRE:- ----------------------- (b) (4)Agree. Skip this and please try to get David back on my morning schedule to startworking on the original paper that we had agreed upon .Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Folkers, Greg (NIH/NIAID) IE] -------- (b) (6)>Sent: Wednesday, March 25, 2020 -9-:2-9- -A-M~ ~ To: Fauci, Anthony (NIH/NIAID) [E] Cb)( > .'.":.========-=-=--:-= Cc: Conrad, Patricia (NI H/N IAID ) [E] Cb()6 )Subject: ---------------------------- (b) (4)(b) (5)NIH-000234From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Wed, 25 Mar 2020 12:08 :27 +0000(b)(6)Subject: RE: wi th love from ItalyRita:Many th anks for you r kind note. It is much appreciat ed.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-O331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: rita .apgar@alice .it (b)(6)Se nt: Wed nesday, March 25, 2020 7:58 AMTo: Fauci, Anthony (NIH/NIAID) [E]------= (b")("=6')>Subject: with love from ItalyDear Doctor Fauci. My name is Rita Apgar and if by chance you not iced my last name, as my father saidmany years ago,' (b) (6)!" I have lived in It aly for almost SO yearsand the sagacious finger of desti ny pointed my way to It aly, the true home of my heart , although not adrop of Italian blood flows through it. But the love of Italy and the Ita lians pumps throug h my heartevery second of my existence .That sagacious finger of destiny pointed the way, and I followed it in faith to (b)(6)where I had lived. As soon as I set foot for t hefi rst t ime in the house in this funky ghost town of a medieval village, I felt that we belonged together.And, practically speaking, at the t ime, it was the perfect solution to some weighty personal problems .Heart and mind were in peaceful agreement.I have a dear frie nd who is an infectious disease specialist at the hospital in Asti. She is, obv iously,extreme ly busy these days but she took the time to call me Sunday evening and we talked about you .She said to me, "you know, when I was j ust a graduate student, I was a secret group ie of Dr. Fauci, andonce when he was at a meeting or a conferenc e or someth ing (I'm not sure whe re or when) I was able toask him a few questions ." I was thri lled, of course, since I also try to watch every appearance you makeon TV. I will not add anyth ing in this regard.NIH-000235But I did say to Mar ia, Doctor Maria Degioanni, "Maria, I want to invite Dr. Fauci to come and visit us fora few days when this crisis is over, God willing and maybe he would come together with (b)(6). who has promised to come and visit again after 20 years. We can put themup in the fancy Relais San Damian above lsolalunga where I live and take them out to dinner at Gente diMare . Dear Doctor Fauci, I like to joke when people ask how we are doing in this time of Covid-19 bysaying : A Name, a guarantee : ISOLAlunga= ISOLAtion I Legend says that the Benedictine monks who gotinto mischief centuries ago were sent here as punishment to work in the olive groves: long isolatio n.Today it's the perfect place to be with a view of the Mediterranean as well as the Maritime Alps fromthe kitchen window and hardly a soul to practice social distancing with!Grazie per esistere as an Italian song goes, "thank you for being you! I would adore getting a reply fromyou, but realize how miraculous tha t woudl be! We would be over the moon if you accepted ourinvitation , at any time and at the drop of a hat!Sincerely, Rita ApgarNIH-000236From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Wed, 25 Mar 2020 10:27 :40 +0000Jon LaPookSubject: FW: Serology for the novel coronavirusTry Barney Graham at the NlAID YRC. You have interviewed him more than once .-----Or iginal Message -----From : Jon LaPook ______ __,(b'")"..(,6.=)Sent: Tuesday, March 24, 2020 2 :17 P-M- ------~~ To : Fauci , Anthony (NTH/NJAlD) [E]..._ ______ (b _ )_( ....Subj ec t: RE: Serology for the novel coronaviru sSigh. Who wou ld you suggest I try to interview?Thanks,Jon-----01i ginal Message- --- -From: Fauc i, Anthony (NIH/NIAlD) [E]..._ _____ (b _ )_( ....Sent: Tuesday, March 24, 2020 I :57 PMTo: Jon LaPook (b) (6)>Subjec t: Re: Serology for the novel coronavirusLots of talk. Not sure about progress> On Mar 23, 2020 , at 6:27 PM, Jon LaPook -------- (b) (6)> wrote: >> Tony ,> Any progress ? Obviously, if we had widespread serologic testing , we co uld identify people with likelyimmunity , and put them on the front lines.> Thanks ,> Jon>> Jonatha n LaPook , M.D.> Chief Medical Correspondent , CBS News> Professor of Med icine> NYU Langone Healtb> Twitter @DrLaPookNIH-000237From:Sent :To:Fauci, Anthony (NIH/N IAID) [E)Wed, 25 Mar 2020 02:26:42 +0000(b)(6)Subject: FW: Serology for the novel coronavirusCliff:Who is the most knowledgeable about serologies for COVID-19? If you know , could you please respond to Jon.Thanks ,Tony-----Original Message-----From: Jon LaPook ,;-.-----= (b"')-=(= >Sent: Tuesday. March 24. 2020 2: 17 PM...-------~To: Fauci, Anthony (NTH/NIAID) [E]Subject: RE: Serology for the novel coronavirusSigh. Who would you suggest I try to interview?Thanks,Jon-----Original Message-----(b)(From: Fauci , Anthony (NIH/N1A ID) [E] -------- (b)(6)> Sent : Tuesday, March 24, 2020 1 :57 PMTo: Jon LaPook (b)(6)Subject: Re: Serology for the novel corona virusLots of talk. Not sure about progress> On Mar 23, 2020, at 6:27 PM, Jon LaPook- ------(b) (6)> wrote: >> Tony,> Any progress? Obviously, ifwe had widespread serologic testing, we could identify people with likely immunity,and put them on the front lines.> Thanks,> Jon>> Jonathan LaPook, M.D.> Chief Medical Correspondent, CBS News> Professor of Medicine> NYU Lango ne Health> Twi tter @DrLaPookNIH-000238From:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [ElWed, 25 Mar 2020 01:53:06 +0000Lerner, Andrea (NIH/NIAID) [ElFW: COVID-19 West Virginia PhenomenonFrom: Daniel Ries (b)(6)>Se nt : Tuesday, March 24, 2020 8 :59- -PM- --- ::;..,..-,= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)> Subject: COVID-19 West Virginia PhenomenonDear Dr Anthony FauciBest regardsDaniel RiesPhD Food TechnologyMassey UniversityNEW ZEALANDNIH-000239(b) (4)(b) (4)(b) (4)NIH-000240From:Sent :Eisinger, Robert (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAID) [ElTue, 24 Mar 2020 17:48:57 +0000To: Fauci, Anthony (NIH/NIAID) [E)Subject: FW: COVID reagent allocation issueEmail response from Jeremy BergRobert W. Eisinger, Ph.D.Special Assistant for Scientific ProjectsImmediate Office of the DirectorNational Institute of Allergy and Infectious DiseasesNational Institutes of Health31 Center Drive, Room 7A-03Bethesda MD 20892Telephone: (b)(6)Email: (b)(From: Berg, Jeremy (b)(6)Sent : Tuesday, March 24, 2020 1:46 PM -----~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6):> Cc: Lerner, Andrea (NIH/NIAID) [E] -=-=-=-=--=-=-===(b~)(6) Subject: Re: COVID reagent allocation issueYou are welcome, Tony. We appreciate anything that you can do with regard tothe reagent allocation issue. The view from the trenches is pretty stark.Keep up the good work and do not hesitate to reach out to me if I can be helpfulin any way.Best, JeremyJeremy M. Berg, Ph.D.University of PittsburghAssociate Senior Vice Chance llor for Science Strategy and Planningin the Health SciencesProfe ssor of Computational and Systems BiologyScaife Hall , S3043550 Terrace S1reetPittsburoh PA 15213(b)(6)(cell)NIH-000241From: Anthony Fauci (b)(6)>Date: Tuesday, March 24, 2020 at 1:44 PMTo: Jeremy Berg CbH6J>Cc: "Lerner, Andrea (NIH/NIAID) [E]"- ------- (b)( > Subject: Re: COVID reagent allocation issueThanks, JeremyOn Mar 23, 2020 , at 9:00 PM, Berg, Jeremy ------ CbH6Jw>r ote:Dear Tony: I am sure you are overwhelmed, but I think it is importantto share the attached with you (which will be sent to you directlythrough regular channels) . CbH6)ais p athologist who is incharge of testing in a large med ical system in Rochester, New York,who has been extremely concerned and frustrated by the lack of accessto reagents for the Roche coronavirus testing platform. They have theplatform but cannot use it because of a lack of reagents (which wereapparently pre-purchased by Quest, LabCorp, and other nationalgroups). The turnaround time for Quest is approximately 5 days andthis is completely useless for making clinical decisions about admissioncompared with local testing with 24 hour per around time.Thank you for your attention and for everything that you are doing tohelp our country through this great challenge.Best, JeremyP.S. I enjoyed the interview with you in Science and admire your clarityof purpose.Jeremy M. Berg, Ph.D.University of PittsburghAssoc iate Senfor Vice Cha ncellor for Science Strategy and Planningin the Health SciencesProfessor of Computationa l and Systems BiologyScaife Hall, S3043550 Terrace StreetPittsburgh, PA 15213(b)(6)NIH-000242Cb) (6) ( cell)(b)(6)<Fauci-Rochester-Reagents.pdf>NIH-000243From:Sent :To:Subject:Fauci, Anthony (NIH/N IAID) [ElTue, 24 Mar 2020 16:27:17 +0000Lerner, Andrea (NIH/N IAID) [ElFW: You may be able to help ....Linda is a former NIH Insti t ute Director. Please figure out what she is ta lkingabout and respo nd to her on my behalfAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from you r mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Birnba um, Linda (NIH/N IEHS) [VJ- ---------(b)(6)> Sent: Tuesday, Mar ch 24, 2020 12:22 PMTo: Fauci, Anthony (NIH/NIAID) [E]------= (b'")~'="' >Subject: You may be able to help ....Hi Tony,Thank you for yo ur tireless efforts to clearly communicate about the pandem ic, including correcting thePresident when necessary. You do it in such a non -threatening and respectfu l style. I think everyoneappreciate s it .--------- (b)(6) runs a home health care company in NC and many other states in the nation . He has managed to get some of the largest home care companies as well as the Home Care Associationof America (their trade organization) to sign off on this call for guidance for their industry whichprovides professional care givers, largely CNAs, to those needing assistance with daily liv ing throughoutthe nation .I am reaching out hoping that you might know to whom this message shoul d really go.Thanks again for all you do - and take care of yourse lf! The nation needs you.Sincerely, LindaNIH-000244Linda S. Birnbaum, Ph.D., D.A.B.T., A.T.SScientist Emeritus (Retired)Former Director, National Institute of Environmental Health Sciencesand National Toxicology Programphone: (b)(6)cell (b)(6)e-mail: """:"""--.-;::======--~~ personal email: (b) (6)(b)(6)----------From: (b)(6)(b)(6)>Sent: Monday, March 23, 2020 10:45 PMTo: Linda Birnbaum ----------- Subject: Message to Dr. FauciDear Dr. Fauci,The home care industry cares for tens of millions of our most vulnerable citizens in their homes everyday. We provide assistance with activi ties of daily living and instrumental activities of daily living, whichkeeps our clients in their homes and in the lowest risk setting. Our professional Caregivers are able andwilling to continue to provide care to clients who test positive for COVID-19 or have been exposed tothe virus.But we need your help so that home care companies do not face unreasonab le liability for providingsuch care. To that end, we ask for your support in getting a bill through congress like the PublicReadiness and Emergency Preparedness Act (PREP Act), 42 USC 247d-6d, that will insulate providers likeus from claims related to the care we will be providing in these extraordinary times.We also ask that you support creating a fund that will provide appropriate personal protectiveequipment to our caregivers. Our clients should not have to bear the additional burden of the addedcost of PPE.Additionally, we would like you to encourage the CDC to clar ify its guidance on caring for COVID-19patients (found here, here and here) that the guidance is applicable to "professional, licensed andinsured, home based care agencies."This clarification will give the industry a workable standard to protect caregivers caring for COVID-19clients. In essence, it would establish that facemasks and gloves are sufficient PPE to care for COVID-19clients in the home, and not require its caregivers to comply with the healthcare setting requirements ofwearing N95 respirators, eye protec tion (goggles or face shields) or gowns. This is important as apractical mat ter because respirators and gowns are not readily available at this time. Moreover, mosthome care workers are not tra ined in the proper use of respirators.Finally, we need your help in pressuring congress to provide day care for the children of our caregivers.If they cannot find adequate care for thei r children, then our clients will suffer. This is a vital step tokeep our clients in the ir homes.NIH-000245With you help, home care companies will be able to:l. Relieve the burden on the healthcare system by keeping our clients out of the hospital; and2. Adhere to shelter-in-place measures which w ill flatten the curve of COVID-19's spread.L~..~.~.:y::, JOn behalf of:Michael Coccaro, Chief Operating Officer and General Counsel, Synergy Home CareEmma Dickison, Chief Executive Officer and President, Home HelpersLisa Foster, Chief Clinical Officer, MGA HomecareDaniel Gottschalk, co-owner and President, Genova HealthMargaret Haynes, Chief Operating Officer, Right at HomeVicki Hoak, Executive Director, Home Care Association of AmericaPeter Ross, Chief Executive Officer and Co-Founder, Senior HelpersTimothy Ryan, General Counsel, AccentCare, Inc.Shelly Sun, Founder, BrightStar Care(b)(6)www.nu rsecarenc.comwww.livhome.comNIH-000246NIH-000247(bXS)- PCP.NIH-000248NIH-000249From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Tue, 24 Mar 2020 15:33:11 +0000Barasch, Kimberly (NIH/NIAID) [CJSubject :Att achment s:FW: The global health leaders call, Wednesday 25 March at 13:00 CET(b)(4 Swisscom Call code.pdfPlease print this out for me for possibility doing the call tomorrow . Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: RYAN, Michae l J. (b)(6)Sent : Tuesday, March 24, 2020 10:59 AMTo: SHOC <shoc@who .int>; Office of the Director-Gene ral <DG0ffice@who .int>; Redfield, Robert R.(CDC/OD) (b)(6)---~~~~~~~~~~~~~----~~~~~~~~~~~--; David_H_e.y.:m. _a_n.n..=; ::====~~-:'.':"'"'."" ('b")'~.C'. ; Felicity Harvey (b)(6)(b)(6) >; Chris.Elias (b)(6); =======~:;,,;;-_ ----============:::::::;.----=-=-= (b)(6) J.Farrar (b)(6)--------- ; Fauci, An-t:h-o_n_y-:{-:N- 'I.H":'/-."::N'- :IA- "I"D.:"-):.-:[-:E-::]-:===========-- (=b)--=(:6--=)GREIN, Thomas (b) (6)·>; COX,(b)(6); SCHWARTLANDER,B ernhard F. ----------(b)( 6),; MINHAS, Raman (b )( 6) '; Conrad, Patricia {NIH/NIA ID) [E](b)( ; MAHJOUR, Jaouad====~~------(b) (6); Thomas R. Frieden(b)(6b ; FALL, lbrahima Soce(b)(6) --==========~~----:----:--" Lynn Banks (b)( ; President I Resolve to Save Lives<president@reso lvetosavelives .org>; (b)(6); AL-SHORBAJI,Farah_=====~-~~------- C_>b<6.); Robynn Leidig(b)(6); DRURY, Patrick Anthony (b)(6),>; Dr VAN KERKHOVE,(b)(6)cherylc (b)( ; GRAAFF, Peter Jan;____;__::==-,;::,;;~--:-:-:-~======~--___:, _ ___.:===(=b)(~~ ; ~Ta rik Mohammed (b)(6) Carlos Navarro Colorado=-=-=-==-=-==-=-=-==-=-==-=-=-~--------- (b~)( 6) Ryan MorhardNIH-000250========,:~"""(.b")("6.) B"R"I-A-N-D-,S: -yl-v"ie: "" (b)(6Jt>M; ORGAN, Oliver ====== (b=)(=6!).;:~.H=arries, Jenny_ __ -:====== (b=)(~6:);: -~A- wwad, David (NIH/NIAID) [C]=====~~~--(b)( ; SIMONSON, Stewart (b)(6Jt>S; INGER,P eter Alexander (b )( 6) Jayatunga, Wikum (b)(6) !!===== ; Julie.HALL (b) (6}; Amelie RIOUX (b)((b) (6)SHIN, Young-Soo (b) (6);(b)(6)Cc: SHOC <shoc@who.int>; Office of the Director-General <DGOffice@who.int>; SCHWARTLANDER,Bernhard F. (b)(6); MAHJOUR, Jaouad (b)(6J:>; FALL, lbrahima Soce(b)(6)·>; GREIN, Thomas (b)(6)·>; MINHAS, Raman (b)( ·; COX, PaulMichael (b)(6r)>; AL-SHORBAJIF, arah (b)(6J:>; POOLE,M arcia(b)( ·; DRURY, Patrick Anthony (b)(6J>; GRAAFF, Peter Jan=====:-=~=====;:~(b,)(;6)-;' "D r VAN KERKHOVEM, aria (b)(6); KABIR,S ophia (b)(6)>; FARESC, hristine Youssef (b)(6); AYLWARD, Raymond Bruce J.=====:-:-::!...,.;------- (b)(6) ·>; SMITH, Ian Michael (b)(6) Subject: The global health leaders call, Wednesday 25 March at 13:00 CETDear colleagues,Dr Tedros would like to invite you to the next informal discussion about the ongoing 2019 novelcoronavirus.The teleconference will be hosted on Wednesday, 25 March at 13:00 CET and the dial-innumber with a passcode is attached.If you experience any technical difficulties joining this conference call, please contact the WHOHQ EOC operator at: +41227912490It would be appreciated if you could kindly confirm your participation to Ms Sophia Kabir, email:kabirso@who.int; mobile no. (b)(6)The agenda and background documents will be shared ahead of the call.Best,MikeNIH-000251Dear participantTo join the upcoming teleconference, please call:From inside WHO(b)(4)From others countr ies please call:CountryArgent inaAustra liaAustriaBelgiumBrazilBulgariaCanadaChileChinaCroatiaCyprusCzech RepublicDenmarkEl SalvadorEstoniaFinlandFranceGermanyGeorgiaGreeceHong KongHungaryIrelandIndiaIsraelItalyJapanKazakhstanLathviaLithuaniaLuxembourgMalaysiaMaltaMexicoNetherlandsNew ZealandNorwayPanamaPeruPhilippinesPolandPortugalPuerto RicoRussiaRomaniaSingaporeSlovakiaSloveniaSouth AfricaSouth KoreaSwedenSwitzerland (English)Switzerland (Italiano)Switzerland (Deutsch)Number+54 115 984 12 00+61 280 147 967+43 720 880 876+32 280 835 50+55 213 958 07 18+35 924 917 399+16136e6 43 59+56 225 95 28 26+86 105 789 7457+38 51 777 63 03+35 72 503 02 78+42 024 €01 95 32+45 699 182 15+50 32 113 37 10+37 26 68 12 68+35 894 270 50 03+33 1 77 69 68 25+49 698 991 47 25+99 57 067 773 41+30 211 198 00 81+85 258 084 851+36180 881 90+35 314 845 940+91 11 712 79 153+97 237 219 661+39 02 479 211 40+81 345 209 476+771 727274 71+3716 765 25 76+37 052 05 89 83+352 208 801 72+603 921 220 20+35 62 778 01 98+52 554 E24 02 27+31 108 920 271+64 99 25 03 39+4721018941+507 836 51 38+51 17 08 54 63+632 2312215+48 221 168 469+351 308 800 872+17 879 05 73 62+749 540 220 27+40318107181+65 315 813 05+42 123 300 69 18+38 61 600 49 18+27 10 590 11 04+82 707 488 31 02+46 840 309 949+41 58 2€2 07 22+41 58 2E2 07 44+41 58 2€2 07 11NIH-000252Access Code(b) (4)Switzerland (Frangais)SpainTadzhikistanTurkeyUnited KingdomUnited States+4 1 58 2€2 07 33+34 931 816 661+99 242 782 22 70+90 21 290 025 60+44 203 370 57 19+16463810889NIH-000253(b) (4)From:Sent :To:Subject:Fauci, Anthony (NIH/N IAID) [E)Tue, 24 Mar 2020 15:32:02 +0000Conrad, Patricia (NIH/NIAID) [E)FW: interview requestTell them no.Anthony S. Fauci, MDDirectorNational Ins titute of Allergy and Infectious DiseasesBui lding 31, Room 7 A-0331 Center Drive , MSC 2520Nationa l Institu tes of HealthBet besda , MD 20892 -2520Phone: (b) (6)FAX: (301) 496 -4409E-mail: (b) (6)The informa tion in this e-mail and any of its attachments is confidential and may contain sensi tive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. lfyou have received this e-mail in errorplease inform the sender and delete it from your mai lbox or any other storage devices. Tue National lnstimt e ofAllergy and Infe ctio us Diseases (NlAID) shall not accept liability for any statements made that are the send er's ownand not expressly made on behalf of the NIAID by one of its representatives.-----Original Message-----From : Raphael De Montferrand <rdemontferrand @rttv .fr>Sent: Tuesday, March 24, 2020 11:27 -A-M- ---~~= To: Fauci, Anthony (NrH/NlAID) [E] (b)(6}Subject: interview reque stdr Faucy ,Hello, my channel is doing a section of its news tonight (at 3:45pm your time) on the coronavirns situation in NewYork . T wondered ifwe could interview you over skype. Do you think that might be poss ible at 3:45pm today yourtime?We have a simultan eous translator as we operate in trench from our stu dio in Pari s.Looking forward to hear from you,Raphael de MontferrandRT France0033608662642NIH-000254Fauci, Anthony (NIH/N IAID) [E)Tue, 24 Mar 2020 14:30:50 +0000(b)( 6)Subject : FW: Boston Globe: In order to save Dr. Fauci, we must destroy himYikes! You have to read t his. Things are gettin g unbelievably crazy.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301) 496-4409E-mail: Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From : Folkers, Greg (NIH/NIA ID) [E] (b)(6)Sent : Tuesday, March 24, 2020 10:16 AMTo : NIAID OCGR Leg <NIAIDOCGRLeg@mail.nih .gov>; NIAID OD AM <NIAIDODAM@n iaid .nih .gov>; NIAIDCOGCORE <COGCORE@mail.nih.gov>Subj ect: Boston Globe: In order to save Dr. Fauci, we must destroy himIn order to save Dr. Fauci, we must destroyhimDr. Anthony Fauci, director of the National Institute of Allergyand Infectious Diseases, is a study of calm and competence inthe middle of a pandemic. Which makes him an endangeredspecies, working as he does for a boss who is notoriouslyinsecure and made his name shouting "You're fired!" on areality TV show.ByKevin Cullen Globe Column ist,Updated March 23, 2020, 5:25 p.m.209NIH-000257Dr. Anthony Fauci'scalm, reassuring competence in response to the coronavirus pandemic is placing him at serious risk ofhearing the words that made his boss famous: You're fired.Jabin Botsford/The Washington PostDr. Anthony Fauci is a bum.A quack, a snake oil salesman.He got his degrees on line, not from Holy Cross and Cornell.He watches Wheel of Fortune but not Jeopardy.He's a Yankees fan.Such character assassination is unsavory but necessary because Fauci's calm, reassuring competence inresponse to the coronavi rus pandemic is placing him at serious risk of hearing the words that made hisboss famous: You're fi red.President Trump is watching and listening to the same thing we are, i.e., Fauci going to the podium torebut with facts the latest outbreak of paranoid anxiety or the president'sr egu larly recklessstatements.Fauci is an oasis of rigor and reason in a barren desert of confusion and fear.Which, given who he works for, makes him an endangered species.During the Vietnam War, some US Army officer supposedly suggested that in order to save a villagefrom the Vietcong they had to destroy it.And so, to save Dr. Fauci, we must destroy him - at least in Trump's eyes.Now that might sound crazy, but we're dealing with a crazy president in crazy circumstances.It's not as if there's no relevant precedent here.Two words: Bill Bratton.Two other words: Rudy Giuliani. Who happens to be Trump's BFF.Before Giuliani grew old, deranged, and more qualified to be a spokesman for Miracle Ear than thepresident's lawyer, he was the reform -minded mayor of New York City.Rudy rode into Dodge, which is what Times Square resembled at the time, and vowed to clean it up. Hishand-picked sheriff was Dorchester's own Bill Bratton.As police commissioner, Bratton did much to stem violent crime in the nation's biggest city, but evenmore rema rkably got his cops to reduce the incidence of more minor , so-called quality of life crimes thatNIH-000258NIH-000259had made New York less livable, from the tony sections of Manhattan to the Tony Fauci sections ofBrooklyn.Bratton did his job too well. He ended up on the cover of Time magazine, hailed as the guy who pulledthe worm out of the Big Apple. He became more popular than the mayor.This drove Giuliani nuts. Rudy had to be the smartest guy in the room, had to get all the credit. Soundfamiliar?So Bratton had to go.That wasn't Bratton's first rodeo. Long before he landed in New York, he became the face ofprogressive, modern policing in his hometown, the youngest-ever Boston Police superintendent. PoliceCommissioner Joe Jordan resented his overly-ambitious No. 2 so he busted Bratton.The point is, insecure bosses don't like being shown up by smarter, more competent subordinates. Smallmen make big mistakes.It may be too late to save Fauci. He just got the star treatment from Maureen Dowd in The NewYork Times.There used to be a thing called the Sports Illustrated curse, that after an athlete appeared on its coverhis or her career tanked.Similarly, being in the Trump administration and getting praised by The New York Times is the kiss ofdeath.Now, normally, you could print something in the Times and chances were the president wouldn't read it.He routinely dismisses the Gray Old Lady as fake news, except when his and his family's lousy books aremass-bought onto the newspaper's bestsellers list. He is not fond of polysyllabic words and prefersto get his news from "Fox & Friends" or whatever wh ite nat ional ist website his aide Stephen Millermight recommend.But Trump reads Mo Dowd because they have known each other forever and she writes about him at anuanced, personal level that drives him especially cuckoo.We're way past the theoret ical here.Tony Fauci is in real danger, and by extension so are the rest of us who expect - nay, pray for - oneperson in the White House to be trustworthy and competent in a time of unprecedented crisis.So, again, repeat after me, Dr. Anthony Fauci is a bum.Long live the bum.Kevin Cullen is a Globe columnist. He can be reached at kevin .cullen@globe .com.Di claimer: Any third-party material in thi email has been shared for internal u e under fair use provisionsof U . . copyright law, without further verification of its accuracy/veracity. It does not necessarily repre eatmy views nor those of IAID, NIH HH , or the U .. government.From:Sent:To:Fauci, Anthony (NIH/N IAID) [E)Tue, 24 Mar 2020 14:13:33 +0000(b)(6)Subject: RE: Update #2: Traffic Advisory: Street ClosuresThanksAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: (b)(6) ------------------- Sent: Tuesday, March 24, 2020 10:01 AM To: Fauci, Anthony (NIH/NIAID) [E] -------------=---:-=,( b)(6) Subject: FW: Update #2: Traffic Advisory: Street ClosuresA lot of street closures. I don't think it wi ll inte rfere with your trip downtown, but just in caseFrom: AlertDC <noreply@everb ri dge.net>Sent: Tuesday, March 24, 2020 7:33 AMTo: ------------------- (b) ~ > Subject: Update #2: Traffic Advisory: Street ClosuresThis is an important message from the District of Columbia AlertDC system.On Tuesday , March 24, 2020, in coordination with the National Park Service, theMetropolitan Police Department will make several street closures beginning at 7:00 a.m.through approximately 8:00 p.m at the following locations:• The Memorial Bridge• Lincoln Memorial Circle• Potomac River Freeway (all exits to Ohio Drive and Independence Avenue)NIH-000260NIH-000261• Rock Creek Parkway/Potomac Parkway Drive between Virginia Avenue andIndependence Avenue , SW (to include Ohio Drive, SW)• Independence Avenue between Ohio Drive and 14th Street , SW• 23rd Street between Constitution Avenue and Lincoln Memorial Circle• Henry Bacon Drive between Constitution Avenue and Lincoln Memorial Circle• 17th Street between Constitution Avenue , NW and Independence Avenue, SW• 15th Street between Constitution Avenue , NW and Independence Avenue, SW• Maine Avenue between Independence and 12th Street, SW• All vehicular exits to East Potomac Park and West Potomac ParkAll street closures and listed times are subject to change based upon prevailing orunexpected conditions .The public should expect parking restrictions along the street and should be guided bythe posted emergency no parking signage . All vehicles that are parked in violation of theemergency no parking signs will be ticketed and towed .Individuals and groups will encounter delays in the vicinity of this closure . To help flattenthe curve , we strongly discourage any Tidal Basin visits because social distancing hasnot been possible due to visitor volume .For more information about the District 's coronavirus response , visit coronavirus.dc .govClick Here to update your profile.To stop receiving future email notifications from this organization unsubscribe here.From: Fauci, Anthony (NIH/N IAID) [E)Sent: Tue, 24 Mar 2020 14:12:54 +0000To: Mi ller, Katie R. EOP/OVPCc: Short, MarcT . EOP/OVP;Conrad, Patricia (NIH/N IAID) [E];Billet, Courtney(NIH/N IAID) [E];O'Ma lley, Devin M. EOP/OVPSubject: RE: Please adviseI called the reporter and she was very receptive to my corrections of the recordand presentation of the facts .Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Miller, Katie R. EOP/OVP (b)(6)>Sent: Tuesday, Mar ch 24, 2020 9:37 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E)_.;....;....:.:::::=====~~Cc: Short , Marc T. EOP/OVP Cb)( >; Conrad, Patricia (NIH/NIAID) [E)(b)(6) Billet, Courtney (NIH/NIAID) [E) (b)( O'Ma lley, Devin M."E:-0:--P-/7 0'.V""""'P.-'"-:-::======---.;._- ("b")"' "('~ >Subject: Re: Please advise(b) (5)Sent from my iPhoneOn Mar 24, 2020, at 9:27 AM, Fauci, Anthony (NIH/NIAID) [E] -------- CbH >wro te:Marc/Katie:NIH-000262TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: --------- (b)(6)(b) (5)The information in this e-mail and any of its attachments is confident ial and maycontain sensitive information. It should not be used by anyone who is not theoriginal intended recipient. If you have received this e-mail in error please inform thesender and delete it from your mailbox or any other storage devices. The NationalInstitute of Allergy and Infectious Diseases (NIAID) shall not accept liability for anystatements made that are the sender's own and not expressly made on behalf of theNIAID by one of its representatives.From: Abuta leb, Yasmeen <Yasmeen.Abutaleb@washpost.com >Sent: Tuesday, March 24, 2020 9:05 AM --------~~ To: Conrad, Patricia (NIH/NIAID) [E) (b)(6)Cc: Parker, Ashley <Ashley.Parker@washpost.com >Subject: Washington Post fact check on Fauci/scientists storyHi Patty,Thanks very much for your help yesterday and hope you' re doing well . We're working on astory today about Trump's re lationship with the scientific and medical experts in thecoronavirus response, including Dr. Fauci. We're reporting this out today but wanted tosend you what we've been hear ing as we get it so there's ample time to fact checkeverything today. Here are some points we'd love to discuss with the best person in youroffice or, better yet, Dr. Fauci himself .NIH-000263• Fauci was apoplectic about Trump's tweet yesterday saying the cure couldn' t beworse than the virus and indicating that he wants to reopen businesses soon.• Fauci has been forceful privately that unproven drugs should not be advertised toAmericans as a panacea (and he of course has publicly spoken about these drugs).• We are also reporting in a separate story that Larry Ellison is building a website forthe federal government that will collect data on the efficacy of remdesivir,chloroquine and hydroxychloroqulne. our understanding Is Fauci is vehementlyopposed to this idea and has pushed back on it, citing patient privacy concernswith the website and collecting data in this way outside of an approved FDA trial.Again, we'd love to speak with Dr. Fauci and any others in your office who may have insightinto these particular issues and other aspects of the coronavirus response. Please feel freeto give me a call on my cell at any time at (b)(6)Thanks very much,Yasmeen AbutalebThe Washington PostHealth policy reportero: 202-334-8387 c: ___ "(b""")"('=6)@yabutaleb7NIH-000264From:Sent :To:Subject:Very good point.(b)(6)Tue, 24 Mar 2020 07:47:49 -0400Pottinger, Matthew F. EOP/WHORe: regarding masks and Covid-19NIH-000265(b)(5)- PCI(bX5)-PCENIH-000266NIH-000267NIH-000268From:Sent:To:(b)(6)Mon, 23 Mar 2020 15:45:21-0400Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Media Request: NPR's lA ShowBegin forwarded message:From: Am anda Williams <amand aw@wamu.org >Date: March 23, 2020 at 3:41:06 PM ED-T- ----~~ To: "Fauci , Anthony (NIH/NIAID ) [E]" (b)(6JiCc: "NIAID NEWS (NIH/NIAID)" <NIAIDNEWS @niaid.nih .gov>Subject: Media Request: NPR's lA ShowHello Dr. Fauci,I'm a producer with National Public Radio's 1A show and we'd like to invite you tojoin our program to talk about coronavirus in the near future. We've bui lt our showon answering our 4+ million listeners' questions and we know Americans have a lotof questions for you right now. We don't take live calls, but we do curate inputfrom voicemails and social media.We would love to have you join us. Please let me know if you are available andinterested anytime soon. We are very flex ible.A bit more about 1A: We launched in January 2017 and we're ranked among thetop 10 public radio programs on a list that includes Morn ing Edition, All ThingsConsidered and Marketplace. We reach 4+ million listeners every week and air onmore than 365 stations across the country. Our major markets include Chicago, LA,NYC, DC, At lanta, Boston, Philadelphia, San Francisco, Miami, Houston, Minneapol isand Seattle.Best,AmandaAmanda WilliamsAcross America ProducerlA, from WAMU and NPR-----(b)(6) (c) I @amandwms I thela.orgNIH-000269Fauci, Anthony (NIH/NIAID) [E)Mon, 23 Mar 2020 19:32:28 +0000(b)(6)(b)(6)Subject: Re: USA Today/David M. Rubenstein-- Coronavirus hero: Anthony Fauci is agreat public servant in a time of great public needAttachments: image002.jpgLove you allOn Mar 23, 2020, at 3:07 PM, (b)(6)1 wrote: ---------------So True!In a message dated 3/23/2020 2:06: 15 PM Easte rn Standard Time,--------- Cb) (6) writes:Lots of a very kind and thoughtful and well-earned words of respect comingyour way Cb) (6)On Mon, Mar 23, 2020 at 12:35 PM (b)( ------------ wrote:That's a very nice piece about you, Cb) (6)I hope you got some rest this weekend. Sending lots of love.On Sun, Mar 22, 2020 at 6:34 PM Fauci, Anthony (NIH/NIAID) [E]---------Cb>< wrote:Wow. David Rubenstein ----(b)(6) used to work for him) was really nice to me.From: Folkers, Greg (NIH/NIAID) [E] Cb)(6)Sent: Sunday, March 22, 2020 11 :36 AMSubject: USA Today/David M. Rubenstein-- Corona:virus hero:Anthony Fauci is a great public servant in a time of grea t pub lic needNIH-000270NIH-000271Coronavirus hero: AnthonyFauci is a great public servant ina time of great public needFauci is the world's leading authority oninfectious diseases and the best person in thecountry to help us deal with the COVID-19crisis.David M. RubensteinOpin ion contrib utorSome viewers of the daily White House coronav irus briefings maywonder why everyone increasingly defers to a diminutive, Brooklynaccented79-year -old doctor, Tony Fauci.They do because , as I have learned over many years of talking with andmore recently interviewing this man, he is without doubt the world'sleading authority on infectious diseases. In any area of human activityor knowledge, there always seems to be one person who is the globalgold standard. In the world of infectious diseases that person is TonyFauci.So the American people - indeed, people around the globe - shouldbe grateful that Tony has dug into this crisis with the same workaround-the-clock, j ust-the-facts ma'am style that he has usedwhile serving under and working with six U.S . presidents. He is asapolitical as anyone can be. I have no idea ifhe is registered with anypoli tical party; I suspect though that he is rabidly Independent. His onlyfocus is getting the facts out, provid ing the best health care treatmentand info1mat ion possible, and saving lives.A top expert from AIDS to EbolaTony Fauci joined the National Institutes of Health in 1968, aftercompleting his medical training at Weill Cornell Medical Center, andhe has led the Nat ional Institute of Allergy and Infectious Disease since1984 - 36 years . Hard to believe anyone can run anything that longand still be at the top of his game. But Tony is. During this period, hehas dealt with every serious infectious disease challenge - malaria ,NIH-000272Among Tony's best known accomplishments, beyond simply runningthe institute and training dozens of the world's top infectious diseaseprofessionals , has been helping to discover how HIV leads to AIDSand, later, leading the effort to create (at President George W. Bush'sdirection) the President's Emergency Plan for AIDS Relief (PEPF AR),which has transformed the treatment of HIV/AIDS in Africa, and otherparts of the developing world. Millions of lives have been save d by thisprogram alone. More recently , he has been an architect and powerfuladvocate of President Donald Trump's plan for ending the AIDSepidemic in the U.S . through HIV antiretrov iral therapy targeted todisease hot spots .In his spare time, Tony has been involved with writing or editing morethan 1,100 scholarly articles and several textbooks, and, in the process,has become one of the most cited authorities of the entire medicalprofession.For these breakthrough activities and his dedicated service (at agovernment salary) for more than a half century (he worked at NIH for16 years before assuming his current role), Tony has received, andearned, the Presidential Meda l of Freedom and a Lasker Award (calledthe American Nobel by many).With this long service and universa l acclaim, one migh t think Tonywould let it get to his head, at least a little bit. Not the case, though.Selfless commitment to public serviceHe is readily accessible to those who need treatment - he still runs alab at NIH - or need information. Tony still lives in the same hou se hebought when he first moved to Washington , and it is there that he andhis wife Christ ine have raised their three talented daughte rs (thoughnone of them chose to attend medical school).Until the latest crisis, Tony has often commuted to NIHby Metro, typically after running three miles for his daily exercise. Andwhen he has been invited to make speeches in the Washington area oron Capito l Hill, he invariab ly turns down a car and driver forthe Metro. (This practice has had to change of late for the obviousreasons).There are, of course, many other dedicated federa l serva nts who alsoview their comm itment to the country and its people over financialrewards. But surely no federa l civil servant , in any area, can exceedTony Fauci's long-term and selfless commitment to this country andthe health of its people.<image002.jpg >I tried years ago, when Tony was approac hing a normal retirement age,to see if he might want after a normal lifetime of federal service, to takesome of his considerable skills and knowledge to the private sector. Hequick ly said no - money did not motivate him, serving the coun trydid. And he stayed at NIH - to the country's good fo1tune.If there is any one medica l profess ional who can he lp the country dealwith the COVID - 19 crisis, it is Tony Fauci, an example of the best thiscountry has to offer.He is not a miracle worker. No one is.But Tony Fauci has the decades of experience needed to understandinfectious disease prob lems and prescribe a trea tment that shou ld, intime , prov ide the requisite comfort , even if, in the short term, themedicine is painfu l and inconve nient.David M Rubenstein is the co-executive chairman of The CarlyleGroup.Disclaimer: Any third-party material in this email has been shared for internaluse under fair use provisions of U.S. copyright law, without further verificationof its accuracy/veracity. It does not necessarily represent my views nor those ofNIAID, NIH, HHS, or the U.S. government.(b)(6)<image002. jpg>NIH-000273NIH-000274NIH-000275From:Sent:To:Cc:(b)(6)Mon, 23 Mar 2020 15:16:17 -0400Barasch, Kimberly (NIH/NIAID) [CJConrad, Patricia (NIH/NIAID) [ElSubject: Fwd: Meeting on the science of COVID-19, Wed. 3/25, 2 - S pmPlease print out for me and have ready in case I do this on WednesdayBegin forwarded message:From: "Tromberg, Bruce (NIH/NIBIB) [E]" (b)(6)>Date: March 23, 2020 at 1 :22: 18 AM EDTTo: "Collin s, Francis (NIH/OD) [E]" -------=-=-=Cc: "Tabak , Lawrence (NIH/OD) [E]"Anthony (NlH/NIAID) [E]" (b)C >Subject: Re: Meeting on the science of COVID-19, Wed. 3/25, 2 - 5 pmHi Francis,Thanks, I'm looking forward to the meeting. Probably not directly relevant to thisupcoming discussion, (b)(S)NIH-000276(b)(S)Best,BruceFrom: "Collins, Francis (NIH/OD) [E]" (b)(6)Date: Sunday, March 22, 2020 at 9:38 PMTo: "ICDDIR-L@LIST.NIH.GOV" <ICDDIR-L@LIST.NIH.GOV>Cc: "Tabak, Lawrence (NIH/OD) [E]" (b)(6) "Wolinetz, Carrie(NIM/OD) [E]" (b)( , "Anderson, James (NIH/OD) [E]"(b)(6), "Parker, Ashley (NIH/OD) [E]" =~===~ 7(b;);(;6:;)->,-:":-M:"cManus, Ayanna (NIH/OD) IE]"(b)(6), "Wood, Gretchen (NIH/OD) [E]"======::e (:bc),:;(::6,:)c,,;---$.~bject: Meet ing on the science of COVID-19, Wed. 3/25, 2 - 5 pmColleagues,(b) (5)I'm glad to hear that most of you are able to join a three -hour virtual meeting onWednesday March 25 to discuss scientific opportunities in the effort to conquer theCOVID-19 pandemic. While NIAID rightly has the lead in this effort for NIH, and is deeplyinvested in projects in both their intramural and extramural programs, it' s clear that anumber of other ICs have creative ideas and a strong motivation to try to help with thisglobal crisis. So this certainly seems like a time where we should gather (virtually of course)NIH-000277to brainstorm together, led by NIAID, and seek to identify any additional areas ofcontribution that could be subject to acceleration and/or collaboration.Hilary Marston recently convened a Deputies meeting on this subject, and I Cs were thenasked to submit examples last Friday of projects they are pursuing in the COVID-19space. Those were forwarded from Bob Eisinger to me. I have used those submissions,including a detailed list of NIAID projects, to put together a tentative agenda forWednesday's meeting . That is attached.(b) (5)There are admittedly a lot of themes and topics here, so this will require some realdiscipline in the one-slide presentations . I will try to serve as time -keeper- or maybe I'llask Larry to do that. □ DAll IC Directors are invited to have one or two subject matter experts join them for thisvirtual discussion.Ashley Parker (b)(6) will be helping me with the logistics and will havefurther instructions about how the log in will work.Here's the specific follow up request that needs your immediate attention :1. If your IC is pursuing a highly relevant project that's not listed here, and that youwant the group to hear about, please send me that informa tion ASAP.2. If your IC is on the draft agenda to make a presentation, please submit your oneslide (except for NIAID, who gets more) to me and Ashley by COB Tuesday3/24. That way we can put the whole set together as a single ppt file.Many thanks! This should provide a welcome respite from the many other tasks we are allfacing right now .FrancisNIH-000278From: Fauci, Anthony (NIH/NIAID) [E)Sent: Mon, 23 Mar 2020 19:06:06 +0000Bee: Aberg, Judith;Adaora Adimora;Grund, Birgit;Glidden, David;Daar, Eric;EricaHardy;Gandhi, Rajesh Tim,M.D.;Jason Baker;Jeff Lennox;Johnson, Steven C- ID;Kim, ArthurY.,M.D.;Marla Keller;Tebas, Pablo (NIH);Susan Davis;Susan Swindells;Susanna Naggie;Tien, Phyllis;AmyDzierba;Mitchell Levy;Laura Evans;Craig Coopersmith ;Greg Martin;Uyek i, Timothy M.(CDC/0010/NCIRD/ ID);Walker, Robert (OS/ASPR/BARDA);Sheikh, Virginia (FDA/CDER);AnneCollie r;Francis, Joe (Contact NLM/OD -External) (b)(6)Subject: Invitation to join the HHS Panel on Guidelines for The Management of COVID-19Dear Colleague ,At the request of the Office of the Secretary, HHS and in conjunction with the White House TaskForce we are creating a COVID-19 management guidelines panel to provide frequently updatedinformation to the pub lic regarding the treatment of patients with COVID-19.This guidance will be an HHS document, will be updated frequently and will be modeled tosome degree after the ART guidelines. The Panel will include academicians and clinicianscurrently caring for persons with COVID-19 and representatives from multiple US governmentagencies (CDC, BARDA, FDA, VA, DoD) and professional societies. Cliff Lane, M.D. Henry Masur,M.D. and Trip Gulick, M.D. will co-chair, and Alice Pau, Pharm.D . will be the exec. sec. for thisnew panel. Those of you who are appointed to represent your federal agencies will be ex officio.Other federal employees will be vot ing members.I would like to invite you to be a member of this new Panel based on your expertise. Weanticipate that work will begin this week and we hope to be able to put out the first guidance in1-2 weeks. We appreciate your will ingness to jo in this very important effort and your work incaring for patients during th is pandemic.The first meeting (by teleconference) will be Tuesday, March 24 at 11:00AM EDT. More detailswill be provided soon.Thank-you for considering this and for all you are doing during this most challenging time.Sincerely,Anthony S. Fauci, MDAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520NIH-000279Phone: (b)(6)FAX: (301) 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyothe r storage devices . The Nat ional Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-000280From:Sent:To:Cc:Fauci, Anthony (NIH/NIAID) [E)Mon, 23 Mar 2020 18:38:21 +0000(b)( 6)(b)(6)Subject: RE: FW: USA Today/David M. Rubenstein-- Coronavir us hero: Anthony f-auci is agreat public servant in a time of great public needLove you all.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)( 6)FAX: (301 496-4409E-mail=--....,. __., (b)(6)The information in t ,s e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: (b)(6)>Sent: Monday , Mar ch 23, 2020 12:35 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6) >(b)(6)Subject: Re: FW: USA Today/Dav id M. Rubenstein-- Coronavirus hero: Anthony Fauci is a great publicservant in a t ime of great publ ic need~ (b)=(6=)That 's a very nice piece about you,I hope you got some rest this weekend . Sending lots of love.On Sun, Mar 22, 2020 at 6:34 PM Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)> wrot e:Wow. David Rubenstein ----(b)(6) used to work for him) was really nice to me.From: Folkers, Greg (NIH/NIAID) [E] (b)(6)>Sent: Sunday, March 22, 2020 11:36 AMSubject: USA Today/David M. Rubenstein-- Coronavirus hero : Anthony Fauci is a great publ ic servantin a time of great publ ic needNIH-000281NIH-000282Coronavirus hero: Anthony Fauci is a greatpublic servant in a time of great public needFauci is the world 's leading authority on infectious diseasesand the best person in the country to help us deal with theCOVID-19 crisis.David M. RubensteinOpinion contributorSome viewers of the daily White House coronavirus briefings may wonder why everyone increasinglydefers to a diminutive, Brooklyn -accented 79-year-old doctor, Tony Fauci.They do because, as I have learned over many years of talking with and more recently interviewingthis man, he is without doubt the world 's leading authority on infectious diseases. In any area ofhuman activity or knowledge, there always seems to be one person who is the global goldstandard . In the world of infectious diseases that person is Tony Fauci.So the American people - indeed, people around the globe - should be grateful that Tony has duginto this crisis with the same work-around-the -clock, just-the-facts ma'am style that he has usedwhile serving under and working with six U.S. presidents. He is as apolitical as anyone can be. I haveno idea if he is registered with any political party; I suspect though that he is rabidly Independent. Hisonly focus is getting the facts out, providing the best health care treatment and information possible,and saving lives.A top expert from AIDS to EbolaTony Fauci joined the National Institutes of Health in 1968, after completing his medical training atWeill Cornell Medical Center, and he has led the National Institute of Allergy and Infectious Diseasesince 1984 - 36 years. Hard to believe anyone can run anything that long and still be at the top of hisgame. But Tony is. During this period, he has dealt with every serious infectious disease challenge -malaria,Among Tony's best known accomplishments, beyond simply running the institute and training dozensof the world's top infectious disease professionals, has been helping to discover how HIV leads toAIDS and, late r, leading the effort to create (at President George W. Bush's direction) the President'sEmergency Plan for AIDS Relief (PEPFAR), which has transformed the treatment of HIV/AIDS in Africa,and other parts of the developing world. Millions of lives have been saved by this programalone. More recently, he has been an architect and powerful advocate of President Donald Trump'splan for ending the AIDS epidemic in the U.S. through HIV antiretroviral therapy targeted to diseasehotspots .In his spare time, Tony has been involved with writing or editing more than 1,100 scholarly articlesand several textbooks, and, in the process, has become one of the most cited authorities of th e enti remedical profession.For these breakthrough activities and his dedicated service (at a government salary) for more than ahalf century (he worked at NIH for 16 years before assuming his current role), Tony has received, andearned, the Presidential Medal of Freedom and a Lasker Award (called the American Nobel by many).With th is long service and universal acclaim, one might think Tony would let it get to his head, at leasta little bit. Not the case, though .Selfless commitment to public serviceNIH-000283He is readily accessible to those who need treatment - he still runs a lab at NIH - or needinformation. Tony still lives in the same house he bought when he first moved to Washington, and it isthere that he and his wife Christine have raised their three talented daughters (though none of themchose to attend medical school).Until the latest crisis, Tony has often commuted to NIH by Metro, typically after running three milesfor his daily exercise. And when he has been invited to make speeches in the Washington area or onCapitol Hill, he invariably turns down a car and driver for the Metro. (This practice has had to changeof late for the obvious reasons).There are, of course, many other dedicated federal servants who also view their commitment to thecountry and its people over financial rewards. But surely no federal civil servant, in any area, canexceed Tony Fauci's long-term and selfless commitment to this country and the health of its people.I tried years ago, when Tony was approaching a normal retirement age, to see if he might want after anormal lifetime of federal service, to take some of his considerable skills and knowledge to the privatesector. He quickly said no - money did not motivate him, serving the country did. And he stayed atNIH - to the country's good fortune.If there is any one medical professional who can help the country deal with the COVID-19 crisis, it isTony Fauci, an example of the best this country has to offer.He is not a miracle worker. No one is.But Tony Fauci has the decades of experience needed to understand infectious disease problems andprescribe a treatment that should, in time, provide the requisite comfort, even if, in the short term,the medicine is painful and inconvenient.David M. Rubenstein is the co-executive chairman of The Carlyle Group.Disclaimer: Any third-party material in this email has been shared for internal use under fair useprovisions of U.S. copyright law, without further verification of its accuracy/veracity. It docs notnecessarily represent my views nor those of NIAID, NIH, HHS, or the U.S. government.Ali FauciFrom :Sent:To:Fauci, Anthony (NIH/N IAID) [E)Mo n, 23 Mar 2020 18:14:25 +0000Barry AlbertsonSubject: RE: Pooled $maplesThanks, Barry.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Barry Albertson <barry@fannocreek .com>Sent: Monday, March 23, 2020 1:03 PM -------=-=--== To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject : FW: Pooled SmaplesImport ance: HighHi Tony,I'm forwarding an email I just sent to Paul Cieslak, MD ..... one of the lead docs atthe Oregon Health Author ity CbH6;l hegives my clinic's Internal Medicine docs an 'ID Update' for my CME Grand Roundseach yea r) ... with this email note from Dr. David Brandon ... hope you rememberDavid .... he was with Lynn's & Mort Lipsett's group at The Clinical Center .... I'd bet a coke you know all about pooled sampling ..... but wanted to pass italong.You have no idea how many people tell me tha t your COVID-19 messages on TV,etc. are top flight , enormously helpful and encourag ing for them with the bestinformation , in a sea now of poor information .NIH-000284Andrew Cuomo is also doing a great job informing all of NY (and the rest of us)about what's going on, and his expectations for the public.Whatever they're paying you ... it's not enough.You keep your powder dry, and extra flints in your pocket!BarryFrom: Barry AlbertsonSent: Monday, March 23, 2020 9:49 AMTo : 'Cieslak Paul R'Subject: Pooled SmaplesImportance: HighGood morning, Paul.Hope you guys at OHA are holding up OK.I'm fine , fam ily is fine. ..- ------ (b)(6) is dong lots of te lemedicine and seeing act ual PEDS patients at Westside Hosp. now a few days a week.My clinic is still open but pretty quiet ... we need to stay open at some level no matter wha t .One of my colleagues from the NIH (Dr. David Brandon ... he actually published with Tony Fauciback in the late '70s I believe !) .. sent me this email on Saturday morningI suspect you all know about poo led sampling, ..... David did it at the NIH for a study that I havelong forgotten about. ...thought I'd pass it along to you ......" I just looked up to see if pooled sampling has been used to detect viruses in the past, andfound that it has been used in a number of cases including during the HIV scare. I am includinga I ink thttp s ://www. israel2 lc. org/israelis-introd u ce-method-for-accel erated-covid-19-testing/ to an article in the lay press reporting on an RT-PCR based test that uses swabs from30-60 individuals to dete rmine if the pooled sample has Covid-19. The study was successfuland they are developing it to test workers in the front line work places such as hospitals. Thereis a body of literature using t his method for other mass screenings."Then I heard that CEPHEID will be getting their Genexpert instrument validated to measureCOVID-19. Turns out we have one in my Lab, use it for Chlamydia & Gonorrhea (we have lotsof patients here needing this testing). But as you so well know, having the inst rumentationwithout the collection swabs/M4 media, etc. Is a bit like biking up a blind alley. I would hopewe'll hear more about t his.NIH-000285NIH-000286Give me a shout if I can do anything to help you all ...... best tack for me, I believe, is to stayout of your way!Barry(b)(5)- PCRNIH-000287From:Sent :To:Subject:Fauci, Anthony (NIH/NIAID) [ElMon, 23 Mar 2020 18:09:12 +0000O'Grady, Naomi (NIH/CC/CCMD) [ElRE: vent rat ioningNaomi :I am not aware of any efforts on rationing ventilators . They speak of makingsure the high priority areas such as NYC get what they need, but there is no ta lk atthis time of "rationing"Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: O'Grady, Naomi (NIH/CC/CCMD) [El- -------- (b)(6b Sent: Monday, March 23, 2020 1:53 PM ------~~ To : Fauci, Anthony {NIH/NIAID) [El- ------- (b)(6)> Subject: vent rationingHi Tony-I know you are very busy but I wanted to see if you know of any effort on the part of the federalgovernment to issue guidance on the rationing of ventilators when the time comes? Many of mycolleagues in critical care across the country have been asking for some such guidance on a federal level.Both for the guidance itself and to protec t themselves from legal liability. Are you aware of any suchefforts? Thanks for any insights on t his. And thanks for all you are doing on the coronavirus effort!Best regards,NaomiNaomi P. O'Grady, MDChief, Internal Medici ne ServicesNIH Clinical CenterNIH-000288From:Sent :To:Cc:Subject:D68Dan:Fauci, Anthony (NIH/NIAID) [E)Mon, 23 Mar 2020 16:48:31 +0000Dan HurleyConrad, Patricia (NIH/NIA ID) [ElRE: 2 questions from NY Times Mag reporter who int erviewed you about EVThanksfor the note . The work on an EV-D68 vaccine will continue . TheCoronavirus vaccine research is the highest prio rity. Both come out of BarneyGraham's group in our VRC. Best to call Barney about the degree of possibleinterference. Books are not on my mind right now.Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Dan Hurley (b)(6)Sent: Monday, Mar ch 23, 2020 11:46 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6>:>Subject: Re: 2 questions from NY Times Mag reporter who inte rviewed you about EV-D68Hi Dr. Fauci and Patty: In addit ion to the two items mentioned in my original email, the NY TimesMagazine is also interested in publishing an interview wit h Dr. Fauci. Thank you, Dan HurleyOn Thu, Mar 19, 2020 at 6:04 PM Dan Hurley --------- (b)(6) wrot e:Hi Dr. Fauci: I interv iewed you by telephone a few months ago for an article in the New York TimesMagazine about enterovi rus D68, the putative causal agent of acute flaccid myelitis. At the time yousaid that NIAID was work ing hard on developing a vaccine for EV-D68. I have two questions:NIH-000289NIH-0002901. Is work on developing a vaccine against the novel coronav irus interrupting or slowing work on EVD68?Hard to believe it wouldn't have an effect .2. When things calm down with COVID-19, would you consider allowing me to write a biographyabout you, or helping you write a memoir? This pandemic has kind of turned you into the face ofmedical science in the United States. I'm the author of four prior science books, and have profiledcountless scientists in the Times, The Atlantic, and elsewhere. I know this is not the time for suchthings. I just want to put the idea out there . I hope and pray you do not find it offensive for mesuggest such a thing at this time of danger and stress.Let me know about that EV-D68 vaccine if you can. I'm also reaching out to Barney Graham. Thankyou, Dan HurleyFrom:Sent:To:Subject:Attachments :Cliff :Thanks,TonyAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [E)Mon, 23 Mar 2020 14:51:53 +0000(b)(6)FW: Dinarello Proposa lDinarello Proposal for COVID-19.docNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)(b)(5The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sende r and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not express ly made onbehalf of the NIAID by one of its representatives.From: char les dinarello (b)(6)>Sent: Sunday, Marc h 22, 2020 9:31 PM -------~~ To: Fauci, Anthony (NIH/ NIAID) [E] (b)(6) --------- Subject: Dinarello Proposal(b)(6)I watch CNN almost constantly to listen to your impressive wisdom. The world listens to you.Shelly would be so proud of you in this world crisis as he was in the HIV-1 crisis. We will notsee each other at the National Academy of Sciences meeting end of April, but hopefully nextyear. I very much enjoyed hearing you place the anecdotal use of chloroquine in its correctcontext. "Chloroquine is an awfully blunt tool and an indicat ion of our desperation", Peter Libbywrote me recently. Tony, attached is a proposal CbH4>I need your guidanc e. I know you are terribly busy so I amcopying Cliff. If there is anyone else who can help me, just forward the attachment.(b)(6)NIH-000291From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Mon, 23 Mar 2020 14:48:07 +0000(b)(6)Cc: Conrad, Patricia (NIH/NIAID) [ElSubject: FW: 23-3-2020 FAO Dr Birx and Dr Fauci - Covid-19 Task Force RE:- Favipiravir =AviganPlease have someone handle.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: (b)(6JiSent: Monday, March 23, 2020 8:32 AMTo: (b)(6) Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Cc: NST Rogers (b) (6)Subject: 23-3-2020 FAQ Dr Birx and Dr Fauci - Covid-19 Task Force RE:-Favipiravir = AviganImportance: High23-3-2020Dear Dr Birx and Dr Fauci,As promised, sorry about the delay.Please see below two articles relating to Favipiravir wh ich has the brand name Avigan. Thisappears to have some beneficial effects with regard to the treatment of Covid-19.I have also included the Wikipedia for Favpiravir .Good Luck w ith regard to managing the epidemic/pandemic.NIH-000292Yours SincerelyNicholas RogersFavipiravirDrugDescriptionFavip iravir, also known as T-705, Avigan, or favilavir is an antiviral drug being developed by ToyamaChemical of Japan with activity against many RNA viruses . Like certain other experimental antiviraldrugs, it is a pyrazinecarboxamide derivative. WikipediaFormula : C5H4FN3O2ChemSpider ID: 431002ChemSpider ID: 431002PubChem CID: 492405FavipiravirFrom Wikipedia, the free encyclopediaJump to navigationJump to searchExperimental antiviral drug with activity against many RNA viruses.Favip irav ir0FYi N~l ,c;N OHNameslUPAC name6-Fl uoro-3-hydroxypyrazine-2-carboxamideOther namesT-705; A vigan; favilavirIdentifiersNIH-000293NIH-000294CAS umber3D model (JSmol)ChEMBLChem SpiderPubChem CIDUNIICompTox Dashboard(EPA)In hi[ how]• 259793-96-9• Interactive image• ChEMBL22 l 722• 431002• 492405• EW5GL2X7E0 ✓y• DTXSID60948878 ,In hl= I / 5H4FN3O2/c6-2-1-8-5( 11)3(9-2)4(7) I 0/h I H,(H2, 7, I 0)(H,8, 11)Key: Z NOVWY BHAU -UHFFFAOY A-NIn h I= I/ 5 H4FN3O2/c6-2-1-8-5( I I )3(9-2)4(7) I 0/h I H,(H2, 7, I 0)(H, , I I)Key: Z GNOVWY BHAU-UHFFFAOYAMSMILES[ how]Oc I ncc(F)nc I (=O)Propert ieshcmical fon11ula 5H4F 30 2Molar ma 157. 104 g·mol- 1PharmacologyAT code J05AX27 (WHO)Except where otherwi e noted , data are given for materia lin their tandard late (at 25 °C [77 °F], 100 kPa).Infobox referenceFavip iravir al o known a T-705 , Avigan or fav ilavir i an antiviral drug being developed byToyama hemical (Fujifilm group) of Japan with activity against many RNA viru e . Likecertain other experimental antiviral drug (T-1 105 and T-1106), it i a pyrazinecarboxamidederivative. In experiment conducted in animal Favipiravir ha hown activity again t influenzaviru e We t Nile viru , yellow fever virus, foot-and-mouth di ea e virus as well a otherflaviviru e , arenaviru e , bunyaviru e and alpbaviru e _[I] Activity again t enteroviru e [2] andRift Valley fever virus ha al o been demon tratect.Pl Favipiravir ha howed limited efficacyagain t Zika viru in animal tudie , but wa le effective than other antiviral uch a MK-608.[4] The agent ha al o hown ome efficacy again t rabie [SJ and ha been u edexperimentally in some human infected with the viru .[61In February 2020, Favipiravir wa being tudied in China for experimental treatment of theemergent COVID-19 (novel coronaviru di ea e).P l[S] On March 17, Chine e officials uggestedthe drug had been effective in treating OVID in Wuhan and ShenzhenJ 9H IO]As of 23 March 2020, it eems that Japan and China have i sued an export ban on the ub tance.Japan and hina are the only countrie in which favirapir i produced and approved a a medicalNIH-000295compound. Some Chinese pharmaceutical companies assure that export rights are still grantedvia international diplomatic means by the Chinese Ministry of Industry and InformationTechnology (MIIT).l lContents• !Mechanism of action• 2Approval status• 3Ebola virus trials• 4Coronavirus disease 2019 (COVID-19)• 5See also• 6ReferencesMechanism of action[edit]The mechanism of its actions is thought to be related to the selective inhibition of viral RNAdependentRNA polymerase.[ 1 I] Other research suggests that favipiravir induces lethal RNAtransver sion mutations, producing a nonviable viral phenotype.(12] Favipiravir is a prodrug thatis metabolized to its active form, favip iravir-ribofuranosyl-5'-trip hosphate (favip iravir-RTP),available in both oral and intravenous formulations.[ I3J[t4] Human hypoxanthine guaninephosphoribosyltransferase (HGPRT) is believed to play a key role in this activation process_[IS]Favipiravir does not inhibit RNA or DNA synthesis in mammalian cells and is not toxic tothem_[l] In 2014, favipiravir was approved in Japan for stockpiling against influenzapandemics. [161 However, favip iravir has not been shown to be effective in primary humanairway cells, cast ing doubt on its efficacy in influenza treatment. [ 17]Approval status[edit]In 2014, Japan approved Fav ipirav ir for treating viral strains unresponsive to currentantivirals.l 18l Toyama Chem ica l initially hoped that Avigan would become a new influenza drugthat could replace Tamiflu. However , animal exper iments show the potential for teratogeniceffects on fetuses, and the approval of production by The Ministry of Health , Labor and Welfarewas greatly delayed and the production condition is limited only in an emergency in JapanV 9lIn March 2015, the US Food and Drug Administration completed a Phase III clinical trialstudying the safety and efficacy of Fa vipi ravir in the treatment of influenza. [20]NIH-000296On March 15, 2020 the drug was approved in China with the name Favilavir for the trea tment ofinfluenza .[2I] The drug was also approved for use in clin ical trials for treating coronavirusdisease 2019 pneumonia. [21]On 22 March, 2020 Italy has approved the drug for exper imental use against COVID-19 and hasbegun conducting trials in 3 regions most affected by the disease. [22l The Italian Pharmace uticalAgency , however, has reminded the public that the existing evidence in support of this drug isscant and prel iminary.[23]Ebola virus trials[edit]Some research has been done suggesting that in mouse models Favipiravir may have efficacyagainst Ebo la. Its efficacy against Ebola in humans is unproven_[24][25][26] During the 2014 WestAfrica Ebola virus outbreak, it was reported that a French nurse who contracted Ebola whilevolunteering for MSF in Liberia recovered after receiving a course of favipiravir. [27l A clinicalh·ial investigating the use of favipiravir against Ebo la virus disease was started in Gueckedou,Guinea, during December 2014.(281 Preliminary results showed a decrease in mortality rate inpatients with low-to-moderate levels of Ebola virus in the blood, but no effect on patients withhigh leve ls of the viru s, a group at a higher risk of death.[29] The trial design has been critic isedby Scott Hammer and others for using only histor ical conh·ols. [30] The results of this clinical trialwere prese nted in February 2016 at the annual Conference on Retroviruses and Opportunist icInfections (CROI) by Daouda Sissoko[3l] and published on March 1, 2016 in PLOSMedicine. [321Coronavirus disease 2019 (COVID-19)[edit]On 17 March 2020, Chinese offic ials suggested that Favip iravir seemed to be effective intreating COVID-19 in Wuhan and Shenzhen_[33J[34][35]A study on 80 patients comparing it to lopinavir/ritonavir found that it significantly reduced viralclearance time to 4 days, compared to 11 for the control group, and that 91.43% of patients hadimproved CT scans with few side effects.P 6J[37]As of 23 March 2020, it seems that Japan and China have issued an export ban on the substance .Japan and China are the only cotmtries in which favirapir is produced and approved as a medicalcompound. Some Chinese pharmaceutical companies assure that export righ ts are still grantedvia interna tional diplomat ic means by the Chinese Ministry of Industry and Informat ionTechnology (MIIT).[ citario1111ee,1d]eSee also[edit]NIH-000297• BCX4430• Brincidofovir• FGI-106• JK-05• REGN-EB3• TKM-Ebo la• Triazav irin• ZMappReferences [ edit]1. A Jump up to: a b Furuta Y, Takahashi K, Shiraki K, Sakamoto K, Smee DF, Barnard DL,Gowen BB, Julander JG, Morrey JD (June 2009). "T-705 (favipiravir) and relatedcompounds: Novel broad-spectrum inhibitors of RNA viral infections". AntiviralResearch. 82 (3): 95- 102. doi:10.1016/j.antivira/.2009.02.198. PMID 19428599.2. /\ Furuta Y, Gowen BB, Takahashi K, Shiraki K, Smee DF, Barnard DL (November2013). "Favipiravir (T- 705), a novel viral RNA poly merase inhibitor". AntiviralResearch. 100 (2): 446- 54. doi:10.1016/j.antiviral.2013.09 .015. PMC 3880838.PMID 24084488.3. /\ Caroline AL, Powell DS, Bethel LM, Oury TD, Reed DS, Hartman AL (April 2014)."Broad spectrum antiviral activity of favipiravir (T-705): protection from highly lethalinhalational Rift Valley Fever". PLOS Neglected Tropical Diseases. 8 (4): e2790.doi:l0 .1371/journal.pntd.0002790. PMC 3983105. PMID 24722586.4. I\ Mumtaz N, van Kampen JJ, Reus ken CB, Boucher CA, Koopmans MP (2016). "ZikaVirus: Where Is the Treatment ?". Current Treatment Options in Infectious Diseases. 8(3): 208- 11. doi:10.1007 /s40506-016-0083-7. PMC 4969322. PMID 27547128.5. /\ Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A (April 2016) . "Efficacy ofFavipiravir (T-705) in Rabies Postexposure Prophy laxis". The Journal of InfectiousDiseases. 213 (8): 1253- 61. doi:10.1093/ infdisljiv586. PMC 4799667. PMID 26655300.6. I\ Mwphy J, Sifri CD, Pruitt R, Hornberger M, Bonds D, Blanton J, Ellison J, CagninaRE, Enfield KB, Shiferaw M, Gigante C, Condori E, Gruszynski K, Wallace RM (January2019). "Human Rabies - Virginia, 2017". MMWR. Morbidity and Mortality WeeklyReport. 67 (5152): 1410- 14. doi:10.15585/mmwr.mm675152a2 . PMC 6334827.PMID 30605446.7. I\ Li G, De Clercq E. Therapeutic options for th e 2019 novel coronav irus (20 19-nCoV) .Nature Reviews Drug Discovery 2020 Feb doi: 10.1038/d41573-020-00016-08. I\ BRIEF-Corrected -Zhej iang Hisun Pha1ma gets approval for clinical trial to test fludrug Favipiravir for pneumonia caused by new coronav irus. Reuters Healthcare, February16, 2020.9. I\ NHK World News 'China: Avigan effective in tackling coronavirus '10. /\ Huaxia. "Favipiravir shows good clinical efficacy in treating COVID-19: officia l."Xinhuanet.com, 17 March 2020NIH-00029811. A Jin Z, Smith LK, Rajwanshi VK, Kim B, Deval J (2013). "The ambiguous base -pairingand high substrate efficiency o.fT-705 (Favipiravir) Ribofuranosyl 5'-triphosphatetowards influenza A virus polymerase". PLOS One. 8 (7): e68347.Bibcode:2013PLoSO ... 868347J. doi:l0.1371/journal.pone.0068347. PMC 3707847.PMID 23874596.12. A Baranovich T, Wong SS, Armstrong J, Marjuki H, Webby RJ, Webster RC, GovorkovaEA (April 2013). "T-705 (favipiravir) induces lethal mutagenesis in influenza A HlNlviruses in vitro". Journal of Virology . 87 (7): 3741- 51. doi:10 .1128/JVI.02346-12 .PMC 3624194. PMID 23325689.13. A Guedj J, Piorkowski G, Jacquot F, Madelain V, Nguyen TH, Rodallec A, et al. (March2018). "Antiviral efficacy offavipiravir against Ebola virus: A translational study incynomolgus macaques". PLOS Medicine. 15 (3): el 002535.doi:10.l 37 l/journaL.pmed.1002535. PMC 5870946. PMID 29584730.14. A Smee DF, Hurst BL, Egawa H, Takahashi K, Kadota T, Furuta Y (October 2009)."Intracellular metabolism offavipiravir (T- 705) in uninfected and influenza A (H5Nl)virus-infected cells". The Journal of Antimicrobial Chemotherapy. 64 (4): 741- 46.doi:10.1093(jac/dkp274. PMC 2740635. PMID 19643775 .15. A Naesens L, Guddat LW, Keough DT, van Kuilenburg AB, Meijer J, Vande Voorde J,Balzarini J (October 2013). ''Role of human hypoxanthine guaninephosphoribosyltransferase in activation of the antiviral agent T-705 (favipiravir)".Molecular Pharmacology. 84 (4): 615- 29. doi:10 .1124/mol.113.087247.PMID 23907213.16. A Koons C (7 August 2014). "Ebola Drug From Japan May Emerge Among KeyCandidates". Bloomberg. com.17. A Yoon JJ, Toots M, Lee S, Lee ME, Ludeke B, Luczo JM, et al. (August 2018). "OrallyEfficacious Broad-Spect rum Ribonucleoside Analog Inhibitor of Influenza andRespiratory Syncytial Viruses". Antimicrobial Agents and Chemotherapy. 62 (8):e00766-18 . doi:10 .1128/AAC.00766-18. PMC 6105843. PMID 29891600.18. A Hayden, Frederick (2019). "Influenza virus polymerase inhibitors in clinicaldevelopment". Current Opinion in Infectious Diseases . 32 (2): 176-186.doi:10.1097/QC0.0000000000000532. PMC 6416007. PMID 30724789.19. A ~l!/=fif ~:#KJP.r!-&!f/ ::}Et; 1tt- li'tl.!ft~-1':.,, 7 J~Jf!(l)"!/!t✓-£''. Retrieved 25Februa,y 2014.20. A "Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of UncomplicatedInfluenza in Adults - T705US316". FDA. Retrieved 17 March 2020.21. A Jump up to: 0 b J!,%-rff"iP otential coronavirus drug approved for marketing -Chinadaily.com.cn". www.chinadaily.com.cn . Retrieved 2020-03 -21.22. A "Coronavirus, il Veneto sperimenta l'antivirale giapponese Favipiravir. Ma l'Aifa: "Cisono scarse evidenze scientifiche su efficacia"". Il Fatto Quotidiano (in Italian). 2020-03-22. Retrieved 2020-03-23 .23. A "AIF A precisa, uso favipiravir per CO VJD-19 non autorizzato in Europa e USA, scarseevidenze scientifiche sull'~fficacia ". aifa .gov . it (in Italian). Retrieved 2020-03-23 .NIH-00029924. A Gatherer D (August 2014) . "The 2014 Ebola virus disease outbreak in West Africa".The Journal o_/General Virology. 95 (Pt8) : 1619- 24. doi:10.1099/vir.0 .067199-0 .PMID 24795448.25. A Oestereich L, Ludtke A, Wurr S, Rieger T, Muiioz-Fontela C, Gunther S (May 2014)."Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in asmall animal model". Antiviral Research. 105: 17-21.doi:10.1016/j.antiviral.2014.02.014. PMID 24583123.26. A Smither SJ, Eastaugh LS, Steward JA, Nelson M, Lenk RP, Lever MS (April 2014) ."Post-exposure efficacy o_foral T-705 (Favipiravir) against inhalational Ebola virusinfection in a mouse model" . Antiviral Research. 104: 153- 55.doi:10.1016(j.antiviral.2014 .01.012 . PMID 24462697.27. A "First French Ebola patient leaves hospital". Reuters. 4 October 2016.28. A "Guinea : Clinical Trial for Potential Ebola Treatment Started in MSF Clinic inGuinea''. Al/Africa - All the Time. Retrieved 28 December 2014.29. A Fink S (4 Februa,y 2015) . "Ebola Drug Aids Some in a Study in West Africa" . The NewYork Times.30 . A Cohen J (26 February 2015). "Results from encouraging Ebola trial scrutinized".Science. doi:10. l l 26/science.aaa7912. Retrieved 21 Janua,y 2016.31. A "Favipiravir in Patients with Ebola Virus Disease: Early Results of the JIKI trial inGuinea I CROI Conference". croiconjerence.org. Retrieved 2016-03-17 .32. A Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, et al.(March 2016). "Experimental Treatment with Favipiravir for Ebola Virus Disease (theJIKI Trial): A Historically Controlled, Single -Arm Proofo_f'-Concept Trial in Guinea".PLOS Medicine . 13 (3): e1001967 . doi :10.1371/journal.pmed.1001967 . PMC 4773183 .PMID 26930627.33. A "Japanese flu drug 'clearly effective ' in treating coronavirus, says China". TheGuardian . 2020-03 -18. Retrieved 2020-03-18.34. A NHK World News 'China: Avigan effective in tackling coronavirus'35. A Huax ia. "Fav ipiravi r shows good clin ical efficacy in treating COVI D- 19: officia l."Xinhuanet.com, 17 March 202036. A Cai, Qingxian; Yang, Minghui; Liu, Dongjing; Chen, Jun; Shu, Dan; Xia, Junxia;Liao, Xuejiao; Gu, Yuanbo; Cai, Qiue; Yang, Yang; Shen, Chenguang (2020-03-18)."Experimental Treatment with Favipiravirfor COVID-19 : An Open-Label ControlStudy" . Engineering . doi: 10.1016/j .eng.2020.03 .007. ISSN 2095-8099.37. A Dong, L; Hu, S; Gao, J (2020). "Discovering drugs to treat coronavirus disease 2019(COVJD-19)". Drug Discoveries & Therapeutics. 14 (]): 58-60.doi:10.5582/ddt.2020.01012. PMID 32147628.Hepatitis Cshow• V• t• eRNA virus antivirals (primarily JOS, also SOIAD andD06BB)NS3/4A • AsunaprevirNIH-000300Pico ma virusAnti-influ enzaprotea seinhibitors (previr)NSSAinhibitor s (asvir)NSSBRNApolymeras einhibitor s (-buvir)Combinationdrugs• Bocep revi.-i• Ciluprevir§• Danoprevirt• Faldaprevirt• Glecaprevi r• Grazop revir• Narla previr• Parita previr• Simeprevir• Sovaprevir t• Telaprevirt• Vaniprev ir• V edroprev ir§• Voxilaprevir• Daclatasvir#• Elbasvir• Ledipasvir• Odalasvir t• Ombitasvir• Pibrentasvir• Rav idasvi rt• Ruzasvirt• Samatasv irt• Velpatasvir• Beclabuvirt• Dasabuvir#• Deleobuvir§• Fi libuvir§• GS-662 0§• Setrobuvir§• Sofosbuvir#• Radalbuv ir t• Upr ifosbuvirt• Elbasvir/grazoprevir• Glecaprevir /pibrentasv ir• Ledipasv ir/sofos buvir#• Ombitasvir/paritaprevir /ritonavir#• Sofosbuv ir/daclatasv ir• Sofosbuv ir/velpatasvi~• Sofosbuvir/velpatasvi r/voxilaprev ir• viral enhy:P lecona rilt• Baloxavir marboxilNIH-000301agents • Pimodivir t• Umifenovi r• adamantane derivatives /M2 inhibitors (Adapromine• Amantadine• Rimantadine)• neuraminidase inhibitors/release phase (Ose ltamivir#• Zanamivir• Peramivir, Laninamivirt)Multiple/generaIInterferonMultiple/unknown• #WHO-EM• !Withdrawn from market• Clinical tria ls:o tPhase IIIo §Never to phase III• Interferon alfa 2b• Peginterferon alfa-2a#• Peginterferon alfa-2b#• EICAR§• Fav ipiravir• Galidesivir t• Remdesivirt• Mericitabine t• MK-608§• NITD008§• Moroxydine• Presatovir t• RibaviriI,#• Taribavirin t• Triazavirinshow• V• t• eFiloviridae• Bundibugyo ebolaviruso BDBVEbola virus Species• Reston ebolaviruso RESTVNIH-000302OutbreaksDrugcandidates• Sudan ebolaviruso SUDV• Tai' For est ebolaviruso TAFV• Zaire ebolaviruso EBOV• 1976 Sudan outbreak• 1976 Zai re outbreak• 2013-2016 West African Ebola virus epidemico Timelineo Reported cases and deathso Responseso United Nations Ebola Response Fundo Operation United Assistanceo in Guineao in Liberiao in Mal io in Nigeriao in Sierra Leoneo in Spaino in the USo in the UKo Ouse to Ouse Tocko W omey massacre• 2014 DR Congo outbreak• 2017 DR Congo outbreak• 2018 Equateur, DR Congo outbreak• Kivu Ebola epidemic• BCX4430• Brincidofovir• DZNep• Favipiravir• FGI-103• FGI-104• FGI-106• JK-05• Lamivudine• mAbl 14• TKM-Ebo la(failed)• Triazavirin• ZMappNIH-0003031lf arburgvirusNotablepeoplePopularcultureMiscellaneousSpeciesOutbreaksDrugcandidatesPopularcultureMiscellaneousCueva virus SpeciesDi<tnlovirus Species• 0c ommons• ® Wikispecies• Vaccineso cAd3-ZEBOVo rVSV-ZEBOV• William Close• Jean-Jacq ues Muyemb e-Tamfum• Peter Piot• Selected patientso Ameyo Adadevobo Kent Brantlyo Pauline Cafferkeyo Thomas Eric Duncano Salome Karwaho Sheik Umar Khano Matthew Luk:wiyao Mayinga N'Sekao Patrick Sawyer• The Hot Zone(l 995 book by Richard Preston)• Outbreak(1995 film)• Ebola Syndrome(l 996 film)• Executive Orders(l996 novel)• 93 Days(2016 film)• Ebola virus disease• Ebola vims disease treatment research• Ebola River• Marburg marburgviruso MARVo RAVV• 1967 Marburg virus outbreak in West Germany• 2017 Uganda Marburg virus outbreak• BCX4430• FGI-103• FGI-106• The Hot Zone(l995 book)• Marburg virus disease• Marburg• Lloviu cuevavirus (LLOV)• Mengla virus (MLA V)Retrieved from "https://en.wikipedia.org /w/index .php?title =F avipiravir&oldid =946951 I 89"Catego ries:• Anti-RNA virus drugsNIH-000304• Pyrazines• Carboxamide• Organofluorides• Ebo la• Hydroxyarenes• Experimenta l drughttps://www.theguardian.com/worl d/2020/mar /18/ja pa nese-fl u-drug-clearly-eff ective-i ntreat in g-co ro n a vi ru s-sa ys-ch in aGuardian Newspaper article dated 18 March 2020 regarding Favi piravir = Avigan (which is theBrand Name) with URL https ://www .thegua rd ian .com/world/2020/ma r /18/japanese-flu-d rugclearly-effective-i n-tr eating -coronavi rus-says-ch i naJapanese flu drug 'clearly effective' in treating coronavirus, says ChinaPatient given the medicine in hcn,1.hcn turned negative in a median of four day Photograph:John Minchillo /APMedical authoritie in hina have said a drug u ed in Japan to treat new strain of influenzaappeared to be effective in coronaviru patient , Japane e media aid on Wedne day.Zhang Xinmin an official at hina ' cience and technology mini try, aid favipiravir,developed by a ub idiary of Fujifilm, had produced encouraging outcome in clinical trial mWuhan and henzhen involving 340 patient ."It has a high degree of safety and i clearly effective in treatment ,' Zhang told reporter onTue day.Patient who were given the medicine in Shenzhen turned negative for the viru after a median offour day after becoming po itive, compared with a median of l J day for tho e who were nottreated with the drug public broadcaster HK aid.In addition, X-ray confirmed improvement in lung condition in about 91% of the patient whowere treated with favipiravir, compared to 62% or tho e without the drug.Coronavirus: the week explained - our expert correspondents put a week's worth developmentsin context in one email newsletterFujifilm Toyama hemical which developed the drug - al o known a Avigan - in 2014 , hadeclined to comment on the claim .hare in the firm urged on Wedne day fo llowing Zhang' comment , clo ing the morning up14. 7% at 5,207 yen , having briefly hit their daily limit higb of 5,23 yen.NIH-000305Doctors in Japan are u i.ng the same dmg in clinica l studies on coro.navirus patients with mild tomodera te ymptom , hoping it will prevent the virus from multiplying in patient .But a Japa ne e hea lth mini try ource ugge ted the drug wa not a effective in peop le withmore severe symptoms. "We've given Avigan to 70 to 80 people , but it doesn't seem to workthat well when the virus has already multiplied ," the source told the Mainichi Shimbun.The same limitations had been identified in tudies involving coronaviru patients using acomb ination of the HIV antiretrovira l lopinavir and ritonavi r, the ource added.In 2016 , the Japane e government upp lied favip iravir a an emergency aid to counter the bolaviru outbreak in Guinea .Fav ipiravi r would need government approva l for full- ca le use on ovid- l 9 pat ient , ince it waorig inally intended to treat flu .A health official told the Mainich i the drug cou ld be approved a early a May . "But if the re ultof clinical re earch are delayed , approval could al o be delayed ."https://asia.nikkei.com/ Business/Pharmaceuticals/China-says-Japan-developed-drug-Aviganworks-against -coronavi rus2Nikkei Asian Review article dated 18th March 2020 regarding Favipirav ir = Avigan (which is theBrand Name) with URL https ://asia. ni kkei .com/Busi ness/Pharmaceutica ls/China -says-Japandeve loped-drug- Av iga n-wo r ks-against-corona virus 2China says Japan-developed flu drug works against coronav irus - . Fujifilm Toyoma Chemicaldeveloped fav ipiravir, sold under the brand Avigan.CoronavirusChina says Japan-developed flu drug worksagainst coronavirusFujifilm group member 's Avigan to be recom mended for trea t mentSHIN WATANABE, Nikkei staff writer March 18, 2020 07:50 JSTThe Chinese government has been conducting clinica l research on a treatment for COVID-19.©AP~fi n21DALIAN, China -- An influenza medicine developed by a Fujifilm Holdings group member iseffective against the novel coronavirus, the Chinese government said Tuesday.The government plans to officially recommend the drug's use for treatment. Fujifilm ToyomaChemical developed favipiravir, sold under the brand Avigan."It has a high degree of safety and is clearly effective in treatment," said Zhang Xinmin, directorof the science ministry's China National Center for Biotechnology Development, in a newsconference. Fujifilm Toyoma Chemical developed the drug in 2014, and it has been provided topatients in Japan as treatment for the novel cornooavirus since February.Zhejiang Hisun Pharmaceutical signed a patent-licensing agreement for favipiravir with Fujifilmin 2016. The drugmaker received clearance to produce the drug from Chinese authorities inFebruary and can ramp up output of a generic version.The clinical trial was conducted at hospitals in Wuhan and Shenzhen, with 200 patientsparticipating. Test results for those receiving the drug turned negative in a shorter period, andtheir pneumonia symptoms improved at a higher rate.NIH-000306From:Sent :To:Fauci, Anthony (NIH/N IAID) [ElMon, 23 Mar 2020 14:47:18 +0000Beige!, John (NIH) [ElCc: (b)(6)Subject :Attachment s:FW: IFN trea t ment for COVID-19Manuscript and Supplement .pdfJohn:Please handle thi s.Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892 -2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Young, Howard (NIH/NCI) (E] ---------(b)( > Se nt: Monday, March 23, 2020 9:57 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] ______ (b_H_.; Beigel, John (NIH) [E)(b)( >Cc: Eleanor Fish (b)(6bSubject: IFN treatmen t for COVID-19Dear Ors. Fauci and SeigelRegards,HowardNIH-000307From: Eleanor Fish (b)(6)> -------- Sent : Saturday , March 21, 2020 5:25 PM --------~= To: Young, Howard (NIH/NCI) [E] _______ (b_H_6lSubject: IFN treatment for COVID-19Dear Howard,I wanted to share with your our findings from a clinical studyPlease keep this confidential.The manuscript has been submitted fo r consideration for publication .Eleanor N. Fish, PhD, FAASUHN EmeritaProfessor & Associate ChairInternational Initiatives & CollaborationsDept . Immunology, University of TorontoNIH-000308(b) (4)From:Sent:To:Subject:Please handle.Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [ElMon, 23 Mar 2020 13:40:42 +0000Cassetti, Cristina (NIH/NIAID) [ElFW:National Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (30 496"'4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformat ion. It should not be used by anyone who is not the orig inal intended recip ient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Schur , Peter H.,M.D. ---------(b)(6)>Sent: Monday, March 23, 2020 9:33 AM To: Fauci, Anthony (NIH/NIAID) [E]-- ------------ --(b)=(6) -= Subject:Dear Dr FauciI am look ing for help and informagtion.I am still wo rking fu lltime at Brigham and Women's Hospital (BWH) as a Rheumatologist-althoughwith the pandemic I am currently working from homeI am also the Medical Director of the BWH Clinical Immunology Lab.We are looking for a company that can provide us with kits to assess lgG and lgM antibodiesto COVID-19. Can you, or one of your staff help us find those companiesWhen I was at WRAIR many years ago (b)(6) they had a walk in -70C freezer with(b) (4)NIH-000313(b) (4)Thank you for your help. Applaud what you are doing on TV. Applaud what you are doingfor this pandemicTrust you are wellPeter H Schur MDSenior Physician Brighasm and Women's HospitalProfessor of Medicine Harvard Medical SchoolBoston MATel: 617-732-5350The information in this e-mail is intended only for the person to whom it isaddressed. If you believe this e-mail was sent to you in error and the e-mailcontains patient information , please contact the Partners Compliance HelpLine athttp://www.partners.org /complianceline . If the e-mail was sent to you in errorbut does not contain patient information , please contact the sender and properlydispose of the e-mail.NIH-0003 14From:Sent:To:Subject:Att achment s:Here it isAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/N IAID) [E)Mo n, 23 Mar 2020 13:02:15 +0000Stephen HahnFW: Quick Review: Press Conference Open - March 23Press Conference Open - March 23 - with Fauci edits .do cxNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7 A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (3 96':44li9E-mail: Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the orig inal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-0003 15NIH-0003 16From:Sent :To:(b)(6)Mon, 16 Mar 2020 14:53:22 -0400Adams, Jerome (HHS/OASH);Brett GiroirSubject : Fwd: Revised social distancing documents - word and powerpoint versionsAttachmen ts: US Social Distancing Recommendations - CDC 1151am_3_16_2020 clean.docx,ATT00001.htm, US Social Distancing Recommendations - CDC 1151am_3_16_2020 track changes.docx,ATT00002.htm, Social Distancing vs 316 2020.pptx, ATT00003.htmFYIBegin forwarded me ssage:From: "Schucha t, Anne MD (CDC/OD)" (b)(6)Date: March 16, 2020 at 12:04: 14 -PM- -E-DT- ----- == To: "Birx, Deborah L. EOP/NSC" (bH6J > , "Azar, AlexOS/IO~ " (b) < , "Giroir, Brett (HHS/OASH) "---------(bH6) , "Harrison, Brian (HHS/1OS)" (b)(6) "Fauci , Anthony (NIH/NIAID) [E]' (b)(6) "Kadlec , Robert(OS/ASPR/ 10)" (b)(6)-----::-::-:-= Cc: "Redfield, Robert R. (CDC/OD)" _____ , "McGowan, Robert (Kyle)(CDC/OD/OCS)" (b)( >, "Schucha t, Anne MD (CDC/OD)"______ (b_H6), "Green, Hugh (CDC/OD/OCS)" (b)( >, "Hoo,Elizabeth (CDC/OD/OCS)" (b)(6)Subject: Revised social distancing documents - word and powerpoint versionsOn behalf of Dr Redfield, I am forwarding a revised word document (clean and trackchanges) and a revised powerpoint with two slides.These drafts incorporate feedback that Dr Redfield received from the WHTF as well as theemE.Leine...av.ide.oc e..::bsae..Jh us WE. !b.. a. vP.c..o,.m b ined o[i.oc_adv icP..o.,o. vp_ct;e_r_dav.'.c,;v er,sinn_th a_~(b) (5)Anne Schuchat, MDPrincipal Deputy DirectorCenters for Disease Control and PreventionRear Adm iral, US Public Health Service (Retired)NIH-000484From:Sent :Fauci, Anthony (NIH/NIAID) [E)Sat, 14 Mar 202012:37:15 +0000To: Howard Bauchner;Butler, Jay C. (CDC/DDID/OD);Preeti Malani;EliPerencevich;Phil FontanarosaCc: Edward LivingstonSubject: RE: Testing - JAMA - ImportantHoward/Jay:I liked Jay's answers to Howard's questions even though there were still some open issues.will have to leave it to Jay and the CDC to continue with the discussion since I am reallyswamped. Sorry.Thanks,TonyFrom: Howard Bauchner <Howard.Bauchner@jamanetwork.org>Sent: Saturday, March 14, 2020 7:48 AM ---- :::-c-r,-= To: Butler, Jay C. (CDC/0010/00) (b)(6) ; Fauci, Anthony (NIH/NIAID) [E]-------- (b)(6l; Preeti Malani <pmalani@med.umich.edu>; Eli Perencevich <Eli- perencevich@uiowa.edu>; Phil Fontanarosa <Phil.Fontanarosa@jamanetwork .org>Cc: Edward Livingston <Edward.Livingston@jamanetwork .org>Subject: Re: Testing - JAMA- ImportantThanks JayHave also copied Ed -This is crossing my desk 4-5 times per day now - and will only get more important (and sadly confusing)- in the weeks to come.Some questions would focus on public others on HCW (where I am sure general guide; talk with yourCMO).I do love the mention of monopo ly - ------------- (b)(6)What you t hink?HCBHoward Bauchner, MDEditor in Chief of JAMA and the JAMA NetworkPlease respect the confidentiality of th is emailNIH-000634listen to my chats with authorsFrom: "Butler, Jay C. (CDC/DDID/OO)" ------- (b)(6)> Date: Saturday, March 14, 2020 at 6:42 AMTo: Howard Bauchner <Howard .Bauchner@jamanetwo rk.org>, Tony Fauci--------- CbH6b , Preeti Malan i <pmalani@med.umich.edu>, Eli Perencevich <Eli- perencev ich@uiowa.edu >, Phil Fontanarosa <Phil.Fonta narosa@jamanetwork.o rg>Subject: Re: Testing - JAMA - Important[Warning External Email]Good morning, Howard-some answers and non-answers. As is the case for most answers, themost accurate is "it depends", but I realize that is not helpful in busy clinical settings:No symptoms - get test posit ive - can you workAt this point in the pandemic, no. While we do not know what role asymptomatic infectionmay play in transmission and it is plausible that someone who is NOT coughing and sneezing (orany other respiratory droplet self-generating acts)is going to be less infectious than someonewho is, persons known to be infected should self-isolate. This, of course, is particularlyimportant for someone who has closed contact with someone at greater risk of severe illnessand health care providers .Symptoms - test negative - can you work- or do you need 2 negatives - or the test has to bedone 2-3-4 days after you develop symptomsEven before COVID-19, working while ill with a respiratory illness puts others at risk. Particularlyduring when flu activity is high. Not toughing it out and going into work while sick is moreimportant now than ever and is an important component of social distancing-this is one of thefounda tional ways that we distribute the impact of the pandemic over as long of a period aspossible. (We are all gett ing good a drawing the two pandemic curves in the air on imaginary xandy-axes.). One of the critical areas where we need more data is on when someone who isinfected becomes test -positive. Presumably, test-positivity would correla te wi th viral load inthe respiratory tract and a + would indicate greater likelihood of infectiousness. But the realchallenge of the return-to-work issue lies in your next question:Test posit ive - back to work when -do you need negative tests- or just time - ? 2 weeks afterfirst symptoms, first test positive.Ah, there is the rub-currently, the recommendations vary-CDC has gone with 2 negativeswabs 24 hours apart, but we do not believe that positivity during recovery necessarily provesinfectiousness. This is a crucial question. We are reviewing the available data, examining athow PCR positivity, cycle threshold, and viral culture line up- the goal is to develop good,NIH-000635NIH-000636clinical parameters to justify ending precautions, rather than requiring microbiological tests. AGet Out of Isolation Free card, if you will. The hypothesis we are testing to 2 weeks after onsetand >72 hours without symptoms. Currently the published recommendations are notsatisfying:https ://www.cdc .gov/co ronav i rus/2019 -nCoV / la b/guid eli nes-cli nica 1-speci mens. htm II may have more information on this topic later today.Finally, in all complex epidemics, there is a tendency to search for a silver bullet-that one thingthat will solve all of our problems. When an intervention is in short supply, the bullet turnsplatinum-"if only we could do x, the problem would be solved". This was vaccine in 2009HlNl, naloxone in the opioid crisis, and now testing in coronavirus. Increased access to testingis desperately needed to control the COVID-19 pandemic. However, it is going to take ascientifically and wholistic and systemic approach to mitigate the impact. You have nicelyoutlined some of the "next questions" that are raised when testing is more widely available.More to follow.Best regards,JayGet Outl ook fo r iOSFrom: Howard Bauchner <Howard.Bauchner@jamanetwo rk.org>Sent: Saturday, March 14, 2020 5:53 AMTo: Butler, Jay C. (CDC/DDID/OD); Fauci, Anthony (NIH/NIAID) [E]; Preeti Malani; EliPerencevich; Phil FontanarosaSubject: Testing - JAMA - ImportantJay/TonySome very complicated questions around testing have come up and will only increase.No symptoms - get test positive - can you workSymptoms - test negative - can you work - or do you need 2 negatives - or the test has to be done 2-3-4 days after you develop symptomsTest positive - back to work when - do you need negative tests - or just time - ? 2 weeks after f irstsymptoms, first test positive .As tests become more widely available this wi ll be devil folks.NIH-000637Any ideas who can write about this.Jay - does CDC have specific recommendations.Sorry to bother on Saturday morning -but would like to get up a VP as soon as Tuesday.HCBHoward Bauchner, MDEditor in Chief of JAMA and the JAMA NetworkPlease respect the confidentiality of this emailListen to my chats with authorsFrom:Sent:To:Subject :Fauci, Anthony (NIH/NIAID) [ElSun, 22 Mar 2020 23:06:12 +0000Lerner, Andrea (NIH/NIAID) [ElFW: Antibody Tests and Follow-on Use of 'Survivors'From: Estes, Franklin J {Frank) LTC USARMY3 35 SIG CMD {USA)- ---------- (b)(6) Se nt: Sunday, March 22, 2020 12:30 AM ------~= To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)>Subject: Antibody Tests and Follow-on Use of 'Survivors'Dr. Fauci,I apologize in advance for bugging you but please read and pass along to the appropriate person, ifuseful.In the coming weeks, an antibody test for COVID-19 should be available (I suspect). As 'survivors' areidentified in the general population and are determined to be largely 'immune ' to COVID-19, I think thosepeople should be given the opportunity to administer testing to others in the general population. Theemployment of VOLUNTEER survivors in the administ ration of tests would allow immune individuals toquickly learn how to collect samples and deal with potential infected patients face-to-face without fear ofj eopardizing their own health or the health of the communities in which they live. This would free uphighly trained nurses and doctors from testing and have an exponential benefit as survivors administertests for infection and tests for antibodies and, thus, identify additional survivors. This would supportmore aggressive testing to bring about the eventual end of this virus when we try to identify every lastinfected individual who needs to be quarantined .Note: I understand we haven't yet determined whether survivors can be re-infected. So early volunteersmay be subjected to further sickness. But the rate of re-in fection should be less as a percentage thanthe rate of infection among the general population. And re-infection would likely be less severe.Note2: Creating a VOLUNTARY REIGSTRY of survivors (those wi th sufficient antibodies) may have asecondary benefit to businesses. It would allow businesses to quickly hire employees who could come incontact with the general public (thinking of current food delivery, grocery stores, daycare ... andlater ... teachers, anyone in the medical or dental field, other retail businesses).I do understand my recommendations would generate HIPAA concerns but these are extraordinary timeswhich call for out-of-the-box ideas ... and this would all be voluntary.Thank you for taking a couple of minutes to read this and thank you for managing a very diffic ult crisis.You and others on your team have saved a lot of lives and we are eternally grateful.Respectfully,Frank Estes(b)(6)----- (cell)NIH-000333From:Sent :Fauci, Anthony (NIH/NIAID) [E)Tue, 17 Mar 2020 11:17:11 +0000To: --------------- (b)( USARM EDCOM (USA) Subject : RE: Recommendation(b)(6)Thank you for your note.Best regards,TonyFrom: (b)(6) USAR MEDCOM (USA)Sent : Tuesday, March 17, 2020 6:52 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: RecommendationDr. Fauci,(b)(6)> -----------I am a Nurse Practitioner (b)(6) for the US Army. I have a recommendation as we movethrough this terrible time in the US as well as the world. To preserve the healthcare workforce why notgive 25% of all health workers in the military the trial vaccine? Keep these workers away from patientsuntil which time that the body can build immun ity . Let 's not expose the entire medical workforce to theCOVID-19. The idea is that this 25% can take care of the population (post-vaccine) without worry ofgetting ill and causing further spread of the disease. If there is possibility of the vaccine, trial age cohortsand demographics could play a crucial part in testing . Thank you for all you are doing to protect thehealth of our Nation.Respectfully,(b)(6)NIH-000454From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Fri, 20 Mar 2020 23:47 :21 +0000To: Hahn,S tephenCc: Redfield, Robert R. (CDC/0D);Birx, Deborah L. EOP/NSC;Lane, Cliff (NIH/NIAID } [E];-- ---------------~-~-- (b)( ·Rom, Colin (FDA/OC) Subject: RE: Treatment DocumentSounds good to me.Thanks,TonyFrom: Hahn, Stephen (b)( >Sent: Friday, March 20, 2020 7:36 PM ------~~ To: Fauci, Anthony (NIH/NIAID) (El (b)(6)Cc: Redfield, Robert R. (CDC/OD) (b)(6) Birx, Deborah L. EOP/NSC==========(=b)( =>~; L ane, Cliff (NIH/NIAID). .[E:)- .:.::::=====~~ __________ Cb _H_6); Rom, Colin (FDA/OC) ______ _Subject: Re: Treatment DocumentTony,Looks like (b)(S). The group wants to make some more edits andthen send out this evening for review . We would like to meet up prio r to or after the task force meetingtomorrow. Sound OK?SteveSent from my iPadOn Mar 20, 2020, at 7:06 PM, Hahn, Stephen _____ C>b<_.> wrote :I have a couple of commentsI'll await for other comments.ThanksSteveSent from my iPadNIH-000375(b)(S)On Mar 20, 2020, at 6:45 PM, Fauci, Anthony (NIH/NIAID) [E]-------- (b)(6)> wrote:Team :As per my discussion with Steve a few minutes ago, I have madesome changes in the document. (b)(5J(b)(5) I am ------------------------- attaching a tracked version of the document that was your FINAL aswell as a clean copy with all of the changes accepted. Please take alook and Steve said that he would like to set up a quick call to discussafter you have had a look . I am very sorry to come in with thesechanges at this late point, but I really did not get a chance to have agood look at the document as I was in a car.Than ks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confiden tialand may conta in sensitive informat ion. It should not be used by anyonewho is not the original intended recipient. If you have received this emailin error please inform the sender and delete it from your mailbox orany other storage devices . The National Institute of Allergy andInfectious Diseases (NIAID) shall not accept liability for any statementsmade that are the sender 's own and not expressly made on behalf of theNIAID by one of its representatives.<dblnformation for Clinicians on COVID-19 Therapies31hcl - with Fauci andLane tracked changes showing.doc><><dblnformation for Clinicians on COVID-19 Therapies31hcl - with Fauci andLane tracked Clean copy.docx>NIH-000376From: Fauci, Anthony (NIH/NIAIO) [E)Mon, 23 Mar 2020 12:58:59 +0000Barasch, Kimberly (NIH/NIAID) [ClSent :To:Subject: FW: Respiratory Protection Program: Temporary Suspension of Fit TestingFor my cli nical center Certifi cation folder.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Wu, Sarah (NIH/OD/ORS)[ El ------- (b)(6) Sent : Monday, March 23, 2020 8:56 AM To: Fauci, Anthony (NIH/NIAID) [El-- ----------=---=---=(b)=((;) > Subject: Respiratory Protection Program : Temporary Suspension of Fit TestingRespiratory Protection Program Participants:Due to the recent COVID-19 outbreak and supply chain shortage, we are temporarilysuspending annua l fit tests for emp loyees at th is time. You w ill still be required to comp lete fittesting if:• you have experienced significant physical changes likely to impact the fit of yourrespirator such as:o substantial weight loss/gaino dental surgeryo cosmetic surgery including the neck area and aboveo an accidento a new medical diagnosis• you are direct ly invo lved in the COVID-19 response and are expected to be in closecontact with potentia l COVID-19 patients• you are emergency response personnel (police, fire department, etc.) required to be onsitethroughout this pandemicNIH-000317NIH-000318If you do not meet these criteria, you are not required to complete your fit test at this time.Please be advised that you will still need to complete the online training despite the suspensionof fit testing. Regular fit testing will resume once the COV/0-19 emergency has subsided.Any questions concerning the Health Rx website should be directed towardsupport@healthrx.com . Please visit the manufacturer's websites for details on your particularrespirator model. If you have questions about N95 respirators in general, feel free to emailnihresp irator@ma il.nih.gov. Thank you for your efforts and consideration during this event.From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 23 Mar 2020 12:58:16 +0000Karen BackmanSubject : RE: Your Unprecedented Leadership and ProfessionalismKaren:Many thanks for your kind note .Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31 , Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made t hat are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Karen Backman (b)(6)Sent: Monday, March 23, 2020 8:5-3 -A-M- -- --.~ To: Fauci, Anthony (NIH/NIAID) [E] (bH >Subject : Your Unprecedented Leadership and ProfessionalismGood morning Dr. Fausi,I am not one to write emails to our leaders in government as I am sure that the message doesn't get towhere it always needs to go. At the risk of you possibly seeing this email, you need to know that you aredoing an incredible job .I doubt you will be broadcasting th is note but you should know that my husband and I take greatcomfort in seeing you up on the podium next to our country's leadership on the COVID-19 pandemic.You are a steady voice of reason and the right person for the job. Even when the President doesn't get itquite right , you manage to be professional in your delivery, information and steadfast manner. We caneasily look past the President but we listen when you speak.From the first time I heard you say on a Sunday morning talk show, "If you th ink we are overacting thenwe are probably doing the right things ." I live in Maine and we are a rural state so we probably won'tsee the numbers that are elsewhere but we are listening and acting on your words of caution.NIH-000319NIH-000320I can't imagine how much pressure you are under doing your job but we need more leadership such asyours. How you choose your words so carefully without getting flustered is a gift . I can only hope thatyou will continue to be the voice to get this country through this unprecedented event.Stay healthy and keep doing what you're doing as it matters so much to this nation.Sincerely,Karen L. BackmanFrom:Sent :To:Subj ect :At tachment s:Here it is.Anthony S. Fauci , MDDirectorFauci, Anthony (NIH/NIAIO) [E)Mon, 23 Mar 2020 12:46:08 +0000(b)(6)ConfidentialPress Conference Open - March 23 - with Fauci edits .docxNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-000321From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 23 Mar 2020 12:25:31 +0000info@mail.mlblists.comSubject: RE: Fill the baseball void: Trivia, A-Rod clinic, classic gamesMy work with the Coronavirus Task Force and the large volume of incoming emailsprecludes me or my staff from answering each individual message. I would encourageyou to visit www.coronavirus .gov for the latest information and guidance related toCOVID-19.Thank you, and best regards.Anthony S. Fauci, M.O.Anthony s. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: Cb()6 )FAX: (301 496-4409E-mail. (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-000322From:Sent :To:(b)(6)Mo n, 23 Mar 2020 07:32:09 -0400DMID Word NerdsSubject: Fwd: COVID-19- NOVEL DRUGAttachments : _________ (b_H_4.) 3_17_2020.pdf, ATT000Ol.htmSent from my iPhoneBegin forwa rded message:From: Radka Milanova (b)(6)Date: March 23, 2020 at 1 :43:46 AM ED-T- ------=-=--:= To: "Fauci, Anthony (NIH/NlAID) [E]" --------- (b)(6>f Subject: COVID-19-NOVEL DRUGDear Dr. Antho ny Fauci:NIH-000323(b)(4)(b) (4)I look forward to hearing from you .Kind regards,Radk11 Milanova , PhD.Office: + 604 488 8880Mobile· (b) (6)Email: milanova@,sliaw.caThis message and any auachme111sa re i11te11ded01 1/y for the use of the addressee and may contain information that lsprivileged and confidential. If the reader of the message is nm the intended recip ient or an authorized representative of theintended recipient, you are hereby notified that My dissemination of this comm1micotio11 is s trictly prohibited. If you havereceived this communication in error . please notify us immediately by e-mail and delete the message and any a/tachmentsji·omyour system.NIH-000324(b) (4)NIH-000325From: Fauci, Anthony (NIH/NIAID) [E]Se nt: Mon, 23 Mar 2020 01:37:39 +0000To: David RubensteinSubject: FW: USA Today/David M. Rubenstein-- Coronavirus hero: Anthony Fauci is agreat public servant in a time of great public needDavid:You were so very kind to me in this article . Thank you so much.Warm regards,TonyCoronavirus hero: Anthony Fauci is a greatpublic servant in a time of great public needFauci is the wo rld's leading authority on infectious diseasesand the best person in the country to help us deal with theCOVID-19 crisis.David M. RubensteinOpinion contributorSome viewers of the daily White House coronavirus briefings may wonder why everyone increasinglydefers to a diminut ive, Brooklyn -accented 79-year-old doctor, Tony Fauci.They do because, as I have learned over many years of talking with and more recent ly interviewing thisman, he is without doubt the world's leading authority on infectious diseases. In any area of humanactivity or knowledge, there always seems to be one person who is the global gold standard. In theworld of infectious diseases that person is Tony Fauci.So the American people - indeed, people around the globe - should be grateful that Tony has dug intothis crisis with the same work-around -the-clock, just-the -facts ma'am style that he has usedwhile serving under and working with six U.S. presidents . He is as apolitical as anyone can be. I have noidea if he is registered with any politica l party; I suspect though that he is rabidly Independent. His onlyfocus is getting the facts out, providing the best health care treatment and information possible, andsaving lives.A top expert from AIDS to EbolaTony Fauci joined the National Institutes of Health in 1968, after completing his medical training at WeillCornell Medical Center, and he has led the National Institute of Allergy and Infectious Disease since 1984- 36 years. Hard to believe anyone can run anything that long and still be at the top of his game. ButTony is. During this period , he has dealt with every serious infectious disease challenge - malaria,Among Tony's best known accomplishments, beyond simply running the institute and training dozens ofthe world's top infectious disease professionals, has been helping to discover how HIV leads to AIDSand, later, leading the effort to create (at President George W. Bush's direction) the President'sEmergency Plan for AIDS Relief (PEPFAR), which has transformed the treatment of HIV/AIDS in Africa,and other parts of the developing world. Millions of lives have been saved by this program alone. Morerecently, he has been an architect and powerful advocate of President Donald Trump's plan for endingthe AIDS epidemic in the U.S. through HIV antiretroviral therapy targeted to disease hotspots.In his spare time, Tony has been involved with writing or editing more than 1,100 scholarly articles andseveral textbooks, and, in the process, has become one of the most cited authorities of the entiremedical profession.For these breakthrough activities and his dedicated service (at a government salary) for more than a half